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Abstract 
Neural induction is the process by which a region of ectoderm acquires a neural identity and 
forms the neural plate. A popular explanation for neural induction is the “default model”. This 
proposes that non-neural cells are specified as epidermal by BMP expression and that 
inhibition of this signal at the end of gastrulation is sufficient to induce neural fate. Although 
this model is attractive in its simplicity, accumulating evidence suggests a more complex 
scenario, where neural induction comprises a series of sequential events and multiple signals. 
However the details of this hierarchy are unclear, as are the specific contributions of different 
signalling pathways. 
Using a range of known markers, we first characterised the progression of neural induction. 
The earliest responses occur in competent cells within 3h of exposure to a grafted organizer, 
but 9-12h are required before cells become committed to a neural fate. To identify all 
transcriptional responses to neural induction during this time-course, an RNA-Seq screen was 
conducted. It identified 482 differentially expressed transcriptional regulators. After verifying 
the expression of 166, we confirm that the screen accurately predicts events that occur in the 
normal embryo during neural induction. Distinct markers define the specification of key states 
before cells adopt neural commitment. Furthermore, transitions between these states are 
probably regulated by multiple layers of transcriptional repression and activation. Therefore 
neural induction must occur as a cascade of molecular events. 
We also demonstrate that FGF signalling makes a major contribution to the onset of neural 
induction by inducing transcription factors and chromatin modifiers. These are normally 
expressed in the pre-streak embryo, providing further evidence that neural induction begins 
before gastrulation. This pre-neural state is transcriptionally similar to the neural plate border 
but is also heavily associated with pluripotency -perhaps suggesting that FGFs function to 
induce a multipotent “pre-neural/pre-border” state. 
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Chapter 1:  Introduction 
1.1 Early embryonic development in chick  
Chicken eggs are laid 20h post fertilisation when the blastoderm already consists of 20,000 
cells generated after rounds of meroblastic, equatorial and vertical cleavage (Arendt and 
Nubler-Jung, 1999, Stern, 2004a). At these early stages, embryonic development is described 
according to the system defined by Eyal-Giladi and Kochav (EGK) using roman numerals 
between I-XIV (Eyal-Giladi and Kochav, 1976). Upon laying, the embryo is already at around 
EGKIX-X and can be divided into two domains: the area opaca, an outer ring of cells whose 
edges are attached to the vitelline membrane and within this, the area pellucida (Eyal-Giladi 
and Kochav, 1976). The epiblast, a single cell thick epithelium, is continuous across both 
regions and several layers of opaque yolky cells underlie the epiblast of the area opaca 
(Bancroft and Bellairs, 1974, Bellairs et al., 1975). In contrast, the area pellucida is more 
translucent, although initially (at EGK IX-X) it too is populated sparsely by islands of yolky cells 
(Eyal-Giladi and Kochav, 1976, Kochav et al., 1980, Fabian and Eyal-Giladi, 1981, Eyal-Giladi, 
1984). The marginal zone marks the boundary between the area pellucida and area opaca 
(Stern and Ireland, 1981, Stern, 1990). Koller’s sickle, a crescent-shaped ridge of cells, projects 
ventrally from the epiblast and marks the posterior border between the area pellucida and 
marginal zone (Koller, 1882, Callebaut and Van Nueten, 1994). 
After further incubation, dramatic cellular and tissue rearrangements take place. First, the 
sparse yolky cells of the area pellucida fuse in a wave starting posteriorly. This forms a 
continuous layer called the hypoblast (Vakaet, 1970, Stern, 1990) which is equivalent to the 
mouse anterior visceral endoderm (AVE) (Bachvarova et al., 1998, Foley et al., 2000, 
Bertocchini and Stern, 2002). At EGKXII the hypoblast has only made a layer over the posterior 
half the area pellucida, but by EGKXIII this is almost complete anteriorly such that the area 
pellucida is now two-layered (Eyal-Giladi and Kochav, 1976, Kochav et al., 1980). Following 
this, the hypoblast starts to become displaced anteriorly by the endoblast which forms from 
the posterior germ wall, a layer of yolky cells firmly attached to the area opaca epiblast (Stern, 
1990). However, neither the hypoblast nor endoblast contributes to the embryo proper; later 
they only contribute to the yolk sac (Rosenquist, 1972, Lawson and Pedersen, 1987). At 
EGKXIV, a thickening referred to as the “posterior bridge”, projects behind Koller’s sickle and 
the primitive streak forms shortly thereafter (Stern, 2004a). 
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1.2 Gastrulation in chick 
Gastrulation, which generates the three germ layers, (ectoderm, mesoderm and endoderm) is 
characterised by the formation and elongation of the primitive streak. Once this begins, chick 
embryonic development is described using Arabic numerals, according to the scheme devised 
by Hamburger and Hamilton (HH) (Hamburger and Hamilton, 1951). Fate mapping experiments 
demonstrate that the streak forms from Koller’s sickle and a population of cells local to the site 
of streak formation (Bachvarova et al., 1998, Wei and Mikawa, 2000) but also incorporates 
cells that ingress from the epiblast over a wide area (Stern and Canning, 1990, Voiculescu et 
al., 2014). It starts at HH2 as a triangular structure at the posterior edge of the area pellucida, 
between the epiblast and endoblast. The streak then lengthens to form a distinctive rod of 
mesenchymal cells which defines HH3 (Hamburger and Hamilton, 1951, Eyal-Giladi and 
Kochav, 1976, Kochav et al., 1980). Recently the large scale tissue movements that occur 
during streak formation have been shown to result from local cell interactions (Voiculescu et 
al., 2014). Epiblast cells fated to form the streak, first intercalate along the prospective midline 
to extend into the centre of the embryo. Starting posteriorly, cells behind the extending tip of 
the prospective streak undergo epithelial-mesenchymal transition and then ingress between 
the epiblast and hypoblast to form streak mesenchyme. Together these two processes can 
account for the characteristic “polonaise” movements that occur in the epiblast either side of 
the forming streak (Voiculescu et al., 2007, Voiculescu et al., 2014). 
At HH3+, the primitive groove develops longitudinally in the epiblast layer of the primitive 
streak, through which streak mesenchyme migrates laterally to form the lateral plate 
mesoderm (Vakaet, 1970). Now, the epiblast of the anterior area pellucida which will later give 
rise to neural tissue is referred to as the “prospective neural plate” (Rudnick, 1935, Spratt, 
1952, Rosenquist, 1981). However, some of these epiblast cells actually migrate through the 
primitive streak to form mesoderm and endoderm between HH3+ and HH4+ (Bellairs, 1953a, 
Bellairs, 1953b, Bellairs, 1957, Vakaet, 1962, Nicolet, 1967, Selleck and Stern, 1991, 
Schoenwolf et al., 1992, Psychoyos and Stern, 1996a, Joubin and Stern, 1999, Kimura et al., 
2006). At HH4, Hensen’s node forms from all three tissue layers as a swelling at the tip of the 
primitive streak (Hensen, 1876) and the neural plate proper arises as a thickening of epiblast 
cells surrounding the node (Bancroft and Bellairs, 1975). The head process emerges anteriorly 
from the node at HH4+ (Spratt, 1947, Bellairs, 1953b), to form the prechordal mesendoderm 
(Seifert et al., 1993, Foley et al., 1997, Joubin and Stern, 1999). Gastrulation is complete by 
HH5 when ingression movements through the streak have ended (Vakaet, 1962, Selleck and 
Stern, 1991, Schoenwolf et al., 1992, Joubin and Stern, 1999). From HH5, the embryo and 
neural plate lengthen posteriorly as Hensen’s node regresses (Spratt, 1947) and starting at 
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HH7, somites bud off sequentially in a rostro-caudal manner from the presomitic mesoderm 
either side of the midline (Keynes and Stern, 1988). The neural folds at the lateral edges of the 
neural plate start to elevate and fuse dorsally by HH9, a process that extends progressively 
down the dorsal midline to form a neural tube (Schoenwolf and Smith, 1990). 
 
1.3 The organizer and neural induction 
During gastrulation in chick the neural plate proper arises as an ectodermal thickening around 
Hensen’s node at HH4, by a process known as neural induction. Embryonic induction was 
defined by Gurdon as “... an interaction between one (inducing) tissue and another 
(responding) tissue, as a result of which the responding tissue undergoes a change in its 
direction of differentiation” (Gurdon, 1987). Therefore, embryonic neural induction refers the 
process by which ectodermal cells acquire a neural fate in response to neuralising signals, and 
form the neural plate rather than give rise to other structures such as epidermis or mesoderm 
(Stern, 2004a). 
In 1924, the ground-breaking experiments of Spemann and Mangold demonstrated that 
transplanting the dorsal lip of the amphibian blastopore to the ventral side of a gastrula stage 
host embryo, generates a secondary axis (Spemann and Mangold, 1924). By using inter-species 
grafts between three species of newt with different pigmentation, they showed that these 
axes include almost the entire early central nervous system derived from the host. In contrast 
the graft differentiated into mesodermal derivatives and contributed some cells to the induced 
floor plate (Spemann, 1921, Spemann and Mangold, 1924, Gimlich and Cooke, 1983). 
Therefore, when transplanted into a region fated to become epidermis, the dorsal blastopore 
lip has the ability to induce a secondary neural axis. It was the first demonstration that 
instructive signals from the dorsal lip of the blastopore, now famously known as the 
Spemann’s Organizer, are capable of neural induction.  
Subsequently, equivalent regions were discovered in all other classes of vertebrates. Hensen’s 
node (Hensen, 1876), at the tip of the primitive streak, is the functional equivalent in birds and 
mammals (Waddington, 1932, Waddington, 1933, Waddington, 1936, Waddington, 1937, 
Beddington, 1994). In teleosts it is known as the embryonic shield; a thickening at the dorsal 
edge of the embryo during the formation of the germ ring (Luther, 1935, Oppenheimer, 1936b, 
Shih and Fraser, 1996). Inter-specific grafts (even across vertebrate classes) can also induce 
secondary axes, suggesting that the mechanisms of neural induction are conserved 
(Waddington, 1934, Oppenheimer, 1936a, Kintner and Dodd, 1991, Blum et al., 1992, Hatta 
and Takahashi, 1996). 
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1.4 The search for neural inducing signals 
After the organizer’s ability to induce a nervous system was demonstrated (Spemann and 
Mangold, 1924), began the search for the responsible inductive signals. For more than six 
decades, embryos and ectodermal explants were exposed to a wide variety of substances 
including: dead organizers boiled in alcohol, methylene blue, high and low pH, guinea pig bone 
marrow, blue jay liver, sterols, fatty acids, grains of sand, steroids and protein extracts. This 
search failed to identify any specific neural inducing signals as all substances were able to 
neuralise embryonic ectoderm as effectively as an organizer graft (reviewed in (Nakamura and 
Toivonen, 1978)). Eventually it was realised that newt ectoderm, which was frequently used, 
could be neuralised in the absence of an inducer just by culturing animal caps in inadequate 
saline, suggesting that newt tissue was unsuitable for these experiments (Barth, 1941, 
Holtfreter, 1944). 
It wasn’t until the mid-90s that several, apparently unrelated, observations started to shed 
light on the molecular basis of neural induction. First, in Xenopus, which is more resistant to 
neuralisation than newt, it was observed that neural tissue can be induced merely by transient 
cell disaggregation of gastrula stage animal caps (Born et al., 1989, Godsave and Slack, 1989, 
Grunz and Tacke, 1989, Sato and Sargent, 1989). With the onset of the molecular era came the 
finding that inhibition of “Activin” signalling by injection of a dominant-negative Activin 
receptor (XAR1, now known as Activin Receptor Type 2B), also generates neural tissue in 
isolated animal caps (Hemmati-Brivanlou and Melton, 1992, Hemmati-Brivanlou et al., 1992, 
Hemmati-Brivanlou and Melton, 1994). Then, three genes which encode proteins with neural 
inducing ability were isolated from the organizer; Noggin (Smith and Harland, 1992, Lamb et 
al., 1993, Smith et al., 1993), Follistatin (Hemmati-Brivanlou et al., 1994) and Chordin (Sasai et 
al., 1994, Sasai et al., 1995). Although a specific function linking these observations was not 
clear, it was suggested that neuralisation might occur by the removal of an inhibitory 
substance in each assay, rather than by an instructive signal (Hemmati-Brivanlou and Melton, 
1994). 
Several other findings began to reinforce the idea of a permissive signal. At around the same 
time, misexpression of BMP4 -a member of the TGFβ superfamily, was found to severely 
ventralise Xenopus embryos (Dale et al., 1992, Jones et al., 1992) by inducing epidermis at the 
expense of neural fated tissue (Hawley et al., 1995, Wilson and Hemmati-Brivanlou, 1995). 
Then, Noggin, Chordin and Follistatin, which have the opposite dorsalising and neuralising 
effect, were found to antagonise BMP signalling by binding to BMPs such as BMP4 (Piccolo et 
al., 1996, Zimmerman et al., 1996, Fainsod et al., 1997). Furthermore, the dominant-negative 
Activin receptor XAR1 was found to inhibit both TGFβ and BMP pathways (Hemmati-Brivanlou 
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and Melton, 1992). Together these findings hinted that neural induction might involve the 
inhibition of BMP signalling. 
 
1.5 BMPs, BMP antagonism and the “default model” 
These observations were finally reconciled by the “default model” of neural induction 
(Hemmati-Brivanlou and Melton, 1997), which suggested that ectodermal cells will 
autonomously acquire a neural fate in the absence of signals. However, in vivo, BMP4 is 
expressed throughout the ectoderm where it potently inhibits the formation of the neural 
plate and instead specifies cells to become epidermis (Fainsod et al., 1994). The model implies 
that the secretion of BMP antagonists from the organizer overcomes this inhibition to 
effectively create a “default” neural state (Hemmati-Brivanlou and Melton, 1997). In 
agreement with this, BMP4 transcripts are initially expressed throughout the ectoderm before 
gastrulation and clear from the neural plate as it forms (Fainsod et al., 1994).  
Consistent with the “default” model’s predictions, animal caps from embryos injected with 
mRNA for BMP pathway targets MSX1 (Suzuki et al., 1997b), SMAD1 (Wilson et al., 1997) or 
SMAD5 (Suzuki et al., 1997a) cannot be neuralised by dissociation, leading to the suggestion 
that dissociation causes neuralisation by diluting away BMPs present in the animal hemisphere 
(Munoz-Sanjuan and Brivanlou, 2002). Conversely, inhibition of BMP signalling by expression 
of dominant-negative BMP receptors (Hemmati-Brivanlou and Melton, 1994), non-cleavable 
forms of BMP4 or BMP7 (Hawley et al., 1995), or antisense BMP RNA (Sasai et al., 1995) can 
neuralise animal caps without dissociation. It seemed that finally a molecular mechanism 
existed to describe neural induction, more than 70 years after Spemann and Mangold first 
discovered the organizer. 
Since then, homologues for Noggin (Valenzuela et al., 1995, Tonegawa and Takahashi, 1998, 
Furthauer et al., 1999), Chordin (Schulte-Merker et al., 1997, Pappano et al., 1998, Streit et al., 
1998) and Follistatin (Albano et al., 1994, Connolly et al., 1995, Bauer et al., 1998) have been 
identified in chick, mouse, zebrafish and many other organisms. The importance of 
endogenous BMP antagonists is further reinforced by the discovery of various other secreted 
factors that inhibit the BMP pathway. Several are also expressed in or around the organizer in 
a number of organisms, including Cerberus (Bouwmeester et al., 1996, Belo et al., 1997), 
Caronte (Rodriguez Esteban et al., 1999, Yokouchi et al., 1999), Dante (Pearce et al., 1999) and 
Xnr3 (Smith et al., 1995, Hansen et al., 1997). A comprehensive summary of secreted BMP 
inhibitors, their expression and targets can be found in (Ozair et al., 2013). 
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Other evidence for the evolutionary conservation of BMP antagonists in neural versus 
epidermal fate decisions come from studies of Drosophila Chordin homologue; short 
gastrulation (SOG) (Francois et al., 1994, Francois and Bier, 1995), which was identified from a 
screen for genes involved in dorsoventral patterning (Zusman et al., 1988). Even in the 
Protostome clade, where dorsal territories give rise to epidermis and ventral territories form 
neuroectoderm (the reversal of blastopore fate, from mouth in Protostomes to anus in 
Deuterostomes, caused a reversal of the oral/aboral axis and consequently also of 
dorsoventral orientation (Geoffroy Saint-Hilaire, 1822)), the separation of these fates still 
requires BMP inhibition (De Robertis and Sasai, 1996). Here, ventral SOG promotes neural fate 
by directly antagonising dorsal Decapentaplegic (DPP) (Holley et al., 1995, Biehs et al., 1996), a 
BMP4 homologue (Padgett et al., 1993), which generates a dorsoventral gradient of DPP 
activity (Ferguson and Anderson, 1992, Wharton et al., 1993, Ashe and Levine, 1999) which is 
lowest ventrally in the future neural domain. The similarities between these proteins is further 
demonstrated by the promotion of dorsal and neural structures by SOG mRNA in Xenopus 
(Holley et al., 1995, Schmidt et al., 1995) and ventral structures by Chordin mRNA in 
Drosophila  or DPP in Xenopus (Holley et al., 1995). Furthermore vertebrate BMP ligands can 
replace DPP in null mutants (Padgett et al., 1993), confirming the conservation function of 
these proteins (De Robertis and Sasai, 1996, Ferguson, 1996). 
Arthropods such as spiders (Akiyama-Oda and Oda, 2006) and beetles (van der Zee et al., 
2006) also rely on SOG to ventralise their ectoderm. Inhibition of HrBMPb -a BMP2/4 
homologue, is required for the formation of anterior neural fate in Halocynthia so it appears to 
function as a neural inhibitor (Miya et al., 1997), however BMP inhibition is not the neural 
inducer in Ciona, another urochordate (Bertrand et al., 2003). Another exception is Acorn 
worms (hemichordates), where BMP misexpression does not inhibit neural markers and BMP 
inhibition does not promote neuralisation, although the ectoderm of this species does not 
normally segregate into distinct neural and epidermal domains (Lowe et al., 2006). 
Together, this body of literature strongly suggests that BMP inhibition is required for neural 
fate specification across a wide range of metazoans. But is it sufficient? 
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1.6 Challenging the “default model”; is BMP inhibition sufficient for 
neural induction? 
The “default model” implies two things; that neural induction occurs during gastrulation and 
that a single stimulus; BMP inhibition by endogenous BMP antagonists in the organizer, is 
sufficient to induce neural fate. Despite considerable evidence supporting the role of BMP 
antagonists in neural induction the “default model” has been challenged by a number of 
observations. 
In chick, neither Noggin or Follistatin are expressed in the organizer when the neural plate 
forms; Follistatin is expressed at HH4 in a ring around Hensen’s node (Levin, 1998) while 
Noggin is first expressed in the head process at HH4+/5, and later in the notochord (Streit and 
Stern, 1999a). They are similarly absent from the embryonic shield in zebrafish (Bauer et al., 
1998). Chordin is expressed in Hensen’s node at HH3 (Streit et al., 1998) so it could contribute 
to neural induction, but it alone is unlikely to function as the “neural inducer” because its 
expression continues beyond HH4 when the node has lost its neural inducing ability (Dias and 
Schoenwolf, 1990, Storey et al., 1992). Furthermore, BMP4 (Streit et al., 1998) and the BMP 
signalling component phospho-SMAD1 (Faure et al., 2002), are already absent from the 
epiblast at HH2-3; before Hensen’s node arises and later they are only expressed in the neural 
plate border at HH4+ (Streit et al., 1998, Faure et al., 2002). As the “default model” (Hemmati-
Brivanlou and Melton, 1997) implies that BMP antagonists present in the organizer are 
sufficient to inhibit BMP expression in the ectoderm during gastrulation, these BMPs and 
antagonists are not expressed in the appropriate tissues or at the appropriate stages in chick 
to fit with this model. 
Loss- and gain-of-function experiments also do not produce the expected results in chick. 
Misexpression of Chordin or Noggin in competent epiblast (see Chapter 1.10) is not sufficient 
to induce an ectopic neural plate or the neural markers SOX3 or SOX2 in cells that can respond 
to signals from a grafted organizer (Streit et al., 1998, Streit and Stern, 1999g). Even a 
combination of several potent BMP inhibitors (SMAD6, dominant-negative BMP receptor, 
Noggin and Chordin) to inhibit BMP signalling as strongly as possible, is still unable to induce 
SOX2 expression (Linker and Stern, 2004). In addition, misexpression of BMP4 or BMP7 in the 
epiblast at EGKXIII or prospective neural plate at HH3+ has no effect on the expression of SOX3 
by HH5, but it can inhibit the expression of SOX2, a later neural marker (Streit et al., 1998, 
Linker and Stern, 2004). However, although it cannot induce SOX3, Chordin can maintain its 
expression after it has been induced by 5h of signals from an organizer graft (Streit et al., 
1998). Together, these results suggest that BMP inhibition is not sufficient for neural induction 
and that BMP signalling can only prevent expression of late but not early neural markers. The 
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interpretation of this is that other signals are required before BMP inhibition, which is only 
required as a later step, perhaps to maintain markers that have already been induced.  
In agreement with this suggestion, zebrafish and mouse mutants are not grossly affected by 
the absence of BMP antagonism. Although ventralised, zebrafish chordino mutants still form a 
slightly smaller neural plate and a relatively normal nervous system (Kishimoto et al., 1997, 
Schulte-Merker et al., 1997, Bauer et al., 1998). In mouse, Noggin (Brunet et al., 1998, 
McMahon et al., 1998) or Cerberus (Belo et al., 2000) mutants still form a neural plate, BMP2 
(Zhang and Bradley, 1996) and BMP7 (Dudley et al., 1995) mutants do not display an early 
epidermal phenotype while BMP4 (Winnier et al., 1995) mutants die of more generalised 
developmental defects. More severe defects are observed in Noggin/Chordin double mutants, 
but these still form a distinct neural plate (Bachiller et al., 2000). Therefore, loss of one or two 
BMPs or BMP antagonists does not significantly affect epidermal versus neural cell choices. 
Severe loss of neural tissue is only observed in Xenopus (Khokha et al., 2005) and zebrafish 
(Dal-Pra et al., 2006) Chordin/Noggin/Follistatin triple morphants, and almost complete loss of 
epidermal differentiation in Xenopus BMP2/4/7 triple morphants (Reversade et al., 2005). 
However, these embryos also display severe phenotypes that could be caused by the abolition 
of dorsoventral patterning (reviewed in (De Robertis and Kuroda, 2004)). The considerable 
redundancy between the large number of BMPs and BMP antagonists and their requirement 
for multiple functions at different times during embryonic development makes it difficult to 
dissect their specific contribution to neural induction by these loss-of-function approaches.  
 
1.7 Other signals are required for neural induction 
BMP inhibition is certainly important for neural induction, but further questions about its 
sufficiency have arisen from experiments considering other signalling pathways. There is 
increasing support for contributions from FGF, IGF, WNT, Retinoic acid, Calcium, Notch and 
Hedgehog signals in neural induction. The evidence for these either individually, in 
combination with BMP inhibition or each other is summarised in the following sections. 
 
1.7.1 FGF signals 
The default model implies that BMP inhibition is sufficient for ectodermal cells to acquire a 
neural fate. Therefore much controversy surrounded observations that FGF signals might also 
be required for neural induction. The earliest suggestion that FGF signals are required for 
neural induction in Xenopus included the finding that neural induction was blocked in embryos 
treated with suramin, a chemical that inhibits ligand binding to tyrosine kinase receptors 
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including FGF/FGFRs (Grunz, 1992). However other evidence from Xenopus suggested that FGF 
signals did not contribute to neural induction. Inhibition of FGF signalling using a dominant 
negative FGFR1 receptor (ΔXFD) in Xenopus embryos or explants demonstrated that it is 
required for mesoderm formation but that neural structures still form (Amaya et al., 1991, Cox 
and Hemmati-Brivanlou, 1995, Lamb and Harland, 1995, Kroll and Amaya, 1996, Holowacz and 
Sokol, 1999, Ishimura et al., 2000, Ribisi et al., 2000, Pownall et al., 2003) (Kengaku and 
Okamoto, 1993, Godsave and Durston, 1997). However neural structures were often 
disorganized and lacking posterior markers in these experiments. In some cases anterior 
markers were still expressed (Ribisi et al., 2000), leading to the suggestion that FGFS are not 
required for neural induction, but only for the formation and patterning of posterior neural 
tissue. 
Other studies came to different conclusions. Young animal caps were induced to express 
anterior neural markers when treated with FGFs or co-cultured with FGF expressing tissues 
(notochord and somites), a response which was blocked by the introduction of ΔXFD into 
animal caps (Barnett et al., 1998). Expression of ΔXFD in whole embryos or animal caps was 
also shown to prevent neural induction by Noggin (Launay et al., 1996), and a greater 
proportion of embryos demonstrated anterior defects when dorso-animal blastomeres were 
targeted, compared to dorso-vegetal blastomeres. These anterior-deficient embryos 
demonstrated loss of NCAM staining and only very small neural structures, suggesting FGFs are 
important anteriorly as well as posteriorly (Launay et al., 1996). In animal caps, co-injection of 
Noggin RNA was unable to rescue NCAM expression when cells expressed ΔXFD (Launay et al., 
1996). Similarly, Chordin is unable to induce neural tissue in animal caps where FGF signalling 
is inhibited (Sasai et al., 1996). ΔXFD also inhibited neural induction in animal caps cultured 
with grafts of Spemann’s organizer or Hensen’s node, suggesting FGF secretion by both 
organizers is necessary for neural induction in Xenopus (Launay et al., 1996).  
A possible explanation for some of the discrepancies regarding the contributions of FGF in 
Xenopus might arise from different contributions of FGF receptors during development. FGF8 
overexpression in Xenopus embryos causes the formation of ectopic neurons in the absence of 
mesoderm, an effect that can only be blocked efficiently by expression of ΔFGFR4 rather than 
ΔFGFR1 (Hardcastle et al., 2000). Similarly, dominant negative FGFR4 constructs are more 
effective than ΔXFD (which lacks the intracellular tyrosine kinase domain of FGFR1) at 
inhibiting neural induction in the embryo, but also the expression of anterior and posterior 
markers in animal caps co-cultured with organizer cells, or animal caps subjected to prolonged 
dissociation (Hongo et al., 1999).These observations suggest that FGF signalling via FGFR4 is 
required for neural induction and that previous experiments relying on ΔXFD, may not have 
10 
 
blocked the FGF signals specific for neural induction effectively enough. Furthermore, FGFR1 is 
only expressed at low levels between stages 10-15 in Xenopus, compared to FGFR4 which is 
expressed at much higher levels (Hongo et al., 1999). In fact FGFR1 is associated more closely 
with mesoderm formation and caudalisation which may account for the varying responses 
observed and the stronger effect of ΔXFD on posterior rather than anterior structures 
(Umbhauer et al., 2000).  
Indeed when Xenopus embryos are treated with SU5402, a broad FGF receptor chemical 
inhibitor, neural induction is blocked in a dose-dependent manner (Delaune et al., 2005). The 
most severely affected embryos do not express the neural plate marker SOX2 and only form 
epidermis, cement gland and endodermal tissues. This tissue loss is not due to cell death, 
suggesting that broad FGF inhibition promotes epidermis formation at the expense of neural 
and mesodermal tissues (Delaune et al., 2005). 
Evidence for FGF signalling in neural induction also comes from other organisms. In ascidians 
such as Ciona or Halocynthia, FGFs are responsible for neural induction (Inazawa et al., 1998, 
Hudson and Lemaire, 2001, Kim and Nishida, 2001, Bertrand et al., 2003, Hudson et al., 2003), 
whereas BMPs and BMP antagonists contribute to neural patterning and differentiation 
(Darras and Nishida, 2001). This suggests an ancient role for FGFs in neural induction.  
However, some of the most widely accepted evidence for FGFs in vertebrate neural induction 
comes from experiments in chick. Early work involving beads grafted into the prospective 
neural plate showed that FGF signals could induce ectopic neural axes from epiblast, without 
induction of mesodermal markers such as Brachyury (Rodriguez-Gallardo et al., 1997, Alvarez 
et al., 1998). These axes expressed markers of anterior-posterior neural tube patterning 
including HOXB9, KROX20 and OTX2. Although this might indicate sufficiency of FGFs for neural 
induction, beads were grafted in close proximity to the embryo so these structures might form 
through the recruitment of cells already fated to contribute to the neural plate. 
Other studies have taken advantage of the extra-embryonic epiblast of the area opaca. The 
inner third of the area opaca can respond to neuralising signals from a node graft (see Chapter 
1.10), but does not contribute to the embryo proper (Gallera and Ivanov, 1964, Storey et al., 
1992, Streit et al., 1995). In this way the assay avoids recruitment of pre-specified cells from 
the embryo’s own neural plate. Here, grafted beads soaked in FGFs were shown to induce 
neural markers including SAX1 and CASH4, but not anterior markers EN-2 or KROX20 (Storey et 
al., 1998). Therefore FGFs tend to induce posterior markers; however this is accompanied by 
Brachyury expression, suggesting that the effect of FGFs may be indirect. 
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Other studies in the extra-embryonic epiblast reveal that BMP inhibition is insufficient to 
induce neural markers. Instead the epiblast can only respond to BMP inhibition after receiving 
5h of signals from Hensen’s node -at this point, Chordin can maintain the otherwise transient 
induction of SOX3 (Streit et al., 1998). This suggests that other organizer signals are necessary 
for neural induction before BMP inhibition. This observation became the basis of a differential 
screen to identify genes induced within 5h of signals from a grafted node (see Chapter 1.11). 
Of the ten genes induced by a node graft, the earliest responses; ERNI, SOX3  (Streit et al., 
2000) and Calfacilitin (Papanayotou et al., 2013) can all be induced within 5h of signals from 
Hensen’s node or a bead soaked in FGF8 (in the absence of mesoderm). Several other genes 
identified by the screen, namely Churchill (Sheng et al., 2003), UBII (Gibson et al., 2011), 
Asterix and Obelix (Pinho et al., 2011), are induced slightly later but also in response to FGFs. 
These findings suggest that FGFs rather than BMP inhibitors are sufficient to induce some of 
the earliest neural responses. However, they are insufficient to induce a neural plate or the 
definitive neural marker SOX2, suggesting that other signals are also required for neural 
induction (Streit and Stern, 1999a, Streit et al., 2000, Linker and Stern, 2004, Linker et al., 
2009). 
Strikingly, the earliest known FGF-induced responses to neural induction (ERNI, SOX3 and 
Calfacilitin) are first expressed throughout the epiblast at EGKXII-XIII (Streit et al., 2000, 
Papanayotou et al., 2013). At these stages, Hensen’s node has not yet formed and the BMP 
antagonists Noggin (Streit and Stern, 1999a) and Follistatin (Levin, 1998) are not expressed. 
Chordin is detected, but only weakly in Koller’s sickle (Streit et al., 1998, Wilson et al., 2000), 
whereas FGFs are more appropriately expressed in the hypoblast underlying the epiblast 
(Streit et al., 2000) to induce early markers (see also Chapter 1.14). 
Similar suggestions were made based on experiments using cultured ectodermal chick 
explants. Epiblast tissue taken from the centre of the area pellucida at EGKVIII, expresses the 
BMP target genes MSX1 and MSX2 after 40h of culture (Wilson et al., 2000). When explants 
are taken later from EGKXII embryos (but still before gastrulation), they do not express MSX 
genes, suggesting that BMPs are expressed very early but are already downregulated by 
EGKXII. Only these later explants go on to express neural markers including SOX2, SOX3, PAX6 
and OTX2 (Wilson et al., 2000), but this is prevented when FGF signalling is blocked using 
SU5402 and instead explants express epidermal markers. In fact, FGF signalling inhibits the 
transcription of BMP4 and BMP7 -providing further evidence that FGF signals are required for 
neural induction before gastrulation (Wilson et al., 2000). 
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1.7.2 IGFs, the MAPK pathway and FGFs as BMP inhibitors  
Although FGFS are now considered an important neuralising signal in chick and amphibians, it 
was initially disputed how their contributions might fit within the “default model”. One 
suggestion came from observations that IGFs were also important for neural induction in 
Xenopus. Misexpression of IGF or IGFBP5 in ectodermal explants induces anterior neural 
markers in the absence of mesoderm, while knockdown of IGF inhibits neural induction by 
Chordin (Pera et al., 2001). Since IGF, FGF, EGF and HGF ligands signal through tyrosine kinase 
receptors to commonly activate the MAPK pathway, the involvement of this pathway in neural 
induction was studied further. Earlier work showed that MAPK pathway activation by EGFs or 
HGFs leads to Serine-phosphorylation of the SMAD1-linker domain at four sites that contain 
the PXSP amino-sequence (Kretzschmar et al., 1997a, Kretzschmar et al., 1999). This 
modification prevents nuclear translocation, unlike BMP signalling which phosphorylates the 
carboxy- terminus of SMAD1 (Kretzschmar et al., 1997d) to activate nuclear translocation and 
target gene expression. Mutations in these PXSP sites or treatment with a MEK inhibitor 
renders SMAD1 insensitive to MAPK activity, and the latter can be rescued by recombinant 
phosphorylated ERK (Kretzschmar et al., 1997a, Kretzschmar et al., 1999). In this way, the 
effects of IGFs and FGFs but also EGFs and HGFs can be incorporated into the default model 
based on their ability to inhibit BMP signalling via SMAD1 (Pera et al., 2003).  
The finding that FGFs can antagonise BMP via SMAD1 might explain observations that FGF 
mediated downregulation of BMPs between EGKVIII and XII, causes chick epiblast explants to 
switch from an epidermal to neural cell fate (Wilson et al., 2000). However, the integration of 
FGF signalling with BMP inhibition cannot account for all responses during neural induction. A 
mouse line carrying mutations that prevent phosphorylation of the SMAD1-linker region, 
displays only mild phenotypes and no gross nervous system defects (Aubin et al., 2004). This 
contrasts with the finding that expression of a linker-mutated SMAD1 in Xenopus results in a 
severely ventralised phenotype, although it is possible that SMAD5/8 may compensate in the 
mouse mutant (Pera et al., 2003). Furthermore, BMP inhibition is not sufficient to rescue 
neural induction when FGF signalling is inhibited, suggesting a role for SMAD1-independent 
FGF signalling (Delaune et al., 2005). This is also consistent with earlier findings that neither 
Chordin (Sasai et al., 1996) nor Noggin (Launay et al., 1996) can induce neural markers in 
Xenopus embryos where FGF has been inhibited (see also Chapter 1.7.1). Additionally, no 
combination of FGF signalling and BMP inhibition is sufficient to induce definitive neural 
markers in either chick or Xenopus (Linker and Stern, 2004), suggesting that other signals 
remain to be discovered.  
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1.7.3 WNT signals 
WNT inhibition has also been associated with neural induction because a number of WNT 
antagonists, including FRZB, SFRP2 (Ladher et al., 2000), Crescent (Pfeffer et al., 1997), and 
DKK1 (Foley et al., 2000) and Cerberus (Zhu et al., 1999) are expressed in or around the 
organizer. Early interest came from experiments which found that overexpression of BMP and 
WNT inhibitors in Xenopus was able to induce complete secondary axes, including head 
structures (Bouwmeester et al., 1996, Glinka et al., 1997, Glinka et al., 1998, Piccolo et al., 
1999).  
In chick, it was found that WNT inhibition promotes neural fates at the expense of epidermal 
differentiation in explants taken from the centre of the epiblast at EGKXII. Furthermore, 
explants taken earlier at EGKX express WNT3A and WNT8C and are specified as epidermis 
(Wilson et al., 2000, Wilson et al., 2001). These observations led to a model (Wilson and 
Edlund, 2001) where WNT signals render epiblast cells insensitive to FGF signals, thereby 
permitting BMP signalling to specify epidermis. In this system, WNT inhibition allows epiblast 
cells to respond to FGF signals and induce neural markers and therefore the status of WNT 
signalling was considered to regulate choices between epidermal and neural fates. Further 
evidence for WNT inhibition came from a screen which identified the WNT antagonist SFRP2 as 
important for the differentiation of neural progenitors from ES cells, a process which is blocked 
by WNT agonists lithium chloride or WNT1 (Aubert et al., 2002). WNT inhibition has also been 
implicated in the induction of anterior neural markers by IGFs which, in addition to inhibiting 
BMP signalling, are potent inhibitors of the WNT pathway at the level of β-catenin (Pera et al., 
2001, Richard-Parpaillon et al., 2002, Pera et al., 2003). 
Yet, there are also reports that canonical WNT signalling can have the opposite effect. 
Overexpression of WNT pathway agonists including WNT8, β-catenin, or dominant-negative 
GSK3 can induce NRP1 expression in animal caps, possibly by repressing BMP4 expression in 
the ectoderm (Baker et al., 1999). In fact, WNT signalling was shown to be a more potent 
dorsal specifier and downregulator of BMP4 than Noggin in these experiments. Yet 
upregulation of canonical WNT signals interferes with neural plate formation while canonical 
WNT inhibition can expand the neural plate (Heeg-Truesdell and LaBonne, 2006). It has been 
suggested that these contradictory observations can be explained by differences in the timing 
of WNT requirement (Stern, 2005) as early WNTs might be necessary to establish dorsoventral 
identity (Baker et al., 1999) but their inhibition may be required later to promote neural 
induction by FGF signals (Wilson et al., 2001, Heeg-Truesdell and LaBonne, 2006). Certainly, no 
combination of FGF signalling plus BMP and WNT inhibition in chick is sufficient to induce the 
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definitive neural marker SOX2, suggesting other signals must be required (Linker and Stern, 
2004). 
 
1.7.4 Retinoic acid signals 
Retinoic acid, the biological derivative of vitamin A, has not been so widely studied in relation 
to neural induction. Instead it is generally known for its contributions to neuronal 
differentiation, neurite outgrowth and axonal regeneration (reviewed in (Maden, 2002, 
Maden, 2007)).  
In the early embryo, retinoic acid has mostly been studied in regard to anterior-posterior 
patterning of the nervous system (Durston et al., 1989, Sharpe, 1991, Simeone et al., 1995, 
Maden et al., 1996, Papalopulu and Kintner, 1996). It is synthesised by RALDH2 which is 
expressed in the posterior mesoderm. In chick, a diverse range of tissues have the potential to 
respond to retinoic acid as retinoic acid receptors are expressed in overlapping domains 
throughout the embryo from HH4 onwards (Blentic et al., 2003, Cui et al., 2003, Reijntjes et al., 
2004, Reijntjes et al., 2005), while CYP26A1 and CYP26C1 (retinoic acid catabolising enzymes) 
are expressed in the anterior neural plate and its underlying mesoderm respectively.  
These and similar observations in other organisms, have led to a gradient model which 
proposes that retinoic acid controls patterning in the neural tube and that its concentrations 
are lower anteriorly (reviewed in (Maden, 2002)). Certainly high retinoic acid levels are 
important for patterning the hindbrain; retinoic acid deficiency causes dose-dependent loss of 
rhombomere identity and boundaries (Durston et al., 1989, Sharpe, 1991, Simeone et al., 
1995, Maden et al., 1996, Papalopulu and Kintner, 1996). Certainly in mouse and chick, retinoic 
acid levels do appear to be higher in the spinal cord but low or undetectable in the early 
forebrain, midbrain and hindbrain (Mendelsohn et al., 1991, Reynolds et al., 1991, Balkan et 
al., 1992, Wagner et al., 1992, LaMantia et al., 1993, Maden et al., 1998), suggesting the 
presence of a concentration gradient. Similar evidence was found in neurula stage Xenopus 
embryos using a luciferase reporter of retinoic acid (Chen et al., 1994).  
Contradicting these, are observations that 9-cis-retinoic acid, rather than all-trans retinoic acid, 
is present at equally high levels anteriorly and posteriorly, so anterior territories may not be 
completely devoid of retinoids (Kraft et al., 1994). This correlates better with the anterior 
expression of CYP26A1 (Reijntjes et al., 2005, Albazerchi and Stern, 2007), which can be 
induced by high concentrations of retinoic acid (White et al., 1996, Loudig et al., 2000). It also 
raises the possibility that separate retinoid isomers may have distinct roles within discrete 
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spatio-temporal domains. However, the expression of CYP26A1 should be interpreted with 
caution as it can also be induced by FGFs (Diez del Corral et al., 2003, Olivera-Martinez and 
Storey, 2007), FGF or WNT inhibition (Kudoh et al., 2002) and Notch (Echeverri and Oates, 
2007) signalling, in different contexts.  
Despite this, the expression of RALDH3 (Blentic et al., 2003) and presence of retinoids in 
Hensen’s node (Chen et al., 1992, Chen and Solursh, 1992) has previously implicated retinoic 
acid signalling earlier during neural induction, especially since beads of retinoic acid are able to 
induce secondary axes when grafted next to the primitive streak (Chen and Solursh, 1992). 
Furthermore, in pre-primitive streak stage (pre-streak) chick embryos, retinoic acid secretion 
by the hypoblast has been implicated in NOT1 and NOT2 expression but also in controlling the 
position of the primitive streak (Knezevic et al., 1995, Knezevic and Mackem, 2001). In 
addition, hypoblast grafts can transiently induce expression of early neural and forebrain 
markers by different combinations of signals (Foley et al., 2000, Albazerchi and Stern, 2007). 
FGF8 induces expression of SOX3 and ERNI, while low levels of FGF8 with WNT and BMP 
antagonists can induce OTX2 and retinoic acid can induce CYP26A1 (Albazerchi and Stern, 
2007). Although the hypoblast can induce an early pre-forebrain character, other signals are 
required to maintain them and no combination can induce the definitive neural marker SOX2 
or a mature neural plate, suggesting that even these signals are insufficient for neural 
induction (Foley et al., 2000, Albazerchi and Stern, 2007).  
The contribution of retinoic acid and FGFs to the expression of early neural markers is 
particularly surprising given that they both act as caudalising factors during spinal cord 
formation (reviewed in (Diez del Corral and Storey, 2004)). Here, the caudal stem zone which 
lies lateral to the regressing Hensen’s node, contributes cells to the forming neuroepithelium 
(Diez del Corral et al., 2003). In these cells, mutual inhibition occurs between FGFs which 
maintain stem zone precursors and retinoic acid which drives precursor differentiation. FGFs 
inhibit retinoic acid signalling and differentiation by promoting expression of CYP26A1 and 
repressing RALDH2, an enzyme that synthesises retinoic acid and RARB, a retinoic acid 
receptor. Retinoic acid limits FGF signalling and promotes differentiation by repressing FGF8 
transcription (Diez del Corral et al., 2003) and may even induce expression of a MAPK 
phosphatase (Moreno and Kintner, 2004). Within this mutually antagonistic environment, 
caudal stem zone cells transition from FGF maintenance to retinoic acid differentiation via a 
WNT mediated switch (Olivera-Martinez and Storey, 2007). Initially FGF signalling in neural 
precursors promotes WNT8C expression which weakly maintains cells in an undifferentiated 
state. Then, as cells enter the neuroepithelium and their exposure to FGFs declines, WNT8C 
promotes retinoic acid synthesis via RALDH2. Increasing retinoic acid levels serve to abolish 
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FGF and WNT8C, finally committing cells to neural differentiation. In this way, balancing the 
exposure of cells to FGF and retinoic acid allows some cells in the caudal stem zone to 
differentiate, while maintaining a precursor pool (Olivera-Martinez and Storey, 2007). 
In vitro experiments suggest that cross-talk between FGF and retinoic acid is a general theme 
during neural differentiation (Stavridis et al., 2010). Similar signalling events are observed, and 
reveal that embryonic stem cell (ESC) neural differentiation actually begins with retinoic acid 
mediated stimulation of the FGF/MAPK pathway on day 1 but FGF inhibition from day 2 
(Stavridis et al., 2010). This initial FGF stimulation appears to be crucial in priming cells for 
differentiation, since retinoic acid cannot drive differentiation when cells are treated with an 
FGFR inhibitor (Stavridis et al., 2007, Stavridis et al., 2010). In fact, despite generally 
antagonising FGFs, retinoic acid is capable of stimulating FGF8 in Xenopus embryos at neurula 
stages (Moreno and Kintner, 2004) and RARs can bind to the FGF8 promoter to activate its 
expression (Brondani et al., 2002, Zhao et al., 2009). A strikingly similar situation occurs during 
chick neural induction, where cells must first be primed by FGF signals (Streit et al., 2000, 
Stavridis et al., 2007). It raises the possibility that some parallels may exist between the 
contributions of FGF and retinoic acid to ESC and spinal cord neural differentiation, and the 
initiation of neural induction in the early embryo -especially given that both signals are present 
in the hypoblast at the earliest stages of neural induction (Knezevic et al., 1995, Streit et al., 
2000, Knezevic and Mackem, 2001). 
Despite this, the contribution of retinoic acid to neural induction must be relatively minimal, or 
can be compensated for, given that vitamin A deficient (VAD) embryos still form a neural tube 
(Maden et al., 1996) and SOX2 expression is only delayed in RALDH2 mutant mice (Ribes et al., 
2009). It may be more important later to promote neural differentiation since SOX1 transcripts 
are reduced in the neural tube of VAD quail embryos as a consequence of excess FGF signalling 
(Stavridis et al., 2010). Indeed the authors suggest that retinoic acid is important to limit FGF 
exposure and drive neural differentiation later. In agreement with this, retinoic acid controls 
the numbers of primary neurons and the timing of their differentiation in fish and amphibians 
(Papalopulu and Kintner, 1996, Franco et al., 1999, Sharpe and Goldstone, 2000a), while genes 
involved in early neural differentiation including GLI3, ZIC2 (Franco et al., 1999) and SHH 
(Sharpe and Goldstone, 2000b) are under the control of retinoic acid in vertebrates. Retinoic 
acid may encourage cross-talk and refine the action of signalling pathways during neural 
induction, but it is difficult to argue for its fundamental importance if neural plate formation 
occurs even in its absence. 
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1.7.5 Calcium signals 
Calcium was first implicated in neural induction by experiments in Rana pipiens, where it was 
considered to mediate a choice between epidermal and neural cell fates (Barth and Barth, 
1964). This was reinforced by experiments in Xenopus laevis and Pleurodeles waltl, where the 
dissociation of animal caps in Ca2+/Mg2+ free medium caused them to adopt a neural fate 
(Grunz and Tacke, 1989, Saint-Jeannet et al., 1990). Although this neuralisation is now 
attributed to the diffusion of BMPs (Munoz-Sanjuan and Brivanlou, 2002) or activation of the 
FGF pathway (Kuroda et al., 2005), the extracellular release of calcium from internal stores was 
also considered to trigger this fate change. Certainly, the increase in extracellular calcium and 
neural induction is abolished when animal caps are dissociated in the presence of a calcium 
chelator (Leclerc et al., 2001). Furthermore, other compounds including caffeine, which 
stimulate calcium release, also behave as strong neuralisers (Moreau et al., 1994, Batut et al., 
2005). Protein kinase C (PKC); a target of calcium signalling, has also been implicated in 
Xenopus neural induction (Otte et al., 1988, Otte et al., 1989, Kuriyama and Mayor, 2009). 
In zebrafish and amphibian embryos, spontaneous calcium fluxes coincide spatio-temporally 
with neural induction (Webb and Miller, 2007) and never occur ventrally in ectoderm fated to 
form epidermis. These transients begin during blastula stages, but increase in frequency and 
intensity until they peak around mid- gastrula stage, when neural induction occurs (Leclerc et 
al., 1997, Leclerc et al., 2000). In amphibian and newt embryos, calcium channels comprised of 
pore-forming CaV subunits are believed to mediate these fluxes by transporting calcium into 
cells. The expression of voltage-gated DHP-Ca2+ channels closely mirrors the appearance of 
calcium fluxes; they are first expressed at blastula stages, but are present at the highest levels 
during mid-gastrulation. Shortly after, as tissue competence to neural induction reduces, so 
does the expression of DHP-Ca2+ channels (Drean et al., 1995, Leclerc et al., 1995). Their 
specific contribution to neural induction is demonstrated by treatment with DHP-Ca2+ channel 
antagonists which abolish calcium transients and downregulate expression of two early neural 
genes, ZIC3 and Geminin. Such embryos also demonstrate severe anterior nervous system 
defects (Leclerc et al., 1997, Leclerc et al., 2000, Leclerc et al., 2001). 
Recently a mechanism to regulate these types of voltage-gated channels was uncovered in 
chick (Papanayotou et al., 2013). Calfacilitin, a transmembrane calcium channel facilitator, was 
identified by a screen for responses to neural induction (see Chapter 1.11). It is expressed in 
the neural plate where it is required for neural plate formation and the expression of neural 
markers including Geminin and SOX2. Calfacilitin functions by increasing calcium flux by 
slowing L-type CaV1.2 channel inactivation. Calfacilitin loss-of-function of can be rescued by 
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increasing intracellular calcium, providing further evidence for the importance of calcium in 
neural induction (Papanayotou et al., 2013).  
It seems that calcium signals converge at multiple levels with FGF and BMP pathways during 
neural induction. DHP-Ca2+ channels can be activated by membrane depolarisation after FGF 
signalling or BMP antagonism, and the resulting calcium fluxes can be prevented by treatment 
with FGF or DHP-Ca2+ channel inhibitors (Lee et al., 2009). Increased intracellular calcium also 
activates the MAPK pathway by phosphorylating ERK (Kuroda et al., 2005). Therefore calcium 
can be integrated into the SMAD1-linker model (Kretzschmar et al., 1997a, Kretzschmar et al., 
1999, Pera et al., 2003), whereby calcium indirectly inhibits epidermis formation by activating 
ERK which in turn phosphorylates and inactivates SMAD1 (Leclerc et al., 2001, Batut et al., 
2005, Kuroda et al., 2005, Lin et al., 2010, Leclerc et al., 2011). Recent evidence for more direct 
targeting of the BMP pathway comes from Calcineurin; a Ca2+/calmodulin-dependent 
serine/threonine phosphatase, which is essential for neural induction in human and murine 
embryonic stem cells (Cho et al., 2014). Calcineurin prevents BMP target gene transcription by 
directly dephosphorylating SMAD1/5 to prevent their translocation to the nucleus. 
Furthermore calcineurin is activated in a calcium and FGF-dependent manner, further 
demonstrating the considerable cross-talk between these signals (Cho et al., 2014). 
 
1.7.6 Notch signals 
Notch signalling has been widely studied in relation to neuronal determination via lateral 
inhibition. Early suggestions that it might be important for specification came from studies in 
Drosophila which showed that mutations at the Notch locus alter cell fate, such that epidermal 
precursors are converted to neuroblasts (Hoppe and Greenspan, 1986). Other studies of the 
Xenopus Xotch homologue showed similar results; deletion of the Xotch extracellular domain 
causes expansion of neural territories in the absence of cell division (Coffman et al., 1990, 
Coffman et al., 1993). In mouse and human ESC cultures, inhibition of Notch signalling 
prevents cells from differentiating into SOX1 expressing neurons, while Notch activation is a 
potent promoter of neuronal differentiation (Lowell et al., 2006). 
Evidence for Notch in neural rather than neuronal specification comes from evidence showing 
Notch is important for determining cell fate in the caudal stem zone -a domain of 
undifferentiated proliferating cells at the caudal end of the somites (Akai et al., 2005). Here 
FGF signalling maintains stem cell self-renewal and is required for expression of the Notch 
ligand Delta1, via expression of ASCL2 (CASH4). Active Notch/Delta1 signalling between these 
cells is also required for cell proliferation though unlike FGF, it is not required to retain cells in 
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the stem zone. However, while loss of Notch signalling causes cells to exit the cell cycle, these 
cells do not undergo neuronal differentiation. This is because as they leave the stem zone and 
enter the caudal neural tube, FGF signalling declines and Notch signalling becomes important 
to specify individual Delta1 expressing neurons by lateral inhibition. Therefore Notch is 
required at two distinct phases; initially to maintain a neural precursor pool and later to 
specify neuronal identity (Akai et al., 2005). 
Evidence implicating Notch in neural specification also comes from experiments demonstrating 
that the neural plate and its border can be expanded by BMP inhibition, but only when 
targeting ectodermal cells in a continuous trail extending from the neural plate border (Linker 
et al., 2009). One interpretation of this is that homeogenetic neural inducing signals can travel 
between BMP-inhibited cells to expand neural territories (Linker et al., 2009). As a juxtacrine 
signal, Notch is a promising candidate especially as it has been implicated in establishing the 
neural plate border (Kintner, 1992, Cornell and Eisen, 2002, Endo et al., 2002, Glavic et al., 
2004). Preliminary Notch gain- and loss-of-function experiments have not produced clear 
results but do not rule out its involvement (C. Linker, A. Rolo, C. D. Stern; unpublished 
observations). More direct evidence for cross-talk between Notch and BMP pathways comes 
from interactions between the Notch intracellular domain (NICD) and SMAD1 (Dahlqvist et al., 
2003, Takizawa et al., 2003, Itoh et al., 2004), SMAD2 (Abe et al., 2005) or SMAD3 (Blokzijl et 
al., 2003). These studies suggest positive co-operation between BMP and Notch signalling, but 
NICD and SMAD1 could also be incorporated into a model where SIP1, which only interacts 
with active phosphorylated SMAD1, provides a readout of BMP pathway activity (see also 
Chapter 1.8.1) (Sheng et al., 2003).  
 
1.7.7 Hedgehog signals 
Despite the expression of Sonic hedgehog (SHH) in Hensen’s node from HH4 (Levin et al., 
1995), the hedgehog pathway has barely been considered in regard to neural induction. This is 
probably because it was assumed to be expressed too late, as neural induction was believed to 
occur before HH4 (see Chapter 1.12). Instead much focus has revolved around the role of SHH 
signals in patterning ventral motor neurons in the neural tube (reviewed in (Ericson et al., 
1995, Dessaud et al., 2008)). 
Early indications that hedgehog signalling may be implicated in epidermal versus neural fate 
decisions came from studies of banded hedgehog (X-BHH), a Xenopus homologue of Indian 
hedgehog (Ekker et al., 1995, Lai et al., 1995). Injection of X-BHH mRNA expanded anterior 
neural (HESX1) and cement gland markers (AG1) and could induce ectopic cement glands in 
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10% of cases. Furthermore, X-BHH overexpresion in animal caps induced OTX2 weakly as well 
as AG1 expression and cement gland morphology; a characteristic of the BMP antagonists 
Noggin and Follistatin (Lamb et al., 1993, Hemmati-Brivanlou et al., 1994). However X-BHH is 
unable to induce later neural markers such as NCAM. Although X-BHH can be induced by 
Activin, its expression in animal caps is neither induced by nor induces Noggin and Follistatin, 
suggesting that it acts independently of these BMP antagonists which can be Activin-induced 
(Ekker et al., 1995, Lai et al., 1995).  
Furthermore, misexpression of hedgehog ligands or GLI1, their downstream transcriptional 
activator, can expand neural plate and anterior neural markers such as SOX2 and OTX2 in 
Xenopus embryos (Min et al., 2011). Conversely, hedgehog loss-of-function expands 
cytokeratin expression at the expense of SOX2 and OTX2, (Min et al., 2011).The authors 
conclude that this occurs due to SUFU mediated cross-talk between hedgehog and WNT 
pathways, since SUFU can inhibit β-catenin. However, neural plate expansion is also a 
characteristic of BMP antagonism, which they cannot rule out as SUFU knockdown weakly 
induces Chordin in these experiments (Min et al., 2011). 
 
1.8 Other perspectives on neural induction 
Other studies have provided new insights into the nature of neural induction in terms of cell 
fate choices and specification states involved, as well as the timing and requirement of critical 
signals. These studies are summarised here as they inform the experiments discussed above, 
demonstrate novel techniques and pose new questions relevant to our understanding of 
neural induction. 
 
1.8.1 A view from the primitive streak 
Churchill is a zinc-finger transcriptional activator that was first identified from a screen for 
responses induced after 5h of neural inducing signals from Hensen’s node (see also Chapter 
1.11). Consistent with a role in neural induction Churchill is first expressed in the prospective 
neural plate at HH3-4, where it later persists in a SOX2-like pattern. In contradiction with the 
“default” model, Churchill is not induced by BMP inhibition, instead it can be induced after 5h 
by a grafted bead soaked in FGF8 (Sheng et al., 2003). 
Functional analyses reveal that Churchill misexpression in the embryonic epiblast causes 
downregulation of the mesodermal marker Brachyury and actually inhibits the formation of 
mesoderm by FGFs by preventing the ingression of epiblast cells through the primitive streak. 
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Churchill achieves this indirectly, initially by binding to CGGGRR motifs in SIP1 regulatory 
sequences to induce its expression. SIP1, which is also expressed in the neural plate, then 
blocks expression of the mesoderm markers Brachyury and TBX6. In this way, Churchill 
regulates epiblast fate by mediating a choice between whether cells ingress through the streak 
to form mesoderm, or remain in the epiblast where they will contribute to the neural plate 
(Sheng et al., 2003). Interestingly, SOX3 (Acloque et al., 2011) and SOX2 (Takemoto et al., 
2011) themselves have been shown to be involved in a similar switch between neural and 
mesodermal fates in both chick and mouse embryos by preventing epithelial to mesenchymal 
transition (EMT). TBX6 is also involved in this process by favouring mesoderm formation -
strikingly, mouse mutants lacking functional TBX6 possess three neural tubes (the 
supernumerary ones lie on either side of the endogenous neural tube and form at the expense 
of somitic mesoderm (Chapman and Papaioannou, 1998)). 
Induction of Churchill after 5h may also regulate a crucial switch in signal requirements. SIP1, a 
SMAD1 interacting protein, only associates with SMAD1 when the BMP pathway is active and 
SMAD1 is phosphorylated (Verschueren et al., 1999, Postigo et al., 2003). Therefore SIP1 
expression is suggested to provide a readout of BMP pathway activity, depending on whether 
it associates with SMAD1. This could neatly explain the observation that chick ectodermal cells 
must be exposed to 5h of signals from an organiser before they can respond to BMP inhibition 
(Streit et al., 1998). So the induction of Churchill by FGFs not only mediates mesodermal versus 
ectodermal cell fate choices, but it can also account for the switch to epiblast sensitivity to 
BMP inhibition after 5h. Therefore Churchill neatly illustrates how neural induction is not 
simply a choice between epidermal or neural cell fates governed by BMP and BMP inhibition, 
as is suggested by the default model. 
 
1.8.2 A view from the neural plate border 
The same screen that identified Churchill also identified nine other responses to an organizer 
graft. Of these ERNI and SOX3 are both are induced within 1-3h of signals from an organizer 
graft by FGFs. Unlike Churchill, they are expressed much earlier in the epiblast at pre-streak 
stages EGKXII-XIII; before gastrulation and earlier than neural induction was previously 
considered to occur (Streit et al., 2000). Expression of both markers continues in the 
prospective neural plate at HH3-4. Soon after, their expression patterns diverge: SOX3 remains 
in the neural plate, whereas ERNI expression clears and instead shifts to the pre-placodal 
region (PPR) by HH5 (Streit et al., 2000). The PPR is a domain that derives from the anterior 
neural plate border and later gives rise to the sensory placodes (Streit, 2008, Schlosser, 2010). 
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Based on the expression patterns of ERNI and SOX3, it has been proposed that the neural plate 
and the neural plate border might derive from a common “pre-neural” border-like domain 
which exists in the epiblast at EGKXII-XIII and is induced by FGFs (Stern, 2004e, Streit, 2008). 
Consistent with this, fate maps reveal that some central epiblast cells at these stages are fated 
to contribute to the neural plate and neural plate border (Hatada and Stern, 1994).  
There are also several functional similarities between the pre-streak epiblast and neural plate 
border which further reinforce this idea. Unlike non-neural ectoderm or the neural plate (Streit 
et al., 1998, Linker and Stern, 2004), the neural plate border is highly responsive to BMP 
signalling as neural and border markers can be expanded when BMP antagonists are 
misexpressed in a continuous line from the neural plate border (Streit and Stern, 1999a, Linker 
et al., 2009). Similarly, explants of chick pre-streak epiblast cells can be readily neuralised by 
BMP inhibition (Wilson et al., 2000, Wilson et al., 2001). Furthermore, when such explants are 
cultured in the absence of signals for 40h, they express neural plate and border markers, 
including SOX3, SOX2, PAX7, MSX1 and SLUG (Linker et al., 2009) as well as DLX5, GATA3, SIX4, 
EYA2 and ERNI (Stower, 2012). These explants never express the definitive neural marker 
SOX1, the mesoderm marker TBX6 or the non-neural ectoderm marker GATA2, suggesting that 
they are generally specified as neural plate border. When such explants are cultured up to 6 
days, they continue to express SLUG, but also acquire the pan-PPR marker PAX6 and lens 
markers δ-Crystallin and MAFA in addition to forming distinctive morphological lenses on the 
culture plate (Stower, 2012). The same dramatic transformation to lens is also observed when 
PPR explants from HH5-6 embryos are cultured in the absence of signals (Bailey et al., 2006). 
These observations demonstrate that the pre-streak epiblast not only expresses neural plate 
border markers, but it also behaves the same way in response to BMP pathway modulation 
and ultimately shares the same default specification fate as the neural plate border/PPR, as 
both tissues differentiate into lens after culture in the absence of signals. Given that ERNI and 
SOX3 are the earliest induced markers of this state, it suggests that one of the first steps in 
neural induction might be the specification of “pre-neural” border/PPR- like state by FGFs 
(Stern, 2004e). Since the default specification fate of this tissue seems to be lens, other signals 
must be required after FGFs to specify neural plate, neural crest and the other placodes 
(olfactory, trigeminal, otic and epibranchial) from this territory (Streit, 2008). 
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1.8.3 A view from the animal cap 
Despite the finding that inter-species organizer grafts can induce secondary axes, some 
consider the molecular basis of neural induction to differ between Xenopus and chick due to 
the apparent differences for BMP inhibition in these organisms. In chick, BMP inhibition cannot 
induce neural plate markers in ectoderm, compared to Xenopus ectodermal explants which are 
readily neuralised (Linker and Stern, 2004). The only region in chick that is sensitive to BMPs is 
the neural plate border, which can be readily expanded by BMP inhibition, but only when 
inhibited cells form a continuous trail to the neural plate or its border, suggesting that 
homeogenetic neural inducing signals can travel between BMP inhibited cells (Streit and Stern, 
1999a, Linker et al., 2009). 
Yet, neural induction in amphibians may not be so different to chick, which appears to begin 
with the induction of a “border-like” state. Fate maps of early (32-64 cell) amphibian embryos 
suggest that blastomeres A2 and A3 contribute progeny to the neural plate border (Jacobson 
and Hirose, 1981, Moody, 1987, Moury and Jacobson, 1989, Moody and Kline, 1990, Moury 
and Jacobson, 1990, Saint-Jeannet and Dawid, 1994, Delarue et al., 1997). Furthermore, fate 
maps of animal caps reveal that the cells within them contribute to the neural plate itself, and 
even the smallest animal caps contribute to the neural plate border (Linker et al., 2009). As 
most functional experiments in Xenopus involve animal caps or these blastomeres, prospective 
neural plate border cells are being targeted -the only ones which can express neural plate 
markers in response to BMP inhibition..  
In agreement with this observation, BMP inhibition in cells that never contribute to the neural 
plate or neural plate border is unable to induce neural markers in Xenopus animal caps or in 
ventral epidermis (Delaune et al., 2005, Linker et al., 2009). This result is the same as BMP 
inhibition experiments in chick extra-embryonic ectoderm, where neural markers cannot be 
induced (Streit et al., 1998, Streit and Stern, 1999g, Linker and Stern, 2004, Linker et al., 2009). 
This contrasts sharply with experiments targeting the A1-A3 blastomeres (and therefore neural 
border cells) which can expand neural markers, as at the neural plate border in chick (Linker 
and Stern, 2004, Delaune et al., 2005, Linker et al., 2009). Therefore these observations go 
some way to reconciling the different results for neural induction by BMP inhibition in chick 
and Xenopus. Since homeogenetic neural inducing signals can travel between BMP inhibited 
cells, animal caps or blastomeres A1-A3 are unsuitable for studying true neural induction 
because they cannot distinguish between de novo induction of neural markers as opposed to 
the expansion of fates that have already been specified (Linker et al., 2009).  
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Studies of neural induction in cells normally fated to form ventral epidermis or extra-
embryonic tissue in Xenopus and chick respectively, offer a more stringent test for true 
instructive induction, as a change of fate. Such assays reveal that BMP inhibition is not 
sufficient to induce neural markers, in both species. This result is observed even when BMP is 
inhibited thoroughly using high concentrations of BMP antagonists and when combinations of 
antagonists (e.g. SMAD6, DN-BMPRs, Noggin and Chordin) are used (Linker and Stern, 2004, 
Delaune et al., 2005, Linker et al., 2009). Careful reanalysis of the contributions of FGF, BMP 
inhibition and WNT inhibition in Xenopus and chick now confirms that FGF signalling before 
gastrulation is required for neural induction but FGFs are not sufficient to induce definitive 
neural markers (Streit et al., 1998, Streit et al., 2000, Linker and Stern, 2004, Delaune et al., 
2005, Linker et al., 2009). High levels of BMP inhibition cannot rescue FGF inhibition even 
when multiple antagonists are used, suggesting that although FGFs may act to inhibit BMPs, 
they also contribute to neural induction in a BMP/SMAD1-independent manner (Delaune et 
al., 2005). BMP inhibition is required for SOX2, but not for the initial phase of SOX3 expression, 
suggesting that it is required but probably as a later step in neural induction (Linker and Stern, 
2004). BMP inhibition is also required to maintain SOX3 thereafter (Streit et al., 1998). 
However some differences still remain between the two model species. FGF plus weak BMP 
inhibition is reported to induce SOX2 in Xenopus ventral epidermis (Delaune et al., 2005), 
whereas these signals, with or without WNT inhibition, were insufficient to induce SOX2 in 
Xenopus or chick extra-embryonic ectoderm, suggesting that yet more signals are required 
(Linker and Stern, 2004, Linker et al., 2009). 
 
1.8.4 A view from the genome 
Biological development is determined by the precise spatio-temporal expression of genes in 
response to combinations of regulatory signals. Whether a gene is transcribed depends on the 
integration of multiple factors including its location in the genome, local chromatin structure 
and its associated transcriptional regulatory elements; promoters, enhancers, silencers, and 
insulators (Maston et al., 2006, Vogelmann et al., 2011). In the systems biology era, new 
bioinformatics tools are now available to explore gene regulation by identifying cis-regulatory 
elements in the genome (Khan et al., 2013).  
One powerful approach has been the identification of conserved promoters and enhancer 
elements and the transcription factor binding sites contained within them. This can identify 
specific motifs responsible for gene expression. For example, thorough analysis has discovered 
over 40 enhancers located up and downstream of the chicken SOX2 gene (Uchikawa et al., 
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2003, Uchikawa et al., 2004, Okamoto et al., 2015). Not only are these conserved in mouse and 
human homologues of SOX2 but they were confirmed experimentally using reporter analysis 
(Streit et al., 2013).  
The overall expression of SOX2 in the neural plate and neural tube is regulated by the 
coordinated integration of five enhancers, each with discrete regional coverage. Two 
enhancers; referred to as N1 and N2, specifically regulate the onset of SOX2 expression in the 
neural plate at around HH4-5 (Uchikawa et al., 2003, Uchikawa et al., 2004). The N1 enhancer 
is located 13kb downstream of SOX2. Its activity is first detected at HH5 around Hensen’s node 
and later follows the node as it regresses caudally. This suggested that N1 activity provides a 
readout of Hensen’s node induced SOX2 expression and accordingly, grafts of Hensen’s node 
can induce N1-reporter expression in the extra-embryonic area opaca. It also confirms that 
ectopic SOX2 induction by a node graft requires that same enhancer usage as SOX2 expression 
in the neural plate. The N2 enhancer is located 4kb upstream of SOX2. N2 activity initially 
covers a broad domain anterior to the node at HH5 and later becomes restricted to the future 
prosencephalon, mesencephalon, and rostral rhombencephalon. Therefore N2 represents a 
good specifier of anterior neural plate development (Uchikawa et al., 2003, Uchikawa et al., 
2004). 
Analysis of transcription factor binding sites in these enhancers has identified conserved 
motifs. The N1 enhancer contains binding sites for a SOX-related protein (possibly SOX3, which 
is expressed earlier than SOX2 in the neural plate), a TCF/LEF homeodomain protein (WNT 
pathway target), and an E-box sequence known to be a target of ZEB/ZFHX family proteins 
(Verschueren et al., 1999, Uchikawa et al., 2003, Uchikawa et al., 2004). SIP1 (ZEB2) shares 
overlapping expression domains in the neural plate with SOX2, so its location is consistent with 
SIP1 potentially regulating SOX2 (Sheng et al., 2003). Mutational analysis of the N1 core, a 
56bp region within the 420bp enhancer, reveals that it is activated synergistically by WNT and 
FGF signals (Takemoto et al., 2006). Consistent with the absence of BMP or BMP pathway-
related binding sites, the N1 core enhancer does not respond to BMP agonism or antagonism 
(Takemoto et al., 2006). This suggests that WNT and FGF, but not BMP signals converge on the 
N1 enhancer to induce SOX2 in the vicinity of Hensen’s node. 
Functional analysis of the anteriorly active N2 enhancer reveals that it contains binding sites 
for ZIC2, OTX and several POU proteins (Iwafuchi-Doi et al., 2011, Iwafuchi-Doi et al., 2012). Its 
activity is regulated by different combinations of transcription factors in different states. When 
epiblast stem cell differentiation was used as model for neural specification, N2-dependant 
SOX2 expression in an “epiblast-like” state requires just ZIC2 and POU5F1 (OCT3/4) binding. 
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Later in a more “anterior neural plate-like” state, SOX2 expression via N2 involves occupancy 
of the OTX binding site and a switch from POU5f1 to POU3fs at the POU site (Iwafuchi-Doi et 
al., 2011, Iwafuchi-Doi et al., 2012). This suggests that SOX2 expression in the anterior neural 
plate requires inputs from OTX2, ZIC2 and POU proteins, consistent with the differences in 
SOX2 expression anteriorly and posteriorly.  
In this way, bioinformatics approaches can identify putative enhancers and the binding sites 
within them to provide a guide for functional techniques. Certainly, the analysis of SOX2 to 
date reveals that its expression in the neural plate integrates information from spatially 
restricted cues such as WNTs, FGFs and specific transcription factors including OTX2 which are 
appropriately expressed in the embryo. These types of analyses reveal the regulatory elements 
necessary for the expression of individual genes and can link transcriptional states by 
converging gene expression on the cis-regulatory elements of downstream targets. 
However, transcription factor binding to the relevant enhancers is not enough to account for 
the spatio-temporal expression of SOX2, as has been demonstrated for the N2 enhancer 
(Papanayotou et al., 2008). Here, an interplay between the SWI/SNF chromatin remodelling 
factor Brahma, the heterochromatin protein repressors HP1α and HP1γ and coiled-coil 
proteins ERNI, Geminin and BERT regulate when this enhancer becomes active (Papanayotou 
et al., 2008). Specifically, it was proposed that in the “basal” state the N2 enhancer is 
constitutively occupied by Brahma, whose activity as a transcriptional activator is blocked by 
the binding of HP1α. At early stages of development, FGF signalling induces ERNI and Geminin, 
which bind to each other through their coiled-coil domains. Geminin also binds to Brahma at 
the same site as HP1α to displace the latter. However, ERNI recruits the related repressor HP1γ 
to a specific sequence at its C-terminal end, which continues to repress N2 enhancer 
expression. At later stages, BERT starts to be expressed and its coiled-coil domain binds to 
those of both ERNI and Geminin and thus disrupts their association, which effectively removes 
HP1γ from this site. This finally allows activation of N2 expression by Brahma, which may act 
by its chromatin-unwinding activity (Papanayotou et al., 2008). It was proposed that this 
mechanism allows cells to build up a “memory” of their signalling history (encoded by 
transcription factors bound to the enhancer, each induced by a different set of signals) before 
removing repression and allowing cells to express a key neural commitment gene like SOX2. An 
important function of this mechanism may be to separate, in time and space, incompatible 
functions of the same signals, such as FGF, which are required for both mesodermal and neural 
induction (Papanayotou et al., 2008). 
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1.9 A screen for secreted signals from the organizer 
In an effort to identify other neural inducing signals, a genetic screen was conducted to isolate 
secreted factors from Hensen’s node between HH3+/4, when it is most potent. It used a yeast 
signal sequence trap vector consisting of a modified yeast invertase gene lacking both its 
methionine start codon and signal peptide, under control of a yeast dehydrogenase promoter 
(Jacobs et al., 1997). The invertase gene mutations mean that yeast colonies transformed with 
the vector are normally unable to grow under invertase selection. However, colony survival 
can be rescued by introduction of native invertase or other cDNAs containing signal sequences 
into a cloning site between the promoter and mutant invertase. A cDNA library of mRNA 
extracted from Hensen’s node at HH3+/4 was transformed into yeast containing the vector 
and screened for secreted proteins by extracting plasmids from colonies that survived 
invertase selection. This screen isolated 137 sequences, including three that were expressed in 
Hensen’s node at the appropriate stages based on in situ hybridisation and confirmed as 
secreted. Functional neural induction analyses have suggested roles for Calreticulin; a calcium 
regulator and nhbr90; a probable non-coding RNA, while a third candidate (Fibulin2) did not 
have any effect in neural induction assays (Marta de Almeida, 2012). 
 
1.10 Competence for neural induction 
The outcome of inductive events depends not only on the signals a tissue receives but whether 
the tissue is competent to respond. For example, grafts of Hensen’s node to the area opaca are 
able to induce ectopic secondary axes but only between HH2-4 when the tissue is competent 
to respond. Between HH4-4+, grafted nodes become unable to induce ectopic neural tissue as 
competence is progressively lost (Gallera and Ivanov, 1964, Storey et al., 1992). 
The dawn of the molecular era enabled this problem to be investigated. The L5220 epitope, an 
N-glycoside linked carbohydrate modification related to the Lewis-X antigen (Streit et al., 
1996), was initially described as an early neural marker (Streit et al., 1990, Roberts et al., 
1991). It starts to be expressed weakly in the posterior area pellucida at EGKXIII and in 
scattered cells of the more central area pellucida. By HH3+, L5220 is expressed strongly around 
the anterior region of the streak, extending to cover the inner third of the area opaca by HH4. 
Shortly after, its expression domain narrows until it is confined to the neural plate at HH6 and 
neural tube at HH9- (Streit et al., 1995). Therefore the spatio-temporal expression of L5220 
correlates closely with regions competent to respond to neural induction.  
Gain- and loss-of function experiments confirm a role for the L5220 epitope in neural 
competence. Grafts of Hensen’s node are able to enhance its expression in the area opaca 
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(Roberts et al., 1991) via HGF/SF signals (Streit et al., 1995). HGF/SF can also delay the loss of 
to L5220 to maintain, but not induce, competence long after it would normally have been lost 
(Streit et al., 1997). Conversely there was a marked decrease in ectopic inductions when cell 
pellets secreting an antibody against the L5220 epitope were grafted together with Hensen’s 
node (Roberts et al., 1991). Despite the finding that the L5220 epitope is of critical importance 
for ectodermal tissue to respond to neural induction, the protein that carries this proteoglycan 
modification remains unknown. 
 
1.11 A screen for transcriptional responses to neural induction 
To establish the molecular processes that occur during neural induction before BMP inhibition, 
a screen was conducted to identify genes that are differentially expressed following 5h of a 
Hensen’s node graft (Streit et al., 2000). This time period was chosen because of the 
observation that chick ectodermal cells cannot respond to BMP signalling by maintaining SOX3 
expression unless they have first been primed by 5h of signals from the organizer (Streit et al., 
1998). Quail nodes were grafted to the inner third of the area opaca, a region which is 
competent to respond to organizer signalling, but which does not contribute cells to the 
embryo proper. After 5h, induced ectoderm from underneath the graft was isolated as well as 
uninduced ectoderm from the contralateral side of the same embryo. From these tissues, 
cDNA libraries were constructed and screened for differentially expressed genes (Streit et al., 
2000).  
The expression of 10 genes was found to be upregulated in induced tissue, including the novel 
genes ERNI (Streit et al., 2000), Churchill (Sheng et al., 2003), Calfacilitin (Papanayotou et al., 
2013), Asterix and Obelix (Pinho et al., 2011) and previously characterised genes: SOX3 (Streit 
et al., 2000), DAD1, UBII, FTH1 (Gibson et al., 2011) and TRKC (Pinho et al., 2011). Consistent 
with a role in neural induction, each gene is expressed in the neural plate at some stage. ERNI, 
SOX3 and Calfacilitin are first expressed in the pre-streak epiblast at EGKXIII and this continues 
in the prospective neural plate at HH3-4, when Churchill, DAD1, UBII, FTH1, Asterix and Obelix 
can also be detected (Pinho et al., 2011). 
SOX3, a transcription factor of the SRY-related HMG-box family has been extensively studied in 
terms of cell fate determination during embryonic development (Stevanovic et al., 1993) and is 
considered to be an early marker of ectoderm that is competent to form nervous tissue (Rex et 
al., 1997). Functional analysis of several other markers reveals their specific contributions to 
neural induction. The role of the zinc-finger transcriptional activator Churchill in regulating the 
ingression of epiblast cells through the primitive streak has already been described (see 
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Chapter 1.8.1). Likewise, the function of Calfacilitin, a transmembrane calcium channel 
facilitator, which is required for neural plate formation, has also been covered (see Chapter 
1.7.5). ERNI seems to function mainly to repress premature neural fate acquisition at least 
partly by controlling the activity of the SOX2 enhancer N2, and has also been discussed above 
(see Chapter 1.8.4).  
DAD1, UBII (UBB) and FTH1 are expressed in the neural plate and have previously been 
implicated in programmed cell death. Although they do not seem to affect neural cell fate, 
their expression appears to protect cells from apoptosis and to restrict this to the neural plate 
border and non-neural ectoderm (Gibson et al., 2011). 
The specific functions of Asterix and Obelix are less clear. Obelix protein mainly localises to the 
nucleus and does not appear to be secreted. Sequence analysis suggests that it shares 
homology to the oligonucleotide/oligosaccharide-binding (OB) domain of eIF1A, a highly 
conserved translation initiation factor (Pinho et al., 2011). The OB domain comprising a five-
stranded beta-sheet which is coiled to form a beta-barrel, specifically imparts the RNA-binding 
properties of eIF1A. Therefore Obelix is predicted to bind RNA but is unlikely to function as an 
elongation initiation factor as it does not share any other homology with eIF1A (Pinho et al., 
2011). Although Asterix is also highly conserved across vertebrates and invertebrates, it 
belongs to a family of as yet uncharacterised proteins (Pinho et al., 2011). 
 
1.12 The timing of neural induction 
Before the molecular era, careful grafting experiments revealed that grafts of Hensen’s node 
can only consistently induce secondary axes up to HH4. Between HH4 to HH4+, it progressively 
loses the ability to induce neural tissue (Gallera and Ivanov, 1964, Gallera and Nicolet, 1969, 
Gallera, 1971, Storey et al., 1992, Storey et al., 1995), at the same time as regions competent 
to respond to these neural inducing signals lose the expression of the L5220 epitope (Streit et 
al., 1997). One interpretation of these observations is that neural induction normally occurs 
during gastrulation and that it ends completely by the onset of neurulation at HH4+. Similar 
suggestions have been made for neural induction in Xenopus, which is considered to end by 
stage 12/13 (Waddington and Needham, 1936, Gurdon, 1987, Sharpe and Gurdon, 1990, 
Servetnick and Grainger, 1991). 
However, assessment of the tissue induced by grafts of the organizer into the area opaca 
reveals that a “neuroid” response is elicited after 6h of grafting, and a morphological neural 
plate appears by 8.5h (Gallera, 1965). Yet, morphology was lost when grafts were removed 
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before 13h (Gallera and Ivanov, 1964, Gallera, 1971). So although initial inductive events may 
occur earlier, it is only later that cells acquire neural plate morphology and become committed 
to a neural fate. In addition, the use of molecular markers enabled the observation that older 
nodes (between HH5-6), which have a greater tendency to self-differentiate, can still induce 
but only posterior neural tissue (Storey et al., 1992, Storey et al., 1995) -leaving open the 
possibility that some inductive events might continue even after HH4+. 
It has sometimes been assumed that neural induction can only begin once the organizer has 
formed, which in chick occurs at around HH4 (Connolly et al., 1995, Hemmati-Brivanlou and 
Melton, 1997, Streit et al., 1998, Streit and Stern, 1999a). More recent results suggest that, the 
earliest responses to neural inducing signals from a grafted node (ERNI, SOX3 and Calfacilitin) 
are normally first expressed in response to FGF signals in the epiblast of EGKXII-XIII embryos 
(Streit et al., 2000, Papanayotou et al., 2013). Fate mapping experiments reveal that this 
territory contains cells which contribute to multiple lineages, including the future neural plate 
(Hatada and Stern, 1994). Taken together, this suggests that neural induction begins well 
before gastrulation - much earlier than previously considered. Furthermore, timed node graft 
experiments reveal that ERNI, SOX3 and Calfacilitin can be induced within 3h of neural 
inducing signals, while Churchill, DAD1, UBII, Asterix and Obelix which require 5h of signals, are 
not expressed until HH3-4 in the prospective neural plate (Sheng et al., 2003, Gibson et al., 
2011, Pinho et al., 2011). Therefore even the earliest responses to neural induction appear to 
occur in two distinct sequential steps, both ectopically and in the normal embryo.  
Although a number of signals and responses to neural induction have been identified at 
different times, it is difficult to determine precisely when neural induction begins and ends. 
Morphological, functional and spatio-temporal observations hint that neural induction might 
occur as a sequence of events spanning a long period, at least between EGKXII and HH4-5. This 
begs the questions: if neural induction comprises a hierarchy of responses, which step 
represents the inductive step? Is it an early, but reversible bias towards a neural fate, or the 
final step which might confer commitment to neural specification? The node graft assay 
represents a useful tool for studying the entire process. The time of grafting represents a clear 
starting for neural induction and since ectopic induction appears to proceed via similar 
morphological and molecular events to the mature neural plate, it also allows later events to 
be dissected.  
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1.13 Is the organizer required for neural induction? 
Although grafting experiments demonstrate that the organizer is an important source of 
neuralising signals, it has been argued that it may not be necessary for neural induction 
particularly since the organizer is never adjacent to the most anterior regions of the neural 
plate in chick or mouse (Stern, 2005). Hensen’s node ablation does not affect nervous system 
formation, although these experiments do not completely remove organizer activity because 
Hensen’s node regenerates (Psychoyos and Stern, 1996c). Even genetic ablations such as 
mouse homozygous HNF3β mutants, lack a node but still form a rudimentary neural tube as do 
zebrafish one-eyed pinhead mutants, which are defective in dorsal mesoderm and organizer 
development (Gritsman et al., 1999, Klingensmith et al., 1999). In addition, zebrafish and 
mouse mutants lacking organizer markers such as the BMP antagonists Noggin, Chordin, 
Follistatin and Cerberus still form nervous tissue (Matzuk et al., 1995, Schulte-Merker et al., 
1997, McMahon et al., 1998, Simpson et al., 1999, Bachiller et al., 2000, Belo et al., 2000, 
Mukhopadhyay et al., 2001). 
 
1.14 Other sources of neural inducing signals in the embryo  
The lack of dependence of neural induction on Hensen’s node might also be explained by 
observations that the organizer is not the only source of neuralising signals in the embryo. The 
earliest responses to a grafted node (ERNI, SOX3 and Calfacilitin) are induced by FGF signals, 
including FGF8 which is first expressed in the hypoblast of normal embryos at EGKXII-XIII (Streit 
et al., 2000) and perhaps FGF3 which is expressed in the epiblast at even earlier stages (Wilson 
et al., 2000). The hypoblast is also an important source of signals including retinoic acid 
(Knezevic et al., 1995, Knezevic and Mackem, 2001) and WNT antagonists DKK1 and Crescent, 
as well as Cerberus (Foley et al., 2000) which can inhibit TGFβ and WNT signalling. Functional 
experiments have revealed a role for the hypoblast in positioning the primitive streak and 
inhibiting the formation of multiple streaks (Foley et al., 2000, Bertocchini and Stern, 2002). 
Like the mouse AVE to which is it equivalent, grafts of the hypoblast are able to induce early 
neural markers transiently, including SOX3 and ERNI by FGFs, CYP26A1 possibly by retinoic 
acid, and OTX2 by FGF together with WNT and BMP antagonism (Foley et al., 2000, Albazerchi 
and Stern, 2007). However, neither can induce later neural markers such as SOX2 or HESX1 nor 
a morphological axis, suggesting that although the hypoblast contains some of the same neural 
inducing signals, it cannot compensate for all signals secreted from the organizer (Foley et al., 
2000, Albazerchi and Stern, 2007). Therefore the hypoblast is a source of the earliest signals 
during neural induction but Hensen’s node takes over once the hypoblast no longer persists. 
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Signals from the node must continue to be important as the node regresses if, as suggested 
(see Chapter 1.12), neural induction proceeds as a sequence of events continuing beyond HH4. 
Certainly older nodes remain important for the induction of posterior markers (Storey et al., 
1992, Storey et al., 1998). The head process forms at HH4+ from the middle layer of Hensen’s 
node, so its derivatives (the prechordal mesendoderm and notochord) may be important 
sources of signals at later stages (Selleck and Stern, 1991, Psychoyos and Stern, 1996a). 
Certainly the contributions of SHH from the notochord to neural tube dorsoventral patterning 
are well known (Dessaud et al., 2008). This is further reinforced by observations that Hensen’s 
node grafts differentiate into NOT1-expressing, notochord-like structures after longer culture, 
as well as contributing cells to the floor plate of ectopic neural axes (Storey et al., 1992, Storey 
et al., 1995). 
 
1.15 Thesis aims 
The “default model” proposes that neural induction occurs during gastrulation in response to 
BMP antagonists secreted from the organizer, which are sufficient to induce neural markers. 
Although attractive in its simplicity, numerous studies now suggest a far more complicated 
picture where neural induction seems to occur as a series of sequential events that begins 
before gastrulation and involves inputs and cross-talk between multiple signalling pathways at 
different time points. However the overall time-course of such a hierarchy is unclear, as are 
the specific contributions of relevant signalling pathways to this process. 
Presented here is a body of work that aims to shed new light on the entire process of neural 
induction. First, we characterise the progression of neural induction using a range of other 
markers already known to be expressed in the neural plate at different stages. Second, we 
conduct a differential screen to identify the full repertoire of transcriptional responses to 
neural inducing signals from Hensen’s node. Finally we begin to determine the precise timing 
and signals responsible for inducing these markers. 
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Chapter 2: Materials and Methods 
2.1 Eggs 
Fertile hens’ eggs (Brown Bovan Gold; Henry Stewart & Co., UK), Japanese quails’ eggs (B.C. 
Potter, Rosedean Farm, UK) or cytoplasmic GFP-transgenic chick eggs (Transgenic Chick 
Facility, Roslin Institute UK), were incubated at 38°C in a humidified chamber to the desired 
stages. Embryos were staged according to (Hamburger and Hamilton, 1951) in Arabic numerals 
or (Eyal-Giladi and Kochav, 1976) in Roman numerals for pre-primitive streak (pre-streak) 
stages. Embryos were dissected in physiological saline: Pannett-Compton, Tyrode’s or 1x PBS 
(Ca2+/Mg2+ free) and fixed in 4% Paraformaldehyde (PFA). 
Pannett-Compton saline was made by combining 40mL of solution A, 900mL of distilled H20 
and 60mL of solution B immediately before use. Solution A contains 121g NaCl, 15.5g KCl, 
10.42g CaCl2·2H2O and 12.7g MgCl2·6H2O, dissolved in H2O to 1L. Solution B contains 2.365g 
Na2HPO4.2H2O and 0.188g NaH2PO4·2H2O, dissolved in H2O to 1L (Pannett and Compton, 
1924). Both solutions were autoclaved prior to use and stored at 4°C once opened. 
A 10x stock of Tyrode's saline was made by combining 80g NaCl, 2g KCl, 2.71g CaCl2·2H2O, 0.5g 
NaH2PO4·2H2O, 2g MgCl2·6H2O and 10g glucose dissolved in H2O to 1L. This was autoclaved and 
stored at 4°C once opened (Voiculescu et al., 2008). Immediately prior to use the stock was 
diluted to a 1x working concentration with H2O. 
A 20x stock of phosphate buffered saline (PBS) was made by dissolving 160g NaCl, 4g KCl, 
28.8g Na2HPO4 and 4.8g KH2PO4 in H2O to 1L. This was autoclaved and stored at room 
temperature. The pH of each batch was tested after diluting to a 1x working concentration; 
batches should measure pH7.4. 
Fresh 4% PFA was made each week by dissolving 2g of Paraformaldehyde pellets (Sigma) in 
50mL of 1xPBS containing 2mM EGTA. The pH was adjusted to pH7.4 using 1M NaOH. This 
mixture was heated in a water bath at 70°C until the PFA dissolved and was then stored at 4°C. 
 
2.2 Harvesting chicken embryos 
Eggs were opened by cracking the shell at one end and windowing with blunt forceps. Albumin 
surrounding the yolk was removed and the opening widened to allow access. The yolk was 
positioned with the embryo uppermost by gently stroking the surface of the vitelline 
membrane with forceps. Dissecting scissors were used to make parallel incisions either side of 
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the embryo and again at right angles, to isolate a square of membrane with the embryo 
attached. A small spoon was used to scoop out the embryo with a little yolk and transfer it to a 
large 10cm Petri dish containing Pannett-Compton, Tyrode’s or 1xPBS (Ca2+/Mg2+ free). Using 
fine forceps, the membrane was first peeled away from the yolk and then the embryo was 
separated from the membrane. Embryos were cleaned of excess yolk and fixed flat in 4% PFA 
for 1h at room temperature or overnight at 4°C. 
 
2.3 Ex ovo culture 
Chicken embryos were cultured ex ovo using a modified New culture method (New, 1955, 
Stern and Ireland, 1981). In brief, eggs were opened with blunt forceps. The albumin 
surrounding the yolk was removed using forceps and a small quantity of thin albumin was 
collected to serve as culture medium. Intact yolks were carefully transferred to a large dish 
containing physiological saline, either Pannett-Compton or Tyrode’s. Any remaining albumin 
was aspirated from the yolks using a fire-polished glass Pasteur pipette. The vitelline 
membrane was cut around the equator of the yolk, keeping the embryo central. The 
membrane was then carefully peeled away from the underlying yolk, while keeping the 
embryo attached. While remaining submerged, membranes were then placed on a watch glass 
with the embryo orientated ventral side up. A glass ring (about 3mm high, cut from glass 
tubing of 27mm diameter) was positioned centrally over the embryo and the edges of the 
membrane wrapped over the ring. This assembly was then lifted out of the dish and adjusted 
under a dissecting microscope while keeping the embryo submerged in a small pool of saline. 
The vitelline membrane was gently pulled taut around the glass ring before the excess was 
trimmed. Excess yolk was dislodged from the membrane and embryo by gently pipetting a 
stream of saline. Finally the saline was removed and replaced with fresh liquid, leaving the 
embryo on an optically clear membrane. At this point, embryos can be cultured as they are or 
with the addition of node or bead grafts (see Chapter 2.4 and 2.5) which were transferred to 
the ring and positioned while the embryo remained submerged.  
To complete the culture, saline was removed from around and within the ring without 
disturbing the embryo and any grafts. The dry ring was then transferred to a 35mm Petri dish 
containing a shallow pool of thin albumin. The edges of the ring were pressed down to prevent 
it from floating, leaving the embryo supported by a shallow bubble of albumin beneath the 
membrane. Dishes were sealed by coating the lid with thin albumin and covering. Completed 
cultures were incubated in a humidified chamber at 38°C for the desired length of time.  
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After culture, embryos were fixed on the membrane with 4% PFA or submerged with ice-cold 
saline to allow tissue dissection. 
 
2.4 Neural induction assays 
Neural induction assays were performed according to (Stern, 2008, Streit and Stern, 2008). For 
Hensen’s node grafts, chick donors at Hamburger Hamilton (HH) 3+/4- and chick hosts at HH3, 
3+, 4-, 4 or 4+ were used and New cultures incubated for 1, 3, 5, 7, 9, 12 or 15h at 38°C in a 
humidified chamber.  
One or two nodes were grafted contra-laterally per embryo, within the inner third of the area 
opaca and at or above the level of the host node. This region is competent to respond to 
neural inducing signals but only contributes to the extra-embryonic membranes and not the 
embryo proper (Streit et al., 1997). Nodes were grafted with their endodermal surface in 
contact with the host epiblast.  
 
2.5 Bead graft assays 
Heparin acrylic (Sigma), Affi-gel Blue (Biorad) or AG1X2 formate (Biorad) beads were used to 
deliver proteins or chemicals, depending on their binding specificity and charge. Beads were 
rinsed 3 times in PBS before soaking for at least 6h or overnight at 4°C in the appropriate 
factor. Immediately prior to use, beads were rinsed twice in PBS to remove excess factor and 
were grafted in the same manner as node tissue. 
For gain-of-function assays, beads were loaded with the following factors at the specified 
concentrations and a single bead was grafted to the area opaca. 
 
Assay Factor Stock 
Loading 
Concentration 
Bead 
Type 
FGF 
Mouse recombinant FGF8b 
R&D Systems 
Cat. No: 423-F8 
100µg/mL in 
0.1% BSA/PBS 
25µg/mL in 0.1% 
BSA/PBS 
Heparin 
acrylic 
Retinoic 
Acid 
All-trans Retinoic acid 
Sigma 
Cat. No: R2625 
5mg/mL in 
100% DMSO 
5µg/mL in 0.1% 
DMSO/PBS 
AG1X2 
BMP 
Inhibition 
Human recombinant Noggin 
R&D Systems 
Cat. No: 6057-NG 
125µg/mL in 
0.1% BSA/PBS 
91µg/mL in 0.1% 
BSA/PBS 
Heparin 
acrylic 
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Assay Factor Stock 
Loading 
Concentration 
Bead 
Type 
WNT 
Inhibition 
IWR-1 
Sigma 
Cat. No:  I0161 
2.44mM in 
100% DMSO 
100µM in 4.1% 
DMSO/PBS 
AG1X2 
SHH 
Human recombinant SHH-N 
R&D Systems 
Cat. No: 1845-SH 
1mg/mL in 
0.1% BSA/PBS 
1mg/mL in 0.1% 
BSA/PBS 
Affi-gel 
Blue 
Table 2.1: The preparation of secreted factors and chemicals for gain-of-function assays. 
 
At these concentrations each factor elicited the appropriate functional response. FGF8b 
induced the target gene SOX3 (Appendix 9) but without inducing the mesodermal marker 
Brachyury (BRA) (Streit et al., 2000). All-trans Retinoic Acid induced CYP26A1 (Albazerchi and 
Stern, 2007). Beads of Noggin grafted at HH4 expanded the domain of SOX2 expression after 
9h (Linker et al., 2009). IWR-1 beads grafted at HH8-10, lateral to Hensen’s node caused a 
delay in RALDH2 expression in the pre-somitic mesoderm and somites after 8h (Olivera-
Martinez and Storey, 2007). Bilateral Nodal expression was induced by beads of SHH-N grafted 
adjacent to Hensen’s node on the embryonic right side (Levin et al., 1995). 
For loss-of-function assays, 6 beads loaded with the following factors were positioned around 
a Hensen’s node graft in the area opaca. Where specified, the host or graft tissue was pre-
incubated in the factor for 20min prior to grafting. 
 
Assay Factor Stock 
Loading 
Concentration 
Additional Notes 
Bead 
Type 
Node + FGF 
Inhibition 
SU5402 
Calbiochem 
Cat. No: 572630 
3mM in 
100% 
DMSO 
25µM in 0.83% 
DMSO/PBS 
Host soaked in 
2.5µM SU5402 in 
0.083% DMSO/PBS 
AG1X2 
Node + FGF 
Inhibition 
FIIN-1-
Hydrochloride 
Tocris 
Cat. No: 4002 
10mM in 
100% 
DMSO 
10mM in 100% 
DMSO 
- AG1X2 
Node +  
Retinoic 
Acid 
Inhibition 
Citral 
Sigma 
Cat. No: C83007 
58mM in 
100% 
DMSO 
100µM in 
0.17% 
DMSO/PBS 
Grafts soaked in 
10µM Citral in 
0.017% DMSO/PBS 
AG1X2 
Node + 
BMP 
Recombinant 
Human BMP4 
R&D Systems 
Cat. No: 314-BP 
50µg/mL 
in  0.1% 
BSA/PBS 
25µg/mL in  
0.1% BSA/PBS 
- 
Affi-gel 
Blue 
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Assay Factor Stock 
Loading 
Concentration 
Additional Notes 
Bead 
Type 
Node + 
WNT 
BIO 
Tocris 
Cat. No: 3194 
5mM in 
100% 
DMSO 
5µM in 0.1% 
DMSO/PBS 
Host soaked in 
0.5µM BIO in 
0.01% DMSO/PBS 
AG1X2 
Node + HH 
Inhibition 
Cyclopamine 
Abcam 
Cat. No: 120392 
11.2mM 
in 100% 
DMSO 
100µM in 
0.89% 
DMSO/PBS 
1µL of the 100µM solution 
was pipetted directly around 
grafts 
Table 2.2: The preparation of secreted factors and chemicals for loss-of-function assays. 
 
At these concentrations each factor elicited the appropriate functional response. SU5402 
reduced or abolished the induction of SOX3 (Appendix 9) by a node graft after 5h (Streit et al., 
2000). Beads of FIIN-1-hydrochloride reduced Sox3 expression when grafted to the prospective 
neural plate at HH2-3 for 6h. Citral reduced or abolished the expression of CYP26A1 induced by 
a node graft after 5h (Streit et al., 2000). Beads of BMP4 grafted into the prospective neural 
plate at HH4-, abolished SOX2 expression after 9h (Linker and Stern, 2004). Beads of BIO 
grafted into the prospective neural plate at HH4- shifted the mid-hindbrain boundary 
anteriorly based on OTX2 expression at HH11 (Nordstrom et al., 2002). Treatment with 2µL of 
a 100µM stock of cyclopamine pipetted directly onto HH4 embryos completely abolished 
Nodal expression after 9h compared to a vehicle control (Levin et al., 1995, Cooper et al., 
1998). 
The following factors were also used to assess the regulation of TRKC; 2µg/ml mouse 
recombinant Noggin (R&D) on heparin acrylic beads, 2µM Ionomycin (Sigma) and 1mM 
somatostatin (Tocris) on AG1X2 beads. 
 
2.6 Node and bead graft removal 
Node and bead grafts were removed after culture by submerging the embryo in saline while 
still attached to the membrane. Fine syringe needles (27g or 30g, B D Microlance) were used to 
peel yolky cells away from the grafted tissue. Grafts were gently lifted away from the 
underlying epiblast by working from the edges. Where grafts were firmly attached, 0.1% 
trypsin dissolved in saline was gently pipetted over the graft site to assist in removal. After 
dissection, trypsin-treated embryos were washed with fresh saline and rinsed briefly with 
heat-inactivated goat serum to neutralise trypsin activity (Stern, 1993). This was then replaced 
with fresh saline and the experimental tissue directly underneath the graft was isolated using 
syringe needles and mounted insect pins. 
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2.7 Tissue collection for RNA-Seq 
For RNA-Seq, HH4- chick nodes were grafted to the area opaca of HH4- chick hosts. A single 
node was grafted to the left or right side per host, and embryos were cultured for 5, 9 or 12h. 
Node grafts were removed as described previously (Chapter 2.6) and the induced epiblast 
directly underneath the graft, which appeared greyish and thickened, was dissected. 
Uninduced epiblast tissue from same position on the contralateral side was also dissected. 
Tissue samples per condition were pooled, frozen on dry ice and stored at -80°C. For each time 
point (5, 9 or 12h) a total of 50 induced and corresponding uninduced pieces of tissue were 
collected. Additionally, 50 pieces of uninduced tissue were collected from HH4- embryos that 
had not been cultured, representing a 0h control. Tissue samples for each condition were then 
pooled and lysed in 1mL TRIzol® (Invitrogen) for RNA extraction. 
 
2.8 RNA-Sequencing 
Transcriptome sequencing was conducted by ARK Genomics (Roslin Institute, University of 
Edinburgh). Total RNA was extracted from Trizol by adding 200µL of 1-bromo-3-chloro-
propane (BCP), mixed and centrifuged for 15min at maximum speed. The solution divided into 
two phases, and 500µL of the upper aqueous phase was removed to a fresh RNAse free tube 
containing 1µL of Linear Acrylamide (Ambion: AM9520). A further 100µL of BCP were added 
and the sample mixed prior to centrifuging for 15min at maximum speed. Of this, 450µL of the 
upper aqueous phase was transferred to a fresh tube and 450µL of isopropanol was added. 
Each sample was allowed to precipitate at room temperature for 20min then centrifuged at 
maximum speed for 30min. The supernatant was removed from the RNA pellet which was 
then washed twice with 70% ethanol. The pellet was allowed to air dry for 10min before being 
re-suspended in 15µL of RNAse free water. RNA quality was assessed using the Agilent 2100 
Bioanalyzer. RNA samples should have a RNA Integrity Number (RIN) >7. All samples registered 
a RIN value between 9.2-10.0 (Appendix 2). 
From these, labelled RNA libraries were constructed using the Illumina® Truseq mRNA library 
preparation kit. In brief, mRNAs were selected from total RNA using oligo-dT conjugated 
magnetic beads to select transcripts with polyA tails. Following purification, mRNAs were 
chemically fragmented to an average size of 180-200 bases. Fragments were then transcribed 
using short random primers and reverse transcriptase to produce single-stranded cDNA. This 
was then used to produce double-stranded cDNA using DNA polymerase I and RNaseH. After 
synthesis the cDNA was blunt-ended and a single A-base added to the 3’ end. Molecularly 
barcoded sequencing adapters were ligated to fragments via a T-base overhang at their 3’ end, 
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to uniquely label separate RNA samples. Adapter-ligated fragments were then purified to 
remove unincorporated adapters before being enriched by 10 cycles of PCR. Library quality 
was checked by electrophoresis and quantified by qPCR. The 7 RNA libraries were sequenced 
over 2 lanes via 100-cycle, paired-end sequencing using the Illumina® HiSeq 2000 system. 
 
2.8.1 Galgal3 RNA-Seq analysis 
RNA-Seq analysis was conducted by M. Khan. 
 
2.8.1.1 Quality control of raw data 
Raw sequencing data for each condition were provided as FASTQ files. Before aligning reads to 
the chicken genome, sequencing reads underwent quality control analysis using the pipeline 
published by (Blankenberg et al., 2010). First, files were converted to FASTQSanger format 
using the “FASTQ Groomer” algorithm. The quality scores of reads were calculated using the 
“FASTQ Summary Statistics” algorithm. Quality scores were measured as phred =-10 log10(p), 
where “p” is the estimated probability of a base being called incorrectly. Reads with a phred 
score of equal to or greater than 20 (i.e. 99% probability of a base being correctly identified) 
were kept, while poor quality reads with phred scores of less than 20 were filtered out using 
the “FASTQ Quality Filter” algorithm. Quality statistics for the remaining paired-end reads were 
summarised as box plots of the average phred scores across bases 1-100 (Appendix 3, 4 and 5). 
Based on these, the reads in each condition were trimmed by 10 base pairs to remove lower 
quality regions which occur at the 3’ ends (where the phred score drops below 20). 
 
2.8.1.2 Alignment of reads to the chicken genome 
All reads that passed quality control analysis were aligned to the chicken genome (assembly 
version Gallus_gallus-2.1, GenBank Assembly ID GCA_000002315.1). Paired reads were aligned 
using the “TopHat” algorithm (Trapnell et al., 2009) to produce spliced alignments as BAM 
files. 
 
2.8.1.3 Differential expression analysis of transcripts 
Differential expression analysis was performed by comparing the counts for each transcript 
between uninduced and induced tissue at each time point (5, 9 and 12h) using two separate 
methods.  
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The first method followed the protocol published by (Trapnell et al., 2012). The “Cufflinks” 
algorithm was used to assemble transcripts from aligned paired reads. Once assembled, the 
transcripts for each pair of experimental and control samples were merged using the 
“Cuffmerge” algorithm. Differential expression analysis for constructed transcripts was then 
performed using “Cuffdiff”. Transcripts that were upregulated or downregulated with a log2 
fold change of at least 1.2 were extracted, and these formed the first data set. 
The second method used the “DESeq” algorithm to calculate differential expression. Initially 
the “easyRNASeq” algorithm (Delhomme et al., 2012), together with the Ensembl Galgal3 
Gene Transfer File (GTF) were used to assemble and count transcripts from aligned paired 
reads. Differential expression analysis for constructed transcripts was then performed using 
the “DESeq” algorithm (Anders and Huber, 2010), which is available as a package in R. 
Transcripts that were upregulated or downregulated with a log2 fold change of at least 1.2 
were extracted and these formed the second data set. 
Both data sets were then compared in an Excel spreadsheet and categorised as follows: 
transcripts commonly identified as significant by both methods (with a log2 fold change cut-off 
of 1.2 and a P-value cut-off of 0.05) were displayed as red, transcripts identified as significant 
by either method were displayed as orange and those identified as insignificant by both 
methods were displayed as yellow.  
 
2.8.1.4 Gene annotations and chromosome locations 
For both Cufflinks and DESeq analyses, gene annotations and chromosome locations were 
added to constructed transcripts using the Ensembl Galgal3 GTF. These analyses identified a 
total of 7745 differentially expressed transcripts across all 3 time points. Gene annotations 
could be assigned to 4508 of these, corresponding to 2333 unique genes. Due to the 
incomplete nature of the Galgal3 chicken genome, 3237 transcripts were left unannotated 
(Appendix 6). 
 
2.8.2 Galgal4 RNA-Seq reanalysis 
After analysing the RNA sequencing against the Galgal3 build of the chicken genome, the more 
complete Galgal4 assembly was released in 2013. We used this opportunity to reassess our 
data and increase the annotation coverage of transcripts. Reanalysis was conducted by M. 
Khan. 
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2.8.2.1 Alignment of reads to the chicken genome 
Reads that passed quality control analysis (Appendix 3, 4 and 5) were aligned to the chicken 
genome (assembly version Gallus_gallus-4.0, GenBank Assembly ID GCA_000002315.2). Paired 
reads were aligned using the “TopHat” algorithm as previously described (Chapter 2.8.1.2).  
 
2.8.2.2 Differential expression analysis of transcripts 
Due to the unstable nature of the Cufflinks suite of algorithms we decided to calculate 
differential expression in the Galgal4 reanalysis by DESeq alone. The “easyRNASeq” and 
“DESeq” algorithms were used as previously described (Chapter 2.8.1.3), only this time using 
the Ensembl Galgal4 GTF instead of Galgal3. The process was then repeated using the UCSC 
Galgal4 GTF to ensure that all available transcripts were constructed and extracted from both 
sets of annotations. 
 
2.8.2.3 Gene annotations and chromosome locations 
For the Ensembl constructed transcripts, gene annotations and chromosome locations were 
added using Ensembl Biomart data. For UCSC constructed transcripts, gene annotations and 
chromosome locations were added using UCSC Galgal4 GTF and annotation data from the 
UCSC table browser. In this way, two different lists of differentially expressed genes were 
generated based on Ensembl or UCSC annotations. Fully annotated transcripts from either 
Ensembl or UCSC lists were combined to provide the most comprehensive set of annotations. 
Unannotated transcipts with chromosome co-ordinates as well as transcripts belonging to 
unknown loci were also extracted from either list, to provide the most comprehensive list of 
differentially expressed transcripts based on currently available Ensembl and UCSC data. 
This reanalysis identified 8673 differentially expressed transcripts across the 3 time points. 
Gene annotations could be assigned to 7184 of these, corresponding to 4145 unique genes 
(1812 more than the initial Galgal3 analysis). Due to the incomplete nature of the chicken 
genome, 989 transcripts still remain unannotated; many less than the Galgal3 analysis 
(Appendix 8). 
 
2.8.3 Gene ontology analysis 
Gene ontology (GO) analysis was conducted on the annotated genes from both Galgal3 and 
Galgal4 analyses using the DAVID Bioinformatics Resources 6.7 (Huang et al., 2009a, Huang et 
al., 2009b). Gene symbols for differentially expressed genes at each time point were uploaded 
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onto the DAVID browser GO terms were assigned and downloaded into Microsoft Excel files. 
These were only used to extract genes with GO terms associated with transcriptional 
regulation. 
 
2.8.4 Identifying transcriptional regulators 
Of the differentially expressed candidates identified by Galgal3 and Galgal4 analysis, we were 
most interested in the transcriptional regulators. These were extracted in several ways from 
each data set. First, they were compared to lists of known transcriptional regulators available 
from transcription factor databases (e.g. JASPAR, Clover, RSAT and Transfac). Second, they 
were compared to all genes identified from gene ontology analysis as being associated with 
transcriptional regulation. Finally, all remaining genes were manually filtered based on full 
gene name, and their function verified using NCBI AceView (Thierry-Mieg and Thierry-Mieg, 
2006). Bar graphs representing log2 of the induced and uninduced base mean at each time 
point were plotted for all differentially expressed transcriptional regulators identified by 
Galgal3 and Galgal4 analyses (by M. Khan). 
 
2.9 Selecting chicken expressed sequence tag clones 
Chicken Expressed Sequence Tag (ChEST) clones were selected to serve as templates for 
riboprobe synthesis. First, the UCSC browser (www.genome.ucsc.edu) was searched using 
chromosome locations from the DE-Seq results, to confirm gene annotations in the Galgal3 or 
Galgal4 build of the chicken genome. The corresponding nucleotide sequences for coordinates 
were then extracted and double-checked with the NCBI BLASTn algorithm 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) using the nucleotide collection as the reference 
database. The nucleotide sequence from the RNA-Seq was then annotated using NCBI and 
Ensembl (http://www.ensembl.org/index.html) to distinguish exons, introns and untranslated 
regions (UTRs) of transcripts. Finally the annotated transcript was used to search the ChEST 
database (www.chick.manchester.ac.uk) for possible clones using the BLAST function 
(Boardman et al., 2002, Hubbard et al., 2005). Clones with the longest alignment coverage 
across exons and UTRs of the target region were selected. Clones that did not align well or 
which targeted intronic regions were avoided. Where possible, clones were picked to target 
known UTRs. Lastly, chosen ChEST clones were BLASTed against NCBI’s nucleotide collection to 
check that they corresponded to the target gene alone. Clones that showed cross-homology to 
other genes were discarded and more specific clones were picked instead.  
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Selected ChEST clones were ordered from Source Bioscience or ARK Genomics as fragments 
cloned into the pBluescriptKS+ vector. They arrived as sequence verified plasmid preparations 
or stab cultures which were used to prepare DNA and glycerol stocks, and served as the 
template from which to generate antisense riboprobes by PCR. A list of all clones obtained is 
provided in Chapter 2.16.2 and 2.16.3. 
 
2.10 RNA extraction 
Chicken tissue from HH14-18 embryos was dissected in sterile, ice-cold PBS and collected on 
ice. Tissue was centrifuged briefly and excess PBS removed. RNA was extracted using TRIzol® 
Reagent (Life Technologies) and following manufacturer’s instructions. Extracted RNA was re-
suspended in 20µL of RNase-free water, the concentration was measured and samples stored 
at -80°C. 
 
2.11 First-strand cDNA synthesis 
Single-stranded cDNA was synthesised from extracted RNA using the SuperScript® II First-
Strand Synthesis kit (Life Technologies, Cat. No: 11904-018). The basic manufacturer’s protocol 
was adapted as follows to generate single-stranded cDNA alongside a minus reverse 
transcriptase control. 
For each reaction the following were combined in a sterile PCR tube; 2µg extracted RNA, 1µL 
of oligo-dT primers (0.5µg/µL), 1µL random hexamers (50ng/µL) and DEPC water added to a 
total volume of 10µL. Tubes were mixed well and incubated at 65°C for 5min and 4°C for 1min. 
In two separate tubes the following were combined; 2µL of 10x reverse transcriptase buffer, 
4µL of 25mM MgCl2, 2µL of 0.1M DTT and 1µL of RNaseOUT™ (40U/µL). This mixture was 
added to the RNA and primer reaction, mixed well and incubated at 42°C for 2min. To one 
tube, 1µL of SuperScript™ II reverse transcriptase was added, while 1µL of DEPC water was 
added to the second tube as a minus reverse transcriptase control. The mixture was incubated 
at 42°C for 50min, 70°C for 15min and stopped at 4°C. The reactions were briefly centrifuged 
and 1µL of RNase H was added to each tube and incubated at 37°C for 20min. A sample of 
each reaction was run on an agarose gel to check for cDNA product. The remaining single-
stranded cDNA was diluted 1:5 in DEPC water and stored at -20°C. 
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2.12 Cloning cDNA templates for riboprobes 
Appropriate ChEST templates could not be identified for some candidates identified by RNA-
Seq. Instead, templates for these were cloned by PCR from single-stranded cDNA using primers 
designed to amplify approximately 1kb regions of the target cDNA. Primers were designed 
using Primer3 software (Koressaar and Remm, 2007, Untergasser et al., 2012) and checked for 
their specificity in Primer-BLAST (Ye et al., 2012). 
The following primers were designed to clone the specified regions of each cDNA target: 
Target cDNA Forward and Reverse Primers 
Primer 
Ta 
Product 
Size 
Coverage 
PRDM1  
ENSGALT00000024824 
F: CAACGTTTGCTCCAAGACCT 
R: TTAGTAACTGGCGAGGCAAC 
58°C 958bp 
Partial exon 
7-3’UTR 
GRHL2 
ENSGALT00000022978 
F: TGACCCCACAAGCACACTAT 
R: AGAGAACTGGCTGGGAATCC 
60°C 924bp 
Partial exons 
4-11 
STOX1 
ENSGALT00000006552 
F: AGTACCTCGGCTGAAGTGTC 
R: TTGTCACTATCATCACGCGC 
58°C 998bp 
Partial exons 
2-3 
TRIM3 
ENSGALT00000029931 
F: CCATCCTCAACCTGGGAGTT 
R: TCCATCCGCATTGTACACCT 
58°C 1028bp 
Partial exons 
6-11 
Table 2.3: Primers targeting chick PRDM1, GRHL2, STOX1 and TRIM3 cDNA fragments. 
 
Primers (Invitrogen) were re-suspended in sterile water to a concentration of 100µM. A 10µM 
working stock was made for each primer. Fragments were cloned by PCR using GoTaq® Flexi 
DNA Polymerase (Promega, Cat. No: M829) and following manufacturer’s instructions.  
A 2µL sample of each reaction was run on an agarose gel to check the product size. Where a 
single band of the appropriate size was generated, the remaining reaction was purified using 
the QIAquick PCR Purification Kit (Qiagen) and following manufacturer’s instructions. Where 
multiple bands were generated, the remaining reaction was run on a fresh gel and the 
appropriate sized bands excised and the DNA extracted using the QIAquick Gel Extraction Kit 
(Qiagen) and following manufacturer’s instructions. The final concentration of the purified 
product was measured. 
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2.13 Ligation of cloned fragments into plasmids 
Cloned fragments were ligated into the pGEM®-T Easy vector (Promega) via their overhanging 
A base at the 3’ end. Ligation reactions were set up following the manufacturer’s instructions 
and incubated for 2h at room temperature or overnight at 14°C.  
Ligation products were transformed into competent bacterial cells (see Chapter 2.14) and 
plated onto LB agar plates supplemented with ampicillin, IPTG and X-gal. Plates were 
incubated overnight at 37°C and 6-10 white colonies were inoculated into 5mL of LB medium 
supplemented with ampicillin.  
Plasmids were extracted using the QIAprep Spin Miniprep Kit (Qiagen) and diagnostic digests 
were used to generate specific fragments by cleaving at one site within the vector and at one 
site within the predicted insert. Plasmids that produced appropriate digest products were 
sequenced by Source Bioscience using T7 or SP6 sequencing primers to confirm clone identity. 
 
2.14 Chemical transformation of competent cells 
Competent cells were produced via chemical transformation using the following protocol 
(Walhout et al., 2000), modified from (Chung and Miller, 1988). 
 
2.15 Plasmid transformation and DNA preparation 
Plasmids were acquired as DNA preparations suspended in water or spotted onto filter paper. 
DNA was recovered from filter paper by soaking it in 50µL of sterile water and incubating for 
2h at 37°C. 
Chemically transformed competent cells were thawed on ice. To these, 10µL of the recovered 
DNA or 1-5µL of DNA from a plasmid preparation was added, mixed gently and incubated on 
ice for 30min. Cells were heat-shocked for 2min at 42°C. Tubes were then returned to ice and 
500µL of SOC medium added. Cells were then incubated for 30min at 37°C while shaking, and 
200µL plated onto LB agar plates supplemented with the appropriate antibiotic resistance 
(100µg/mL ampicillin, 50µg/mL kanamycin, 100µg/mL carbenicillin or 10µg/mL tetracycline). 
Where blue/white colony selection was required, plates were treated with 100µL of 100mM 
IPTG and 20μL of 50mg/mL X-Gal prior to plating. 
Plated colonies were grown overnight and a single colony was inoculated into 5, 50 or 200mL 
(depending on mini, midi or maxi preparation requirements) of LB medium supplemented with 
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the appropriate antibiotic. Plasmids were extracted using the appropriate mini-, midi- or maxi-
prep kits (Qiagen) and following the manufacturer’s instructions.  
Glycerol stocks were generated by adding 500 µL of the bacterial culture suspension to 500µL 
of sterile glycerol. Tubes were flicked to mix, snap-frozen on dry ice and stored at -80°C. 
 
2.16 Synthesis of labelled riboprobes for in situ hybridisation 
Antisense riboprobes were generated from plasmid templates containing a cDNA clone of the 
gene of interest either by initial digest or PCR. 
 
2.16.1 Riboprobe synthesis by restriction enzyme digest 
To generate probes by digest, 10µg of plasmid was linearised by using the appropriate 
restriction enzyme to cut 5’ of the insert in the sense orientation. Digest reactions were then 
run on an agarose gel to confirm complete linearisation. DNA was extracted into the top phase 
after adding an equal volume of phenol:chloroform. It was then precipitated overnight at -20°C 
by adding sodium acetate and absolute ethanol. DNA was pelleted by centrifugation for 15min 
at 13.2rpm in a chilled centrifuge and washed with 70% ethanol. The pellet was spun again for 
15min and the alcohol removed. The pellet was allowed to air-dry completely, before being re-
suspended in 8µL of ultrapure water to give an approximate concentration of 1µg/mL.  
This linearised template was used to transcribe probes in the antisense direction using the 
appropriate T7, T3 or SP6 polymerase (Promega) and following manufacturer’s instructions. 
Reactions were set up for 3h at 37°C using 1µL or 3µL of template and digoxigenin (DIG) or 
fluorescein (FLU) labelled nucleotides to generate antisense labelled riboprobes. Next, RNase-
free DNase was added for 45min at 37°C to digest the DNA template. To check that a probe 
had been synthesised and the template digested, 2µL of the reaction was run on an agarose 
gel. The reaction was stopped by adding EDTA and the RNA precipitated overnight at -20°C 
using lithium chloride and absolute ethanol. RNA was pelleted by centrifugation for 15min at 
4°C and then washed with 70% ethanol and spun again. Finally the pellet was washed with 
100% ethanol, spun and left to air-dry completely. Pellets were dissolved in 50µL of ultrapure 
water and the concentration measured. To this, Hybridisation (HYB) solution was added to give 
a 1:1 ratio of water:HYB and the probe stored at -20°C. Working probes were diluted to 
approximately 1µg/mL in HYB. 
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2.16.1.1 List of riboprobes synthesised by digest 
The following riboprobes were generated by restriction digest and transcription. 
Gene Kind gift of Linearised Transcribed Reference 
BMI1 T. Sauka-Spengler XhoI SP6 
(Fraser and Sauka-
Spengler, 2004) 
BRACHYURY (T)  V. Cunliffe  XbaI  T3 (Smith et al., 1991) 
CBFA2T2 
(MTGR1) 
N. Koyano-
Nakagawa 
NotI T7 
(Koyano-Nakagawa 
and Kintner, 2005) 
CCND1 F. Pituello HindIII T7 (Lobjois et al., 2004) 
CDX2 A. Fainsod ClaI T3 (Marom et al., 1997) 
CDX4 G. Sheng ApaI SP6 (Alev et al., 2010) 
CHORDIN - EcoRI SP6 (Streit et al., 1998) 
CYP26A1 M. Maden BamHI T7 (Swindell et al., 1999) 
DACH1 C. Tabin SmaI T7 (Heanue et al., 2002) 
DLX3 E. Pera HindIII SP6 (Pera and Kessel, 1999) 
DLX5 G. Lizarraga BamHI T3 (Ferrari et al., 1995) 
EOMES B. Pain SalI T7 
(Pernaute et al., 2010)  
(Jean et al., 2015) 
ERNI - KpnI T3 (Streit et al., 2000) 
ETS2 (ETV3) A. Mey NheI T3 (Mey et al., 2012) 
ETV1 (ER81) K. Storey NotI T7 (Lunn et al., 2007) 
ETV4 (PEA3) K. Storey NotI T7 (Lunn et al., 2007) 
EYA2 S. Tomarev NotI T7 
(Mishima and 
Tomarev, 1998) 
GATA2 - NdeI T7 
(Sheng and Stern, 
1999) 
GATA4 B. Pain ApaI SP6 
(Chapman et al., 2007) 
(Jean et al., 2015) 
GATA5 B. Pain ApaI SP6 
(Chapman et al., 2007) 
(Jean et al., 2015) 
GATA6 B. Pain NcoI SP6 
(Chapman et al., 2007) 
(Jean et al., 2015) 
GBX2 A. Streit BglII T3 
(Shamim and Mason, 
1998) 
GLI2 J. Briscoe HindIII T3 (Marigo et al., 1996) 
GLI3 J. Briscoe EcoRV T3 
(Schweitzer et al., 
2000) 
GOOSECOID - NotI T7 
(Izpisua-Belmonte et 
al., 1993) 
HAND1 D. Srivastava BamHI T7 (Srivastava et al., 1995) 
HESX1 S. Mackem XhoI T3 (Hermesz et al., 1996) 
HEY1 M. Gessler EcoRI T3 
(Leimeister et al., 
2000) 
HNF1B (vHNF1) C. Pujades SacII T7 
(Aragon and Pujades, 
2009) 
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Gene Kind gift of Linearised Transcribed Reference 
HOXB1 V. Prince XbaI T7 (Paxton et al., 2010) 
ID2 M. Bronner EcoRI T7 (Martinsen et al., 2004) 
IRX2 T. Ogura XhoI T3 
(Matsumoto et al., 
2004) 
KLF2 P. Antin EcoRI T7 (Antin et al., 2010) 
KLF4 P. Antin NotI T3 (Antin et al., 2010) 
KLF5 
ChEST429a18 
P. Antin NotI T3 (Antin et al., 2010) 
KLF6 
ChEST837d22 
P. Antin NotI T3 (Antin et al., 2010) 
LIN28A B. Pain ApaI SP6 
(Yokoyama et al., 2008) 
(Jean et al., 2015) 
LMO7 
ChEST860d14 
D. Burt NotI T3 - 
LMX1B C. Tabin SpeI T7 (Riddle et al., 1995) 
MAFA (L-MAF) H. Ogino XbaI T7 
(Ogino and Yasuda, 
1998) 
MSX1 K. Liem BglII T3 (Suzuki et al., 1991) 
MSX2 C. Tickle SacI T7 (Brown et al., 1997) 
NANOG B. Pain ApaI SP6 
(Lavial et al., 2007) 
(Jean et al., 2015) 
NKX6-2 J. Ericson XbaI T7 (Pattyn et al., 2003) 
NODAL M. Kuehn NotI T7 (Levin et al., 1995) 
NOT1 M. Kessel EcoRI T7 (Stein et al., 1996) 
NOT2 M. Kessel HindIII T7 (Stein et al., 1996) 
OTX2 L. Bally-Cuif XhoI T3 (Bally-Cuif et al., 1995) 
PITX2 M. Levin PstI T7 (Zhu et al., 1999) 
RUNX1T1 
(MTG8) 
N. Koyano-
Nakagawa 
NotI T7 
(Koyano-Nakagawa 
and Kintner, 2005) 
SIX3 P. Bovolenta ClaI T3 (Bovolenta et al., 1998) 
SMAD6 P. Szendro XbaI T7 
(Vargesson and Laufer, 
2001) 
SMAD7 E. Laufer EcoRI T3 
(Vargesson and Laufer, 
2001) 
SMAD9 (SMAD8) J. Hurle SacI T7 
(Zuzarte-Luis et al., 
2004) 
SNAI1 
ChEST366k21 
ARK Genomics NotI T3 
(Garcia-Castro et al., 
2000) 
SOX1 H. Kondoh XhoI T7 (Kamachi et al., 1998) 
SOX11 M. Bronner BamHI T3 - 
SOX2 P. Scotting PstI T7 (Rex et al., 1997) 
SOX3 P. Scotting PstI T7 (Rex et al., 1997) 
SP5 S. Kuratani EcoRI T7 (Kuraku et al., 2005) 
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Gene Kind gift of Linearised Transcribed Reference 
STOX2 
ChEST851g13 
A. Streit NotI T3 - 
TBX3 C. Tickle XhoI T3 (Isaac et al., 1998) 
TBX6 S. Mackem XbaI T7 (Knezevic et al., 1997) 
TGIF1 J. Hurle SacI T7 
(Lorda-Diez et al., 
2009) 
TRKC C. Kalcheim BamHI T7 
(Kahane and Kalcheim, 
1994) 
ZEB2 (SIP1) - SacII SP6 (Sheng et al., 2003) 
ZIC2 K. Storey NcoI SP6 (Warner et al., 2003) 
Table 2.4: The source and preparation of riboprobes synthesised by digest. 
 
2.16.2 Riboprobe synthesis by PCR 
Where cDNA plasmids contained M13F and M13R promoter sites flanking the insert and RNA 
polymerase sites (e.g. ChEST clones and other pBluescript or pGEM-T-easy vectors), the insert 
was first amplified by PCR. This approach was quicker than the digest method as it requires 
much less starting material (5ng as opposed to 10µg of DNA) and so mini-prep DNA is 
sufficient. In addition, ChEST plasmids tend to comprise 600-1000bp cDNA fragments cloned 
into the same pBluescriptKS+ (Stratagene) vector, so it is simple to set up the same PCR 
reaction for different templates. 
Primers for M13F (GTAAAACGACGGCCAGT) and M13R (GCGGATAACAATTTCACACAGG) 
promoter sites were used to amplify the insert and flanking T3/T7/SP6 polymerase sites. PCR 
reactions were set up on ice using the following reagents and cycling conditions. Control 
reactions were set up by omitting the plasmid and substituting with H20. 
 
Reagents Volume (µL)  Step Purpose Conditions 
Ultrapure H20 4.6  1 Hot start 95°C for 5min 
GoTaq® Flexi Buffer (5x) 2.0  2 Denature 95°C for 1min 
MgCl2 (25mM) 1.0  3 Annealing 50°C for 1min 
dNTP mix (10mM) 0.2  4 Extension 72°C for 1min/kb 
M13F (10µM) 0.5  5 Return to step 2 34 times 
M13R (10µM) 0.5  6 Final extension 72°C for 5min 
Plasmid DNA (5ng/µL) 1.0  7 Hold 4°C forever 
GoTaq® Polymerase 0.2     
Total 10.0     
Table 2.5: PCR recipe and conditions for riboprobe amplification from cDNA plasmids. 
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Upon completion, 1µL of each reaction was run on an agarose gel to check that a single band 
had been amplified. A very faint, larger band may also be observed for the plasmid template. 
Reaction products were used directly as the transcription template, without the need for 
purification. Transcription reactions were set up as described for riboprobes generated by 
digest (Chapter 2.16.1), using 1µL or 3µL of the PCR reaction as a template from which to 
directly to synthesise labelled antisense riboprobes. RNA was precipitated and re-suspended in 
HYB as before. 
 
2.16.2.1 List of riboprobes synthesised by PCR 
The following riboprobes were generated by PCR followed by transcription. 
Gene 
Obtained 
from/Kind gift of 
Linearised Transcribed Reference 
AHR 
ChEST355d19 
Source Bioscience M13F/R T3 - 
AXIN2 
ChEST755b16 
C. Kiecker M13F/R T3 (Quinlan et al., 2009) 
ARID5B 
ChEST60e17 
Source Bioscience M13F/R T3 - 
ATF3 
ChEST425m11 
Source Bioscience M13F/R T3 - 
BACH1 
ChEST761e22 
Source Bioscience M13F/R T3 - 
BACH2 
ChEST593g13 
Source Bioscience M13F/R T3 - 
BHLHE40 
(BHLHB2) 
ChEST258o16 
Source Bioscience M13F/R T3 - 
CDCA7 
ChEST252j12 
Source Bioscience M13F/R T3 - 
CEBPB 
ChEST664e19 
Source Bioscience M13F/R T7 - 
CITED4 (CITED3) 
ChEST150g1 
Source Bioscience M13F/R T3 (Andrews et al., 2000) 
CREB3L1 
ChEST441l21 
Source Bioscience M13F/R T3 - 
CREG1 
ChEST368d4 
Source Bioscience M13F/R T3 - 
CRIP2 
ChEST741k5 
Source Bioscience M13F/R T3 - 
CSRP2 
ChEST77p7 
Source Bioscience M13F/R T3 - 
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Gene 
Obtained 
from/Kind gift of 
Linearised Transcribed Reference 
DMBX1 
ChEST244g19 
Source Bioscience M13F/R T3 (Ferran et al., 2007) 
DNMT3A 
ChEST425j12 
A. Streit M13F/R T3 (Hu et al., 2012) 
DNMT3B 
ChEST405f22 
A. Streit M13F/R T3 
 
ELF1 
ChEST188c18 
Source Bioscience M13F/R T3 - 
ELF3 
ChEST546f17 
Source Bioscience M13F/R T3 - 
ENC1 
ChEST689f18 
Source Bioscience M13F/R T3 - 
EPAS1 (HIF2A) G. Sheng M13F/R SP6 (Ota et al., 2007) 
ESRRG 
ChEST593B16 
ARK Genomics M13F/R T3 - 
ETV5 (ERM) 
ChEST337i4 
M. Bronner M13F/R T3 (Lunn et al., 2007) 
EZH2 
ChEST511d7 
Source Bioscience M13F/R T3 - 
FKHR (FOXO1A) 
ChEST232b16 
Source Bioscience M13F/R T3 - 
FOXO3 
ChEST558l10 
Source Bioscience M13F/R T3 - 
FRY 
ChEST309m11 
Source Bioscience M13F/R T3 - 
GRHL1 
ChEST301e4 
Source Bioscience M13F/R T3 - 
GRHL2 
Cloned by K. 
Trevers 
M13F/R T7 - 
GRHL3 
ChEST664c10 
Source Bioscience M13F/R T3 - 
HIC2 
ChEST902c20 
Source Bioscience M13F/R T3 - 
HIPK2 
ChEST436n24 
Source Bioscience M13F/R T3 - 
HIVEP2 
ChEST8c12 
Source Bioscience M13F/R T3 - 
HIVEP3 
ChEST341h23 
Source Bioscience M13F/R T3 - 
HOXA1 
ChEST1010d14  
Source Bioscience M13F/R T3 
(McClintock et al., 
2003) 
HOXA2 
ChEST671c8  
Source Bioscience M13F/R T3 
(Prince and Lumsden, 
1994) 
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Gene 
Obtained 
from/Kind gift of 
Linearised Transcribed Reference 
ID3 
ChEST2M18 
ARK Genomics M13F/R T3 
(Kee and Bronner-
Fraser, 2001) 
ING5 
ChEST696i13 
A. Streit M13F/R T3 - 
IRF7 (IRF3) 
ChEST45h21 
Source Bioscience M13F/R T3 - 
ISX 
ChEST595l5 
Source Bioscience M13F/R T3 - 
IVNS1ABP 
ChEST452o4 
Source Bioscience M13F/R T3 - 
JMJD4 
ChEST427j1 
Source Bioscience M13F/R T3 - 
KAT2B 
ChEST481p23 
Source Bioscience M13F/R T3 - 
KDM4A 
ChEST121j8 
Source Bioscience M13F/R T3 - 
LHX5 
ChEST455n21 
Source Bioscience M13F/R T3 - 
LIN28B 
ChEST770i7 
Source Bioscience M13F/R T3 - 
LMO1 
ChEST410h4 
Source Bioscience M13F/R T3 - 
MAML2 
ChEST243a24 
Source Bioscience M13F/R T3 - 
MBNL2 
ChEST476i5 
Source Bioscience M13F/R T3 - 
MEF2D 
ChEST535j15 
Source Bioscience M13F/R T3 - 
MEIS1 
ChEST397o24 
Source Bioscience M13F/R T3 (Mercader et al., 1999) 
MEIS2 A. Streit M13F/R SP6 (Mercader et al., 1999) 
MTA1 
ChEST87a11 
Source Bioscience M13F/R T3 - 
MYC (C-MYC) 
ChEST895e1 
M. Bronner M13F/R T3 
(Khudyakov and 
Bronner-Fraser, 2009) 
MYCN (N-MYC) 
ChEST442N13 
M. Bronner M13F/R T3 
(Khudyakov and 
Bronner-Fraser, 2009) 
NCOA2 
ChEST304i18 
Source Bioscience M13F/R T3 - 
NFKBIZ 
ChEST142K1 
ARK Genomics M13F/R T3 - 
NKX1-2 
ChEST427n5 
Source Bioscience M13F/R T3 (Bertrand et al., 2000) 
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Gene 
Obtained 
from/Kind gift of 
Linearised Transcribed Reference 
NRIP1 
ChEST97g15 
Source Bioscience M13F/R T3 - 
NSD1 
ChEST995e21 
A. Streit M13F/R T3 - 
OVOL2 
ChEST627k2 
Source Bioscience M13F/R T3 - 
PDCD4 
ChEST132g13 
Source Bioscience M13F/R T3 - 
PDLIM1 
ChEST982m14 
Source Bioscience M13F/R T3 - 
PDLIM4 
ChEST384d10 
Source Bioscience M13F/R T3 - 
PDLIM5 
ChEST594j18 
Source Bioscience M13F/R T3 - 
PITX3 
ChEST292n23 
Source Bioscience M13F/R T3 - 
PPARGC1A 
ChEST999p5 
Source Bioscience M13F/R T3 - 
PRDM1 (BLIMP1) 
Cloned by K. 
Trevers 
M13F/R T7 (Ha and Riddle, 2003) 
PTRF 
ChEST224k9 
Source Bioscience M13F/R T3 - 
RARB 
ChEST392d11 
Source Bioscience M13F/R T3 - 
RASSF7 
ChEST733e13 
Source Bioscience M13F/R T3 - 
RB1 
ChEST613e5 
Source Bioscience M13F/R T3 - 
RFX3 
ChEST399m9 
Source Bioscience M13F/R T3 - 
RREB1 
ChEST262i21 
ARK Genomics M13F/R T3 - 
SALL1 
ChEST818L4 
ARK Genomics M13F/R T3 
(Sweetman et al., 
2005) 
SCML2 
ChEST818b24 
Source Bioscience M13F/R T3 - 
SERTAD2 
ChEST464c24 
Source Bioscience M13F/R T3 - 
SETD2 
ChEST525a17 
A. Streit M13F/R T3 - 
SMARCA2 
ChEST885f13 
Source Bioscience M13F/R T3 - 
SOX13 
ChEST103b23 
Source Bioscience M13F/R T3 - 
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Gene 
Obtained 
from/Kind gift of 
Linearised Transcribed Reference 
STOX1 
Cloned by K. 
Trevers 
M13F/R SP6 - 
TAF1A 
ChEST580f1 
Source Bioscience M13F/R T3 - 
TBL1XR1 
ChEST921d17 
Source Bioscience M13F/R T3 - 
TCF12 
ChEST101h2 
Source Bioscience M13F/R T3 - 
TCF7L1 (TCF3) A. Munsterberg M13F/R T3 (Schmidt et al., 2004) 
TCF7L2 (TCF4) 
ChEST583d9 
Source Bioscience M13F/R T3 
(Hartmann and Tabin, 
2000) 
TFAP2A 
ChEST765g1 
Source Bioscience M13F/R T3 
(Khudyakov and 
Bronner-Fraser, 2009) 
TFAP2C 
ChEST712l8 
Source Bioscience M13F/R T3 (Qiao et al., 2012) 
TFAP2E 
ChEST104e8 
Source Bioscience M13F/R T3 - 
TFCP2L1 
ChEST831a6 
Source Bioscience M13F/R T3 - 
TRIM3 
Cloned by K. 
Trevers 
M13F/R T7 - 
TRIM9 
ChEST850f24 
Source Bioscience M13F/R T3 - 
TRIM24 
ChEST401k15 
A. Streit M13F/R T3 - 
VGLL1 
ChEST869b3 
Source Bioscience M13F/R T3 - 
WWTR1 
ChEST1024a14 
Source Bioscience M13F/R T3 - 
YEATS4 (GAS41) 
ChEST9i5 
A. Streit M13F/R T3 - 
ZBTB46 
ChEST22g17 
Source Bioscience M13F/R T3 - 
ZFHX3 
ChEST472L4 
A. Streit M13F/R T3 - 
ZFPM1 
ChEST999l13 
Source Bioscience M13F/R T3 - 
ZIC3 
ChEST289o16 
Ark Genomics M13F/R T3 - 
ZMYND11 
ChEST675h24 
Source Bioscience M13F/R T3 - 
ZNF185 
ChEST630j23 
Source Bioscience M13F/R T3 - 
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Gene 
Obtained 
from/Kind gift of 
Linearised Transcribed Reference 
ZNF423 
ChEST39g7 
A. Streit M13F/R T3 - 
ZNF462 
ChEST236b12 
A. Streit M13F/R T3 - 
ZNF469 
ChEST231n23 
Source Bioscience M13F/R T3 - 
Table 2.6: The source and preparation of riboprobes synthesised by PCR. 
 
2.17 Whole-mount in situ hybridisation 
Whole-mount in situ hybridization using DIG- or FLU-labelled riboprobes was performed as 
previously described (Stern, 1998, Streit and Stern, 2001). This protocol is mainly based on 
those by D. Henrique and D. Ish-Horowicz, who in turn modified protocols from R. Conlon, R. 
Harland, P. Ingham and D. Wilkinson.  
In brief, embryos were fixed in 4% PFA for 1h at room temperature or overnight at 4°C and 
stored in 100% methanol at -20°C for up to one week. They were then progressively 
rehydrated through a 75%, 50%, 25% series of methanol in 1x PBS containing 0.1% Tween-20 
(PBTW) before being washed on a rocker for 2 x 10min in PBTW. Embryos were then incubated 
in 10µg/mL of Proteinase K (Sigma) diluted in PBTW to permeabilise tissue and digest RNAses. 
Tubes were gently rotated to coat the entire tube with Proteinase K and the length of 
incubation varied depending on the stage of embryo and whether it had been New cultured. 
Typical times include 3-5min for EGK XII-HH3, 8min for HH3-5 and, 12min for HH6-8 and 15min 
or more for HH9 onwards. New cultures embryos were never incubated for longer than 8min 
due to their fragile nature. Embryos were then rinsed briefly in PBTW and post-fixed for 30min 
with 4% PFA containing 0.1% Tween-20 and 0.1% glutaraldehyde. Finally they were rinsed 
twice briefly in PBTW to remove fixative and stored until required at -20°C in hybridisation 
(HYB) solution. HYB contains final concentrations of 50% formamide, 1.3x SSC pH4.5, 5mM 
EDTA pH8.0, 50µg/mL Torula Yeast RNA (Sigma), 100µg/mL Porcine Heparin (Sigma), 0.5% 
CHAPS, 0.2% Tween-20 dissolved to a final volume of 1L in autoclaved H2O. 
Prior to hybridisation, embryos and riboprobes were pre-heated in a water bath to 70°C for 2-
3h. Probes were then added to embryos and hybridised overnight at 70°C. For probes shorter 
than 400nt, the hybridisation temperature was reduced to allow annealing; 65-68°C for 200-
350nt and 62-65°C for 100-200nt. For double-labelled in situ hybridisation, a mixture of 2 
probes was added to embryos, each labelled with DIG or FLU. 
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The following day, probes were removed and saved for re-use. Embryos were rinsed 3x and 
washed for 2x 30min with preheated HYB at 70°C. Next, they were washed for 20min with a 
preheated 1:1 mixture of HYB:TBST. TBST was diluted 1:10 from a 10x stock containing 80g 
NaCl, 2g KCl, 250mL 1M Tris-HCl pH7.5, 110g Tween-20, dissolved to a final volume of 1L with 
H2O. Embryos were then rinsed 3x followed by 3x 30min washes with 1xTBST before being 
blocked for 3h at room temperature. Blocking buffer contained 5% heat inactivated goat 
serum with 1mg/mL Bovine Serum Albumin (BSA) dissolved in TBST. Embryos were then 
incubated overnight at 4°C on a rocking platform in fresh blocking buffer containing sheep 
anti-DIG-AP conjugated Fab fragments, or anti-FLU-AP conjugated Fab fragments (Roche) at a 
1:5000 concentration. 
On day 3, the antibody solution was removed and embryos were rinsed 3x TBST and washed 
3x 1h TBST before being returned to the 4°C rocker overnight. On day 4 embryos were washed 
in NTMT for 2x 10min. NTMT contains a final concentration of 100mM NaCl, 100mM Tris-HCl 
pH9.5, 50mM MgCl2 and 1% Tween-20. Colour staining was developed at room temperature 
by adding colour buffer containing 2.3µL of 5-Bromo-4-chloro-3-indolyl phosphate (BCIP) and 
3µL of 4-Nitro-blue-tetrazolium chloride (NBT) (Roche) per mL of NTMT.  Embryos were 
protected from the light and left rocking. Staining was stopped by rinsing embryos in NTMT at 
4°C for several days before washing 2x 10min in PBTW and storing in 4% PFA. 
For double-labelled in situ hybridisation, embryos were fixed for at least 24h at 4°C. Then, they 
were rinsed 3x and washed 5x 30min in TBST containing 0.1% Tween-20 rather than 1%. 
Remaining alkaline phosphatase activity was quenched by incubating embryos at 70°C for 1h 
before washing 3x 15min in TBST containing 0.1% Tween and 3x 15min in TBST containing 1% 
Tween. Embryos were blocked for 2h at room temperature as before and then incubated 
overnight at 4°C with anti-DIG or anti-FLU to reveal the second probe. 
After removing the antibody, embryos were washed as before; 3x rinses followed by 3x 1h 
washes with TBST and 2x 10min washes in NTMT. Colour was developed by adding NTMT 
containing 7.5µL INT-BCIP (Roche) per mL and stopped by washing in NTMT at 4°C for several 
days before washing 2x 10min in PBTW and fixing in 4% PFA. 
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2.18 Whole-mount antibody staining 
Antibody staining was performed after in situ hybridisation. Embryos were re-fixed in 4% PFA 
overnight at 4°C and then rinsed 3x 10min and washed 3x 1h in PBTW. They were then blocked 
for 1h at room temperature in blocking buffer containing 1mg/mL BSA, 5% heat inactivated 
goat serum in PBTW before being incubated for 2 nights at 4°C with primary antibody diluted 
in blocking buffer as previously described (Streit et al., 1995, Streit et al., 1997). Next, embryos 
were rinsed 3x 10min and washed 3x 1h with PBTW before being incubated in Horse radish 
peroxidase (HRP)-conjugated secondary antibody in blocking buffer overnight at 4°C. Again, 
embryos were rinsed 3x 10min and washed 3x 1h with PBTW before being washed 2x 20min 
with 0.1M Tris-HCl pH7.4. HRP activity was revealed using 0.5mg/mL 3, 3'-diaminobenzidine 
(DAB) in 0.1M Tris-HCl pH7.4 containing 0.003% hydrogen peroxide. 
To reveal quail graft tissue, mouse monoclonal QCPN IgG; 1:5 (Developmental Studies 
Hybridoma Bank) followed by goat anti-mouse-HRP IgG; 1:1000 (Jackson Immunoresearch). 
For staining GFP-chick graft tissue, rabbit polyclonal anti-GFP IgG; 1:2000 (Molecular Probes) 
followed by goat anti-rabbit-HRP IgG; 1:2000 (Santa-Cruz).  
 
2.19 Paraffin embedding and sectioning of embryos 
Where necessary, embryos were sectioned after whole-mount imaging. They were prepared 
for paraffin embedding by processing with the following solutions; absolute methanol for 
10min, propan-2-ol for 5min and tetrahydronaphthalene for 30min. To this, melted paraffin 
wax was added to give a 1:1 mixture of tetrahydronaphthalene:wax and embryos were left to 
equilibrate at 60°C. Fresh wax was then replaced 3x 1h and then left overnight at 60°C. The 
following day embryos were embedded into small plastic trays and the wax left to cool gently. 
Wax blocks were trimmed and orientated before being sectioned to 10-12µm on a microtome. 
Sections were mounted on slides treated with glycerin-albumin. Slides were left to dry 
overnight at 37°C before subsequent dewaxing with histoclear. The first histoclear wash was 
left overnight and the second for several hours. Coverslips were mounted using a 3:1 mixture 
of Canada Balsam:histoclear and left to dry completely before imaging. 
 
2.20 Imaging of whole-mount and sectioned embryos 
Whole-mount embryos were imaged on a white background and illuminated with transmitted 
and reflected light. All images were taken from the dorsal perspective unless otherwise stated. 
Embryos were oriented on an Olympus SZH10 Stereomicroscope with an Olympus DF PlanApo 
1X objective and an Olympus NFK 3.3x LD 125 photo eyepiece.   
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Sections were imaged on an Olympus Vanox-T optical microscope using either Olympus SPlan 
20x (0.46 PL 160/0.17) or Olympus SPlan 10x (0.30 PL 160/0.17) objectives.  
Images were captured using the QImaging Retiga 2000R Fast 1394 camera and QCapture Pro 
software. They were saved as 24-bit, colour TIFF files with dimensions of 1600 x 1200 pixels, at 
300dpi. 
 
2.21 NanoString nCounter 
2.21.1 A custom NanoString probe set for neural induction  
NanoString experiments were run on the nCounter Analysis System, using a custom probe set 
and following NanoString guidelines. The probe set was designed to include the following: 
1. Upregulated genes at 5, 9 and 12h with a fold change of 1.2 log2 and RNA-Seq induced 
base mean of at least 45.  
2. Downregulated candidates at 5, 9 and 12h with a fold change of 1.2 log2 and RNA-Seq 
uninduced base mean of at least 200.  
3. All candidate genes from the original 5h neural induction screen. 
4. Standard housekeeping genes (ACTB, GAPDH and LDHA) and endogenous controls 
identified from the RNA-Seq screen, which show no variation between samples. 
5. Markers of apoptosis and proliferation 
6. Transcriptional readouts of FGF, BMP, WNT, Retinoic acid, Notch and Hedgehog 
signalling. 
7. Markers of other cell fates: epithelial, mesodermal, endodermal, neural plate border, 
pre-placodal region, neural crest and Hensen’s node. 
8. Standard NanoString control probes: 6 positive and 8 negative. 
 
2.21.2 Tissue collection for NanoString analysis 
Uninduced tissue or induced epiblast that had been exposed to node and bead grafts was 
dissected as previously described (Chapter 2.6). Per condition, 4-12 pieces of tissue were 
dissected in ice-cold PBS and collected in triplicate. Tissue was collected on ice and promptly 
processed by adding 4µL of lysis buffer from the RNAqueous®-Micro Total RNA Isolation Kit 
(Ambion). Where fewer pieces of tissue were collected, these were processed in 2µL of lysis 
buffer and later combined with other samples to make up the numbers and volume. After the 
addition of lysis buffer, tubes were immediately snap-frozen on dry ice and stored at -80°C. 
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Tissue for all NanoString experiments was collected in this way. To refine the time-course of 
induction, induced and uninduced tissue was collected after Hensen’s node grafts for 1, 3, 5, 7, 
9 and 12h. The contributions of particular signalling pathways to neural induction were 
assessed by perturbation. Tissue from FGF, BMP inhibition, WNT inhibition, retinoic acid and 
Sonic Hedgehog gain- and loss-of-function experiments was collected after 5 and 9h. 
 
2.21.3 Tissue processing for NanoString analysis 
Tissue samples were processed using the provided NanoString kit and following 
manufacturer’s instructions. Samples were processed in batches of 12. In brief, cell lysates 
were defrosted on ice, together with a single vial of custom reporter probes and capture 
probes. Once defrosted, 130µL of hybridisation buffer and 13µL of RNase-free water was 
added to the reporter probes to make a master mix. Of this, 21µL was gently pipetted into a 
strip of 12 sterile PCR tubes. To each tube, 1-4µL of cell lysate was added (depending on the 
number of lysed pieces of dissected tissue) and topped up to a total of 4µL with lysis buffer 
(Ambion). Finally 5uL of capture probes were added to give a total volume of 30µL in each PCR 
tube. Tubes were flicked gently to mix well and vortexed gently, to prevent probe shearing. 
Probes were hybridised to cell lysates overnight for 17h at 65°C. 
Next, samples were transferred to the NanoString prep-station robot, which was set up to 
process the hybridised samples using the following materials. Two high sensitivity (50ng) prep-
plates were defrosted for 30min at room temperature and centrifuged for 2min at 1000 rpm. 
One NanoString cartridge was defrosted at room temperature and placed on the robot with 
the electrodes in each well. One rack of tips, two racks of tip sheaths and two strips of sterile 
PCR tubes were also added. Lastly, the hybridised samples at 65°C were added to the prep-
station and the standard processing programme was run for around 3h. During this time 
probe-target complexes are purified from the hybridisation mix and immobilised on the 
cartridge. Any unbound probes are removed and finally complexes are aligned. 
Once processing was complete, the underside of the cartridge was treated with immersion oil 
and placed on the NanoString Analyzer, where the standard programme was used to digitally 
count probe-target complexes for each experiment from 600 fields of view. 
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2.21.4 Raw NanoString data quality control analysis 
Raw NanoString data were imported into Microsoft Excel and analysed according to 
NanoString guidelines with some minor adjustments. Firstly, data for each assay were checked 
to ensure 600 (or very close to) fields of view were counted and that binding density values fell 
within the 0.05-2.25 range. Next, the sum of the 6 positive controls probes was calculated for 
each assay, and then averaged across the entire data set. From these, a positive lane 
normalisation factor (PLNF) was calculated by dividing the average sum of all assays by the 
total sum for each assay. This value should fall between 0.3-3.0. For each lane, negative and 
endogenous probe raw counts were multiplied by their respective PLNF to normalise data 
across the entire set of assays. The mean, standard deviation, and mean plus two times 
standard deviation (M+(2xSD)) was calculated from the 8 normalised negative control probes. 
Each sample was adjusted to remove background binding levels by subtracting the (M+(2xSD)) 
from normalised endogenous gene counts. Any transcript counts that became negative as a 
result, were reset to zero. Next, the data were transformed by adding 1 to all counts in each 
assay. These normalised and adjusted raw values were used to calculate the total sum of RNAs 
in each assay. Individual transcript counts were divided by their assay total, to quantify 
transcript expression as a proportion of the total transcripts counted. 
 
2.21.5 Differential expression analysis 
Data from paired experimental and control conditions were compared to calculate transcript 
differential expression. The mean and standard deviation was calculated from each triplicate 
of assays. Transcript fold change was calculated by dividing the mean for experimental 
conditions by the corresponding control mean. Fold change thresholds of ≥1.2 or ≤0.75 were 
used to define transcripts as upregulated or downregulated in the experimental condition 
respectively. The statistical significance of these results was calculated using a Two-tailed Type 
2 T-Test with a P-value of 0.05. Using Excel, the results for selected markers and readouts were 
plotted as bar graphs comparing experimental and control means. Graphs were saved in 
Microsoft Powerpoint as JPEG files at a resolution of 300dpi. 
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Chapter 3: Neural induction proceeds as a cascade of events 
3.1 Introduction 
Neural induction is the process by which a region of embryonic ectoderm acquires a neural 
identity, and in vertebrates, culminates in the formation of the neural plate. Investigating its 
molecular basis established the “default model” (Hemmati-Brivanlou and Melton, 1997), which 
proposes that ectodermal cells will automatically acquire a neural fate in the absence of 
signalling (see Chapter 1.5). However, in chick expression patterns of BMPs and BMP 
antagonists do not fit with the predictions of the “default model” (Streit et al., 1998, Streit and 
Stern, 1999). Furthermore BMP inhibition is not sufficient to induce neural markers (Streit and 
Stern, 1999, Linker and Stern, 2004), in fact chick ectoderm can only respond to BMP inhibition 
if it has first been exposed to 5h of organizer signals (Streit et al., 1998). Additionally, there are 
reports that neural induction requires FGFs (Lamb and Harland, 1995, Launay et al., 1996, 
Linker and Stern, 2004, Delaune et al., 2005), but many other signals have also been implicated 
(see Chapter 1.7). Together, these findings indicate that the “default model” is too simplistic, 
and that other signals must be required in addition to BMP inhibitors for neural induction.  
Chick is a powerful model in which to study this problem. Grafts of the organizer, Hensen’s 
node (Hensen, 1876), to a region of competent extra-embryonic ectoderm can induce ectopic 
neural tubes derived from the host ectoderm (Waddington, 1933, Waddington and Schmidt, 
1933, Waddington, 1934, Waddington, 1936, Gallera and Ivanov, 1964, Storey et al., 1992). 
Using this technique, a differential screen identified 10 genes that are induced following 5h of 
a graft (Streit et al., 2000). The earliest responses (ERNI, SOX3 (Streit et al., 2000) and 
Calfacilitin (Papanayotou et al., 2013)) are induced within 3h of a node graft and are normally 
expressed in the EGKXII-XIII epiblast. Others, (Churchill (Sheng et al., 2003), DAD1, UBII (Gibson 
et al., 2011), Asterix and Obelix (Pinho et al., 2011)) require 5h of exposure to a node and are 
first detected in the prospective neural plate at HH3-4. Furthermore, a number of markers 
were found to be induced by FGFs, rather than BMP antagonists (see Chapter 1.11).  
To date, the relative timing of markers induction correlates with the sequence of their 
expression in the embryo (Pinho et al., 2011), suggesting that neural induction in an ectopic 
region mimics the endogenous process and that it might occur as a sequence of events (see 
Chapter 1.12). However the screen did not identify many other neural markers. For example, 
NOT1, NOT2 (Knezevic et al., 1995, Knezevic and Mackem, 2001), OTX2 (Bally-Cuif et al., 1995) 
(Foley et al., 2000) and CYP26A1 (Albazerchi and Stern, 2007) could also be early responses to 
neural induction as they are expressed in either the epiblast at EGKXII-XIII or the prospective 
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neural plate at HH3+/4-. Definitive neural markers such as SOX2 (Rex et al., 1997) and SOX1 
(Pevny et al., 1998), which are normally expressed even later than the markers identified by 
the screen, were also not detected. To determine whether these are also responses to neural 
induction, we investigated their expression following grafts of Hensen’s node in time course.  
Expression of TRKC (or NTRK3), the last remaining candidate identified from the original 
differential screen, has also been observed at primitive streak stages (Bernd and Li, 1999, Li 
and Bernd, 1999). To confirm whether TRKC is also expressed as a response to neural 
induction, we verified its earliest expression and then tested whether it is induced by signals 
from Hensen’s node.  
We find that each of these markers is induced by grafts of Hensen’s node, but at different time 
points. At least 9h of signals are required before definitive neural markers are induced, but 
cells require 12h of signals before they are committed to a neural fate. This suggests that 
neural induction must occur as a sequence of molecular events that occur between 0-12h of a 
node graft. 
 
3.2 Results 
3.2.1 TRKC is expressed in the neural plate 
(Part of Pinho et al., 2011) 
Whole-mount in situ hybridisation was used to confirm the expression of TRKC in chick 
embryos between EGKXII and HH8 (Fig. 3.1). Weak TRKC expression is first evident anterior to 
the node in the prospective neural plate at HH3+ (Fig. 3.1B). This expression intensifies in the 
anterior neural plate as the head process emerges between HH4+ to 6 (Fig. 3.1D-F). By HH8, 
TRKC is strongly expressed in the anterior neural tube and neural folds, extending caudally as 
far as the somites (Fig. 3.1G). Expression of TRKC at primitive streak stages is consistent with 
the published expression pattern (Bernd and Li, 1999) and was never observed in the primitive 
streak, neighbouring ectoderm or notochord. In addition, no specific staining was observed 
prior to gastrulation in pre-streak embryos (Fig. 3.1A). Therefore TRKC is expressed at the 
appropriate time in the neural plate to be a response to neural induction. 
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Figure 3.1: TRKC expression during early chick development.  
TRKC expression was assessed at a range of stages by in situ hybridisation. Expression is first 
observed at HH3+ in the prospective neural plate (B; arrow). TRKC expression continues in the 
anterior neural plate (C-F) and later in the neural folds and neural tube (G and H). No TRKC 
expression was detected in pre-streak embryos (A). 
 
3.2.2 TRKC is induced by grafts of Hensen’s node 
(Part of Pinho et al., 2011) 
The presence of TRKC in the neural plate during gastrulation, together with its identification 
from the differential screen, suggests that TRKC may be induced by Hensen’s node during 
neural induction. To test this, its induction was studied in time course, by grafting a quail 
Hensen’s node at HH3+/4- into a chick host at HH3+/4- followed by incubation for different 
periods of time (Fig. 3.2A).  
In situ hybridisation for TRKC reveals that it is induced to differing extents in response to timed 
quail node grafts (Fig. 3.2). Very weak induction of TRKC was detected after 3h of incubation 
but only by a proportion of grafts (Fig. 3.2B; 6/8). Slightly stronger expression was seen at 4h 
by 3/3 grafts (Fig. 3.2C). Robust expression was observed after 6h (Fig. 3.2D; 5/5) and this 
persisted after 9h (Fig. 3.2E; 4/4). These results confirm that TRKC expression can be induced 
robustly within 4-6h of signals from a grafted organizer. It suggests that TRKC can be induced 
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by grafts of Hensen’s node and that its expression, which first arises in the ectoderm adjacent 
to Hensen’s node, is likely a response to signals from the organizer. 
 
 
Figure 3.2: A time-course of TRKC induction by grafts of Hensen’s node.  
Grafts of quail Hensen’s node at HH3+/4- into chick hosts at HH3+/4- (A) were analysed in 
time-course after in situ hybridisation (B-E). Very weak TRKC expression is observed after 3h in 
6/8 grafts (B). Slightly stronger expression is observed in the extra-embryonic ectoderm after 
4h (C; 3/3). TRKC is strongly induced 6-9h after grafting (D; 5/5 and E; 4/4). 
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3.2.3 The regulation of TRKC by chemical and secreted factors 
(Part of Pinho et al., 2011, conducted in collaboration with M. Stower) 
Having demonstrated that TRKC expression is induced robustly within 6h of organizer signals, 
we sought to establish which factors might be involved. FGF8 is sufficient to induce ERNI, SOX3 
(Streit et al., 2000), Churchill (Sheng et al., 2003), Calfacilitin (Papanayotou et al., 2013), DAD1, 
UBII (Gibson et al., 2011) and Asterix (Pinho et al., 2011). Furthermore, it is expressed by the 
hypoblast and Hensen’s node at stages relevant to the induction of early responses to neural 
induction (Streit et al., 2000). To test whether FGF8 signalling regulates TRKC expression, gain- 
and loss-of-function experiments were performed. Heparin beads soaked in FGF8b were 
grafted to a competent region of the area opaca, or beads of the FGF inhibitor SU5402, were 
grafted together with a node (Fig. 3.3A). 
Beads of FGF8b failed to induce TRKC expression after 6 or 14h of incubation (Fig. 3.3B and C). 
Furthermore, beads of SU5402 did not inhibit TRKC induction by a node graft after 6h (Fig. 
3.3D; 6/6). This suggests that FGF8 signalling is neither sufficient nor necessary for the 
induction of TRKC by Hensen’s node. Other factors were tested in an attempt to discover 
which might be involved. Retinoids are known to be present in Hensen’s node (Chen and 
Solursh, 1992) (Chen et al., 1992) but beads of retinoic acid (Fig. 3.3E; 0/4) were also unable to 
induce TRKC. Similarly TRKC was not induced by ionomycin, a calcium ionophore (Fig. 3.3F; 
0/4), the BMP inhibitor noggin (Fig. 3.3G; 0/3) nor the neuropeptide somatostatin have any 
effect (Fig. 3.3H; 0/8). As none of these signals is able to induce TRKC, other factors or 
combinations of factors must be responsible for inducing TRKC. 
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Figure 3.3: Regulation of TRKC induction by chemical and secreted factors.  
Gain or loss-of-function experiments were used to assess which signals might be responsible 
for regulating TRKC (A). TRKC was not induced by beads of FGF8b after 6 or 14h (B; 0/11 and C; 
0/12; black arrows). TRKC was induced after 6h in the presence of SU5402 (D; 6/6). After 6h 
beads of retinoic acid (E; 0/4), ionomycin (F; 0/4), noggin (G; 0/3) and somatostatin (0/8) were 
also unable to induce TRKC. (Arrows show bead placement). 
 
3.2.4 Is the neural plate responsive to NT-3 signalling during neural 
induction? 
(Part of Pinho et al., 2011) 
TRKC is a receptor tyrosine kinase responsible for specific, high affinity binding of 
Neurotrophin 3, a factor involved in neuronal survival and differentiation (Arévalo and Wu, 
2006). Although TRKC is present in the neural plate as early as HH3+/4, it is unknown whether 
it mediates neurotrophin signalling at these stages. RT-PCR has previously detected NT-3 
mRNA from whole embryos in the chick at stages 5-8 but this does not reveal where NT-3 is 
localised at these stages (Yao et al., 1994, Baig and Khan, 1996). To explore whether tissues 
expressing TRKC might be responsive to NT-3 signalling during early development, NT-3 
expression was assessed by in situ hybridisation (Fig. 3.4). 
The expression of NT-3 was examined over a range of stages. It is not expressed before 
primitive streak formation at EGKXII or even at HH4 (Fig. 3.4 A-B), when TRKC is present in the 
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neural plate. The earliest NT-3 expression was detected at HH9-10 (Fig. 3.4C) so it is possible 
that NT-3 signalling may occur via TRKC from HH9-10 onwards when they are co-expressed in 
the anterior neural tube. However, NT-3 expression does not seem to coincide with TRKC 
expression during neural induction, so any function of TRKC at these stages could be 
independent of NT-3. 
 
 
Figure 3.4: NT-3 expression in the early embryo.  
NT-3 expression cannot be detected prior to gastrulation in EGKXII embryos (A), or at HH4 
during gastrulation (B). Weak NT-3 expression is first observed in the anterior neural tube at 
HH9-10 extending caudally as far as the somites (C). 
 
3.2.5 NOT1 and NOT2 can be induced by grafts of Hensen’s node 
NOT1 and NOT2 are CCR4-Not complex transcription factors that are expressed in the axial 
mesoderm from HH4+ (Stein and Kessel, 1995, Stein et al., 1996), but prior to this they are 
expressed in the pre-streak epiblast at EGKXII-XIII (Knezevic et al., 1995, Knezevic and Mackem, 
2001). Given the similarity of their early expression to ERNI and SOX3 (Streit et al., 2000), we 
tested whether these transcription factors might also be induced by grafts of Hensen’s node. 
Like TRKC, there is no evidence of NOT1 or NOT2 induction after 1h (Fig. 3.5A and D). After 
receiving 3h of signals, NOT1 and NOT2 are induced but only in a proportion of cases (Fig. 3.5B; 
8/18, E; 8/13). After 5h, incomplete induction of both genes is still observed (Fig. 3.5C; 8/13, F; 
10/16). Therefore grafts of Hensen’s node do provide signals which induce NOT1 and NOT2 
after 5h, but are not able to induce them in all cases. It is possible that more than 5h of signals 
are required for complete induction. Alternatively, since the expression of NOT1 and NOT2 in 
the endogenous prospective neural tissue is only transient -by HH4+ they are only expressed in 
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the head process (Fig. 3.5C and F); they might only be induced very transiently by a node with 
subtle variations in timing between grafts. 
 
 
Figure 3.5: A time-course of NOT1 and NOT2 induction by grafts of Hensen’s node.  
The induction of NOT1 and NOT2 was studied in time-course by grafts of Hensen’s node. No 
induction of either NOT1 or NOT2 is observed after 1h (A; 0/21, D; 0/16) when expression is 
observed only in the node graft itself. After 3 and 5h, both NOT1 (B, B’, C, C’) and NOT2 (E, E’, 
F, F’) are induced, but only by a proportion of grafts. Presence (black arrows) or absence (red 
arrows) of NOT1 and NOT2 induction is shown in closer detail (B’, C’ E’, F’). Horizontal lines 
show where sections through grafts were taken (B, C, E, F). 
 
3.2.6 OTX2 is also induced by grafts of Hensen’s node 
The anterior neural markers OTX2 (Bally-Cuif et al., 1995) and CYP26A1 (Swindell et al., 1999, 
Blentic et al., 2003) are also expressed appropriately in the prospective neural plate to be 
involved in neural induction. Both can be induced by grafts of the hypoblast: CYP26A1 by 
retinoic acid and OTX2 by a combination of FGFs with BMP and WNT antagonists (Albazerchi 
and Stern, 2007). Although these signals are also present in Hensen’s node, neither gene was 
detected in the original 5h screen. To test whether these might also be induced in response to 
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organizer signals, chick nodes were grafted to the area opaca to determine a time-course for 
their possible induction (Fig. 3.6) 
OTX2 induction by a node graft is similar to SOX3 (Streit et al., 2000). No induction was 
observed in the adjacent epiblast after 1h (Fig. 3.6A; 0/8); the only detectable staining is 
restricted to the node graft itself. After 3 and 5h, OTX2 was induced in all cases (Fig. 3.6B; 7/7 
and C; 6/6). After 1h there was also no induction of CYP26A1 (Fig. 3.6D; 0/21) but unlike OTX2, 
it was only induced by a proportion of grafts after 3 and 5h (Fig. 3.6E; 8/13, F; 7/13). Where 
expression was observed, it always appeared as a trail (red arrow) or patch (black arrows) of 
cells extending between the host expression domain and the grafted node. Grafts placed even 
slightly further away from the embryo, but still in a region competent to respond to neural 
induction, were never associated with CYP26A1 expression. This suggests that CYP26A1 
expression can only be readily expanded from the neural plate after 3-5h, but not induced 
ectopically.  
 
 
Figure 3.6: Time-course of OTX2 and CYP26A1 induction by node grafts. 
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Grafts of chick Hensen’s node into chick hosts were analysed in time course for the induction 
of OTX2 (A-C) and CYP26A1 (D-F). OTX2 is not induced in the epiblast after 1h (A; 0/8) and 
staining is only visible in node tissue. However, OTX2 is fully induced after 3h (B; 7/7, arrow) 
and 5h (C; 6/6). CYP26A1 induction is not observed after 1h (D; 0/21) and is only associated 
with a proportion of grafts after 3h (E; 8/13) and 5h (F; 7/13), when it only appears as a patch 
(black arrows) or trail of cells (red arrow) connected to the host expression domain.  
 
3.2.7 The definitive neural marker SOX2 can be induced within 9h 
The neural induction screen successfully identified early responses to grafts of Hensen’s node. 
These markers are all expressed in the prospective neural plate at HH3+/4- (Pinho et al., 2011); 
prior to formation of the neural plate proper. Therefore, no later neural markers were 
detected. 
SOX2 is first expressed anterior to the node in the forming neural plate between HH4/4+ (Rex 
et al., 1997). Its expression persists throughout the neural plate and later in the neural tube, 
where it is considered a marker of neural specification (Rex et al., 1997). Since 5h of signals are 
insufficient to induce definitive neural markers or a neural plate, we sought to determine the 
period of signals required to induce SOX2 by studying the timing of its ectopic induction. 
In situ hybridisation for SOX2 shows that it is induced to different extents in response to timed 
node grafts. No SOX2 expression was detected after 3h of incubation (Fig. 3.7B; 0/8). Weak 
expression was observed after 5h, but only by a proportion of grafts (Fig. 3.7C; 7/12). Robust 
induction could be seen after 9h in all cases (Fig. 3.7D; 8/8). This continued over 12-15h of 
incubation when the induced domains lengthen to form secondary axes which strikingly 
resemble the host (Fig. 3.7E-F). This suggests that 9h of signals from a grafted node are 
required before SOX2 expression is fully induced. 
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Figure 3.7: A time-course of SOX2 induction by grafts of Hensen’s node.  
Grafts of chick Hensen’s node into chick hosts were analysed in time-course for induction of 
SOX2 (A). No induction in the epiblast is observed after 3h (B) and weak expression is observed 
after 5h but only in 7/12 grafts (C). Robust expression is induced after 9h (D) by all grafts. This 
progressively strengthens over 12 and 15h (E-F). 
 
3.2.8 Does host age influence the timing of ectopic induction? 
Our observation that SOX2 is induced after 9h, is consistent with some previous experiments 
(Streit and Stern, 1999) but differs from suggestions that 12h are necessary (Pinho et al., 
2011).Therefore we considered factors which might influence the timing of induction  
Earlier work established that expression of the L5 epitope defines the region of epiblast which 
is competent to respond to neural inducing signals (Streit et al., 1995). At HH3+/4 this domain 
extends anteriorly and laterally as far as the inner third of the area opaca. After HH4 the 
epiblast simultaneously loses L5 expression and neural competence (Gallera and Ivanov, 1964, 
Storey et al., 1992, Streit et al., 1995). Although the timing of grafting is important in terms of 
competence, we wondered whether stage differences within this window could account for 
72 
 
variation in the timing of SOX2 induction. To test this, HH3+ chick nodes were grafted to hosts 
between HH3 and HH4+ and the timing of SOX2 induction assessed (Fig. 3.8). 
 
 
Figure 3.8: The timing of SOX2 induction varies with host age.  
HH3+ chick nodes were grafted to hosts at HH3, 3+, 4-, 4 and 4+ and incubated for 3, 5, 9 or 
12h (A, F, K, P, U). Irrespective of whether nodes were grafted into hosts at HH3 (A-E), 3+ (F-J) 
and 4- (K-O), the same time-course of induction was observed. No expression was observed 
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after 3h (B, G, L) and only weak induction in 25-40% of node grafts after 5h (C, H, M). Complete 
SOX2 induction was observed after 9h (D, I, N), which strengthened after 12h (E, J, O). Nodes 
grafted into HH4+ hosts did not induce SOX2 expression in the host epiblast at any time point 
(U-Y). Nodes grafted into HH4 embryos did induce SOX2 fully after 12h (T; 4/4), but only by a 
proportion of grafts after 5h (R; 5/10) and 9h (S; 5/7). At 3h no SOX2 induction was observed, 
only self-differentiation (Q; 0/7). (Red boxes highlight the timing of complete induction.) 
 
As expected, nodes grafted into HH4+ hosts did not induce SOX2 expression in the majority of 
cases at any time point; staining was mainly observed in the nodes themselves as they self-
differentiated (Fig. 3.8U-Y). This is in agreement with observations that the host epiblast is 
unable to respond to neural inducing signals after HH4 (Storey et al., 1992). Nodes grafted into 
HH4 embryos did induce SOX2 fully, but only after 12h (Fig. 3.8T 4/4). Induction was only 
observed by a proportion of grafts after 5 and 9h (Fig. 3.8R; 5/10, S; 5/7). No SOX2 induction 
was observed after 3h, only self- differentiation (Fig. 3.8Q; 0/7).  
At stages where the host epiblast is competent to respond to a node graft (HH3, 3+ and 4-) the 
same time-course of induction was observed (Fig. 3.8 A-E, F-J, K-O). Induction was never 
detected after 3h (Fig. 3.8B, G, L) and only weak induction in 25-40% of node grafts after 5h 
(Fig. 3.8C, H, M). SOX2 was induced robustly by all grafts after 9h (Fig. 3.8D, I, N) and persisted 
after 12h (Fig. 3.8E, J, O).  
This confirms the initial observation that SOX2 can be fully induced within 9h; 3h earlier than 
previously considered. It also demonstrates that differences in host age between HH3, 3+ and 
4- when the epiblast is competent (Storey et al., 1992, Streit et al., 1997) do not influence the 
timing of induction. When HH4 hosts were used, complete SOX2 induction was only observed 
after 12h so host age does influence the timing of SOX2 expression between HH4- and HH4 as 
the epiblast begins to lose competence. 
 
3.2.9 The initial induction of SOX2 after 9h is transient 
The neural induction screen was designed to identify genes induced within the first 5h of 
signals from Hensen’s node because chick ectodermal cells must be sensitised by 5h of signals 
from the organizer before they can respond to BMP antagonists. Specifically, SOX3 expression 
induced after 5h can be maintained by Chordin-secreting cells (Streit et al., 1998), but is 
otherwise lost after the node is removed. 
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Having demonstrated that 9h of signals are required to induce SOX2 expression, we next 
questioned whether this expression is stable or if, like SOX3, further signals are required to 
maintain it. To test this, chick nodes at HH3+/4- were grafted to the area opaca of chick hosts 
and incubated for 5, 9 or 12h. Node grafts were removed and the embryos incubated for a 
further 12h before SOX2 expression was assessed (Fig. 3.9A). 
Normally 5h of incubation only induces weak SOX2 by a proportion of grafts while 9h is 
sufficient to induce SOX2 robustly in all cases (Fig. 3.7C and D). Node removal after 5h causes 
complete loss of SOX2 expression (Fig. 3.9B), while SOX2 expression remained but only very 
faintly in 4/8 cases after 9h (Fig. 3.9C). However, when the epiblast receives node signals for 
12h, SOX2 expression is expressed strongly after node removal, in almost all cases (Fig. 3.9D; 
4/5). As node removal earlier than 12h causes significant reduction or loss of SOX2 expression, 
it suggests that the initial induction of SOX2 expression by a node graft is transient and that it 
is only stabilised after 9-12h. 
 
 
Figure 3.9: SOX2 expression is lost if grafted nodes are removed before 12h.  
Nodes grafted to HH3+/4- embryos were removed after 5, 9 or 12h of incubation and host 
embryos cultured for a further 12h. When nodes are removed after 5h, there is no evidence of 
SOX2 expression in the region that received the graft (B; 0/7). When nodes are removed after 
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9h weak SOX2 expression persisted in 4/8 cases (C; arrow); SOX2 remains in almost all cases 
after 12h (D; 4/5). 
 
3.2.10 Establishing a time-course for SOX1 induction 
SOX1, another SOXB1 family transcription factor, is considered to be a definitive neural 
marker. SOX1 expression in neural progenitors has been associated with their commitment 
and differentiation to a neural fate (Pevny et al., 1998). Previously, SOX1 has been predicted to 
be induced within 13-14h of a node graft, but this was based upon the assumption that SOX2 
was first induced after 12h (Pinho et al., 2011). The exact timing of its expression in the neural 
plate and its induction by a node has not been examined. 
Initially the normal expression of SOX1 was confirmed by in situ hybridisation. No expression 
was detected at EGKXIII or at streak stages HH4- and HH5 (Fig. 3.10A-C). The earliest SOX1 
expression was detected in the neural tube of HH8-9 embryos, where it extends posteriorly to 
the regressing node (Fig. 3.10D). SOX1 can also be induced by grafts of Hensen’s node. It is 
induced in the majority of cases after 12h (Fig. 3.10E; 10/13), and almost completely after 15h 
(Fig. 3.10F; 11/12). Therefore SOX1 expression begins later than SOX2 in the endogenous 
neural plate and in a time-course of node induction. 
 
 
Figure 3.10: The normal expression of SOX1 and its induction by node grafts.  
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In the normal embryo, SOX1 expression could not be detected in pre-streak (A), during 
gastrulation (B), or in the neural plate at HH5 (C). It is first expressed in the neural tube from 
HH8-9 (D). It is induced by the majority of node grafts after 12h (E; 10/13) and 15h (F; 11/12). 
 
3.3 Discussion 
Described here are a group of genes that mark neural tissue at different stages during its 
development. Despite differences in the onset of their normal expression, we show that all are 
induced as responses to the neural induction by signals from Hensen’s node. These differences 
are reflected in the timing of their induction by node grafts, suggesting that they are not co-
regulated and revealing greater complexity to neural induction. 
TRKC was one of ten genes upregulated in a screen (Streit et al., 2000) designed to identify 
genes induced within 5h of an ectopic node graft (Pinho et al., 2011). It belongs to a family of 
Tropomyosin-related kinase (TRK) neurotrophin receptors and is a well-studied membrane 
receptor for NT-3 (Arévalo and Wu, 2006). Although its expression in the neural plate has been 
studied previously, it had not been implicated as a response to neural induction (Bernd and Li, 
1999, Li and Bernd, 1999). We verify that TRKC is first expressed weakly in the neural plate at 
around HH3+/4-. This expression broadens until it is expressed strongly throughout the 
anterior neural plate, and later the neural tube. The absence of NT-3 expression during 
gastrulation and neural induction suggests that whatever the function of TRKC at these stages, 
it is unlikely to involve NT-3. Our findings contradict observations that NT-3, as well as other 
TRK receptors (TRKA, TRKB) and ligands (NTF, BDNF) are expressed in avian embryos at HH5-8 
(Yao et al., 1994, Baig and Khan, 1996, Zhang et al., 1996). However these were probably 
detected at much lower levels by RT-PCR, a more sensitive approach than in situ hybridisation. 
OTX2 is a transcription factor known to be expressed in the epiblast at EGKXII-XIII (Foley et al., 
2000) and in the future neural plate at HH3+/4- (Bally-Cuif et al., 1995, Albazerchi and Stern, 
2007). Later its expression is restricted anteriorly and confers regional identity to the neural 
axis, including an important function in defining the mid-hindbrain boundary (Millet et al., 
1999). Given its early SOX3-like expression, we might have expected it to be identified as an 
early response by the neural induction screen. Likewise, the CCR4-Not transcription factors 
NOT1 and NOT2 also share this early pre-streak expression domain (Knezevic et al., 1995, 
Knezevic and Mackem, 2001).  
In contrast, SOX2 and SOX1 are absent from epiblast tissue at EGKXII-XIII and the prospective 
neural plate at HH3+/4-. Instead they are detected much later in the normal embryo. SOX2 
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expression begins between HH4/4+ just anteriorly to the node, but it is only expressed 
robustly throughout the neural plate by HH5 (Rex et al., 1997). SOX1 expression begins later 
still; the first transcripts can be detected weakly in the neural tube at HH8-9 (Pevny et al., 
1998).  
 
3.3.1 Responses to neural induction occur at different times 
Analysing the ectopic induction of these markers reveals that they are all induced by grafts of 
Hensen’s node. OTX2 is expressed in a similar time course to SOX3, ERNI and Calfacilitin (Pinho 
et al., 2011), which are expressed in the epiblast at EGKXII-XIII as well as being induced within 
3h of grafting (Streit et al., 2000, Papanayotou et al., 2013). TRKC more closely resembles 
markers such as Churchill, DAD1, UBII, Asterix and Obelix which are all induced within the first 
5h of grafting and are first expressed in the neural plate by HH3+/4 (Pinho et al., 2011). 
Therefore even within the first 5h, we can begin to separate the earliest neural responses 
based on their temporal expression dynamics. 
Although grafts of Hensen’s node have the ability to induce NOT1 and NOT2, their responses 
differ from OTX2 and TRKC as they are never completely induced within 3-5h. It is possible that 
this could happen after longer exposure to a node graft. However, we suspect that incomplete 
induction occurs because they are only transiently induced in neural territories. In the early 
embryo; both NOT1 and NOT2 are expressed in the EGKXII-XIII epiblast (Knezevic et al., 1995, 
Knezevic and Mackem, 2001) and prospective neural plate at HH3+/4-, but  do not persist in 
the neural plate at HH4+ (Stein and Kessel, 1995, Stein et al., 1996). By sampling node grafts 
after 3h and 5h, we might detect their initial induction but also their imminent 
downregulation. Subtle differences between embryos in the exact window when this occurs, 
would explain why complete induction is never achieved at either time point. Therefore the 
incomplete induction observed, may actually reflect the normal transient nature of their 
expression. If so, it demonstrates that the node graft assay accurately represents the timing 
and dynamics of events that occur in the embryo. 
Apart from these early responses, we also investigated the timing of later neural markers. 
Secondary axes induced by Hensen’s node grafts not only exhibit the same columnar epithelial 
morphology as the neural plate (Gallera, 1968), but they express neural plate (SOX2) and 
neural tube specific markers (SOX1) (Rex et al., 1997, Pevny et al., 1998). However these 
markers require more than 5h of signals from a grafted node before they are induced; SOX2 
can be induced within 9h and SOX1 almost completely within 12h. Even at these later time 
points, the relative timing of their induction reflects their temporal expression in the neural 
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plate, as SOX2 is expressed robustly in the neural plate at HH5, while SOX1 is expressed later in 
the neural tube at HH8-9.  
Since all markers identified by the screen are earliest co-expressed in the prospective neural 
plate, it suggests that ectopic neural induction after 5h closely resembles the endogenous 
process at HH3+/4-, before the neural plate has formed. Therefore, it is not surprising that 
markers of the neural plate (SOX2) and neural tube (SOX1) were not identified. As signals 
secreted from the organizer are sufficient to induce mature neural tissue and the time of 
grafting represents a clear starting point, the node graft assay is a useful tool to study the 
entire process of neural induction. These experiments, together with those conducted 
previously (Sheng and Stern, 1999, Streit et al., 2000, Papanayotou et al., 2008, Gibson et al., 
2011, Pinho et al., 2011) suggest that responses to neural induction do not occur at the same 
time. Even the earliest events proceed as a sequence and consequently it is difficult to 
distinguish a single “inductive” event. 
 
3.3.2 Host age does not affect the timing of induction while the epiblast is 
competent  
In the above experiments, chick nodes were always grafted into chick hosts at HH3+/4-. This 
turns out to be particularly important as subtle differences in host age can influence the timing 
of induction. SOX2 can be induced consistently after 9h, when nodes were grafted to hosts at 
HH3, 3+ and 4-, but when HH4 hosts are used; 12h of a node graft are required before SOX2 is 
completely induced. Therefore, differences in the timing of SOX2 induction observed by Pinho 
et al. 2011 and Streit et al., 1998, could be due to the former having used slightly older 
embryos as hosts. Although we do not test precisely why this occurs, it is likely due to the 
effect of competency. At HH4+ the epiblast is not competent to respond due to absence of the 
L5220 epitope (Streit et al., 1997). L5220 expression starts to be lost from HH4, so it is possible 
that reduced competence at HH4 already hinders neuralisation, which occurs more easily at 
HH4-. However, as long as hosts receive grafts when the epiblast is competent to respond 
(between HH3 and HH4-), host age does not influence the timing of SOX2 induction. To ensure 
consistency of timing, future experiments should never use hosts older than HH4-. 
Our conclusions differ from those of Gallera, who suggested that host age does influence 
ectopic induction by a node graft (Gallera, 1968). In these experiments, a morphological neural 
plate was induced simultaneously by a HH4 node grafted to a host at HH2, and a HH4 node 
grafted to the same embryo later at HH4 (i.e. the first graft took longer to induce than the 
second). In contrast, we observe that HH4 hosts actually take longer to respond to a node 
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graft. These differences can probably be explained based on the timing of the competency 
window. As the L5220 epitope confers competency between HH3-4 (Streit et al., 1997), the 
initial graft was probably unable to neuralise the area opaca until the HH2 host was older. 
Therefore the first graft seemed to take longer because the two grafts could only induce 
neural tissue simultaneously once competency was acquired. This would fit with Gallera’s 
interpretation that the timing of neural induction is linked to an intrinsic property of the 
epiblast (Gallera, 1968). 
However, Gallera also suggests that an embryo-wide mechanism synchronises the onset of 
induction across the whole embryo, as he observes ectopic neural induction to occur at the 
same time as the endogenous process in the host (Gallera, 1968). With the benefit of specific 
temporal markers, as opposed to relying just on morphology, we have observed SOX2 
expression in the host when it is absent ectopically, and vice-versa (data not shown). Therefore 
our experiments argue against a more clock-type mechanism that regulates precisely when 
tissue responds. Certainly the timing of ectopic and endogenous induction events is intimately 
linked by the brief window of L5220 expression which spans the prospective neural plate and 
area opaca. This permits induction by a graft to occur within the same period as the host, but 
not necessarily at exactly the same time. 
 
3.3.3 Cells are only committed to a neural fate 12h after a node graft 
We also demonstrate that although cells express SOX2 after 9h, a further 3h of exposure to a 
node graft are required before its expression is maintained. This is strikingly similar to SOX3, 
which can be induced within 5h but expression is lost if a node is removed earlier than 12h 
(Streit et al., 1998, Streit and Stern, 1999). Taken together, these observations suggest that 
12h of signals from Hensen’s node are required to commit cells to a neural fate. This is roughly 
consistent with classical grafting experiments which suggest that 8.5h of signals from a node 
are required to form a morphological neural plate (Gallera, 1965) but 13h are necessary before 
cells are committed to a neural fate (Gallera and Ivanov, 1964, Gallera, 1971). 
SOX1 has previously been implicated in neural precursor commitment and differentiation in 
vitro (Pevny et al., 1998). Its induction after 12h of grafting places it appropriately at the time 
when cells become committed to a neural fate. Consequently, SOX1 may represent a better 
marker of the definitive neural state than SOX2, which confers neural specification to 
progenitors (Graham et al., 2003). 
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3.3.4 Hensen’s node and the hypoblast as sources of neuralising signals 
Grafts of Hensen’s node must contain at least the minimal information required to impart 
normal neural identity, to induce definitive neural markers. As our analyses, and those of 
others, suggest that neural induction must occur as a sequence of events and that FGFs and 
BMP inhibition are not sufficient for these, neural induction must be regulated by additional 
signals at different times. 
Although Hensen’s node contains all the signals required for neural induction, it is yet to form 
when the earliest markers (e.g. ERNI, SOX3 and OTX2) are induced in the pre-streak epiblast. 
At these stages the hypoblast, which is equivalent to the mouse anterior visceral endoderm, is 
an important source of early neural signals (Foley et al., 2000, Albazerchi and Stern, 2007). For 
example SOX3 and ERNI expression are regulated by FGF8 from the underlying hypoblast 
(Streit et al., 2000). The hypoblast is also important for the early expression of OTX2, NOT1 and 
NOT2. Although their regulation has not been tested here, retinoids from the hypoblast have 
been implicated in regulating NOT1 and NOT2 expression in the pre-streak epiblast (Knezevic 
et al., 1995, Knezevic and Mackem, 2001). However this response seems to occur 
synergistically with other factors including Activin and FGFs. Similarly, hypoblast grafts can 
induce OTX2 within 3-4h in response to FGF signalling combined with BMP and WNT inhibition, 
but this effect is only transient as OTX2 expression is lost completely after 10-12h (Albazerchi 
and Stern, 2007), suggesting that further signals are required for its maintenance. 
Unlike these early responses, TRKC is not expressed in the pre-streak epiblast. Its expression 
begins at HH3+/4-, when the hypoblast has been displaced (Rosenquist, 1972, Lawson and 
Pedersen, 1987). As TRKC expression is first observed adjacent to Hensen’s node, it is the likely 
endogenous source of signals regulating TRKC. However, TRKC cannot be induced by FGFs, nor 
are they required for its expression. Retinoic acid, Noggin, and calcium signalling, which also 
contribute to neural induction are similarly insufficient to induce TRKC. Nor does it respond to 
somatostatin, a neuropeptide which is expressed in the prechordal mesendoderm and has 
been implicated in inducing PAX6 expression in the anterior neural plate border (Lleras-Forero 
et al., 2013). Therefore we predict that as yet unidentified signals from the node are 
responsible for its expression (Pinho et al., 2011).  
Similarly, grafts of the hypoblast are insufficient to induce the forebrain marker HESX1, or 
SOX2 (Foley et al., 2000, Albazerchi and Stern, 2007), the latter can only be induced by node 
grafts. Even though FGFs together with BMP and WNT antagonists are required for neural 
induction, no combination of these is sufficient to induce SOX2 (Linker and Stern, 2004). This 
indicates that SOX2 also requires as yet unidentified signals from the node. It will be 
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particularly important to identify new signals secreted from the node or its derivatives that 
coincide with SOX2 expression between HH4-5 (or after 5-9h of grafting). Since 12h of grafting 
are required to induce SOX1 expression and stabilise SOX2, these responses may need longer 
exposure to factors that that are already present after 9h. Alternatively they could also require 
additional signals that are secreted between HH5-8 in the normal embryo or from a graft after 
9-12h. 
CYP26A1 differs from these other markers as node grafts can only expand its endogenous 
domain but never induce it ectopically. A similar response is observed after grafts of the 
hypoblast or beads soaked in retinoic acid, which expand CYP26A1 from the neural plate and 
can even shift endogenous expression towards the graft (Albazerchi and Stern, 2007). CYP26A1 
is known to be induced by retinoic acid as a means of regulating its own concentration (White 
et al., 1996, Loudig et al., 2000), and therefore its expression may provide a readout of high 
retinoid levels (Reijntjes et al., 2005). It would be reasonable to expect node grafts to induce 
CYP26A1 consistently given that retinoids are present in Hensen’s node (Chen et al., 1992, 
Chen and Solursh, 1992, Blentic et al., 2003), but perhaps the concentration of retinoids in 
node grafts is not sufficient to induce CYP26A1 expression ectopically. Instead nodes grafted 
closer to the neural plate might expand CYP26A1 expression because they contribute to an 
existing domain that already has high retinoic acid levels. This might explain why CYP26A1 
expression was only associated with node grafts in close proximity to the host CYP26A1 
expression domain.  
Alternatively, grafts of Hensen’s node or hypoblast may only expand, but not induce CYP26A1, 
if other signals in the embryo contribute to its normal expression in the prospective neural 
plate, or if signals in the area opaca might prevent its induction. Certainly there are reports 
that CYP26A1 can be induced by WNT inhibition (Kudoh et al., 2002), and FGF inhibition 
(Kudoh et al., 2002) or activity (Wahl et al., 2007) in different contexts. However, only beads of 
retinoic acid and not FGF8 are able to induce CYP26A1 in the area opaca (Albazerchi and Stern, 
2007). Other reports suggest that CYP26A1 also responds to Notch signalling (Echeverri and 
Oates, 2007). If juxtacrine signalling via Notch is involved in our context, it might explain why 
CYP26A1 could only be expanded as a patch or trail of cells extending from the host. What 
these studies do suggest is that CYP26A1 regulation is probably more complex than just 
retinoic acid. While reasons for the specific response of CYP26A1 to a node graft remains 
unclear, it seems that despite being expressed in the prospective neural plate, it may not be 
required during the equivalent stages of ectopic neural induction as it is not induced by all 
grafts. 
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3.3.5 Neural induction proceeds as a sequence of events 
Although we are not yet able to define molecularly the entire process of neural induction, it is 
possible to illustrate it as a simple cascade of responses based on the markers analysed to date 
(Fig. 3.11). It follows the same temporal cascade of responses ectopically and in the embryo. 
The earliest responses are expressed in the epiblast of EGKXIII embryos; prior to gastrulation. 
They are induced robustly within the first 3h of a node graft, and include markers such as ERNI, 
SOX3, Calfacilitin and OTX2. NOT1 and NOT2 are also induced although possibly only 
transiently. Additional markers are acquired after 5h of a node graft, including Churchill, DAD1, 
UBII, Asterix, Obelix and TRKC. These are first expressed in the HH3+/4- prospective neural 
plate at around the time that NOT1 and NOT2 are downregulated. These early markers (red 
and blue) are expressed before the neural plate proper forms and therefore we consider them 
to define a pre-neural state. FGF signalling contributes significantly to these early responses 
but does not regulate them all. It is only after these first 5h of signalling from a node, or at 
approximately HH3+, that induced tissue is able respond to BMP inhibition (Streit and Stern, 
1999). SOX2 can be induced completely after 9h and is expressed robustly in the neural plate 
proper by HH5, where we consider it to mark neural specification. Later, SOX1 expression is 
acquired later at around the time that cells become committed to a neural fate.  
In this way, the period of neural induction in the normal embryo can be defined according to 
the time-course of the earliest and latest neural markers. The earliest responses occur within 
3h of a graft or in the embryo before gastrulation, where they define a pre-neural state. 
However cells do not acquire SOX2 expression and neural specification until 9h or HH5, but 
even then, they are not committed to a neural fate until 12h, the same time they express 
SOX1. This scheme fits nicely with classical experiments suggesting that a “neuroid” response 
can be induced after 6h of a node graft, but that 8.5h are required to induce a morphological 
neural plate (Gallera, 1965) and 13h for cells to commit to a neural fate (Gallera and Ivanov, 
1964, Gallera, 1968, Gallera, 1971). As none of these steps in isolation is sufficient for cells to 
acquire a neural fate, it is difficult to identify a single neural “inductive” event. Therefore, we 
must consider that neural induction proceeds as a cascade of responses to multiple signals 
between 0-12h of a Hensen’s node graft, or in the embryo between EGKXII and HH8-9. These 
findings contrast with the “default model” of neural induction, which predicts that neural 
induction occurs during gastrulation in response to a single stimulus; BMP antagonists from 
the organizer (Hemmati-Brivanlou and Melton, 1997). 
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Figure 3.11: Neural induction proceeds as a cascade in response to different signals.  
A temporal cascade of neural markers is expressed in response to neural induction. Coloured 
bars represent the expression period of each gene in relation to the timing of induction by a 
node graft (hours) and the stage of their expression in the normal embryo. (Solid lines, 
complete induction; dashed lines, incomplete induction.) Genes can be grouped into 4 
“epochs” based on the timing of their expression. The earliest responses (red) can be induced 
by a node graft within 3h and are expressed in the pre-streak epiblast. A second set of markers 
(blue) is first expressed at HH3+/4- or after 5h of a node graft. Red and blue markers define a 
pre-neural state that exists prior to the formation of the neural plate. Many of these early 
markers are regulated by FGFs (solid arrow; FGF sufficiency, dashed arrow; FGFs necessary). 
Later expression of SOX2 after 9h of a node graft or approximately HH5 marks the onset of 
definitive neural specification but commitment to neural fate and differentiation only begins 
around 12h when SOX1 is induced. The approximate expression domain of markers is shown in 
the embryo at EGKXIII, HH3+, HH5 and HH8+ (adapted from (Pinho et al., 2011)). 
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3.4 Conclusions 
The emerging picture illustrated by these experiments, is that 9-12h of signals from a grafted 
node are required before definitive neural markers and cells are irreversibly committed to a 
neural fate. The responses identified within the first 5h correspond closely to events that occur 
in the normal embryo prior to the formation of the definitive neural plate. As such they specify 
the induction of a pre-neural territory.  
Ectopic induction proceeds according to the same molecular events as the host neural plate, so 
the node graft assay is a useful tool to study the entire process of neural induction. Since we 
demonstrate that neural induction must proceed as a sequence of responses and BMP 
antagonists are not sufficient to regulate all these events, our results dispute the widely 
accepted “default model” of neural induction. 
Although the duration of neural induction can now be better defined, it is evident from just 
these markers, that the formation of a definitive neural plate requires additional factors and 
responses at different time points. FGF signalling contributes to the regulation of early 
markers, but we know little about events that occur or signals that are required after more 
than 5h of a node graft. 
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Chapter 4: A time-course of responses to neural induction, 
analysed by RNA-Seq 
4.1 Introduction 
In the previous chapter we investigated the process of neural induction using a group of 
selected markers. Node graft assays revealed that the earliest responses are upregulated 
within 1-3h and include genes such as ERNI, SOX3 (Streit et al., 2000), Calfacilitin (Papanayotou 
et al., 2013), OTX2 (Bally-Cuif et al., 1995), NOT1 and NOT2 (Knezevic et al., 1995, Knezevic and 
Mackem, 2001), which are normally expressed in the pre-streak embryo. Following this, a 
second wave of responses is induced after 5h including Churchill (Sheng et al., 2003), Asterix, 
Obelix, TRKC (Pinho et al., 2011), DAD1 and UBII (Gibson et al., 2011), whose expression is first 
detected in the prospective neural plate at around HH3-4. After these early responses, SOX2 is 
induced after 9h and SOX1 after 12h. 
Although we have not focused on the specific function of these markers, they clearly illustrate 
previously unappreciated characteristics of neural induction. First, the earliest markers are 
expressed in the pre-streak epiblast, indicating that neural induction begins before 
gastrulation. Second, at least for the markers where this was tested, BMP antagonism is not 
sufficient to induce their expression. In several cases, FGFs and possibly retinoic acid are 
responsible (Knezevic et al., 1995, Foley et al., 2000, Streit et al., 2000, Knezevic and Mackem, 
2001, Sheng et al., 2003, Gibson et al., 2011, Pinho et al., 2011, Papanayotou et al., 2013), 
consistent with the proposal that BMP antagonists function later in the neural induction 
process (Linker and Stern, 2004). These data suggest that neural induction proceeds as a 
cascade of sequential responses to signals from Hensen’s node (Pinho et al., 2011) including 
FGFs. This contrasts with the accepted “default model” of neural induction which proposes 
that ectodermal cells will automatically (by “default”) acquire a neural fate in the absence of 
signals (Hemmati-Brivanlou and Melton, 1997) and implies that BMP antagonists secreted 
from the organizer effectively create a “default” neural state by inhibiting BMPs which are 
expressed in the ectoderm (Lamb et al., 1993, Hemmati-Brivanlou et al., 1994, Sasai et al., 
1994, Sasai et al., 1995). 
Of the responses studied to date, most were identified by a differential screen which 
compared uninduced epiblast to tissue exposed to a node graft for 5h (Streit et al., 2000). This 
successfully identified 10 early neural markers, each of which is expressed in the prospective 
neural plate in response to signals from Hensen’s node (Streit et al., 2000, Sheng et al., 2003, 
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Gibson et al., 2011, Pinho et al., 2011, Papanayotou et al., 2013). However, it now seems that 
these markers only define the earliest stages of neural induction (Pinho et al., 2011), and that 
they are not the only early responses (see Chapter 3). More than 5h of exposure to a node 
graft are required to induce the definitive neural markers SOX2 (9h) and SOX1 (at least 12h) 
and we know almost no other genes that mark these or the intermediate steps in the cascade. 
In addition, it is surprising that the original screen did not identify markers that are 
downregulated in response to a graft of Hensen’s node, which could function normally to 
repress neural fates in non-neural regions of the ectoderm.  
The preceding observations suggest that neural induction is more complex than previously 
considered. It proceeds as a temporal cascade of multiple responses and signals between 0-
12h of a node graft or stages EGKXII-HH9 in the embryo. However many of the transcription 
factors which describe the process and the signals which regulate it are unknown. Next 
generation sequencing now provides the opportunity to reinvestigate the neural induction 
cascade with greater sensitivity. To uncover all genes that change during this period, an RNA-
Seq analysis of induced and uninduced tissue at key time points was conducted. We decided to 
begin by studying responses to a grafted node after 5h; to seek genes that may have been 
missed by the previous screen and after 9h; to characterise the unexplored gap between early 
responses and genes leading to induction of SOX2 and neural plate specification. Lastly, to 
detect responses that coincide with the induction of SOX1 and commitment to a neural fate, 
we also chose to study markers after 12h following a node graft. 
 
4.2 Methods 
4.2.1 RNA-Seq analysis of responses to neural induction 
Chick HH4- Hensen’s nodes were grafted into chick hosts at the same stage and incubated for 
5, 9 or 12h. To minimise the possible contribution of embryonic asymmetries, nodes were 
grafted to either the left or right side of the embryo. At each time point, 50 pieces of induced 
epiblast were dissected from underneath the graft, as well as 50 pieces of uninduced epiblast 
from the contralateral side. Uninduced epiblast was also isolated from HH4- embryos to serve 
as a 0h control (Fig. 4.1A). Tissue from each condition was pooled, the RNA extracted and its 
quality assessed (Appendix 2). Library samples were prepared using the Illumina mRNA TruSeq 
system and analysed by 100-cycle paired-end RNA-Seq (Fig. 4.1B).  
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Figure 4.1: RNA-Seq screen experimental set-up and RNA processing.  
For the RNA-Seq screen, Hensen’s nodes at HH4- were grafted to a competent region of the 
area opaca (the inner third, at the level of the host node shown in blue) of hosts at HH4- (A). 
Nodes were grafted to the left or right side, and embryos cultured for 5, 9 or 12h. At each time 
point, 50 pieces of induced epiblast in contact with the graft and of contralateral (uninduced) 
tissue were collected. In addition, 50 pieces of tissue were taken from the area opaca of HH4- 
embryos to serve as a 0h time point. For each condition RNA was extracted and cDNA libraries 
constructed as follows (B). First, mRNA was enriched using oligo-dT and chemically fragmented 
into approximately 200bp fragments. From these, cDNA was synthesised using random 
primers and then adaptors ligated to barcode each sample. Barcoded libraries were purified to 
remove unincorporated adaptors, and enriched using 10 cycles of PCR. Finally these were 
processed using 100bp paired-end sequencing. 
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For each library sequenced, raw reads underwent quality control assessment (Appendix 3, 4 
and 5). Low quality reads were filtered out and the remainder were trimmed at the 3’ end to 
remove lower quality regions over the last 10bp (Blankenberg et al., 2010). High quality paired 
(forward and reverse) reads remained, which overlapped by 80bp. These were mapped to the 
chicken genome (Trapnell et al., 2009), annotated and their expression levels quantified. 
Finally differential expression of transcripts was determined by comparing induced and 
uninduced reads at 5, 9 and 12h. 
 
4.3 Results 
4.3.1 RNA-Seq Analysis 
Conducted by M. Khan in collaboration with K.E. Trevers 
Initially, reads were mapped to the available Galgal3 version of the chicken genome (assembly 
version Gallus_gallus-2.1, GenBank Assembly ID GCA_000002315.1) and annotated using the 
Ensembl database. Differential expression was calculated using two separate methods, the 
first used the Cufflinks suite of algorithms and the second used DE-Seq (Anders and Huber, 
2010, Delhomme et al., 2012, Trapnell et al., 2012). In both cases a threshold log2 fold change 
of 1.2 was used to define differential expression. The results of Cufflinks and DE-Seq analyses 
were compared and transcripts were categorised depending on whether they were statistically 
significant (P≤0.05) in both analyses (red), either analysis (orange), or in neither (yellow) 
(Appendix 6). This approach identified 7745 differentially expressed transcripts across all three 
experimental time points (Appendix 7). Gene annotations could be assigned to 4508 of these, 
corresponding to 2333 unique genes. Due to the incomplete nature of the Galgal3 chicken 
genome, 3237 transcripts were left unannotated (Appendix 6).  
Upon release of the Galgal4 version of the chicken genome (assembly version Gallus_gallus-
4.0, GenBank Assembly ID GCA_000002315.2) the RNA-Seq data was reanalysed to obtain 
extra annotations. This time, differential expression was calculated only using DE-Seq and 
using a threshold log2 fold change of 1.2, while annotations were obtained using both Ensembl 
and UCSC databases (Anders and Huber, 2010, Delhomme et al., 2012). Cufflinks was not used 
due to the unstable nature of the algorithm, which gives different results each time it is used. 
With this approach, the Galgal4 reanalysis identified 8673 differentially expressed transcripts 
across all three experimental time points (Appendix 8). Gene annotations could be assigned to 
7184 of these, corresponding to 4145 unique genes (1812 more than the initial Galgal3 
analysis). These data are summarised using volcano plots comparing fold change and P-value 
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and heat maps representing the expression levels of transcripts from induced and uninduced 
tissue at each time point (Fig. 4.2, 4.3, 4.4). Despite the incomplete nature of the chicken 
genome only 989 transcripts remained unannotated -many fewer than the Galgal3 analysis 
(Appendix 8).  
 
 
Figure 4.2: DE-Seq analysis of 5h induced vs. uninduced transcripts.  
Differentially expressed genes were identified using DE-Seq analysis to compare transcripts 
from uninduced and induced tissue at the 5h time point. The results shown here are based on 
the Galgal4 version of the chicken genome. A volcano plot of P-value and fold change for all 
transcripts in the 5h induced vs. 5h uninduced comparison (A). The X axis represents log2 fold 
change and the Y axis represents -log10 of the P-value. Transcripts that pass a P-value threshold 
of 0.05 and a fold change cut-off of log2 1.2 are shown in red. Those that don't pass the P-value 
threshold of 0.05 but pass the fold change cut-off of log2 1.2 are in blue. Transcripts that are 
not differentially expressed are shown in black. Heat map visualisations with hierarchical 
clustering of differentially expressed transcripts based on a log2 fold change of 1.2, in 5h 
induced tissue compared to 5h uninduced control tissue. Downregulated transcripts (green) 
are expressed lower in the induced condition compared to the uninduced control (B). 
Upregulated transcripts (red) are expressed higher in the induced condition compared to the 
uninduced control (C).  
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Figure 4.3: DE-Seq analysis of 9h induced vs. uninduced transcripts.  
Differentially expressed genes were identified using DE-Seq analysis to compare transcripts 
from uninduced and induced tissue at the 9h time point. For details, see Fig. 4.2. 
 
 
Figure 4.4: DE-Seq analysis of 12h induced vs. uninduced transcripts. 
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Differentially expressed genes were identified using DE-Seq analysis to compare transcripts 
from uninduced and induced tissue at the 12h time point. For details, see Fig. 4.2. 
 
4.3.2 The screen detects anticipated transcriptional responses to neural 
induction  
To assess whether the RNA-Seq screen successfully identified responses associated with neural 
induction, we looked for the differential expression of responses already known, or predicted 
to be involved with this process (Table 4.1).  
 
 
5h 9h 12h 
 
UP DOWN UP DOWN UP DOWN 
Transcription 
Factors 
SOX3 
OTX2 
GATA2 
MSX1 
SMAD6 
SMAD7 
SOX2 
OTX2 
GBX2 
GATA2 
MSX1 
SMAD6 
SMAD7 
SOX1 
SOX2 
OTX2 
HOXB1 
NEUROG2 
GATA2 
MSX1 
SMAD6 
SMAD7 
↑ Neural 
 
↓ Non-
neural 
Other 
Markers 
ERNI 
KRT7 
KRT19 
NCAM1 
KRT7 
KRT19 
NCAM1 
KRT7 
KRT19 
Signalling 
Readouts 
SPRY1 
SPRY2 
SPRED1 
FRZB 
SFRP1 
LFNG 
HEY1 
PTCH2 
 
BMP2 
BMP7 
AXIN2 
RARB 
SPRY1 
SPRY2 
SPRED1 
FRZB 
SFRP1 
CYP26A1 
LFNG 
HEY1 
PTCH2 
PTCH1 
BMP2 
BMP7 
AXIN2 
RARB 
SPRY1 
SPRY2 
FRZB 
SFRP1 
CYP26A1 
LFNG 
HEY1 
PTCH2 
PTCH1 
BMP2 
BMP7 
AXIN2 
RARB 
↑ FGF 
↑ RA 
↑ Notch 
↑ HH 
 
↓ BMP 
↓ WNT 
 
Table 4.1: Anticipated responses to neural induction, as identified by RNA-Seq.  
The following markers and signalling readouts were identified as being either up- or down-
regulated after 5, 9 or 12h. Known responses to neural induction include the upregulation of 
ERNI, SOX3, SOX2 and SOX1 at the appropriate time points, in addition to downregulation of 
non-neural ectoderm and epidermal markers such as GATA2, MSX1, KRT7 and KRT19. These 
are accompanied by readouts of signalling events associated with neural induction including 
FGF signalling, plus BMP inhibition and WNT inhibition. Also detected are readouts of retinoic 
acid, Notch and hedgehog pathways. 
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The neural markers SOX3, SOX2 and SOX1 are upregulated at the appropriate time points: 5, 9 
and 12h respectively (Streit et al., 2000). Markers of neural tube anterior-posterior patterning 
are progressively acquired, including OTX2 (Bally-Cuif et al., 1995) at each time point, GBX2 
(Shamim and Mason, 1998) after 9h and HOXB1 (Paxton et al., 2010) after 12h. Upregulation 
of the proneural gene NEUROG2 (Perez et al., 1999), is also detected at the 12h time point. 
Epidermal markers including KRT7 (Heller et al., 1998) and KRT19 (McLarren et al., 2003) are 
downregulated at each time point, while the neural marker NCAM1 (Chuong and Edelman, 
1985) is upregulated after 9 and 12h. 
Also identified, are transcriptional readouts of signalling pathways previously associated with 
neural induction. We detect early and persistent upregulation of FGF signalling targets 
including SPRY1, SPRY2 and SPRED1 (Sivak et al., 2005). BMP signalling is generally inhibited. 
BMP2 (Francis et al., 1994) and BMP7 (Monroe et al., 2000) are downregulated at each time 
point, as is the BMP signalling component SMAD6 (Vargesson and Laufer, 2001) and BMP 
target genes GATA2 (Sheng et al., 2003) and MSX1 (Suzuki et al., 1991). WNT inhibition is also 
prevalent; the WNT antagonists SFRP1 (Esteve et al., 2000) and FRZB (Ladher et al., 2000) are 
consistently upregulated, while AXIN2 (Quinlan et al., 2009) -an endogenous reporter of WNT 
signalling, is downregulated. In addition, we also identify distinct readouts of other signalling 
pathways. The upregulation of CYP26A1 (Swindell et al., 1999, Albazerchi and Stern, 2007) 
after 9 and 12h might suggest high levels of retinoic acid, but the retinoic acid receptor RARB 
(Cui et al., 2003) is simultaneously downregulated. Transcriptional targets of Notch signalling 
such as LFNG (Sakamoto et al., 1997) and HEY1 (Leimeister et al., 2000) are consistently 
upregulated. There is also evidence of hedgehog signalling as the receptors PTCH1 and PTCH2 
(Pearse et al., 2001) are consistently upregulated at 5, 9 and 12h. 
Therefore the screen successfully identified upregulation of factors known to be expressed in 
neural tissue together with downregulation of factors associated with non-neural ectoderm. 
These changes coincide at the appropriate time points with signalling events that are required 
for neural induction, namely early upregulation of FGF signalling together with general WNT 
and BMP inhibition. Since the screen detects the precise types of markers and signalling 
readouts we would anticipate, it gives confidence that other newly identified markers within 
the data should also be relevant to neural induction. 
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4.3.3 Differentially expressed transcriptional regulators accompanying 
neural induction 
Within these RNA-Seq data, the differential expression of transcriptional regulators is of 
particular interest because these determine tissue specification by exerting global control over 
gene transcription during neural induction. In total, the Galgal3 analysis identified 284 unique 
differentially expressed transcriptional regulators (Appendix 6 and 7) while the Galgal4 
reanalysis identified 482 (Fig. 4.3 and Appendix. 8). These are depicted as heat maps and Venn 
diagrams representing their differential expression across the three experimental time points. 
They reveal that transcriptional regulators are expressed at a wide range of levels (Fig. 4.5A). 
Some are consistently up- or downregulated, others are unique to a time point or span two 
time points (Fig. 4.5B), while 24 are up- and downregulated but at different time points. 
Therefore differentially expressed transcriptional regulators vary in terms of the levels and the 
timing of their expression and differential expression, during neural induction. 
 
 
Figure 4.5: Differentially expressed transcriptional regulators from Galgal4 RNA-Seq. 
94 
 
Differentially expressed genes were identified using DE-Seq analysis to compare transcripts 
from uninduced and induced tissue at each time point, using the Galgal4 version of the chicken 
genome and a log2 fold change cut-off of 1.2. Extracted from this analysis are 1009 transcripts 
coding for 482 unique transcriptional regulators. These are represented as heat maps with 
hierarchical clustering of upregulated (red) and downregulated (green) transcriptional 
regulators across the 3 time points (A). The same data are displayed as Venn diagrams of up- 
and downregulated transcriptional regulators, split according to the time points at which they 
are differentially expressed (B).  
 
4.3.4 The normal expression of differentially expressed transcriptional 
regulators 
To confirm whether these transcriptional regulators are expressed appropriately for a role in 
neural induction, their expression was determined in the normal embryo. The original 
intention was to confirm the expression of all differentially expressed transcriptional 
regulators, but the screen identified more candidates than expected. Therefore we decided to 
confirm a proportion of these by in situ hybridisation. Beginning with the Galgal3 analysis, we 
chose to verify the expression of 135 transcriptional regulators that were categorised as red or 
orange; those calculated as being significantly differentially expressed by Cufflinks, DE-Seq, or 
both (Appendix 6). When the new assembly and annotations (Galgal4) were released, we 
added candidates that showed significant differential expression in DE-Seq (Appendix 8), 
colour coded red in the volcano plots (Fig. 4.2A, Fig. 4.3A and Fig. 4.4A). This generated a 
shortlist of 138, of which 97 were common to the Galgal3 analysis. Therefore in total 176 
candidates were picked across both versions of the analysis: 88 upregulated and 88 
downregulated.  
We are mainly interested in these transcriptional regulators as markers of specification states 
rather than their specific function during neural induction. To date, the expression of 166 
transcriptional regulators has been verified by in situ hybridisation at four embryonic stages 
equivalent to key time points in the screen. To test whether candidates are induced earlier 
than 5h, their expression was assessed prior to gastrulation at EGKXII-XIII. Then, expression 
was verified in the prospective neural plate at HH3-4 for candidates induced after 5h. Later, 
expression was confirmed between HH5-7, roughly corresponding to induction of SOX2 after 
9h, and at HH8-9, equivalent to the induction of SOX1 after 12h.  
Of the 166 genes assessed so far, 86 have been previously characterised in chick but not 
always at stages relevant to neural induction. These are highlighted in bold, and a brief 
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description of their expression and the relevant references in chick are provided. A further 80 
transcriptional regulators have not been previously studied in the chicken embryo. These are 
highlighted as underlined and are formally described here. References to these genes or the 
proteins they encode in other organisms or experimental systems are provided. 
 
4.3.4.1 Upregulated transcriptional regulators 
The expression of 83 transcription factors which were upregulated after 5, 9 or 12h was 
verified by in situ hybridisation. These included many known markers of neural fate, but also 
numerous markers which have not previously been implicated in neural induction and 31 not 
previously studied in chick. 
BMI1 (Fig. 4.6A-E) is expressed in the pre-streak epiblast, prospective neural plate and forming 
mesoderm at HH3-4, in the neural plate proper but also in the axial and lateral plate 
mesoderm at HH5-7 and the anterior neural tube at HH8-10 (Fraser and Sauka-
Spengler, 2004). 
CBFAT2T2 (Fig. 4.6F-J) is expressed weakly in the neural plate at HH3-4 and mainly in the 
forming mesoderm. This continues at HH5-7 and HH8-10, where it is upregulated 
anteriorly in the future lens placode (Koyano-Nakagawa and Kintner, 2005). 
CCND1 (Fig. 4.6K-O) is expressed in the area opaca, weakly in the prospective neural plate at 
HH3-4 but also across the posterior streak. Later it is expressed in the neural plate and 
pre-somitic mesoderm at HH5-7 and the neural tube, somites, lateral plate and pre-
somitic mesoderm at HH8-10 (Lobjois et al., 2004). 
CDCA7 encodes a transcriptional regulator which associates with MYC (Goto et al., 2006, Gill et 
al., 2013). It was identified as upregulated at all screen time points. Consistent with 
this, CDCA7 is expressed in the prospective neural plate at HH4, the neural plate 
proper at HH7 and in the neural tube at HH9. At these stages it is also expressed 
weakly in the primitive streak but there is no specific CDCA7 expression at EGKXIII (Fig. 
4.6P-T). 
CITED4 (Fig. 4.6U-Y) is upregulated only at the 5h time point and is expressed in the pre-streak 
epiblast at EGKXII-XIII and the prospective neural plate at HH3-4. It is downregulated in 
the neural plate by HH5-7, when it is expressed weakly in the neural plate border. By 
HH8-10 it is only expressed anteriorly in the neural folds and head surface ectoderm 
(Andrews et al., 2000). 
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CRIP2 encodes a putative LIM domain transcription factor (Weiskirchen et al., 1995). It was 
identified as upregulated after 5 and 9h. In the embryo, CRIP2 is expressed strongly in 
the neural plate at HH4, HH5 and HH8-. It is also weakly expressed in the epiblast at 
EGKXIII (Fig. 4.6Z-AD). 
DACH1 (Fig. 4.7A-E) is expressed weakly in the epiblast and more strongly in the prospective 
and neural plate proper at HH3-4 and HH5-7. By HH8-10 it is expressed broadly in the 
embryo and throughout the forming neural tube (Heanue et al., 2002). 
DMBX1 (Fig. 4.7F-J) expression is absent from the early embryo and the prospective neural 
plate. Instead expression is first detected at HH5-7 in the anterior neural plate border 
and pre-placodal domain. The expression continues at HH8-10 in the anterior neural 
folds (Ferran et al., 2007). 
DNMT3A (Fig. 4.7K-O) is expressed strongly at all stages assessed. It is present in the pre-
streak epiblast, prospective neural plate, neural plate proper and forming neural tube 
(Hu et al., 2012). 
DNMT3B (Fig. 4.7P-T) is expressed strongly at all stages assessed. It is present in the pre-streak 
epiblast, prospective neural plate, neural plate proper and forming neural tube 
(Rengaraj et al., 2011). 
ENC1 regulates the transcription factor NRF2 (Wang and Zhang, 2009). It was identified as 
upregulated in each time point. By in situ hybridisation, ENC1 is expressed weakly in 
the epiblast at EGKXIII and in the prospective neural plate and mesoderm at HH4. By 
HH6 it is expressed strongly in the neural plate, primitive streak and the underlying 
mesoderm. Expression continues in the caudal mesoderm at HH8+, when it becomes 
restricted to the anterior neural folds (Fig. 4.7U-Y). 
EOMES (Fig. 4.7Z-AD) is expressed broadly throughout the area opaca but also posteriorly in 
the area pellucida at EGKXII-XIII. By HH3-4 it is expressed strongly in the prospective 
neural plate and the mesoderm exiting the streak. Expression then decreases such that 
it is only expressed weakly in the neural plate at HH5-7 and cannot be detected by 
HH8-10 (Jean et al., 2015). 
ERNI (Fig. 4.8A-E) is expressed strongly in the pre-streak epiblast at EGKXII-XIII and prospective 
neural plate at HH3-4. Then its expression clears from the neural plate at HH5-7 and 
shifts to the neural plate border and pre-placodal region. By HH8-10 it is expressed 
strongly in the anterior neural folds and head surface ectoderm (Streit et al., 2000). 
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ETV1 (Fig. 4.8F-J) is expressed weakly in the posterior epiblast at EGKXII-XIII and in the epiblast 
around Hensen’s node at HH3-4. Later it is absent from the neural plate and neural 
tube, instead being expressed in the axial and lateral plate mesoderm at HH5-7 and 
HH8-10 (Lunn et al., 2007). 
ETV4 (Fig. 4.8K-O) is expressed strongest in the epiblast and prospective neural plate at EGKXII-
XII and HH3-4 respectively. Later it is mainly expressed posteriorly in the mesoderm 
but also weakly in the posterior neural plate at HH5-7 and in the anterior neural folds 
and the future hindbrain at HH8-10 (Lunn et al., 2007). 
ETV5 (Fig. 4.8P-T) is expressed weakly in the epiblast at EGKXII-XIII but more strongly in the 
prospective neural plate at HH3-4. By HH5-7 it is expressed throughout the neural 
plate and at HH8-10 it is expressed anteriorly to the somites in the forming neural tube 
but also in the paraxial mesoderm (Lunn et al., 2007). 
EYA2 (Fig. 4.8U-Y) is weakly expressed in the epiblast at EGKXII-XIII, but it cannot be detected 
in the prospective neural plate at HH3-4. By HH5-7 it is expressed in the forming head 
fold and by HH8-10 it is detected in the anterior neural tube, neural folds and head 
surface ectoderm (Mishima and Tomarev, 1998). 
EZH2 belongs to the polycomb group of transcriptional repressors (Vire et al., 2006). EZH2 was 
upregulated only at the 12h time point, and no specific expression was detected in the 
embryo at EGKXII or HH4-. At HH7 it appears to be upregulated in small groups of cells 
in the head fold and heart forming region and by HH9- it is only weakly upregulated in 
the neural tube (Fig. 4.8Z-AD).  
GBX2 (Fig. 4.9A-E) is expressed in the hypoblast layer but not the epiblast at EGKXII-XIII. By 
HH3-4 it is expressed broadly throughout the area pellucida ectoderm including the 
prospective neural plate. By HH5-7, GBX2 expression clears from the anterior neural 
plate but remains in the neural plate border and in the future hindbrain, pre-cardiac 
and paraxial mesoderm. This expression continues at HH8-10 when it is expressed in 
the forming neural tube, but is upregulated in the hindbrain where it forms a boundary 
with the midbrain (Shamim and Mason, 1998). 
GLI2 (Fig. 4.9F-J) and GLI3 (Fig. 4.9K-O) are not detected at EGKXII-XIII or HH3-4. Instead both 
are expressed in the anterior neural plate at HH5-7 and forming neural tube at HH8-10 
(Schweitzer et al., 2000). 
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HESX1 (Fig. 4.9P-T) cannot be detected at EGKXII-XIII or at HH3-4. It is expressed weakly in 
neural plate anterior to Hensen’s node at HH5-7 and more strongly in the anterior 
neural folds at HH8-10 (Chapman et al., 2002). 
HEY1 (Fig. 4.9U-Y) expression cannot be detected at EGKXII-XIII, HH3-4 or HH5-7. It is only 
weakly expressed in the neural tube at HH8-10 (Leimeister et al., 2000). 
HIVEP3 encodes a zinc finger protein of the human immunodeficiency virus type 1 enhancer-
binding protein family (Hicar et al., 2001). HIVEP3 is upregulated at the 5h time point 
but there is only broad low level expression detected throughout the embryo at all 
stages (Fig. 4.10A-E). 
HOXB1 (Fig. 4.10F-J) is absent from the pre-streak embryo at EGKXII-XIII. By HH3-4 it is 
expressed strongly in the axial mesoderm exiting the posterior primitive streak. This 
continues at HH5-7, and by HH8-10 it is also expressed posteriorly in the neural tube, 
but remains absent from the neural tube anterior to the somites (Paxton et al., 2010). 
ING5 may function as a component of the histone acetyltransferase complex (Doyon et al., 
2006). In the screen, it is upregulated after 5 and 9h and similar expression dynamics 
are observed by in situ hybridisation. ING5 is expressed strongest at early stages, in the 
epiblast at EGKXIII and prospective neural plate at HH4. By HH6, expression clears 
anteriorly from the neural plate and is restricted to a band across the anterior border 
and pre-placodal region. Expression continues weakly at HH8+ throughout the neural 
tube (Fig. 4.10K-O) 
IRX2 (Fig. 4.10P-T) cannot be detected at EGKXII-XIII and HH3-4. Expression is observed in the 
neural plate and at HH5-7 and in the forming neural tube and somites at HH8-10 
(Matsumoto et al., 2004). 
IVNS1ABP modifies the Aryl hydrocarbon receptor (AHR) pathway, to increase the 
concentration of AHR available to activate transcription (Dunham et al., 2006). In the 
screen, it is upregulated after 5 and 9h. By in situ, IVNS1ABP expression is first 
detected in the prospective neural plate at HH4. It remains in the neural plate and 
neural tube at HH6 and HH8+ (Fig. 4.10U-Y). 
KAT2B encodes a protein with histone acetyltransferase activity. In association with p300/CBP 
it interacts with core histones and nucleosomes to regulate transcription (Zhang and 
Bieker, 1998). KAT2B is upregulated after 5h in the screen but expression is not 
detected early at EGKXIII or HH4. There appears to be ubiquitous low level expression 
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throughout the embryo at HH5. It is only upregulated in the neural tube at HH9 (Fig. 
4.10Z-AD). 
KDM4A encodes a protein with histone demethylase activity (Zhang et al., 2005) which is 
upregulated after 9 and 12h in the screen. It is detected in the epiblast at EGKXIII and 
the prospective neural plate at HH4. Later, it is expressed robustly in the neural plate 
at HH5 and the neural tube at HH8 (Fig. 4.11A-E). 
LHX5 belongs to a large family of LIM homeobox proteins (Zhao et al., 2000). It was only 
identified as upregulated after 12h. In the embryo LHX5 is not observed at EGKXIII and 
by HH4 there is only weak expression in the neural plate. At HH6 it is strongly 
expressed in the anterior neural plate, extending into the pre-placodal region. This 
continues in the neural tube at HH8-, when it is also expressed in the notochord (Fig. 
4.11F-J). 
LIN28A (Fig. 4.11K-O) is expressed strongly in the epiblast at EGKXII-XIII. At HH3-4 it is 
expressed in the prospective neural plate but is absent from regions closest to the 
primitive streak. Later at HH5-7 and HH8-10 it is expressed broadly and strongly 
throughout the embryo, including the neural plate and neural tube (Jean et al., 2015). 
LIN28B (Fig. 4.11P-T) is expressed weakly in the epiblast and prospective neural plate at 
EGKXII-XIII and HH3-4. No expression is detected at HH5-7, but it is expressed strongly 
in the neural tube at HH8-10 (Bobbs et al., 2012, Jean et al., 2015). 
LMO1 encodes a putative transcriptional regulator that contains two zinc finger domains 
(McGuire et al., 1991). It was detected as an upregulated candidate after 9 and 12h. In 
the embryo expression can first be detected at HH4 in the ectodermal cells overlying 
the node. By HH6, LMO1 is expressed strongly in the neural plate but is specifically 
absent from the anterior neural plate border and pre-placodal region surrounding the 
neural plate. At HH8 it is expressed strongly throughout the neural tube (Fig. 4.11U-Y). 
LMX1B (Fig. 4.11Z-AD) is not expressed at EGKXII-XIII or HH3-4. Strong expression is detected 
in the neural plate and neural plate border at HH5-7, but is absent from the most 
anterior domains. By HH8-10 it is expressed throughout the forming neural tube and 
the migrating neural crest (Riddle et al., 1995). 
MAFA (Fig. 4.12A-E) is expressed strongly in the epiblast at EGKXII-XIII and prospective neural 
plate at HH3-4. Its expression weakens in the neural plate at HH5-7 and neural tube at 
HH8-10 (Ogino and Yasuda, 1998). 
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MAML2 functions as a transcriptional co-activator by interacting with the Notch intracellular 
domain (NICD) (Wu et al., 2002). It is upregulated after only 9 and 12h and consistent 
with this, expression was not observed at EGKXIII or HH4 or HH5. However, by HH8 it is 
strongly expressed throughout the forming neural tube, but also the lateral plate 
mesoderm and somites (Fig. 4.12F-J). 
MEIS1 (Fig. 4.12K-O) expression cannot be detected at EGKXII-XIII or HH3-4. By HH5-7 it is 
expressed strongly in the caudal neural plate but also in the mesoderm emerging from 
the posterior streak. This expression continues in the caudal neural tube at HH8-10 
(Mercader et al., 1999). 
MEIS2 (Fig. 4.12P-T) is also absent at early stages, but is expressed in the caudal neural plate 
and neural tube and lateral plate mesoderm at HH5-7 and HH8-10 (Mercader et al., 
1999). 
MTA1 is predicted to regulate transcription via HDAC1 (Yoo et al., 2006). It is upregulated after 
5 and 9h and is strongly expressed in prospective neural tissue at all stages examined. 
Expression is first detected in the epiblast at EGKXIII and in the prospective neural 
plate at HH4. This continues in the neural plate and lateral plate mesoderm at HH6 and 
HH9- (Fig. 4.12U-Y). 
MYCN, or N-MYC, (Fig. 4.12Z-AD) is also expressed strongly at all stages assessed. It is detected 
in the epiblast and prospective neural plate at EGKXII-XIII and HH3-4. Later, at HH5-7 
and HH8-10 expression persists in the neural plate and neural tube, but also in lateral 
plate mesoderm (Khudyakov and Bronner-Fraser, 2009). 
NKX1-2 (Fig. 4.13A-E) expression is not detected at EGKXII-XIII and HH3-4. Instead it is 
expressed in the posterior lateral plate mesoderm at HH5-7. This continues at HH8-10, 
when it is also expressed in the caudal neural tube (Bertrand et al., 2000). 
NKX6-2 (Fig. 4.13F-J) is expressed ubiquitously at low levels at EGKXII-XIII and HH3-4. Later at 
HH5-7 and HH8-10 it is expressed only weakly in the neural plate and forming neural 
tube (Pattyn et al., 2003). 
NOT1 (Fig. 4.13K-O) is expressed at all stages assessed. Transcripts are present in the epiblast 
at EGKXII-XIII and prospective neural plate at HH3-4, when it is expressed strongest 
around Hensen’s node. Later at HH5-7 and HH8-10 it is expressed in the neural plate 
directly adjacent to the regressing node, as well as in the notochord (Knezevic et al., 
1995, Stein et al., 1996). 
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NOT2 (Fig. 4.13P-T) is also expressed strongly in the epiblast at EGKXII-XIII and in the ectoderm 
around Hensen’s node at HH3-4. Later it is expressed strongly in the notochord, but 
weakly in the caudal ectoderm surrounding the regressing node (Stein et al., 1996, 
Knezevic and Mackem, 2001). 
NRIP1 modulates transcription by interacting with nuclear receptors (Subramaniam et al., 
1999). It was detected as upregulated only at the 5h time point. In the embryo, NRIP1 
is expressed weakly in the epiblast at EGKXIII and more strongly in the prospective 
neural plate at HH4. However it is absent from the neural plate at HH6 and by HH9- it 
is mainly expressed in the lateral plate and pre-somitic mesoderm (Fig. 4.13U-Y). 
NSD1 encodes a SET domain histone methyltransferase (Qiao et al., 2011). It was identified by 
the screen as upregulated at each time point and strong NSD1 expression is observed 
at all stages assessed. It is detected in the epiblast at EGKXIII and the prospective 
neural plate at HH4. This continues in the neural plate and neural tube at HH7 and 
HH9+ (Fig. 4.13Z-AD). 
OTX2 (Fig. 4.14A-E) is expressed strongly in the epiblast and EGKXII-XIII and prospective neural 
plate HH3-4. Later at HH5-7 it is restricted to the anterior neural plate extending 
outwards to cover the pre-placodal region. This continues at HH8-10 when OTX2 is 
expressed in the anterior neural tube and neural folds (Bally-Cuif et al., 1995). 
PDCD4 is a tumour suppressor that interacts with eIF4A to prevent transcription (Schlichter et 
al., 2001, Palamarchuk et al., 2005). In the screen, it was upregulated at the 12h time 
point only. By in situ, PDCD4 transcripts are detected in the epiblast at EGKXIII and in 
the prospective neural plate at HH4-. By HH6 it is strongly expressed in the neural plate 
and lateral plate mesoderm. At HH8 it is expressed throughout the neural plate and in 
the head surface ectoderm (Fig. 4.14F-J). 
PDLIM4 contains PDZ and LIM domains. It was upregulated in the screen at each time point. 
No specific expression was detected at EGKXIII, but by HH4 it is expressed in the 
prospective neural plate. This continues in the neural plate proper at HH6 when it is 
also expressed in lateral plate mesoderm. By HH8+ it is expressed in the dorsal neural 
folds and posteriorly in the neural plate and its border (Fig. 4.14K-O). 
PRDM1 (Fig. 4.14P-T) is expressed in the epiblast at EGKXII-XIII and prospective neural plate at 
HH3-4. Later at HH5-7 and HH8-10, it is absent from the neural plate and neural tube. 
Instead it is expressed in the pre-placodal region surrounding the anterior neural plate 
and later in the future lens, otic and epibranchial placodes (Ha and Riddle, 2003). 
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RB1 is a negative regulator of the cell cycle and acts as a transcriptional repressor of E2F1 
target genes (Feinstein et al., 1994, Rubin et al., 2005). It was identified as an 
upregulated target, but only in the Galgal3 version of the RNA-Seq analysis. RB1 
expression is not detected at EGKXIII, HH4 or HH5. However by HH8 it is strongly 
expressed throughout the neural plate (Fig. 4.14U-Y). 
RFX3 is a transcriptional factor of the RFX family (Nakayama et al., 2003). It was identified as 
upregulated at each time point but specific expression was not observed at EGKXIII, 
HH4 or HH7. Weak expression is only detected in the neural tube at HH8+ (Fig. 4.14Z-
AD). 
RUNX1T1 (Fig. 4.15A-E) is expressed strongest in the epiblast at EGKXII-XIII. Expression 
continues, but only weakly in the prospective neural plate, neural plate proper and 
neural tube at HH3-4, HH5-7 and HH8-10 respectively (Koyano-Nakagawa and Kintner, 
2005).  
SALL1 (Fig. 4.15F-J) is expressed broadly throughout the area opaca and area pellucida at 
EGKXII-XIII, except in the posterior marginal zone. By HH3-4 it is expressed weakly in 
the prospective neural plate and Hensen’s node. Later at HH5-7 and HH8-10 it is 
expressed throughout the neural plate and neural tube, but also in lateral plate 
mesoderm (Sweetman et al., 2005). 
SETD2 is a H3K36 methyltransferase (Yoh et al., 2008). In the screen it is upregulated at all 
stages. Strong SETD2 expression is also detected by in situ hybridisation at all stages. It 
is one of the strongest expressed markers in the epiblast at EGKXIII. This continues in 
the prospective neural plate at HH4, the neural plate proper at HH7 and forming 
neural tube at HH9- (Fig. 4.15K-O). 
SIX3 (Fig. 4.15P-T) expression cannot be detected at EGKXII-XIII or HH3-4. By HH5-7 SIX3 is 
expressed strongly in the anterior neural plate extending to cover the pre-placodal 
region. This continues in the neural tube and neural folds at HH8-10, in the region 
contributing to the future forebrain (Bovolenta et al., 1998). 
SNAI1 (Fig. 4.15U-Y) is expressed broadly throughout the area opaca and hypoblast at EGKXII-
XIII, but is also expressed posteriorly in the epiblast. By HH3-4, expression is detected 
weakly in Hensen’s node and at HH5-7 and HH8-10 it is present in the somites, paraxial 
mesoderm and lateral plate (Garcia-Castro et al., 2000). 
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SOX1 (Fig. 4.15Z-AD) expression cannot be detected at EGKXII-XIII, HH3-4 or HH5-7. It is first 
expressed in the neural plate and neural tube at HH8-10 (Pevny et al., 1998). 
SOX2 (Fig. 4.16A-E) is not expressed at EGKXII-XIII or HH3-4. Instead it is first expressed in the 
neural plate at HH5-7 and this continues in the forming neural tube at HH8-10 (Rex et 
al., 1997). 
SOX3 (Fig. 4.16F-J) is expressed strongly in the epiblast at EGKXII-XIII and prospective neural 
plate at HH3-4. By HH5-7 expression continues in the neural plate proper but clears 
from a region just anterior to Hensen’s node. At HH8-10 it is expressed throughout the 
forming neural tube (Rex et al., 1997). 
SOX11 (Fig. 4.16K-O) is also expressed strongly in the epiblast at EGKXII-XIII and prospective 
neural plate at and HH3-4, when it is also detected in the primitive streak and 
Hensen’s node. By HH5-7 it is expressed throughout the neural plate and pre-placodal 
region, but also in the lateral plate mesoderm. This continues at HH8-10 (Uwanogho et 
al., 1995). 
SOX13 is another member of the SOX (SRY-related HMG-box) family of transcription factors 
(Roose et al., 1999). Like SOX11 it is also upregulated at each time point in the screen. 
Expression is observed weakly in the epiblast at EGKXIII, but much stronger in the 
prospective neural plate at HH4. This continues in the neural plate proper at HH5 and 
HH8 (Fig. 4.16P-T). 
SP5 (Fig. 4.16U-Y) is only expressed posteriorly, in Koller’s sickle at EGKXII-XIII. At HH3-4 it is 
absent from the prospective neural plate but is expressed posteriorly in the early 
mesoderm and primitive streak. Mesodermal expression continues at HH5-7, but 
transcripts are also detected in the caudal neural plate. By HH8-10 it is expressed 
throughout the neural tube as well as in the cardiac mesoderm and lateral plate 
(Kuraku et al., 2005). 
STOX1 is a transcription factor of the storkhead-box domain family (Rigourd et al., 2009). It 
was identified as upregulated at each time point, but expression was not observed at 
any stage between EGKXIII-HH9 (Fig. 4.16Z-AD). 
STOX2 is another storkhead-box domain protein (Fenstad et al., 2010). It was identified as 
upregulated at the 9 and 12h time points. In the embryo, STOX2 is detected at all 
stages. Transcripts are weakly expressed in the epiblast at EGKXIII, but stronger in the 
prospective neural plate at HH4. By HH7 it is observed throughout the neural plate but 
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also in the pre-somitic and lateral plate mesoderm. This continues at HH8+ (Fig. 4.17A-
E). 
T (Brachyury) (Fig. 4.17F-J) is not expressed at EGKXII-XIII. At HH3-4 it is expressed in the 
primitive streak and emerging early mesoderm. By HH5-7 it is expressed strongly in the 
notochord but also in the lateral plate and weakly in the caudal neural plate. This 
continues at HH8-10 (Smith and Eichele, 1991). 
TAF1A encodes a TATA box-binding protein-associated factor that plays a role in the assembly 
of the RNA polymerase I preinitiation complex (Friedrich et al., 2005). It is only 
detected in the screen as an upregulated gene after 12h. In the embryo, TAF1A 
expression was not observed at any stage assessed (Fig. 4.17K-O). 
TBL1XR1 acts as a component of the N-Cor co-repressor complex (Perissi et al., 2004). It was 
identified as upregulated at each time point in the screen. In situ hybridisation reveals 
that it is expressed broadly throughout the embryo at all stages assessed, but is mildly 
upregulated in the neural tube at HH8-10 (Fig. 4.17P-T). 
TBX6 (Fig. 4.17U-Y) is expressed posteriorly in the epiblast at EGKXII-XIII and in the ectoderm 
of the primitive streak and early mesoderm at HH3-4. Later, expression continues 
posteriorly in the streak ectoderm and lateral plate mesoderm (Knezevic et al., 1997). 
TCF7L1 (Fig. 4.17Z-AD) is expressed weakly at EGKXII-XIII and in the prospective neural plate at 
HH3-4. By HH5-7 it is strongly expressed in the neural plate proper and this continues 
in the forming neural tube at HH8-10 (Schmidt et al., 2004). 
TCF7L2 (Fig. 4.18A-E) is expressed ubiquitously at low levels at EGKXII-XIII and HH3-4, but it is 
upregulated it is expressed in the anterior neural plate at HH5-7 and in the anterior 
neural tube and folds by HH8-10 (Hartmann and Tabin, 2000). 
TCF12 (Fig. 4.18F-J) also shows no specific expression at the earlier stages, but is upregulated 
in the neural plate at HH5-7. By HH8-10 it is strongly expressed in the neural tube 
(Helms et al., 1994). 
TGIF1 (Fig. 4.18K-O) is weakly expressed in the epiblast at EGKXII-XIII but is expressed much 
more strongly in the ectoderm including the prospective neural plate at HH3-4. 
Expression weakens in the neural plate proper at HH5-7, but it is detected throughout 
the forming neural tube at HH8-10 (Lorda-Diez et al., 2009). 
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TRIM9 is a member of the tripartite motif (TRIM) family (Reymond et al., 2001). In the screen it 
was detected as upregulated at each time point. TRIM9 expression was not detected at 
EGKXIII and at HH4 it is only weakly expressed in the mesoderm. By HH7 it is expressed 
strongly in the neural plate but is absent from the anterior lateral edge of the neural 
plate. At HH9-, TRIM9 is expressed along the inner wall of the neural tube (Fig. 4.18P-
T). 
TRIM24 is another TRIM family member which regulates transcription by interacting with the 
AF2 region of nuclear receptors (Tsai et al., 2010). It was identified as being 
upregulated, but only at the 5h time point. In the embryo it is expressed strongly in the 
epiblast at EGKXIII and also in the prospective neural plate at HH4. By HH6 it is 
expressed along the lateral edges of the neural plate and by HH9+ it is only expressed 
weakly in the neural tube (Fig. 4.18U-Y). 
YEATS4 is putative transcription factor (Zimmermann et al., 2002). It is upregulated 
consistently in the screen and is expressed strongly at all stages assessed. Transcripts 
are detected in the epiblast and prospective neural plate at EGKXIII and HH4. By HH5 it 
is expressed in the neural plate and this continues in the neural tube at HH10 (Fig. 
4.18Z-AD). 
ZEB2 (Fig. 4.19A-E) expression is not detected at EGKXII-XIII and it is only expressed weakly in 
the early mesoderm at HH3-4. By HH5-7 it is expressed more strongly in the neural 
plate and throughout the forming neural tube by HH8-10 (Sheng et al., 2003). 
ZIC2 (Fig. 4.19F-J) is expressed at low levels throughout the embryo between pre-streak and 
HH5-7. Even by HH8-10, it is only expressed weakly in the forming neural tube (Warner 
et al., 2003). 
ZIC3 (Fig. 4.19K-O) is expressed strongly in the epiblast at EGKXII-XIII and in the prospective 
neural plate and primitive streak at HH3-4. At HH5-7 and HH8-10 it is expressed 
strongly in the anterior neural plate and neural tube and in the lateral plate mesoderm 
(Warner et al., 2003). 
ZNF423 (also known as OAZ) belongs to the family of Kruppel-like C2H2 zinc finger proteins and 
functions as a DNA-binding transcription factor (Hata et al., 2000). In the screen it is 
upregulated, but only at the 9 and 12h time points. Accordingly, expression is not 
observed at EGKXIII or HH4. It is strongly expressed in the neural plate at HH6 and 
HH8+. Therefore it resembles the expression profile of SOX2 (Fig. 4.19P-T). 
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ZNF462 is a nuclear zinc finger protein predicted to function as a chromatin modifier or 
transcription factor (Masse et al., 2011). In the screen it is upregulated at each time 
point and in the embryo ZNF462 is expressed in the epiblast at EGKIII and prospective 
neural plate at HH4. Later at HH6 and HH8+, it is expressed in the neural plate and 
lateral plate mesoderm (Fig. 4.19U-Y). 
ZNF469 is also a predicted zinc finger transcription factor (Abu et al., 2008). It was identified as 
upregulated, but only at the 5h time point. In the embryo, expression is not observed 
at EGKXIII, HH4 or HH5+. At HH8 it is expressed broadly but seems to be upregulated in 
the neural plate (Fig. 4.19Z-AD). 
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Figure 4.6: Expression of BMI1, CBFAT2T2, CCND1, CDCA7, CITED4 and CRIP2.  
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The expression of upregulated markers was assessed by in situ hybridisation at four key stages: 
pre-streak at EGKXII-XIII (A, F, K, P, U, Z), during gastrulation at HH3-4 (B, G, L, Q, V, AA), at 
neural plate stages HH5-7 (C, H, M, R, W, AB) and neural tube stages HH8-10 (D, I, N, S, X, AC). 
Expression patterns are compared to the absolute transcript counts as quantified by RNA-Seq 
(E, J, O, T, Y, AD). Expression levels at each time point are plotted as bar graphs of log2 of the 
base mean for induced (red or dark grey) and uninduced (green or light grey) tissues at each 
time point. Where columns are coloured red and green, induced and uninduced values differ 
by at least log2 1.2 and markers are differentially expressed. Columns coloured dark and light 
grey distinguish when markers are not differentially expressed.  
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Figure 4.7: Expression of DACH1, DMBX1, DNMT3A, DNMT3B, ENC1 and EOMES.  
For details, see Fig. 4.6.  
110 
 
 
Figure 4.8: Expression of ERNI, ETV1, ETV4, ETV5, EYA2 and EZH2.  
For details, see Fig. 4.6.  
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Figure 4.9: Expression of GBX2, GLI2, GLI3, HESX1 and HEY1.  
For details, see Fig. 4.6. 
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Figure 4.10: Expression of HIVEP3, HOXB1, ING5, IRX2, IVNS1ABP and KAT2B.  
For details, see Fig. 4.6.  
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Figure 4.11: Expression of KDM4A, LHX5, LIN28A, LIN28B, LMO1 and LMX1B.  
For details, see Fig. 4.6.  
114 
 
 
Figure 4.12: Expression of MAFA, MAML2, MEIS1, MEIS2, MTA1 and MYCN.  
For details, see Fig. 4.6. 
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Figure 4.13: Expression of NKX1-2, NKX6-2, NOT1, NOT2, NRIP1 and NSD1.  
For details, see Fig. 4.6.  
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Figure 4.14: Expression of OTX2, PDCD4, PDLIM4, PRDM1, RB1 and RFX3.  
For details, see Fig. 4.6. 
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Figure 4.15: Expression of RUNX1T1, SALL1, SETD2, SIX3, SNAI1 and SOX1.  
For details, see Fig. 4.6.  
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Figure 4.16: Expression of SOX2, SOX3, SOX11, SOX13, SP5 and STOX1.  
For details, see Fig. 4.6.  
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Figure 4.17: Expression of STOX2, T, TAF1A, TBL1XR1, TBX6 and TCF7L1.  
For details, see Fig. 4.6.  
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Figure 4.18: Expression of TCF7L2, TCF12, TGIF1, TRIM9, TRIM24 and YEATS4.  
For details, see Fig. 4.6.  
121 
 
 
Figure 4.19: Expression of ZEB2, ZIC2, ZIC3, ZNF423, ZNF462 and ZNF469.  
For details, see Fig. 4.6.  
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4.3.4.2 Downregulated transcriptional regulators 
Also verified by in situ hybridisation, were the expression of 83 transcriptional regulators 
which are downregulated by grafts of Hensen’s node, including 49 not previously studied in 
chick. Such responses have not been previously detected by screens for neural induction 
(Streit et al., 2000). Although the expression of these factors may not contribute to neural 
identity, these responses could have important functions to repress neural fates, or they may 
provide evidence of alternative cell state or cell fate decisions that accompany neural 
induction. 
AHR encodes a ligand-activated transcription factor, whose ligands included a variety of 
aromatic hydrocarbons (Allan and Sherr, 2005). In the screen AHR is downregulated 
but specific expression is not detected at EGKXII-XIII, HH4 or HH5. Only very faint 
expression can be detected in the neural tube at HH8 (Fig. 4.20A-E).  
ARID5B encodes a DNA binding protein which forms a histone H3K9 demethylase complex 
with PHF2 (Baba et al., 2011). The screen detects ARID5B transcripts as downregulated 
after 9 and 12h. Consistent with this, ARID5B is expressed only in the area opaca at 
HH5 and HH8+. Expression was not observed in embryonic tissues, or earlier at EGKXIII 
and HH4 (Fig. 4.20F-J). 
ATF3 is a member of the mammalian activation transcription factor/cAMP responsive element-
binding (CREB) protein family. It exists as two isoforms. The longer isoform represses 
transcription via ATF binding elements. The shorter isoform lacks a basic leucine zipper 
motif and does not bind to DNA. Instead it appears to stimulate transcription by 
sequestering inhibitory co-factors (Chen et al., 1994). In the screen, ATF3 is 
upregulated after 5h, but downregulated after 9 and 12h. Despite using a probe which 
targets all ATF3 isoforms, expression was not detected at EGKXIII or HH4. At HH5, it is 
strongly expressed in lateral plate mesoderm directly adjacent to the anterior neural 
plate. By HH9, ATF3 is weakly expressed in the lumen of the anterior neural tube (Fig. 
4.20K-O). 
BACH1 functions to repress transcription from MAF recognition elements (Warnatz et al., 
2011). It was identified as being consistently downregulated. By in situ hybridisation, 
BACH1 appears to be expressed ubiquitously at low levels at HH4-, HH6 and HH8. No 
specific expression is detected at EGKXII (Fig. 4.20P-T). 
BACH2 is similar in structure and function to BACH1, and also represses transcription from 
MAF elements (Yoshida et al., 2007). It was downregulated at each time point in the 
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screen. BACH2 appears to be weakly expressed in the neural plate at HH4- and HH5 
and this expression strengthens in the neural tube at HH9-. However it is also 
expressed at a similar level in extra-embryonic tissue at these stages (Fig. 4.20U-Y). 
BHLHE40 encodes a basic helix-loop-helix transcription factor which has been implicated in 
circadian regulation (Sato et al., 2004). In the screen BHLHE40 is downregulated at 
each time point but no specific expression is detected at EGKXIII, HH4 or HH7. It is only 
expressed at HH9 in multiple regions including the notochord, heart field and 
hindbrain (Fig. 4.20Z-AD). 
CDX2 (Fig. 4.21A-E) is consistently absent from prospective neural tissues and is expressed 
strongly in the area opaca at all stages assessed. At HH3-4 it is also expressed 
posteriorly in the early mesoderm, and later at HH5-7 and HH8-10 in the lateral plate 
mesoderm (Marom et al., 1997). 
CDX4 (Fig. 4.21F-J) expression is not detected at EGKXII-XIII or HH3-4. By HH5-7 it is expressed 
caudally in the lateral plate mesoderm. This continues at HH8-10, when it is also 
expressed in the caudal neural tube adjacent to Hensen’s node (Alev et al., 2010). 
CEBPB encodes a transcription factor which can regulate chromatin conformation (Burk et al., 
1993, Plachetka et al., 2008). CEBPB is downregulated at 9 and 12h in the screen, but 
there is no observable expression at any of the stages assessed (Fig. 4.21K-O). 
CREB3L1 is a transcription factor which activates transcription via B-box elements (Omori et 
al., 2002). It is downregulated at the 12h time point in the screen. No specific 
expression is observed at EGKXIII and HH4. CREB3L1 is absent from the neural plate 
and tube at HH6 and HH9-. Instead, strong expression is detected in the heart field, 
lateral plate mesoderm and in the extra-embryonic blood islands (Fig. 4.21P-T). 
CREG1 antagonises transcriptional activation by the adenovirus E1A protein, which normally 
functions to promote proliferation and inhibit differentiation (Veal et al., 1998). CREG1 
is downregulated at the 5h time point but no specific CREG1 expression was detected 
at any stage (Fig. 4.21U-Y). 
CSRP2 belongs to the CSRP family of genes with putative zinc finger binding activity 
(Weiskirchen et al., 1995). In the screen, CSRP2 is downregulated at each time point 
and it is absent from neural tissue at all stages. It is expressed strongly in the hypoblast 
at EGKXIII and in the germinal crescent at HH4. Later at HH6 and HH8+ it is expressed 
in lateral plate mesoderm, non-neural ectoderm and germinal crescent (Fig. 4.21Z-AD). 
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DLX3 (Fig. 4.22A-E) is expressed broadly at very low levels at EGKXII-XIII and HH3-4. By HH5-7 it 
is expressed in the neural plate but also in the lateral plate mesoderm and anterior 
non-neural ectoderm. This continues at HH8-10 (Pera and Kessel, 1999). 
DLX5 (Fig. 4.22F-J) expression is not detected at EGKXII-XIII or HH3-4. By HH5-7 it is strongly 
expressed in the neural plate border, pre-placodal region and non-neural ectoderm. 
This continues at HH8-10 in the neural plate border and neural folds (Ferrari et al., 
1995). 
ELF1 encodes an E26 transformation-specific related transcription factor (Leiden et al., 1992). 
In the screen, it is detected as downregulated at each time point. Specific ELF1 
expression was not observed at EGKXIII or HH4. It is very weakly expressed in the 
neural plate and neural tube at HH7+ and HH9 (Fig. 4.22K-O). 
ELF3 is an epithelial specific ETS-related transcription factor (Oettgen et al., 1997, Brembeck et 
al., 2000). It is downregulated at each time point. There is no specific ELF3 expression 
at EGKXIII or HH4. It is expressed in the lateral plate mesoderm adjacent to the 
posterior neural plate at HH7 and by HH8 very faint expression is detected in the 
neural tube (Fig. 4.22P-T). 
EPAS1 (Fig. 4.22U-Y) is broadly expressed at low levels at EGKXII-XIII and very weakly in the 
early mesoderm at HH3-4. Later it is absent from the neural plate but is expressed 
strongly in the extra-embryonic and embryonic non-neural ectoderm as well as the 
germinal crescent (Ota et al., 2007). 
ESRRG encodes an oestrogen receptor-related receptor (Hentschke et al., 2009). It was 
identified as downregulated at the 5h time point but at EGKXIII and HH4 no specific 
expression is detected. By HH6, it is ubiquitously expressed throughout the embryo 
and area opaca and is strongest in the head fold. By HH8 it is expressed in the neural 
plate border and head fold as well as the area opaca (Fig. 4.22Z-AD). 
ETS2 (Fig. 4.23A-E) is expressed strongly in the area opaca at EGKXII-XIII, but no expression was 
detected by HH3-4. Later, at HH5-7 it is expressed weakly in mesoderm of the lateral 
plate and head fold. By HH8-10 it is expressed mainly in the embryonic mesoderm and 
blood islands (Mey et al., 2012). 
FKHR belongs to the forkhead family of transcription factors and is a key target of insulin 
signalling (Biggs et al., 2001, Zhang et al., 2002, Nakae et al., 2012). It is downregulated 
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after 9 and 12h by the screen. No specific expression is observed at any stage assessed 
(Fig. 4.23F-J). 
FOXO3 also belongs to the forkhead family of transcription factors (Biggs et al., 2001, Bakker et 
al., 2004). It was identified as being consistently downregulated. Expression is not 
observed at EGKXIII, HH4- or HH8+. However at HH5 it appears to be expressed just 
anterior to the head fold and in patches of extra-embryonic tissue (Fig. 4.23K-O). 
FRY has also been demonstrated to function as a transcriptional activator by repressing 
microRNA gene silencing in Xenopus (Goto et al., 2010). It is downregulated in the 
screen at each time point. In the embryo, FRY is expressed ubiquitously at low levels in 
the stages assessed (Fig. 4.23P-T). 
GATA2 (Fig. 4.23U-Y) is consistently absent from neural tissue. At EGKXII-XIII it is expressed in 
the area opaca and anteriorly in a domain fated to form non-neural ectoderm. By HH3-
4 it is expressed in the posterior primitive streak. Later at HH5-7 and HH8-10 it is 
expressed strongly in the embryonic and extra-embryonic ectoderm, lateral plate 
mesoderm and blood islands (Sheng and Stern, 1999, Sheng et al., 2003). 
GATA4 (Fig. 4.23Z-AD) is expressed in Koller’s sickle at EGKXII-XIII and then strongly in the 
primitive streak and area opaca at HH3-4. No specific expression is detected at HH5-7, 
but by HH8-10 it is strongly expressed in the lateral plate and pre-cardiac mesoderm 
(Chapman et al., 2002, Jean et al., 2015). 
GATA5 (Fig. 4.24A-E) and GATA6 (Fig. 4.24F-J) display similar expression patterns. No specific 
expression was detected at EGKXII-XIII, but they are expressed in the germinal crescent 
and early endoderm at HH3-4. Later they are expressed weakly in the lateral plate 
mesoderm and anteriorly in the endoderm of the head fold. By HH8-10 they are 
detected more strongly in the lateral plate and pre-cardiac mesoderm as well as the 
anterior intestinal portal (Jean et al., 2015). 
GRHL1 encodes a member of the grainyhead family of transcription factors (Wilanowski et al., 
2002, Ting et al., 2003) which is downregulated at each time point in the screen. At 
EGKXIII, there is weak expression in the area opaca and Koller’s sickle. Later at HH4, 
HH5 and HH8 expression is ubiquitous at low levels (Fig. 4.24K-O). 
GRHL2 also belongs to the grainyhead family of transcription factors (Wilanowski et al., 2002, 
Ting et al., 2003). In the screen it is downregulated at 9 and 12h. Consistent with this 
there is no specific expression at EGKXIII and HH3+. Later at HH6, GRHL2 is absent from 
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the neural plate but upregulated in the bordering pre-placodal region. This expression 
continues at HH9 in the neural folds, future placodes and head surface ectoderm (Fig. 
4.24P-T). 
GRHL3 encodes another member of the grainyhead family of transcription factors (Wilanowski 
et al., 2002, Ting et al., 2003). It is strongly downregulated in each time point and is 
absent from neural tissue at all stages. At EGKXIII it is expressed weakly anteriorly in 
cell fated to contribute to non-neural ectoderm. By HH4 expression is restricted to the 
area opaca. Later, it is expressed strongly in non-neural ectoderm surrounding the 
neural plate and pre-placodal region at HH5. This continues at HH8 (Fig. 4.24U-Y). 
HAND1 (Fig. 4.24Z-AD) is expressed weakly in the hypoblast at EGKXII-XIII and in the early 
endoderm and mesoderm at HH3-4. This continues at HH5-7 and HH8-10, where it is 
expressed strongly in embryonic and extra-embryonic lateral plate mesoderm and 
blood islands (Srivastava et al., 1995). 
HIC2 is closely related to HIC1 (Deltour et al., 2001), which encodes a transcriptional repressor 
(Pinte et al., 2004). In the screen it was downregulated at each time point. In the 
embryo, it is expressed anteriorly at EGKXIII. By HH4 it is expressed in the area opaca 
and also in the primitive streak. By HH7 and HH8+ it is expressed in the area opaca and 
in the embryonic non-neural ectoderm bordering the neural plate and neural tube (Fig. 
4.25A-E). 
HIPK2 acts as a co-repressor of SMAD1 mediated BMP signalling (Harada et al., 2003). The 
screen detects it as being downregulated only at the 12h time point. HIPK2 expression 
is not observed at EGKXIII. By HH4 it is expressed weakly in the zone between the area 
opaca and the area pellucida. By HH7, HIPK2 is expressed throughout the extra-
embryonic ectoderm and lateral plate mesoderm. Expression is restricted to the lateral 
plate mesoderm and the heart field at HH9 (Fig. 4.25F-J). 
HIVEP2 is a member of the human immunodeficiency virus type 1 enhancer-binding protein 
family (Nomura et al., 1991), which has been implicated in regulating TGFB signalling 
(Shukla et al., 2009). In the screen, HIVEP2 is downregulated after 9 and 12h. Weak 
HIVEP2 expression is detected in the primitive groove at HH4 but no specific staining 
was observed at any other stages (Fig. 4.25K-O).  
HNF1B (Fig. 4.25P-T) is weakly expressed in the hypoblast at EGKXII-XIII and in the germ wall at 
HH3-4. This continues at HH5-7 and HH-10, when it is also expressed in the anterior 
intestinal portal, caudal hindbrain and future spinal cord (Aragon and Pujades, 2009). 
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HOXA1 (Fig. 4.25U-Y) is not detected at EGKXII-XIII. By HH3-4 it is expressed posteriorly in the 
emerging lateral plate mesoderm of the primitive streak. This continues more strongly 
at HH5-7, when it is also expressed in the non-neural ectoderm surrounding the 
anterior neural plate. By HH8-10, it is absent anteriorly but is expressed in the caudal 
neural tube and lateral plate mesoderm (McClintock et al., 2003). 
HOXA2 (Fig. 4.25Z-AD) expression is similar to HOXA1. No expression is detected at EGKXII-XIII 
and only very weak expression is observed in the posterior primitive streak at HH3-4. It 
is robustly expressed in the lateral plate and pre-somitic mesoderm at HH5-7 and this 
continues at HH8-10 in the somites, lateral plate mesoderm and caudal hindbrain 
(Prince and Lumsden, 1994). 
ID2 (Fig. 4.26A-E) is mainly expressed in the area opaca and Koller’s sickle at EGKXII-XIII. Then, 
at HH3-4 its expression is restricted to the germ wall. Later at HH5-7 it is expressed 
weakly in the area opaca but also in the forming anterior intestinal portal, lateral plate 
mesoderm, pre-cardiac mesoderm and sub-regions of the neural plate. This continues 
at HH8-10 (Martinsen et al., 2004). 
ID3 (Fig. 4.26F-J) is expressed in the hypoblast at EGKXII-XIII and in embryonic and extra-
embryonic ectoderm, germinal crescent and early mesoderm at HH3-4. By HH5-7, it is 
mainly expressed in the lateral plate and pre-cardiac mesoderm of the forming 
anterior intestinal portal. This continues at HH8-10, when it is also expressed in the 
forming somites and anterior neural tube (Kee and Bronner-Fraser, 2001). 
IRF7 encodes a member of the interferon regulatory transcription factor (IRF) family (Caillaud 
et al., 2002, Bentz et al., 2010). IRF7 transcripts are detected as downregulated in the 
screen after 9 and 12h and in the embryo IRF7 is generally absent from neural tissue. 
At EGKXIII it is expressed in cells at the outer edge of the area opaca, and weakly in the 
marginal zone at HH4. By HH7 and HH8+ it is expressed very weakly in the neural plate 
and anterior neural tube respectively, but more strongly in the area opaca (Fig. 4.26K-
O). 
ISX encodes a member of the RAXLX homeobox gene family and regulates vitamin A 
metabolism (Seino et al., 2008, Lobo et al., 2013) which is only downregulated at the 
12h time point. There is no specific expression at EGKXIII but at HH4, HH6 and HH8, ISX 
is expressed in the marginal zone and area opaca, but never in embryonic tissue (Fig. 
4.26P-T). 
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JMJD4 belongs to the jumonji family of transcription factors (Zhang et al., 2005, Liu et al., 
2013). It is downregulated after 5 and 9h, but only by the Galgal3 analysis. Expression 
of JMJD4 was not detected at EGKXIII or HH4. By HH6, it is expressed strongly in 
patches of the area opaca and at HH9- it is weakly expressed in the neural tube (Fig. 
4.26U-Y). 
KLF2 (Fig. 4.27A-E) is expressed broadly at low levels throughout the embryo at EGKXII-XIII, 
HH3-4 and HH5-7. At HH8-10 it is upregulated in the forming somites (Antin et al., 
2010). 
KLF4 (Fig. 4.27F-J) demonstrates a similar expression pattern to KLF2. It is weakly but 
ubiquitously expressed at all stages assessed (Antin et al., 2010).  
KLF5 (Fig. 4.27K-O) is expressed at low levels throughout the embryo at EGKXII-XIII and HH3-4. 
Then at HH5-7 it is expressed in the embryonic non-neural ectoderm surrounding the 
neural plate. This continues at HH8-10 when it is also observed in the head surface 
ectoderm (Antin et al., 2010). 
KLF6 (Fig. 4.27P-T) expression is not detected at EGKXII-XIII, HH3-4 or HH5-7. It is strongly 
expressed in the head mesenchyme and surface ectoderm at HH8-10 (Antin et al., 
2010). 
LMO7 encodes a protein implicated in the expression of genes required for myogenesis 
(Holaska et al., 2006, Dedeic et al., 2011). It is downregulated in the neural induction 
screen at each time point. LMO7 expression is not observed at EGKXIII, and at HH4 it is 
expressed only in cells at the outer edge of the area opaca (not shown). By HH7, faint 
expression is observed along the notochord. This continues at HH9+, when LMO7 is 
also expressed in the lateral plate mesoderm and the anterior intestinal portal (Fig. 
4.27U-Y). 
MBNL2 is a member of the muscleblind family. It encodes a protein which modulates 
alternative splicing of pre-mRNAs (Ho et al., 2004, Huang et al., 2008). MBNL2 was 
identified as being downregulated at every time point in the screen, but specific 
expression was not detected at any stage assessed (Fig. 4.27Z-AD). 
MEF2D is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription 
factors (Breitbart et al., 1993). In the screen, it was identified as downregulated after 
5, 9 and 12h. In the embryo expression is not observed at EGKXIII or HH4. By HH7 it is 
strongly expressed in pre-cardiac mesoderm and this continues at HH8+ (Fig. 4.28A-E). 
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MSX1 (Fig. 4.28F-J) is expressed in the area opaca at EGKXII-XIII. Then at HH3-4 it is expressed 
posteriorly in the early lateral plate mesoderm. This continues at HH5-7 and HH8-10, 
when it is also expressed in the neural plate border and neural folds (Suzuki et al., 
1991). 
MSX2 (Fig. 4.28K-O) expression is not detected at EGKXII-XIII and at HH3-4 it is detected only 
weakly at the posterior end of the streak. Robust expression is observed at HH5-7, 
where MSX2 is expressed in the embryonic and extra-embryonic lateral plate 
mesoderm, blood islands and anterior non-neural ectoderm. By HH8-10 it is also 
expressed throughout the neural folds (Brown et al., 1997). 
MYC, or C-MYC (Fig. 4.28P-T) is weakly at expressed in the area opaca at EGKXII-XIII. By HH3-4 
it is also expressed in the lateral plate mesoderm emerging from the posterior 
primitive streak. This expression continues at HH5-7, when it is also present in the 
extra-embryonic blood islands. Expression persists in the caudal lateral plate 
mesoderm at HH8-10 when it is also observed in the anterior neural folds (Khudyakov 
and Bronner-Fraser, 2009). 
NANOG (Fig. 4.28U-Y) is strongly expressed in the epiblast at EGKXII-XIII and embryonic and 
extra-embryonic ectoderm at HH3-4. At later stages NANOG expression cannot be 
detected at HH5-7 or HH8-10 (Lavial et al., 2007). 
NCOA2 encodes a nuclear receptor co-activator (Voegel et al., 1996). In the screen it was 
identified as downregulated but only after 12h. In the embryo, it is expressed in the 
hypoblast at EGKXIII, but is more ubiquitously expressed by HH4. At HH6 and HH8, 
expression appears in the neural plate and neural tube, but also throughout the area 
opaca (Fig. 4.28Z-AD). 
NFKBIZ is a transcriptional co-activator required for the expression of NFκB target genes 
(Totzke et al., 2006, Hildebrand et al., 2013). It is downregulated at each time point in 
the screen, but specific expression was not detected at any of the stages assessed (Fig. 
4.29A-E). 
OVOL2 is zinc finger transcription factor which functions downstream of BMP signalling during 
mesendoderm development (Zhang et al., 2013). It was identified as downregulated at 
the 9 and 12h time points of the screen. However, only low level ubiquitous expression 
is detected at HH4, HH5 or HH8+. It appears to be weakly expressed in Koller’s sickle at 
EGKXIII (Fig. 4.29F-J). 
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PDLIM1 functions as a co-activator of LIM homeodomain transcription factors, but inhibits 
transcriptional activation mediated by oestrogen receptor alpha (Johnsen et al., 2009). 
It was identified as being downregulated after 9 and 12h by the screen. Specific 
expression was not observed at EGKXIII, HH4 or HH5. By HH8+ PDLIM1 is strongly 
expressed in the neural folds, neural plate border and lateral plate mesoderm but is 
absent from the neural plate itself (Fig. 4.29K-O).  
PDLIM5 is a member of the PDZ-LIM family, which can sequester nuclear factors to control 
transcription (Krcmery et al., 2010). The screen identified it as a downregulated 
candidate at each time point. Specific expression is not observed in the embryo at 
EGKXIII, HH4, or HH8+. However at HH5, PDLIM5 is expressed in patches of extra-
embryonic cells (Fig. 4.29P-T). 
PITX2 (Fig. 4.29U-Y) is expressed strongly in the posterior marginal zone and adjacent area 
opaca at EGKXII-XIII. By HH3-4 it is absent from the prospective neural plate and 
expressed strongly in the area opaca and germ wall. At later stages it continues to be 
expressed extra-embryonically. However it is also expressed in the pre-cardiac 
mesoderm at HH5-7 and in the head mesenchyme and lateral plate mesoderm on the 
left side of the embryo at HH8-10 (Zhu et al., 1999). 
PITX3 encodes a bicoid class homeodomain transcription factor (Semina et al., 1998). It was 
downregulated only after 5h in the screen. PITX3 expression was not observed at 
EGKXIII. Instead at HH4, HH7 and HH9- it is expressed in the area opaca and is 
completely absent from embryonic tissue (Fig. 4.29Z-AD). 
PPARGC1A functions as a transcriptional co-activator (Knutti et al., 2000, Puigserver and 
Spiegelman, 2003, Ueda et al., 2005). It was identified as being downregulated at each 
time point in the screen, but PPARGC1A expression could not be detected at any of the 
stages assessed (Fig. 4.30A-E). 
PTRF encodes a protein that enables the dissociation of paused ternary polymerase I 
transcription complexes (Jansa et al., 1998). It was identified as downregulated at each 
time point by the screen. PTRF is strongly expressed at the outer edge of the embryo 
at EGKXIII and HH4. Specific expression is not observed at HH5 or HH8+ (Fig. 4.30F-J). 
RARB (Fig. 4.30K-O) expression is not detected at EGKXII-XIII or HH3-4. At later stages it is 
expressed weakly in the area opaca, but also in the caudal neural plate and neural 
tube at HH5-7 and HH8-10 (Mercader et al., 2000). 
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RASSF7 modulates transcription by negatively regulating JNK signalling (Takahashi et al., 2011). 
It was identified as a downregulated candidate at each time point in the screen. 
Expression of RASSF7 is first detected in the hypoblast at EGKII and in the germinal 
crescent and endoderm overlying the node at HH4. By HH7 it appears to be expressed 
in the anterior neural plate but by HH9- it is only weakly expressed in the neural tube 
(Fig. 4.30P-T). 
RREB1 encodes a zinc finger transcription factor (Miyake et al., 1997). It is consistently 
downregulated in the screen and is appropriately absent from neural tissue. RREB1 is 
weakly expressed in Koller’s sickle at EGKXIII and the marginal zone at HH4. By HH5 it is 
strongly expressed in the germinal crescent, lateral plate mesoderm and area opaca. 
At HH8 it is mainly expressed in the lateral plate mesoderm (Fig. 4.30U-Y). 
SCML2 contributes to a polycomb complex involved in transcriptional repression (Bonasio et 
al., 2014). In the screen it was identified as downregulated, but specific expression was 
not observed at any stage assessed (Fig. 4.30Z-AD). 
SERTAD2 acts at E2F-responsive promoters to integrate PHD or bromodomain-containing 
transcription factors (Hsu et al., 2001). It was identified as downregulated by a node 
graft after 9 and 12h, but SERTAD2 transcripts were not detected at the stages 
assessed (Fig. 4.31A-E). 
SMAD6 (Fig. 4.31F-J) is weakly expressed in the anterior edge of the hypoblast at EGKXII-XIII. 
By HH3-4 it remains in the germinal crescent but is also expressed in the germ wall and 
early mesoderm. Later it is expressed strongly in the lateral plate mesoderm and extra-
embryonic blood islands at HH5-7 and HH8-10 (Vargesson and Laufer, 2001). 
SMAD7 (Fig. 4.31K-O) is detected in the area opaca at EGKXII-XIII. At HH3-4 and HH5-7 it is 
expressed weakly in the germ wall and lateral plate mesoderm. This continues at HH8-
10, when it is also expressed in pre-cardiac mesoderm (Vargesson and Laufer, 2001). 
SMAD9 (Fig. 4.31P-T) expression is not detected at EGKXII-XIII. By HH3-4 expression is 
observed in the lateral plate mesoderm and germinal crescent and this continues at 
HH5-7. By HH8-10, SMAD9 is expressed in the posterior lateral plate and weakly in the 
neural tube (Zuzarte-Luis et al., 2004). 
SMARCA2 is a member of the SWI/SNF family of chromatin modifiers and is highly similar to 
the brahma protein in Drosophila (Goodwin, 1997, Papanayotou et al., 2008). In the 
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screen it was identified as a downregulated candidate at each time point but 
expression was not detected at any of the stages assessed (Fig. 4.31U-Y). 
TBX3 (Fig. 4.31Z-AD) is expressed strongly in the hypoblast at EGKXII-XIII and the germ wall at 
HH3-4. Later it is expressed strongly in the area opaca and embryonic lateral plate 
mesoderm at HH5-7 and HH8-10, but remains absent from neural territories (Isaac et 
al., 1998). 
TFAP2A (Fig. 4.32A-E) is strongly expressed at all stages assessed. At EGKXII-XIII and HH3-4 it is 
only expressed in the area opaca. Later, expression shifts to non-neural ectoderm as 
well as the neural plate border and pre-placodal region at HH5-7 and the neural folds 
at HH8-10 (Khudyakov and Bronner-Fraser, 2009).  
TFAP2C (Fig. 4.32F-J) is expressed in the epiblast and prospective neural plate at EGKXII-XIII 
and HH3-4 respectively. Then, its expression shifts to the non-neural ectoderm, neural 
plate border and neural folds at HH5-7 and HH8-10 (Qiao et al., 2012). 
TFAP2E also belongs to the AP2 family of transcription factors (Tummala et al., 2003). It is 
identified in the screen as downregulated at each time point. Expression of TFAP2E is 
not observed at EGKXIII or HH4. By HH5 it is expressed at a low level throughout the 
embryo but more strongly in the lateral plate mesoderm. This continues at HH8 when 
it is also expressed in the dorsal neural folds (Fig. 4.32K-O). 
TFCP2L1 contains a region coding for a CP2 domain and is related to the grainyhead family of 
transcription factors (Rodda et al., 2001). It was identified as downregulated at each 
time point in the screen. Specific expression could not be detected at EGKXIII, but by 
HH4 it is weakly expressed in the neural plate. At HH6 and HH8+ expression is 
completely absent from the embryo itself and is expressed only in the area opaca (Fig. 
4.32P-T). 
TRIM3 is a member of the tripartite motif (TRIM) family which has three zinc-binding domains 
(El-Husseini and Vincent, 1999). In the screen it is consistently downregulated. 
Expression could not be detected at EGKXIII by in situ hybridisation. However, it is 
upregulated in the prospective neural plate at HH4, the neural plate at HH6 and neural 
tube HH8+ but is also ubiquitously expressed at low levels in other tissues (Fig. 4.32U-
Y). 
VGLL1 binds TEA domain family of transcription factors through a vestigial homology domain 
to function as a TEF co-activator (Vaudin et al., 1999). VGLL1 was identified in the 
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screen as downregulated at each time point. Specific expression is not detected at 
EGKXIII or at HH8+. At HH4 and HH5 it is completely absent from embryonic tissue and 
is expressed only in the area opaca (Fig. 4.32Z-AD). 
WWTR1 is a transcriptional co-activator which functions as a downstream regulatory target of 
the Hippo signalling pathway (Kanai et al., 2000, Di Palma et al., 2009). In the screen it 
is identified as downregulated at each time point, however specific expression could 
not be detected at any of the stages assessed (Fig. 4.33A-E). 
ZBTB46 is a zinc finger transcription factor (Meredith et al., 2012). It was identified as 
downregulated after 9 and 12h in the screen. Non-specific expression was observed at 
EGKXIII and only weak expression in the prospective neural plate at HH4. This 
continues in the neural plate at HH6 and by HH8 it is expressed weakly throughout the 
neural tube but also in the extra-embryonic mesoderm and blood islands (Fig. 4.33F-J). 
ZFHX3 encodes a transcription factor with multiple homeodomains and zinc finger motifs 
(Berry et al., 2001, Mori et al., 2007). It was identified as consistently downregulated in 
the screen. In the embryo, expression is only observed at HH8+ when it is ubiquitously 
expressed but is more strongly expressed in the lateral plate mesoderm (Fig. 4.33K-O). 
ZFPM1 protein can either activate or repress transcription by functioning as a cofactor for 
GATA proteins (Freson et al., 2003). It was identified as a downregulated candidate at 
each time point of the screen. Specific expression could not be observed at EGKXIII. At 
HH4 and HH6 it is expressed in the germinal crescent and lateral plate mesoderm and 
is specifically absent from neural territories. By HH9 it is also detected in the blood 
islands (Fig. 4.33P-T). 
ZMYND11 encodes a protein with a PHD finger and bromodomain, which functions as a 
transcriptional repressor (Masselink and Bernards, 2000, Velasco et al., 2006). It was 
identified as a downregulated candidate at each time point in the screen however 
expression was not observed at any of the stages evaluated (Fig. 4.33U-Y). 
ZNF185 encodes a LIM-domain zinc finger protein (Heiss et al., 1997). It was found to be 
downregulated at each time point in the screen and in situ hybridisation reveals broad 
expression throughout the embryo at all stages assessed (Fig. 4.33Z-AD). 
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Figure 4.20: Expression of AHR, ARID5B, ATF3, BACH1, BACH2 and BHLHE40.  
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The expression of downregulated markers was assessed by in situ hybridisation at four key 
stages: pre-streak at EGKXII-XIII (A, F, K, P, U, Z), during gastrulation at HH3-4 (B, G, L, Q, V, AA), 
at neural plate stages HH5-7 (C, H, M, R, W, AB) and neural tube stages HH8-10 (D, I, N, S, X, 
AC). Expression patterns are compared to the absolute transcript counts as quantified by the 
RNA-Seq screen (E, J, O, T, Y, AD). Expression levels at each time point are plotted as bar 
graphs of log2 of the base mean for induced (red or dark grey) and uninduced (green or light 
grey) tissues at each time point. Where columns are coloured red and green, induced and 
uninduced values differ by at least log2 1.2 and markers are differentially expressed. Columns 
coloured dark and light grey distinguish when markers are not differentially expressed.  
 
 
136 
 
 
Figure 4.21: Expression of CDX2, CDX4, CEBPB, CREB3L1, CREG1 and CSRP2.  
For details, see Fig. 4.20.  
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Figure 4.22: Expression of DLX3, DLX5, ELF1, ELF3, EPAS1 and ESRRG.  
For details, see Fig. 4.20.  
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Figure 4.23: Expression of ETS2, FKHR, FOXO3, FRY, GATA2 and GATA4.  
For details, see Fig. 4.20.  
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Figure 4.24: Expression of GATA5, GATA6, GRHL1, GRHL2, GRHL3 and HAND1.  
For details, see Fig. 4.20. 
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Figure 4.25: Expression of HIC2, HIPK2, HIVEP2, HNF1B, HOXA1 and HOXA2.  
For details, see Fig. 4.20. 
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Figure 4.26: Expression of ID2, ID3, IRF7, ISX and JMJD4.  
For details, see Fig. 4.20.  
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Figure 4.27: Expression of KLF2, KLF4, KLF5, KLF6, LMO7 and MBNL2.  
For details, see Fig. 4.20.  
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Figure 4.28: Expression of MEF2D, MSX1, MSX2, MYC, NANOG and NCOA2.  
For details, see Fig. 4.20.  
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Figure 4.29: Expression of NFKBIZ, OVOL2, PDLIM1, PDLIM5, PITX2 and PITX3.  
For details, see Fig. 4.20.  
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Figure 4.30: Expression of PPARGC1A, PTRF, RARB, RASSF7, RREB1 and SCML2.  
For details, see Fig. 4.20.  
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Figure 4.31: Expression of SERTAD2, SMAD6, SMAD7, SMAD9, SMARCA2 and TBX3.  
For details, see Fig. 4.20. 
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Figure 4.32: Expression of TFAP2A, TFAP2C, TFAP2E, TFCP2L1, TRIM3 and VGLL1.  
For details, see Fig. 4.20. 
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Figure 4.33: Expression of WWTR1, ZBTB46, ZFHX3, ZFPM1, ZMYND11 and ZNF185.  
For details, see Fig. 4.20.  
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4.3.4.3 Summarising the normal expression of differentially expressed 
transcriptional regulators 
Generally, the screen has identified markers with the types of expression patterns we would 
expect as responses to neural induction. Upregulated genes are expressed in prospective 
neural tissue at some stage during early neural development in the embryo. Some, like SOX11 
(Fig. 4.16K-O) and SOX13 (Fig. 4.16P-T) are expressed at all stages, while others such as ZNF423 
(Fig. 4.19P-T) or LHX5 (Fig. 4.11F-J) are absent from the epiblast and prospective neural plate 
at EGKXIII and HH4 but are expressed later in the neural plate proper. 
In contrast, the expression of downregulated genes tends to be more varied. Often these are 
expressed in various non-neural tissues. Examples include ZFPM1 (Fig. 4.33P-T) which is 
expressed strongly in the lateral plate mesoderm and extra-embryonic blood islands. GRHL3 
(Fig. 4.24U-Y) is absent from the neural plate, neural plate border and pre-placodal region but 
is expressed strongly in the surrounding embryonic ectoderm. ISX is consistently 
downregulated in the screen and its expression is detected only in the area opaca (Fig. 4.26P-
T). Despite these differences, a common theme among downregulated candidates, is that they 
tend to be relatively absent from neural tissue as compared to neighbouring regions.  
Moreover, candidate expression is generally detected at stages corresponding to the time 
points predicted by the screen. Markers upregulated across each time point such as NSD1 (Fig. 
4.13Z-AD), SETD2 (Fig. 4.15K-O) and ZIC3 (Fig. 4.19K-O) are first expressed prior to gastrulation 
in the epiblast at EGKXIII, and their expression persists later in the prospective neural plate, 
neural plate proper and neural tube. These contrast with genes such as ERNI (Fig. 4.8A-E), 
CITED4 (Fig. 4.6U-Y), PRDM1 (Fig. 4.14P-T) and MAFA (Fig. 4.12A-E), which are upregulated 
only after 5h and are expressed stronger in the epiblast and prospective neural plate than in 
the neural plate from HH6 onwards. Alternatively, LHX5 (Fig. 4.11F-J) and ZNF423 (Fig. 4.19P-T) 
are only upregulated at later time points and are absent from the early embryo, but expressed 
in the neural plate at later stages. Therefore candidates tend to be normally expressed in the 
appropriate space and time, based on their predicted responses to neural induction by a 
grafted node. 
However not all candidates demonstrate such clear expression patterns. Some, such as HIVEP3 
(Fig. 4.10A-E), KAT2B (Fig. 4.10Z-AD), NFKBIZ (Fig. 4.29A-E) and WWTR1 (Fig. 4.33A-E) appear 
to be more ubiquitously expressed while others; RFX3 (Fig. 4.14Z-AD), STOX1 (Fig. 4.16Z-AD), 
AHR (Fig. 4.20A-E) and CREG1 (Fig. 4.21U-Y) are barely detected, if at all. The RNA-Seq screen 
predicts that these candidates are expressed at absolute levels lower than base mean 128, or 7 
log2. So although they are differentially expressed, it seems that these changes are occurring at 
150 
 
levels which cannot be detected by in situ hybridisation. This is especially clear when 
compared to robustly expressed candidates such as DNMT3A (Fig. 4.7K-O), SETD2 (Fig. 4.15K-
O), CSRP2 (Fig. 4.21Z-AD) and GATA2 (Fig. 4.23U-Y) which were detected by the RNA-Seq at 
absolute levels higher than 1024 (10 log2). These observations may also explain some 
differences between the stage of expression in the embryo and timing of induction in the 
screen. For example MEIS2 (Fig. 4.12P-T) and GLI2 (Fig. 4.9F-J) are identified as upregulated 
candidates at each time point, but their expression is not detected early at EGKXIII or HH4 
when the RNA-Seq predicts base mean levels less than 64 (6 log2). Instead transcripts are 
detected later between HH5-7 and HH8-10 when the absolute expression values increase 
above 250 (8 log2) at the 9 or 12h time points. 
As a general rule, expression by in situ hybridisation was never detected at base mean levels 
less than 64 (6 log2) and was only weakly or rarely detected at base mean levels less than 128 
or (7 log2). Expression was almost always observed when base mean levels were detected 
above 250-500 (8-9 log2).  
 
4.4 Discussion 
Presented here are the results of an RNA-Seq screen conducted to identify a time-course of 
responses to neural induction. The most up-to-date Galgal4 analysis revealed 8673 
differentially expressed transcriptional responses to neural induction over 5, 9 and 12h. These 
correspond to 4145 unique genes: 1903 upregulated, 2002 downregulated and 240 that are up 
and downregulated at different times.  
 
4.4.1 Neural induction is a highly dynamic process 
Heat maps representing expression intensity demonstrate that responses to neural induction 
are highly dynamic in terms of absolute levels (Fig. 4.2, Fig. 4.3 and Fig. 4.4). The RNA-Seq 
detected transcripts across a wide range of expression levels; ERNI is one of the highest 
expressed transcripts in the screen and is detected at a base mean induced value of over 
15000, compared to the lowest differentially expressed gene MIR1538 which was detected at 
an induced level of 0.849479697. Therefore the RNA-Seq approach detects expression across a 
wide dynamic range. Heat maps and Venn diagrams comparing differential expression across 
the three time points also reveal the dynamic temporal nature of expression (Fig. 4.5). Gene 
expression varies widely over this time-course; genes can be up- or down-regulated at each 
time point while others are differentially expressed at some time points but not others. One 
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particular example is ATF3 (Fig. 4.20K-O) which is upregulated after 5h yet downregulated by 9 
and 12h. Therefore the screen reveals more dynamic transcriptional activity during neural 
induction than was previously appreciated.  
 
4.4.2 The screen predicts spatial expression levels in the normal embryo 
To define the progressive specification changes that cells undergo during neural induction, we 
have focused on 482 differentially expressed transcriptional regulators (Fig. 4.5). The original 
plan was to confirm the expression of all transcriptional regulators by in situ hybridisation, but 
the screen detected so many differentially expressed markers that this was not feasible. 
Therefore, we instead chose to verify a proportion -those calculated as statistically significant.  
By picking candidates based on P-value, genes were selected from a wide range of expression 
levels. At some stage, upregulated candidates are expressed in neural territories while 
downregulated candidates are relatively absent. Often, where clear in situ expression patterns 
were not detected, those candidates were predicted to be expressed at lower absolute levels 
by the screen compared to markers that are more robustly expressed. The clearest in situ 
expression patterns are those with the highest absolute expression values or greatest 
differential expression between tissues. The ubiquitous low level in situ staining observed for 
some markers probably reflects low level transcript expression. The robustness with which we 
can predict embryonic expression of markers based on their absolute values and the 
identification of known and anticipated responses to a node graft, suggests that the screen 
predicts the transcriptional dynamics that accompany early stages of neural development in 
the embryo. The present findings suggest that the other highly expressed but as yet unverified 
markers are also likely to be expressed in the embryo. 
 
4.4.3 The screen predicts appropriate temporal expression in the embryo 
Many upregulated markers are expressed in neural territories at all stages. However, other 
markers are expressed with a more dynamic temporal time-course. This was initially confirmed 
by the detection of SOX3 (Fig. 4.16F-J), SOX2 (Fig. 4.16A-E) and SOX1 (Fig. 4.15Z-AD) as distinct 
markers of the 5, 9 and 12h time points respectively. By verifying the expression of a broad 
cohort of markers we demonstrate that this is a more general feature of the screen. 
Some markers such as CITED4 (Fig. 4.6U-Y), ERNI (Fig. 4.8A-E), ING5 (Fig. 4.10K-O), and MAFA 
(Fig. 4.12A-E) are more associated with the earlier stages of neural induction. They are 
expressed robustly in the epiblast prior to gastrulation and the prospective neural plate, but 
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later their expression decreases. This characteristic is reflected by the screen which predicts 
that they are highly expressed initially and lower later. Transcript levels in the pre-gastrula 
embryo are normally very low and increase as the embryo develops, so this type of expression 
pattern is highly unusual. In contrast, DMBX1 (Fig. 4.7F-J), HOXB1 (Fig. 4.10F-J), LHX5 (Fig. 
4.11F-J), SIX3 (Fig. 4.15P-T) are examples of markers which were only predicted to be 
expressed at high levels after 9 and 12h -corresponding well with their expression which is only 
observed later between HH5-10. 
This temporal trend is less obvious in downregulated candidates, which have more varied 
expression patterns and are more consistently differentially expressed across the 3 time 
points. HOXA2 (Fig. 4.25Z-AD) expression cannot be detected at EGKXII-XIII or HH3-4 when it is 
predicted to be downregulated. Instead it is expressed in the caudal neural tube, coinciding 
with it being detected at higher levels in induced tissue after 12h. Conversely, NANOG (Fig. 
4.28U-Y) and TFAP2C (Fig. 4.32F-J) expression is absent from the neural plate and neural tube 
between HH5-10 when they are predicted to be downregulated. Both are expressed in the 
epiblast and prospective neural plate at EGKXII-XIII and HH3-4 when the RNA-Seq registers 
high expression values in the 5h induced condition. Therefore the screen not only accurately 
predicts the spatial expression of differentially expressed markers, but also their expression 
over time. 
 
4.4.4 Distinct classes of expression pattern imply functional significance 
Within our data, up- and downregulated candidates have different functional significance. In 
neural territories, upregulated candidates probably contribute to progressive neural 
specification. Downregulated genes tend to be relatively absent from the neural plate as they 
are often markers of alternative (non-neural) fates. However, they may function normally to 
repress neural induction. Although we do not investigate the specific function of these 
markers, it is possible to infer putative functions to groups of markers based on the timing and 
location of their expression.  
The neural induction cascade is defined by the expression of three SOXB1 subgroup 
transcription factors; SOX3, SOX2 and SOX1 (Uwanogho et al., 1995, Rex et al., 1997, Uchikawa 
et al., 1999). Each has a distinct temporal expression pattern: SOX3 is induced within 3h, SOX2 
after 9h and SOX1 after 12h. As such, they are associated with different phases of neural 
induction: SOX3 marks a pre-neural state, SOX2 marks definitive neural specification, while 
SOX1 expression coincides with commitment to the neural fate (Pinho et al., 2011). The screen 
successfully identifies these markers at the appropriate times as well as two previously 
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unappreciated members the SOXC and SOXD subgroups; SOX11 (Fig. 4.16K-O) and SOX13 (Fig. 
4.16P-T) respectively. They are induced at each time point and are expressed strongly 
throughout neural induction. SOX11 has been implicated in nervous system development via 
its expression in older embryos (Uwanogho et al., 1995). Furthermore, SOX11 homozygous 
knock-out mice display neonatal lethality and abnormal nervous system development 
(Bhattaram et al., 2010, Wang et al., 2013). Though neither SOX11 nor SOX13 has been studied 
directly in relation to neural induction, their expression at all relevant stages, suggests that 
they may have important roles in the process. 
Also expressed strongly at all stages are many chromatin remodelling factors including 
DNMT3A (Fig. 4.7K-O), DNMT3B (Fig. 4.7P-T), SETD2 (Fig. 4.15K-O), NSD1 (Fig. 4.13Z-AD), BMI1 
(Fig. 4.6A-E), KDM4A (Fig. 4.11A-E) and MTA1 (Fig. 4.12U-Y). They are upregulated after 5h and 
are already strongly expressed in the pre-streak epiblast, suggesting that they may be among 
some of the earliest induced genes. Since chromatin modifiers exert global control over 
chromatin structure and activity, and since some (such as Brahma) have been implicated in the 
regulation of the timing of SOX2 expression, together with ERNI and Geminin (Papanayotou et 
al., 2008), it is reassuring that they are expressed early, when they may control the initial 
transition from non-neural to neural specification. Such genes and the signals that induce them 
will be critical in launching the neural induction programme. Given their similarity to ERNI and 
SOX3 in terms of timing and location of expression (Streit et al., 2000), it is possible that they 
also function together with Brahma/Geminin/ERNI, and may also be co-regulated by FGF 
signals. 
ERNI-like genes represent another class of markers. Although ERNI and SOX3 are expressed in 
the epiblast at EGKXII-XIII and prospective neural plate at HH3-4, later their expression 
diverges. SOX3 remains in the neural plate while ERNI is downregulated and expression shifts 
to the neural plate border and pre-placodal region by HH6 (Streit et al., 2000). Since ERNI and 
SOX3 are co-expressed in the epiblast at EGKXIII (Streit et al., 2000), it has been suggested that 
the neural plate and its border might derive from a common pre-neural state (Streit, 2008). 
Within the screen, CITED4 (Fig. 4.6U-Y) (Andrews et al., 2000) and PRDM1 (Fig. 4.14P-T) (Riddle 
et al., 1995) respond in the same way to a node graft as ERNI and are also upregulated only 
after 5h. Although TFAP2C (Fig. 4.32F-J) (Qiao et al., 2012), was identified only as a 
downregulated candidate after 9 and 12h, it too is mildly upregulated after 5h in induced 
tissue. The ERNI-like expression patterns of these genes further reinforces the idea that a state 
common to the neural plate and its border already exists is the early embryo (Linker et al., 
2009) and that induction of this state might be one of the first responses to neural inducing 
signals. 
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Other markers display more SOX2-like expression patterns, where they are absent at EGKXIII 
and HH3-4, but are expressed in the neural plate from around HH5 onwards. Examples include 
the hedgehog pathway targets GLI2 (Fig. 4.9F-J) and GLI3 (Fig. 4.9K-O) (Marigo et al., 1996, 
Schweitzer et al., 2000) and the SMAD interacting proteins ZEB2 (Fig. 4.19A-E) (Postigo et al., 
2003, van Grunsven et al., 2007) and ZNF423 (Fig. 4.19P-T) (Hata et al., 2000). 
Other distinct markers induced after 9h are LMO1, TRIM9 and LHX5. At HH6, LHX5 (Fig. 4.11F-
J) is expressed in the anterior neural plate and extends broadly to encompass the PPR. At this 
stage its expression is highly reminiscent of OTX2 (Bally-Cuif et al., 1995) and SIX3 (Bovolenta 
et al., 1998), which are also upregulated at the 9h time point. As such, these markers are 
appropriately expressed to be involved in conferring anterior neural and PPR identity. 
Conversely, LMO1 (Fig. 4.11U-Y) is expressed exclusively in the neural plate and is markedly 
absent from the anterior border/PPR domain. Similarly, TRIM9 is absent from the neural 
plate’s anterior lateral edges (Fig. 4.18P-T). Many neural markers including SOX2 (Fig. 4.16A-E) 
(Rex et al., 1997) and OTX2 (Fig. 4.14A-E) (Bally-Cuif et al., 1995) are commonly expressed in 
the neural plate as well as the neural border and PPR. Therefore, LMO1/TRIM9-like and ERNI-
like markers could be important specifiers separating neural plate from border derived fates. 
The diverse range of expression patterns for downregulated genes and their absence from the 
neural plate makes it more difficult to speculate on the roles of these candidates. Some, such 
as VGLL1 (Fig. 4.32Z-AD), PITX3 (Fig. 4.29Z-AD) and ARID5B (Fig. 4.20F-J) are only expressed in 
the area opaca. Others including EPAS1 (Fig. 4.22U-Y) (Ota et al., 2007) and RREB1 (Fig. 4.30U-
Y) are strongly expressed in embryonic non-neural ectoderm. Another new marker of this state 
is GRHL3 (Fig. 4.24U-Y), whose expression perfectly borders all neural territories at HH5 and 
HH8. 
These differ from other downregulated markers such as DLX5 (Fig. 4.22F-J) (McLarren et al., 
2003), GRHL2 (Fig. 4.24P-T), GATA2 (Fig. 4.23U-Y) (Sheng et al., 2003), MSX1 (Fig. 4.28F-J) 
(Suzuki et al., 1991), MSX2 (Fig. 4.28K-O) (Brown et al., 1997), TFAP2A (Fig. 4.32A-E) 
(Khudyakov and Bronner-Fraser, 2009) and HIC2 (Fig. 4.25A-E), which are expressed in the 
neural plate border or its derivatives the PPR, neural folds and neural crest. Given that so 
many markers are common to the neural plate and neural plate border, the downregulation of 
border and non-neural ectoderm specific markers in the neural plate could be the major 
mechanism separating neural border from neural plate fates (Streit, 2004). 
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4.4.5 Which signals might be responsible for inducing these responses? 
This time-course of new responses now provides the opportunity to identify the signals that 
regulate them. The specific contribution of signalling pathways has not been assessed here. 
However it has been possible to extract transcriptional readouts of pathways known to be 
required for neural induction, and some not previously considered. 
FGF signalling has previously been implicated in the onset of neural induction by inducing the 
earliest neural markers ERNI and SOX3 (Streit et al., 2000). We now find that these are not the 
only FGF responses identified within the first 5h of a node graft. The FGF signalling targets 
SPRY1 and SPRY2 (Minowada et al., 1999) are consistently upregulated. Furthermore the 
transcriptional regulators ETV4 and ETV5 are also regulated by FGF signalling (Lunn et al., 
2007) and are similarly upregulated over 5, 9 and 12h. Therefore, the screen provides further 
evidence of the prominence of FGF signalling throughout neural induction. 
BMP inhibition has long been championed as the neural inducing signal by the “default model” 
(Lamb et al., 1993, Hemmati-Brivanlou et al., 1994, Sasai et al., 1995, Hemmati-Brivanlou and 
Melton, 1997). We confirm that targets of BMP signalling; GATA2 (Sheng et al., 2003), MSX1 
(Suzuki et al., 1991), SMAD6 and SMAD7 (Vargesson and Laufer, 2001) are consistently 
downregulated. Previous work suggests that chick ectodermal cells are insensitive to BMP 
signalling until they have received 5h of signals from an organizer graft (Streit et al., 1998) and 
that BMP inhibition does not induce the earliest neural responses ERNI and SOX3 (Streit et al., 
2000). BMP inhibition appears to be important to downregulate border and non-neural 
ectoderm markers including DLX5 (McLarren et al., 2003), GATA2 (Sheng and Stern, 1999), 
MSX1 (Suzuki et al., 1991) and MSX2 (Brown et al., 1997). It remains to be tested whether it 
induces de novo transcription of neural markers and if so, at what time. 
WNT inhibition has also been implicated in neural induction by allowing the ectoderm to 
respond to FGF signals, a response suggested to be under negative regulation by WNTs (Wilson 
and Edlund, 2001). This implies that WNT signalling has an important early role in the process. 
Accordingly, the WNT antagonists SFRP1 and FRZB (Ladher et al., 2000) are consistently 
upregulated while the endogenous WNT reporter AXIN2 (Quinlan et al., 2009) is 
downregulated. This suggests overall dampening of the WNT pathway throughout neural 
induction.  
Retinoic acid has also been associated with the induction of early neural responses. NOT1 and 
NOT2 are regulated by retinoic acid signalling from the hypoblast (Knezevic et al., 1995, 
Knezevic and Mackem, 2001) while CYP26A1 which can be induced by retinoic acid, is 
expressed in the prospective neural plate (Swindell et al., 1999, Albazerchi and Stern, 2007). 
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Appropriately then, NOT1 and NOT2 are upregulated in the screen at each time point, while 
CYP26A1 and RAI1, are induced but only after 9 and 12h. This might suggest that retinoic acid 
makes a greater contribution to neural induction at later stages when its levels are higher. 
However, CYP26A1 can also be induced by FGF signalling (Wahl et al., 2007), WNT or FGF 
inhibition (Kudoh et al., 2002) and Notch (Echeverri and Oates, 2007) so its expression may not 
necessarily reflect the presence of retinoic acid. RARB (Cui et al., 2003), a more specific retinoic 
acid target (Olivera-Martinez and Storey, 2007) is consistently downregulated perhaps 
indicating that retinoic acid signalling is restricted. This is quite possible as it could be 
antagonised by persistent FGF signalling (Diez del Corral and Storey, 2004, Olivera-Martinez 
and Storey, 2007) throughout the time-course. 
Notch signalling is known to contribute to neural crest development (Kintner, 1992, Cornell 
and Eisen, 2002, Endo et al., 2002, Glavic et al., 2004) and the observation that homeogenetic 
signals travel between BMP-inhibited cells has previously implicated Notch signalling in neural 
induction (Linker et al., 2009). Furthermore, ES cells do not differentiate into neurons when 
Notch signalling is blocked, suggesting that Notch promotes either neural specification or 
differentiation (Lowell et al., 2006). Consistent with this, upregulation of the Notch pathway 
modifier LFNG is detected at each time point.  
Calcium signalling has also been implicated in neural induction. Calcineurin integrates FGF and 
BMP signalling (Cho et al., 2014), while the calcium channel modulator Calfacilitin increases 
intracellular calcium levels and is required for SOX2 and Geminin expression (Papanayotou et 
al., 2013). Furthermore, Calreticulin, a calcium binding protein, has been identified from a 
screen for secreted factors from the Hensen’s node (Marta de Almeida, 2012).  Here we find 
that the transcription factor ATF3, a direct target of the calcium activated cAMP response 
element binding protein (Zhang et al., 2011, Ahlgren et al., 2014), is upregulated after 5h but 
downregulated later. These various observations do not clarify the precise role of Calcium in 
neural induction, but it seems possible that it is involved in multiple events, at different times. 
Despite the role of Sonic hedgehog (SHH) in patterning the neural tube (Chiang et al., 1996, 
Patten and Placzek, 2000, Dessaud et al., 2007, Dessaud et al., 2008), to date, the hedgehog 
pathway has been given little consideration in terms of neural induction. The receptors PTCH2 
and PTCH1 are direct targets of hedgehog signalling (Pearse et al., 2001) and are upregulated 
at each time point in the screen. Furthermore, the transcription factors and hedgehog targets 
GLI2 (Schweitzer et al., 2000) and GLI3 (Marigo et al., 1996) are similarly upregulated. Their 
expression is detected by in situ hybridisation at HH5, which positions them closer to the 9h 
time point. Furthermore, SHH is first expressed in Hensen’s node around HH4 (Levin et al., 
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1995), coinciding with the onset of SOX2 expression around Hensen’s node in the definitive 
neural plate (Rex et al., 1997). Therefore ligands, receptors and transcriptional targets of the 
hedgehog pathway are appropriately expressed in the embryo or are induced in our screen, 
consistent with a role in the relatively late steps of neural induction. 
Although a more thorough and functional analysis of signalling readouts in the screen is 
necessary, it has already been possible to extract basic signalling trends from the RNA-Seq 
data. Our observations confirm that neural induction is accompanied by early FGF signalling as 
well as general BMP and WNT inhibition. We also obtained evidence of calcium and retinoic 
acid modulation and directly associate hedgehog signalling with neural induction. How these 
pathways function during neural induction remains to be determined, but it will now be 
possible to test their contributions to the transcriptional responses identified here. 
 
4.4.6 Comparing RNA-Seq to the original 5h neural induction screen 
The original 5h screen revealed 10 markers induced by a node graft (Streit et al., 2000, Sheng 
et al., 2003, Gibson et al., 2011, Pinho et al., 2011, Papanayotou et al., 2013), but results in 
Chapter 3 demonstrated that these were not the only responses to neural induction. The 
increased sensitivity of next generation sequencing provided a new opportunity to reassess 
the effects of grafting a node graft for 5h. RNA-Seq now reveals 1987 genes as differentially 
expressed at this time point, of which 129 are upregulated and 122 are downregulated 
transcriptional regulators. We successfully identified ERNI and SOX3 from the original screen 
(Streit et al., 2000), as well as NOT1, NOT2 (Knezevic et al., 1995, Knezevic and Mackem, 2001) 
and OTX2 (Bally-Cuif et al., 1995) which were predicted and verified in Chapter 3. Therefore we 
have identified many new transcriptional regulators at this time point, and for the first time 
identify responses that are specifically downregulated by a node graft.  
Somewhat unexpectedly, ERNI and SOX3 are the only candidates from the original screen 
common to this new analysis. However other genes from the 5h screen are expressed much 
weaker than ERNI and SOX3. For example, FTH1 is expressed so weakly that it has not been 
possible to assess its induction by a node graft (Gibson et al., 2011). Therefore, it seems 
plausible that the other genes which were not detected (Churchill (Sheng et al., 2003), 
Calfacilitin (Papanayotou et al., 2013), Dad1, UBII (Gibson et al., 2011), Asterix, Obelix and 
TRKC (Pinho et al., 2011)) may not be differentially expressed above the stringent threshold 
fold change used here. Lowering this below 1.2 log2 causes a substantial increase in the 
number of transcripts identified as well as the false discovery rate. To focus on the best 
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markers, we chose to maintain a high threshold cut-off to limit the selection of potential false 
positives. As a consequence, subtler responses to neural induction have not been selected. 
 
4.4.7 Limitations of the RNA-Seq differential screen 
The RNA-Seq screen has identified hundreds of new, relevant responses to neural induction. 
These are accompanied by appropriate signalling dynamics, suggesting that ectopic induction 
by a node accurately represents the endogenous process. One benefit of this assay is that the 
time of grafting represents the beginning of the process, allowing the entire period of neural 
induction to be studied. By comparing ectopic induction to contralateral uninduced tissue, we 
have been able to extract differentially expressed markers specific for the process. However 
this approach has a number of important limitations that should also be considered. 
An RNA-Seq protocol was chosen because it has certain advantages compared to microarray 
analysis. It provides base level resolution and deeper transcriptome coverage and is able to 
identify specific alleles, splice variants, SNPs and non-coding RNAs (Wang et al., 2009). Also, 
RNA-Seq is quantitative and measures transcriptome dynamics more accurately, making it 
ideal for our screen. However it does suffer from biases introduced via RNA fragmentation and 
amplification, which can preferentially identify shorter transcripts over longer ones (Wang et 
al., 2009). In addition, by using oligo-dT to extract mRNAs, most microRNAs (which might have 
regulatory contributions) would not be detected. Despite this, a number of microRNAs did 
appear in our data, though their expression has not been studied here. Another complication 
arises from the dependence of RNA-Seq on a reference genome to identify transcripts, as 
annotation of the chicken genome is currently very incomplete. Although reanalysis of our 
data with the Galgal4 build identified many more transcripts than Galgal3, some remain 
unannotated. Fortunately, these data can be reanalysed against future releases of the genome 
to complete the data set. 
Any screen based around differential expression deliberately ignores ubiquitously expressed 
genes that may function in concert with differentially expressed ones. Despite this, we have 
identified many new factors that have not been previously associated with neural induction. 
Lowering the fold change threshold would further increase the number of responses and make 
it harder to study the overall process. We do not discount that more ubiquitous markers might 
function during neural induction, but we have chosen to focus on some of the best markers to 
describe the progression of the neural induction cascade.  
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An additional caveat of the screen design is created by conducting the differential screen in the 
area opaca. Although uninduced tissue was used to subtract the effects of culture and identify 
specific responses to neural induction, the area opaca is not a naïve tissue, and might differ 
from the embryonic ectoderm where the normal decision to make the neural plate takes 
place. For example WNTs are expressed throughout the area opaca (Skromne and Stern, 
2001). Therefore some markers may be downregulated as re-specification responses, rather 
than as direct targets of neural induction. These re-specification events are likely to occur soon 
after a node is grafted and therefore be identified as early as the 5h time point. Conversely, 
some genes already expressed in the area opaca could be required for neural induction but 
these will not be identified as being induced.  
Other issues arise when comparing the differential expression of markers in the area opaca to 
their actual expression level in the neural plate. Differentially expressed genes in the screen 
may function at only marginally upregulated levels in the neural plate while some 
downregulated genes may still be required but only at slightly lower levels. Therefore some 
up- and downregulated genes may not be expressed strongly or completely absent from the 
neural plate. Furthermore, we find that markers present in induced tissue are actually 
expressed at far higher levels in the embryonic neural plate. This has greater implications for 
downregulated genes, which were identified because they are expressed at higher levels in the 
area opaca than in induced tissue. Their normal expression will contradict the screen’s 
predictions if expression in the neural plate proper exceeds that of the area opaca, as appears 
to be the case with TRIM3 (Fig. 4.32U-Y) and possibly also DLX3 (Fig. 4.22A-E) and ID3 (Fig. 
4.26F-J). This problem is more likely with downregulated markers expressed at low levels in 
the area opaca, where the impact of fold change means that the absolute difference between 
induced and uninduced values is smaller than between more highly expressed genes.   
It is also worth considering that some genes expressed in the neural plate and neural tube may 
be induced by combinations of signals from surrounding tissues, which a graft of Hensen’s 
node may not be able reproduce. These types of response will not be identified by our screen, 
but they are more likely to include markers of neural plate patterning since grafts can induce 
markers of the entire neural plate such as SOX2 and SOX1.  
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4.5 Conclusions 
Presented here is a RNA-Seq analysis of a time-course of responses to neural induction, which 
identified 4145 differentially expressed genes including 482 transcriptional regulators. Of these 
we have confirmed the expression of 83 upregulated and 83 downregulated transcriptional 
regulators and demonstrate that the screen accurately predicts the location and timing of their 
normal expression. Upregulated genes tend to be expressed in the neural plate at some stage, 
while downregulated genes are relatively absent. Despite conducting the analysis ectopically, 
the pattern of markers and signalling readouts closely resembles the spatio-temporal events 
that occur in the neural plate. Therefore we consider the screen to be an accurate 
representation of the transcriptional responses that occur during endogenous neural 
induction. Among these responses are many that have not previously been implicated in 
neural induction and 80 that are previously undescribed in chick.  
Although we have not yet tested the function of these during neural induction, we can 
speculate on the putative roles of distinct classes of markers based on the timing and location 
of their expression. Different combinations of upregulated genes mark the neural plate at 
stages before the expression of SOX1, thereby revealing the dynamic and complex nature of 
neural induction. These events overlap with varying combinations of downregulated genes 
which may act normally to repress the process.  
It has also been possible to extract accompanying signalling trends; some previously associated 
with neural induction such as FGFs, BMP inhibition and WNT inhibition as well as others less 
appreciated including responses to hedgehog signals. How these contribute to neural 
induction remains to be determined, but it is now possible to evaluate their relative 
contributions to the expression of the neural markers found here. 
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Chapter 5: FGFs regulate most early responses to neural 
induction 
5.1 Introduction 
In Chapter 4, a screen conducted to identify responses to neural inducing signals revealed a 
large set of differentially expressed transcription factors -key regulators of neural induction. 
Analysis of their expression patterns reveals that they can be separated into distinct classes 
based on the timing and location of their expression in the normal embryo.  
To date, the earliest known responses to neural induction were ERNI and SOX3 (Streit et al., 
2000). We have now identified new ERNI-like markers such as CITED4 (Fig. 4.6U-Y), ETV4 (Fig. 
4.8K-O), MAFA (Fig. 4.12A-E), PRDM1 (Fig. 4.14P-T) and TFAP2C (Fig. 4.32F-J), which are 
normally expressed in the pre-streak epiblast at EGKXIII and prospective neural plate at HH3-4. 
Later, they are downregulated in the neural plate but are expressed in the neural plate border 
and pre-placodal region from HH5 and then in the future placodes after HH9. These differ from 
SOX3-like genes, such as MTA1 (Fig. 4.12U-Y), SOX13 (Fig. 4.16P-T), STOX2 (Fig. 4.17A-E) and 
TCF7L1 (Fig. 4.17Z-AD), which are also expressed in the pre-streak epiblast and prospective 
neural plate, but persist in the neural plate and neural tube after HH4, as ERNI-like genes are 
downregulated. Later neural markers are not expressed in the early embryo, but are present in 
the neural plate after HH4. For example, SOX2-like genes including GLI2 (Fig. 4.9F-J), GLI3 (Fig. 
4.9K-O), ZEB2 (Fig. 4.19A-E), ZNF423 (Fig. 4.19P-T) and LHX5 (Fig. 4.11F-J) are expressed in the 
neural plate and PPR between HH5-7 while LMO1 (Fig. 4.11U-Y) is expressed in the neural 
plate but is specifically absent from the PPR. SOX1 (Fig. 4.15Z-AD), is expressed later still as it 
can first be detected in the neural tube at HH8-9. This panel of markers, which are expressed 
at different stages of neural induction, serve as useful indicators of a hierarchical progression 
through distinct, definable states along the pathway towards acquisition of neural fate.  
The RNA-Seq screen also identified markers that are downregulated upon exposure to 
Hensen’s node. Although these are more varied in their expression patterns, several classes 
could be distinguished. Markers that are excluded from the embryo and only expressed in the 
area opaca include ISX1 (Fig. 4.26P-T) and VGLL1 (Fig. 4.32Z-AD), while HIC2 (Fig. 4.25A-E) and 
GRHL3 (Fig. 4.24U-Y) are examples of markers normally expressed in embryonic non-neural 
ectoderm. Other downregulated genes include those that that mark the neural plate border 
from HH6 such as DLX5 (Fig. 4.22F-J) (Streit, 2002) and MSX1 (Fig. 4.28F-J) (Suzuki et al., 1991), 
as well as GRHL2 (Fig. 4.24K-O) and TFAP2A (Fig. 4.32A-E) (Khudyakov and Bronner-Fraser, 
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2009), which are expressed early in the EGKXIII area opaca and later the neural plate border. 
Therefore it is now possible to define the time-course of neural induction by the loss of non-
neural and neural border markers as well as the acquisition of neural markers. 
Considerable evidence already implicates FGFs as an important early signal during neural 
induction. They are sufficient and necessary to induce ERNI and SOX3 within 1-3h of neural 
induction (Streit et al., 1998, Streit et al., 2000), and are required or sufficient for the 
expression of OTX2 (Albazerchi and Stern, 2007), Churchill (Sheng et al., 2003), Asterix, Obelix 
(Pinho et al., 2011) and SOX2 (Linker and Stern, 2004, Delaune et al., 2005). The RNA-Seq 
screen further reiterates the important contribution of FGFs, as transcriptional targets of the 
FGF pathway including ERNI, SOX3 (Streit et al., 2000), SPRY1, SPRY2 (Minowada et al., 1999), 
SPRED1 (Sivak et al., 2005) and ETV5 (Lunn et al., 2007), are upregulated within the first 5h. 
However, many of these continue to be upregulated over 5-12h of a node graft suggesting that 
FGF signals may also function later during the cascade. Changes in the expression of AXIN2 
(Quinlan et al., 2009), RARB (Cui et al., 2003), GATA2 (Sheng and Stern, 1999) and PTCH2 
(Pearse et al., 2001), targets of the WNT, retinoic acid, BMP and hedgehog pathways, predict 
that neural induction is accompanied by hedgehog pathway activity and inhibition of BMP, 
WNT and retinoid signals. Therefore transcriptional reporters of signalling pathways provide 
clues as to which signals cells are exposed and respond to throughout neural induction.  
The induction by Hensen’s node of ERNI and SOX3 are, to date, the earliest confirmed 
responses to neural induction. Their expression, in the epiblast at EGKXIII or after 3h of a node 
graft by FGFs (Streit et al., 2000), has been predicted to define a pre-neural state similar in 
specification to the neural plate border (NPB) (Stern, 2004). Like the border, epiblast can be 
neuralised by BMP antagonists (Streit and Stern, 1999, Wilson et al., 2000, Wilson et al., 2001) 
and can be induced to form ectopic lens after prolonged culture in the absence of further 
signals (Bailey et al., 2006, Stower, 2012). This suggests that the pre-streak epiblast shares a 
common specification with the neural plate border, and that neural induction might begin with 
the induction of such a state by FGF signals (Stern, 2004). 
To establish the precise timing and signals responsible for inducing distinct specification states 
during neural induction, a selected panel of key markers were used to study responses in more 
detail. A first set of ERNI-like, SOX3-like, and SOX2-like markers as well as markers which are 
downregulated by neural induction, were selected to more precisely define the progression of 
the neural induction cascade by assessing the timing of their responses over a refined time-
course. Then, the relative contribution of FGF signalling to their expression was assessed by 
FGF gain- and loss-of-function experiments.  
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The time-course screen also provides the opportunity to determine whether the pre-streak 
epiblast is more generally specified as “border-like”. If this is the case, then markers expressed 
in the PPR and induced as early responses to neural induction should also be expressed as ERNI 
and SOX3; in the pre-streak epiblast and prospective neural plate. These would confirm 
whether neural induction begins with the specification of a “border-like” state and we can 
then test FGF signals are responsible for its induction. 
 
5.2 Results 
5.2.1 A detailed analysis of neural induction and the contribution of FGFs 
The identification of many new transcriptional regulators that are differentially expressed 
during neural induction provides the opportunity to assess the timing and regulation of key 
responses in greater detail. A custom NanoString probe set targeting specific transcripts, was 
used to quantify gene expression in control and experimental conditions. Specific markers 
were used to describe important states that accompany neural induction. ERNI-like (ERNI, 
CITED4, ETV4, MAFA, PRDM1, TFAP2C), SOX3-like (SOX3, MTA1, SOX13, STOX2, TCF7L1), SOX2-
like (SOX2, GLI2, GLI3, ZEB2, ZNF423), other later neural markers (LHX5, LMO1, SOX1, TRKC) 
and PPR markers (EYA1, SIX1, SIX3), were used to define the phases of pre-neural and neural 
specification and finally neural commitment (Fig. 3.11). The simultaneous downregulation of 
area opaca (ISX, VGLL1), non-neural ectoderm (HIC2, GRHL3, KRT19) and neural plate border 
markers (DLX5, PAX7, GRHL2, TFAP2A) was also assessed. Signalling changes were monitored 
using SPRY2, RARB, AXIN2, PTCH2, GATA2 and MSX1; readouts of FGF, retinoic acid, WNT, 
hedgehog and BMP pathways. Brachyury (BRA) and TBX6 were included as markers of 
mesoderm, while potential contamination by grafted tissue was monitored using Goosecoid 
(GSC) to mark Hensen’s node itself, and Noggin (NOG) to mark grafted node tissue later when 
it self-differentiates into notochord. 
 
5.2.1.1 A refined time-course of responses to neural induction over 1-12h 
To establish the earliest responses to neural induction and to refine the time-course, epiblast 
exposed to a node graft and an equivalent piece of uninduced contralateral area opaca 
epiblast were isolated after 1, 3, 5, 7, 9, and 12h of culture. The expression level of markers 
was quantified using NanoString (in triplicate). Genes were considered to be differentially 
expressed in induced tissue when they were upregulated by at least 1.2-fold or downregulated 
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by at least 0.75-fold. (Fig. 5.1-5.6 are also provided as a slideshow on the accompanying CD; 
see Appendix 10.) 
Transcriptional changes can already be detected in induced tissue after just 1h (Fig. 5.1). ERNI 
is already upregulated, as is the ERNI-like marker PRDM1. No obvious trends are detected for 
other neural markers, which record only low level fluctuations. Some non-neural and area 
opaca markers including GRHL3, KRT19, HIC2 and VGLL1 are downregulated, as are the neural 
plate border markers DLX5 and TFAP2A.  
Greater transcriptional divergence is observed after 3h of a node graft (Fig. 5.2). All ERNI-like 
markers (CITED4, ETV4, MAFA, PRDM1 and TFAP2C) are now upregulated, while weak 
upregulation of SOX3 and the SOX3-like markers (MTA1, STOX2 and TCF7L1), is now observed. 
Downregulation of all non-neural and area-opaca markers is detected, as well as the neural 
plate border markers DLX5, GRHL2 and TFAP2A.  
No new responses are detected after 5h of signals from Hensen’s node. Instead the induction 
of ERNI- and SOX3-like markers is maintained and reinforced (Fig. 5.3). Little expression is yet 
detected for SOX2-like and other neural markers, which are only detected at very low levels, if 
at all. Non-neural, area opaca and neural plate border markers continue to be strongly 
downregulated.  
Responses after 7h of a grafted node (Fig. 5.4) are similar to those observed over the first 5h, 
except that later neural markers including SOX2, GLI2, GLI3, ZEB2, ZNF423, LHX5, LMO1 and 
TRKC are now upregulated, though only at very low levels. Non-neural, area opaca, neural 
plate border and PPR markers are generally downregulated, although the PPR marker and 
forebrain marker SIX3 is mildly upregulated.  
It is only after 9h (Fig. 5.5) that later neural markers including SOX2, GLI2, GLI3, ZEB2, ZNF423, 
LHX5, LMO1, TRKC and SIX3, are robustly upregulated. Even so, SOX1 can still only be detected 
at very low levels. ERNI- and SOX3-like markers continue to be upregulated but, compared to 
the earlier time points, their induced relative expression levels are slightly decreased. All non-
neural, area opaca and border markers are downregulated apart from SIX3 and EYA2, the 
latter being only very weakly induced.  
After 12h of signals from Hensen’s node, all neural markers are robustly expressed (Fig. 5.6). 
SOX2-like and later neural markers including SOX2, GLI2, GLI3, ZEB2, ZNF423, LHX5, LMO1, 
TRKC and SOX1 are expressed at much higher levels than they were after 9h. There is also 
general upregulation of the PPR markers SIX1, SIX3 and EYA2, although neural plate border 
markers including DLX5, GRHL2 and TFAP2A remain downregulated, alongside area opaca and 
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non-neural markers. Although ERNI-like and SOX3-like genes are still upregulated, their 
induced expression levels have further decreased.  
Transcriptional readouts of signalling pathways provide clues as to the types of signals cells 
receive over the 1-12h period of a node graft. Robust downregulation of AXIN2, GATA2 and 
MSX1 is observed after just 1h of organizer signals (Fig. 5.1). At this time point, PTCH2 is 
upregulated, while SPRY2 is also weakly induced (Fig. 5.1).  The retinoid receptor RARB is also 
downregulated from 3h (Fig. 5.2), before these transcriptional responses are enhanced and 
maintained over the following time points (Fig. 5.3 – 5.6). 
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Figure 5.1: The induction of neural and non-neural markers after 1h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced (green or light grey) and induced (red or dark grey) conditions after 1h. 
Differentially expressed genes (fold change >1.2 or <0.75) are shown in colour. Black dots mark 
statistically significant differences. High level expression changes are plotted on the primary 
axis (0-0.12), while lower level changes are shown on the secondary axis (0-0.014). Genes 
include ERNI-like, SOX3-like, SOX2-like, other neural (Other N), PPR, border, non-neural (Non-
N), area opaca, signalling pathway readouts (P. readouts), mesoderm (M) and graft (G) 
markers.  
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Figure 5.2: The induction of neural and non-neural markers after 3h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced and induced conditions after 3h. For details, see Fig. 5.1.  
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Figure 5.3: The induction of neural and non-neural markers after 5h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced and induced conditions after 5h. For details, see Fig. 5.1.  
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Figure 5.4: The induction of neural and non-neural markers after 7h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced and induced conditions after 7h. For details, see Fig. 5.1.  
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Figure 5.5: The induction of neural and non-neural markers after 9h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced and induced conditions after 9h. For details, see Fig. 5.1.  
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Figure 5.6: The induction of neural and non-neural markers after 12h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced and induced conditions after 12h. For details, see Fig. 5.1.  
 
To summarise, all neural markers are upregulated at some stage during neural induction. The 
earliest responses are upregulated after 1h and include ERNI and PRDM1 (an ERNI-like gene), 
perhaps representing an early transition towards a neural fate (Fig. 5.1). A more robust neural 
response is observed after 3h when all ERNI- and SOX3-like markers are upregulated, 
characterising a pre-neural state. This state is then maintained and reinforced over 3-5h (Fig. 
5.2-5.3). As we would predict, SOX2-like markers are only induced after 7-9h of a node graft 
(Fig. 5.4 and 5.5), when they define neural specification. Then, once cells are committed to a 
neural fate after 12h (Gallera and Ivanov, 1964, Gallera, 1965, Gallera, 1971), all neural 
markers including SOX1 are robustly upregulated, or have been upregulated at some point 
during the time course (Fig. 5.6).  
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Although ERNI-like markers are still upregulated after 9 and 12h, closer examination of their 
expression levels over time, reveals that their induction peaks after 7h (Fig. 5.4) before 
decreasing mildly over 9-12h (Fig. 5.5, 5.6). In particular, TFAP2C is weakly upregulated 
between 1-5h (Fig. 5.1-5.3) and robustly downregulated from 7h (Fig. 5.4-5.6). This is 
consistent with the idea that ERNI-like genes are expressed in the prospective neural plate, but 
downregulated in the neural plate proper from HH5. SOX3-like marker expression similarly 
peaks over 7-9h (Fig. 5.4, 5.5). Therefore pre-neural markers are less dominant, as the 
expression of later neural markers takes over during neural specification and commitment 
after 9-12h (Fig. 5.6). The transcriptional changes we describe occur over substantial levels or 
as general trends over time. They are not accompanied, at any time point, by substantial 
expression of either Goosecoid or Noggin. This indicates that induced tissue is not significantly 
contaminated with grafted tissue. It is likely that the probe designed for SOX13 failed to 
hybridise to its target transcripts as, despite being strongly expressed in the embryo, 
NanoString was unable to detect SOX13 expression at any time point. 
Unlike neural-associated markers which are induced in 4 distinct waves between 1-12h, 
markers of non-neural ectoderm and the area opaca are downregulated early (within 1-3h) 
and remain strongly inhibited by node grafts throughout the remaining time-course. Neural 
plate border and PPR markers including DLX5, GRHL2, and TFAP2A are also downregulated 
early but some PPR and anterior neural plate markers (EYA2, SIX3 and SIX1) are upregulated 
between 9-12h (Fig. 5.6), which, correlates well with PPR formation between HH6-7. 
Accompanying these responses, is evidence of early FGF signalling, as demonstrated by 
upregulation of FGF responses such as ERNI, SOX3, ETV4 and SPRY2 over 1-3h (Fig. 5.1, 5.2). 
Simultaneously, the BMP and WNT pathways also seem to be inhibited within 1h, as target 
genes GATA2 and MSX1 are downregulated alongside AXIN2 (Fig. 5.1). Inhibition of retinoid 
signalling may also occur after 3h as RARB is downregulated. Grafts of Hensen’s node are 
sufficient to induce the hedgehog pathway receptor and target PTCH2 after 1h, but other 
targets of the hedgehog pathway; GLI2 and GLI3, are not robustly upregulated until 9h (Fig. 
5.5).  
 
5.2.1.2 FGFs regulate most early responses to neural induction after 5h 
The FGF targets ERNI and SOX3 are known to be upregulated within 1-3h of a node graft (Streit 
et al., 2000, Pinho et al., 2011). Therefore, other early responses also induced within this time 
period might also be regulated by FGFs (Fig. 5.1 and 5.2). To evaluate the contribution of FGF 
signalling to the regulation of these markers, we assessed their expression by gain- and loss- 
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of-function experiments. Genes were considered to be differentially expressed in response to 
FGF perturbation when they were upregulated by at least 1.2-fold or downregulated by at 
least 0.75, compared to the uninduced control. (Fig. 5.7-5.8 are also provided as a slideshow 
on the accompanying CD; see Appendix 10.) 
To test whether FGF signals are sufficient for early neural responses, the expression of markers 
in uninduced tissue was compared to 5h of signals from a bead soaked in FGF8b (Fig. 5.7). FGFs 
are sufficient to induce ERNI itself and the ERNI-like markers ETV4, MAFA and PRDM1, but not 
CITED4. SOX3 and SOX3-like genes including MTA1, STOX2 and TCF7L1 are also upregulated. 
The SOX2-like marker ZNF423 is also upregulated, but FGFs have little or no effect on other 
later neural markers, though these are not normally expressed after 5h. FGF signals also 
dramatically downregulate HIC2, GRHL3, KRT19 and VGLL1 -markers of non-neural ectoderm 
and the area opaca. The neural plate border markers GRHL2 and TFAP2A are also 
downregulated, though DLX5 is upregulated. As expected, FGF signals induce SPRY2, but they 
also upregulate PTCH2 and robustly downregulate AXIN2, RARB, GATA2 and MSX1. Despite 
prior verification by in situ hybridisation that 25µg/ml FGF8b does not induce mesoderm after 
5h (Appendix 9), NanoString is sensitive to detect upregulation of Brachyury and TBX6. 
Therefore these results should be interpreted with caution as the induction of pre-neural 
markers could be indirect. 
To test whether FGF signals are required to regulate these early responses, their expression 
after 5h of a node graft was compared to their induction when FGF signalling from a grafted 
node is inhibited by SU5402 (Fig. 5.8). FGF inhibition downregulates ERNI and ERNI-like 
markers such as CITED4, ETV4 and MAFA, but paradoxically upregulates PRDM1. FGF signals 
are also necessary for the expression of SOX3 and MTA1, but not for the SOX3-like markers 
STOX2 or TCF7L1. Upregulation of non-neural and neural plate border markers including 
KRT19, GATA2, GRHL2 and TFAP2A is observed upon FGF inhibition, although HIC2 is 
downregulated and DLX5 is unaffected. Loss of FGF signalling causes mild downregulation of 
SPRY2 and PTCH2, but has little or no effect on RARB or AXIN2. 
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Figure 5.7: The induction of neural and non-neural markers after 5h of FGF signalling.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced epiblast (green or light grey) and FGF exposure (orange or dark grey) after 5h. 
Differentially expressed genes (fold change >1.2 or <0.75) are shown in colour. Black dots mark 
statistically significant differences. High level expression changes are plotted on the primary 
axis (0-0.2), while lower level changes are shown on the secondary axis (0-0.01). Genes include 
ERNI-like, SOX3-like, SOX2-like, other neural (Other N), PPR, border, non-neural (Non-N), area 
opaca, signalling pathway readouts (P. readouts), mesoderm (M) and graft (G) markers.  
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Figure 5.8: The induction of neural and non-neural markers after 5h of FGF inhibition.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
induced tissue (red or light grey) after 5h to neural induction when FGFs are inhibited (blue or 
dark grey). For details, see Fig. 5.7.  
 
In summary (Fig. 5.9) FGFs regulate early neural responses to varying degrees. They are 
sufficient and necessary to induce ERNI, ETV4, MAFA, SOX3, MTA1 and TCF7L1 expression. 
CITED4 requires FGF signalling, but this is not sufficient for its expression. Conversely, FGFs are 
sufficient but not necessary for the expression of TFAP2C and STOX2. Simultaneously, FGF 
signals are sufficient and necessary to downregulate GRHL2, TFAP2A, GRHL3, VGLL1 and 
GATA2. They are sufficient but not necessary to downregulate HIC2, but necessary and 
sufficient for MSX1. Although PRDM1 is upregulated in response to FGF signalling, it is also 
upregulated by FGF inhibition. Furthermore, DLX5, which is normally downregulated in 
response to a node graft, is actually upregulated by FGF alone, although FGFs are not required 
for its expression. Therefore, other signals must contribute to CITED4, MSX1, STOX2, TFAP2C 
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and HIC2 expression, and modulate the responses of PRDM1 and DLX5 to FGF signalling during 
neural induction.  
As expected, FGFs are sufficient and necessary to upregulate the FGF target SPRY2, but the 
results also suggest that they can regulate markers normally associated with other signalling 
pathways. FGFs are sufficient and necessary to dramatically downregulate GATA2 and MSX1, 
and sufficient to repress RARB and AXIN2. They are sufficient and necessary for PTCH2 
expression. This suggests that FGFs can facilitate hedgehog signalling and may even antagonise 
BMP, WNT and retinoic acid pathways during neural induction.  
 
 
Figure 5.9: The contribution of FGFs to neural induction after 5h.  
A Venn diagram summarising upregulated (red) and downregulated (green) genes that require 
FGFs, those for which FGF signalling is sufficient for their responses, and those that respond 
differently to FGFs. 
 
5.2.1.3 FGFs maintain early responses and are required for the expression of 
later markers after 9h 
After 5h, it is only possible to assess the effects of FGF perturbation on the earliest neural 
responses, as later neural markers are not induced until at least 7-9h of signals from a node 
graft. Therefore, to evaluate the contribution of FGF signalling to the regulation of later 
markers and the continuing expression of early responses, we assessed their expression after 
9h of FGF perturbation. (Fig. 5.10-5.11 are also provided as a slideshow on the accompanying 
CD; see Appendix 10.) 
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To test the sufficiency of FGFs for responses after 9h, the expression of markers in uninduced 
tissue was compared to their response after 9h of signals from a bead soaked in FGF8b. FGFs 
are still sufficient to induce ERNI, SOX3, ETV4, MAFA, PRDM1, TFAP2C, MTA1, STOX2, and 
TCF7L1 after this period (Fig. 5.10), although they now downregulate the ERNI-like marker 
CITED4. FGFs remain sufficient to upregulate ZNF423, but even after 9h, they are unable to 
fully upregulate SOX2, GLI2, GLI3, ZEB2, LHX5, LMO1 or TRKC, which are normally expressed at 
much higher levels following a node graft. FGFs continue to downregulate non-neural markers 
including HIC2, GRHL3, KRT19 and VGLL1. The neural border markers SIX1 and GRHL2 are also 
slightly downregulated in response, although TFAP2A and MSX1, which were mildly 
downregulated after 5h, are now weakly upregulated. FGF signals still downregulate AXIN2, 
RARB and GATA2 and induce SPRY2 and PTCH2. As observed after 5h (Fig. 5.7), expression of 
Brachyury and TBX6 can also be detected at 9h.  
In response to FGF inhibition for 9h (Fig. 5.11), the ERNI-like genes ETV4 and CITED4 are 
downregulated, while ERNI and TFAP2C are mildly upregulated and MAFA and PRDM1 are 
relatively unaffected. SOX3 and MTA1 are downregulated, though other SOX3-like genes 
(STOX2 and TCF7L1) are mildly upregulated. Later neural markers such as GLI3, ZEB2, ZNF423, 
LHX5 and LMO1 are weakly downregulated, although SOX2 and GLI2 are relatively unaffected. 
The expression of GRHL2 and TFAP2A increases slightly upon FGF inhibition, but other neural 
plate border markers are not generally affected. The non-neural markers KRT19, HIC2 and 
GRHL3 are even further downregulated after 9h than after 5h. In terms of signalling readouts, 
the BMP targets GATA2 and MSX1 are mildly upregulated. SPRY2 and PTCH2 which were 
downregulated after 5h are now weakly upregulated, while AXIN2 and RARB are 
downregulated.  
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Figure 5.10: The induction of neural and non-neural markers after 9h of FGF signalling.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced (green or light grey) and FGF induced (orange or dark grey) conditions after 9h. 
Differentially expressed genes (fold change >1.2 or <0.75) are shown in colour. Black dots mark 
statistically significant differences. High level expression changes are plotted on the primary 
axis (0-0.2), while lower level changes are shown on the secondary axis (0-0.01). Genes include 
ERNI-like, SOX3-like, SOX2-like, other neural (Other N), PPR, border, non-neural (Non-N), area 
opaca, signalling pathway readouts (P. readouts), mesoderm (M) and graft (G) markers.  
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Figure 5.11: The induction of neural and non-neural markers after 9h of FGF inhibition.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
induced tissue (red or light grey) after 9h to neural induction when FGFs are inhibited (blue or 
dark grey). For details, see Fig. 5.10.  
 
The responses that occur after 9h of FGF perturbation can be summarised as follows (Fig. 
5.12). FGFs are still necessary and sufficient to induce ETV4, SOX3 and MTA1, but also ZNF423. 
Where FGFs were sufficient and necessary after 5h, they are sufficient but no longer required 
for ERNI, MAFA, STOX2 and TCF7L1 expression after 9h. Expression of later neural markers 
such as GLI2, GLI3, ZEB2, LHX5 and LMO1 requires FGF signalling, but it is not sufficient for 
their expression. FGFs remain sufficient and required to downregulate GRHL2, TFAP2A, VGLL1 
and GATA2, but only required for MSX1 inhibition. They are sufficient, but no longer necessary 
to downregulate HIC2 and GRHL3 after 9h. FGF signalling continues to upregulate DLX5, 
despite node grafts normally repressing its expression. TRKC, SIX3 and surprisingly also SOX2, 
do not appear to respond to FGF activity or antagonism, suggesting that their expression might 
be relatively FGF independent. CITED4 is now downregulated by both FGF activity and 
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inhibition, while TFAP2C, which is normally downregulated after 9h of neural induction, is 
upregulated by both FGF gain- and loss-of-function. It could be that CITED4 and TFAP2C are 
normally regulated by signals which compete with MAPK signalling, such as IGFs, EGFs or HGFs.  
After 9h, FGF signals still downregulate the BMP target GATA2, although FGF activity 
upregulates MSX1. They are also sufficient but not necessary to downregulate RARB and AXIN2 
after 9h suggesting that other factors normally inhibit their expression. Although ETV4 and 
SOX3 are downregulated by FGF inhibition after 9h, SPRY2 expression is unaffected. This 
observation raises the possibility that FGF signals may not be effectively inhibited after 9h and 
if so, the requirement of FGF signalling may not be accurately assessed. Alternatively, it is 
possible that SPRY2 expression may now be FGF-independent. 
Generally, FGFs remain an important regulator of some early neural markers after 9h, but 
other signals now seem to maintain the responses of STOX2, TCF7L1, HIC2 and GRHL3. 
Although FGFs are sufficient to induce ZNF423, they are only required for the expression of 
other neural markers after 9h. This supports the idea that additional signals are required after 
5h for the expression of later neural markers. Furthermore, the effects of FGF signalling on 
targets of BMP, WNT and retinoid signalling after 5h, will have downstream consequences at 
later time points. 
 
 
Figure 5.12: The contribution of FGFs to neural induction after 9h.  
Venn diagram summarising which upregulated (red) and downregulated (green) genes require 
FGFs, those for which FGF signalling is sufficient for their responses, and those that respond 
differently to FGFs.  
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5.2.2 A detailed analysis of pre-neural markers and their regulation by FGFs 
Until now, ERNI and SOX3 were the two earliest genes known to be expressed during neural 
induction (Streit et al., 2000). Both are induced within 3h of a node graft and in response to 
FGF signalling. In the embryo, their expression in the epiblast at EGKXII-XIII first suggested that 
neural induction starts before gastrulation (Streit et al., 2000). Later, they are commonly 
expressed in the prospective neural plate at HH3-4, but their expression diverges from HH5 
when SOX3 expression persists in the neural plate and neural tube, whereas ERNI expression 
shifts to the neural plate border (NPB) and pre-placodal region (PPR) (Streit et al., 2000). The 
PPR is a domain which derives from the anterior NPB and later gives rise to the sensory 
placodes (Papalopulu, 1995, Baker and Bronner-Fraser, 2001, Bailey and Streit, 2005, Streit, 
2008). Based on experiments using ERNI and SOX3 as markers, it has been suggested that the 
neural plate and PPR might derive from a common “border-like” pre-neural territory (Stern, 
2004, Streit, 2008). 
To determine whether the pre-streak epiblast can be more generally characterised as “border-
like”, the expression of other neural plate and PPR markers was assessed. Transcriptional 
regulators commonly identified by two separate screens were selected for analysis; markers 
upregulated after 5h in the neural induction RNA-Seq screen (above a base mean induced level 
of 45), and upregulated in a microarray screen of PPR tissue conducted by Andrea Streit’s 
group at King’s College London. From this, 20 markers of the neural plate and pre-placodal 
region were selected, including ERNI and SOX3. To test whether these markers are also 
expressed in the early embryo their normal expression was assessed by in situ hybridisation at 
EGKXII-XIII and HH3-4 (Fig. 5.13). The expression of these was already shown in Chapter 4, but 
is repeated here for clarity. 
Of the 20 transcriptional regulators assessed, 16 are robustly expressed in the epiblast at 
EGKXII-XIII and in the prospective neural plate at HH3-4 (Fig. 5.13). These include the 
transcription factors ETV5 (Fig. 5.13E, M), MYCN (Fig. 5.13G, O), OTX2 (Fig. 5.13Q, Y), SOX11 
(Fig. 5.13T, AB) and ZIC3 (Fig. 5.13W, AE). Also expressed are genes coding for verified or 
putative chromatin modifiers including BMI1 (Fig. 5.13A, I), DNMT3A (Fig. 5.13B, J), DMNT3B 
(Fig. 5.13C, K), ING5 (Fig. 5.13F, N), NSD1 (Fig. 5.13H, P), SETD2 (Fig. 5.13R, Z), TRIM24 (Fig. 
5.13U, AC), YEATS4 (Fig. 5.13V, AD), and ZNF462 (Fig. 5.13X, AF). Despite subtle differences in 
expression pattern (for example, OTX2 is expressed in Hensen’s node), the similarity of 
expression of these genes to ERNI (Fig. 5.13D, L) and SOX3 (Fig. 5.13S, AA) is striking. This 
confirms that other NPB/PPR markers are expressed in the EGKXII-XIII epiblast and HH3-4 
prospective neural plate. Therefore the pre-neural state can be more generally described as 
being “border-like”.  
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Non-specific expression was observed for four other markers at these stages; BCL11A, HEY1, 
TBL1XR1 and ZHX2 (see Appendix 11), but these were all predicted to be expressed at much 
lower levels by the RNA-Seq analysis. 
 
 
Figure 5.13: Transcriptional regulators common to early neural induction and the PPR.  
The expression of 20 markers, common to a microarray screen of PPR tissue and an RNA-Seq 
screen for responses to 5h of neural inducing signals, was assessed at two stages: before 
gastrulation at EGKXII-XIII (A-H, Q-X), and during gastrulation at HH3-4 (I-P, Y-AF). Of these, 16 
are robustly expressed in the epiblast at EGKXII-XIII and the prospective neural plate at HH3-4, 
including BMI1 (A, I), DNMT3A (B, J), DMNT3B (C, K), ERNI (D, L), ETV5 (E, M), ING5 (F, N), 
MYCN (G, O), NSD1 (H, P), OTX2 (Q, Y), SETD2 (R, Z), SOX3 (S, AA), SOX11 (T, AB), TRIM24 (U, 
AC), YEATS4 (V, AD), ZIC3 (W, AE) and ZNF462 (X, AF). 
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5.2.2.1 A refined time-course of pre-neural markers over 1-5h 
Although these pre-neural markers were selected because they are upregulated within the 
first 5h of signals from a grafted node, ERNI and SOX3 are known to respond even faster. SOX3 
requires 3h of neuralising signals to be induced, while ERNI expression is dramatically 
upregulated after just 1h (Streit et al., 2000). Therefore some of these pre-neural “border-like” 
markers could also be induced even earlier than 5h.  
To determine the earliest induction of these markers and to refine the time-course of neural 
induction, their expression was assessed in response to node grafts after 1, 3 and 5h. At each 
time point, expression was measured in uninduced and node induced tissue using NanoString 
technology (in triplicate). The relative expression of markers is plotted as bar graphs 
comparing uninduced and node induced conditions. (Fig. 5.14, 5.15 and 5.16 are also provided 
as a slideshow on the accompanying CD; see Appendix 12.) 
Transcriptional changes can already be detected in cells that have received 1h of signals from 
Hensen’s node (Fig. 5.14). As previously observed (Streit et al., 2000), ERNI is upregulated at 
high levels in induced tissue after 1h. Also induced, but at lower levels are MYCN, OTX2, 
TRIM24, ZIC3 and ZNF462. The chromatin modifier BMI1 is weakly downregulated, while 
SPRY2 and SPRED1; targets of FGF signalling, are subtly upregulated. 
After 3h of signals from Hensen’s node, ERNI, MYCN, OTX2, TRIM24, ZIC3 and ZNF462 continue 
to be upregulated but at higher levels than after 1h (Fig. 5.15). Newly induced after 3h, are 
ETV5, ING5 and YEATS4, as well as SOX3 -in agreement with previous observations (Streit et 
al., 1998, Streit et al., 2000). 
After 5h, all pre-neural markers are upregulated except DNMT3A, NSD1 and SOX11, which can 
be barely detected (Fig. 5.16). DNMT3B and SETD2 are newly upregulated after 5h, while the 
expression of ERNI, ETV5, ING5, MYCN, OTX2, SOX3, TRIM24, YEATS4, ZIC3 and ZNF462 as well 
as SPRY2 and SPRED1, is maintained or reinforced, compared to 3h of induction. 
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Figure 5.14: The induction of pre-neural markers after 1h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced (green or light grey) and induced (red or dark grey) conditions after 1h. 
Differentially expressed genes (fold change >1.2 or <0.75) are shown in colour. Black dots mark 
statistically significant differences. High level expression changes are plotted on the primary 
axis (0-0.15), while lower level changes are shown on the secondary axis (0-0.012). Genes 
include pre-neural and mesodermal markers, but also FGF targets.  
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Figure 5.15: The induction of pre-neural markers after 3h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced (green or light grey) and induced (red or dark grey) conditions after 3h. For details, 
see Fig. 5.14.  
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Figure 5.16: The induction of pre-neural markers after 5h of a grafted node.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced (green or light grey) and induced (red or dark grey) conditions after 5h. For details, 
see Fig. 5.14.  
 
To summarise, these pre-neural markers are upregulated alongside ERNI and SOX3, and 
therefore are among the earliest responses to neural induction. ERNI, MYCN, OTX2, TRIM24, 
ZIC3 and ZNF462 are all induced after 1h and continue to be upregulated over 3h and 5h, when 
additional pre-neural markers are progressively acquired. All pre-neural markers are induced 
by 5h, except BMI1 which is only weakly induced by a grafted node. Therefore an early event 
during neural induction includes the upregulation of transcription factors and chromatin 
modifiers which confer pre-neural “border-like” character to the ectoderm progressively over 
1-5h. 
To verify whether similar transcriptional changes can also be detected by in situ hybridisation, 
a time-course of TRIM24 induction by a node graft was assessed over the same period. TRIM24 
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encodes a protein which interacts with the AF2 domain of nuclear receptors (Tsai et al., 2010) 
and we chose to verify its induction because it was predicted by NanoString to be among the 
earliest responses. TRIM24 transcripts were not detected by in situ hybridisation after 1h of 
signals from a grafted node (Fig. 5.17A, A’), but could be observed in all cases after 3h (Fig. 
5.17B, B’) and 5h (Fig. 5.17C). Therefore NanoString analysis comparing induced and 
uninduced tissue predicts appropriate transcriptional changes during neural induction, but is 
more sensitive to detect responses earlier, at levels which cannot be observed by in situ 
hybridisation. 
 
 
Figure 5.17: A time-course of TRIM24 induction by grafts of Hensen’s node.  
The induction of TRIM24 by a Hensen’s node was examined after 1, 3 and 5h of exposure to a 
node graft. No induction was observed after 1h (A, A’; 0/4) by in situ hybridisation, staining at 
this time point is observed only in the grafted node itself. Instead, transcripts are detected in 
induced epiblast tissue after 3h (B, B’; 4/4) and 5h (C; 6/6). Lines in A and B mark the level at 
which sections A’ and B’ were taken. 
 
5.2.2.2 FGFs induce pre-neural markers within 5h  
The similarity of these pre-neural markers to ERNI and SOX3, in terms of the timing and 
location of their expression, raises the possibility that they are co-regulated. Since ERNI and 
SOX3 are already known to be induced by FGF8 (Streit et al., 2000), we tested whether other 
pre-neural markers are also regulated by FGF signals. (Fig. 5.18-5.19 are also provided as a 
slideshow on the accompanying CD; see Appendix 12.) 
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Beads soaked in FGF8b were grafted for 5h to a competent region of the area opaca that 
normally responds to signals from a grafted node. The relative expression of markers in FGF 
induced tissue was compared to their expression in uninduced tissue after 5h of culture (Fig. 
5.18). As previously demonstrated (Streit et al., 1998, Streit et al., 2000), ERNI and SOX3 are 
upregulated after 5h of FGF signals (Fig. 5.18). In addition, FGFs are also sufficient to induce 
BMI1, DNMT3B, ETV5, ING5, MYCN, SETD2, TRIM24, YEATS4, ZIC3 and ZNF462. FGFs are 
insufficient to induce OTX2, as previously reported (Albazerchi and Stern, 2007). These 
responses are accompanied by the upregulation of FGF signalling targets SPRY2 and SPRED1, 
but also Brachyury and TBX6. 
The expression of these markers after a node graft was also assessed when FGF signals are 
inhibited by SU5402 (Fig. 5.19). The expression of almost all pre-neural markers is repressed by 
FGF inhibition. ING5, OTX2, YEATS4 and ZIC3 are robustly downregulated, while BMI1, 
DNMT3B, ETV5, MYCN, SETD2, SOX3 and ZNF462 are downregulated weakly. ERNI and TRIM24 
barely respond to loss of FGF signalling, suggesting that it is not required for their expression. 
This contrasts with observations that FGFs are necessary and sufficient for ERNI expression 
(Streit et al., 2000). Although the FGF targets SPRY2 and SPRED1 are mildly downregulated, it is 
possible that the concentration of SU5402 used here may not effectively inhibit all targets of 
the FGF pathway.  
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Figure 5.18: The induction of pre-neural markers after 5h of FGF signals.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
uninduced (green or light grey) and FGF8 induced (orange or dark grey) conditions after 5h. 
Differentially expressed genes (fold change >1.2 or <0.75) are shown in colour. Black dots mark 
statistically significant differences. High level expression changes are plotted on the primary 
axis (0-0.15), while lower level changes are shown on the secondary axis (0-0.012). Genes 
include pre-neural and mesodermal markers, but also FGF targets.  
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Figure 5.19: The induction of pre-neural markers after 5h of FGF inhibition.  
Gene expression, as a proportion of the mRNA count, plotted as a bar graph comparing 
induced tissue (red or light grey) after 5h to neural induction when FGFs are inhibited (blue or 
dark grey). For details, see Fig. 5.18.  
 
The changes of these pre-neural markers over time after a node graft and their response to 
FGF signals can be summarised as follows (Fig. 5.20). Markers are acquired progressively over 
1, 3 and 5h of a node graft (Fig. 5.20A). Almost all “border-like” markers respond to some 
extent to perturbation of FGF signalling (Fig. 5.20B). FGFs are necessary and sufficient to 
induce ING5, YEATS4 and ZIC3, and necessary but insufficient for OTX2. FGF signalling may also 
be necessary and sufficient for BMI1, DNMT3B, ETV5, MYCN, SETD2, SOX3 and ZNF462 
expression, as they are weakly downregulated upon exposure to node signals in the presence 
of FGF inhibition. The induction of ERNI and TRIM24 is barely affected by SU5402, suggesting 
that FGF signalling is sufficient, but may not be necessary for their expression. However, it is 
also possible that FGF signals were not inhibited enough to markedly alter their expression. 
Despite being upregulated to high levels in the RNA-Seq screen, NSD1, SOX11 and DNMT3A are 
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scarcely detected in any NanoString experiment. It is possible that the probes designed to 
target these transcripts do not hybridise appropriately, so their responses cannot be 
considered accurately. 
 
 
Figure 5.20: Summary of the responses of pre-neural markers to neural induction and FGFs.  
Pre-neural markers are progressively induced within 1-5h of a Hensen’s node graft (A). FGF 
signalling makes a major contribution to the regulation of pre-neural markers after 5h, but the 
extent of their responses differs (B). 
 
5.3 Discussion 
The identification of additional responses to neural inducing signals by the RNA-Seq screen 
provides new opportunities to assess more precisely the timing and signals responsible for 
their induction. We have successfully used NanoString technology to quantify multiple 
transcripts simultaneously in induced and uninduced ectoderm. Presented here are the 
findings for this analysis, using two panels of markers for distinct specification states. 
 
5.3.1 A refined time-course of transcriptional responses to neural induction 
To perform a more refined analysis of the neural induction time-course and the transitions 
through different specification states that accompany it, a panel of markers was selected. 
Neural markers were picked based on the similarity of their expression to known markers of 
distinct specification states during the neural induction cascade. ERNI- and SOX3-like genes are 
expressed early in the epiblast at EGKXIII and prospective neural plate at HH3-4 (Streit et al., 
2000). Their expression is considered to represent a pre-neural state which is induced as the 
earliest response to neuralising signals (Pinho et al., 2011). Although similar in their early 
192 
 
expression, ERNI and SOX3-like markers later differ; SOX3-like markers persist in the neural 
plate while ERNI-like markers are downregulated and instead mark the neural plate border and 
pre-placodal region (Streit et al., 2000). SOX2-like genes are not expressed in the early embryo 
(Jean et al., 2015), but are first expressed in the neural plate proper around HH5-7 (Rex et al., 
1997) and persist in the neural tube at HH8-10 when cells are committed to a neural fate and 
also express SOX1 (Pevny et al., 1998). Therefore the markers selected provide a useful 
readout of the progress through distinct specification states that accompanies neural induction 
(Pinho et al., 2011). To define neural induction by not only the markers acquired, but also 
those that are lost, key downregulated responses were also included for analysis. These were 
separated into distinct groups: markers of the area opaca and embryonic non-neural ectoderm 
but also the neural plate border and pre-placodal region which are either up- or 
downregulated at different stages of the process.  
By studying their differential expression over time in some detail after a node graft, this panel 
of markers was used to describe the transition from area opaca to neural fate. As expected, all 
ERNI-like and SOX3-like markers are induced over the first 1-3h of a grafted node. 
Simultaneously there is rapid and large scale downregulation of area opaca, non-neural 
ectoderm and neural plate border markers including TFAP2A, GATA2, MSX1, DLX5, GRHL2, 
GHRL3 and KRT19. Therefore even within a very short time frame, potent signals from 
Hensen’s node induce major transcriptional changes in ectodermal tissue. 
Very little change is observed in the ectoderm between 3-5h. The initial responses observed 
over the first 1-3h are maintained and reinforced, but no new markers are induced. Subtle 
changes are next observed after 7h, when later neural markers including SOX2, GLI2, GLI3, 
ZEB2, ZNF423 and LHX5 start to be upregulated, though only at very low levels. It is not until 
9h that these are robustly upregulated, while SOX1 can only be detected after 12h. Over this 
period, markers of non-neural ectoderm, the area opaca and neural plate border are 
consistently downregulated, but PPR markers including EYA2, SIX1 and SIX3, which are 
expressed in the anterior neural tube, start to be induced. Although ERNI-like markers CITED4, 
ETV4, MAFA and PRDM1 are upregulated throughout the time-course, their expression 
progressively decreases in induced tissue over 7-12h, correlating well with their general 
clearance from the neural plate after HH4-5 (Streit et al., 2000). Another ERNI-like gene, 
TFAP2C follows the same expression dynamic but at different levels as it is only weakly 
upregulated over 1-5h, before being completely downregulated later. 
Overall, markers for specific states and stages in the embryo are differentially expressed at the 
time points we would predict; pre-neural markers between 1-5h, early neural markers 
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between 7-9h and later neural markers between 9-12h. Non-neural markers are 
downregulated quickly in response to Hensen’s node and not expressed again later.  
 
5.3.2 A refined time-course of signalling responses during neural induction 
Transcriptional readouts of selected signalling pathways also respond quickly to neural 
inducing signals. AXIN2, an endogenous reporter of the WNT pathway, is robustly 
downregulated after 1h, as are GATA2 and MSX1, BMP signalling targets. These findings 
suggest that node grafts quickly inhibit signalling via the BMP and WNT pathways. The retinoic 
acid receptor RARB is also downregulated within 3h, indicating that retinoid signalling, at least 
via this receptor, may be repressed. Known FGF targets including ERNI, SOX3 (Streit et al., 
2000), ETV4 (Lunn et al., 2007) and SPRY2 (Sivak et al., 2005) are upregulated within 1-3h, 
reiterating the prominence of early FGF signals during neural induction. In addition, 
upregulation of the receptor PTCH2 (Pearse et al., 2001) within 1-3h suggests that cells 
responding to neural induction also integrate signals from the hedgehog pathway. These 
responses occur quickly after exposure to a grafted node and are then maintained over the 
remaining time-course. Although signalling by other pathways may also be altered, these 
selected markers provide possible clues about the signals to which cells are exposed. 
Responding cells seem to be integrating a mixture of FGF and hedgehog signals at the same 
time that signalling by BMPs, WNTs and retinoic acid appears to be inhibited. 
 
5.3.3 FGFs are a major contributor to the induction of early responses 
FGFs are already known to be among the earliest signals during neural induction. They are 
necessary and sufficient to induce expression of the earliest neural markers ERNI and SOX3 
(Streit et al., 2000), and are required for SOX2 expression (Linker and Stern, 2004, Delaune et 
al., 2005). To evaluate the contribution of FGFs to neural induction, the response of markers 
already studied in time-course was assessed after FGF perturbation. FGFs are sufficient and 
necessary for almost all early responses to neural induction after 5h. We also demonstrate for 
the first time, that FGFs are sufficient and necessary to downregulate non-neural markers 
including GRHL2, TFAP2A, GRLH3, VGLL1, MSX1 and GATA2 rapidly. Therefore FGFs contribute 
instructively to the onset of neural induction by regulating rapid and striking transcriptional 
changes over the first 5h.  
However, there is evidence to suggest they are not the only signals acting at these stages. FGFs 
are required but not sufficient to induce expression of CITED4. Conversely, they are sufficient 
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but not required to regulate STOX2, TFAP2C and HIC2. Furthermore, DLX5 (a downregulated 
marker) is dramatically upregulated by FGF activity (McLarren et al., 2003, Litsiou et al., 2005), 
suggesting that other signals normally prevent DLX5 from responding to Hensen’s node as a 
source of FGFs. FGFs are also potent inducers of ZNF423 after 5h, a marker which is normally 
only upregulated after 7-9h of signalling from a node graft. It is possible that other signals 
normally prevent ZNF423 from responding to FGFs until later. In addition, PRDM1 is 
upregulated both by node signals when FGF is inhibited and in response to FGF alone, raising 
the possibility that it is normally regulated by signals that compete with FGF ligands. This 
implicates IGFs, EGFs and HGFs, which also activate the MAPK pathway and have been 
previously been suggested to play a role in neural induction (Streit et al., 1995, Kretzschmar et 
al., 1997, Streit et al., 1997, Kretzschmar et al., 1999, Pera et al., 2003, Aubin et al., 2004, 
Kuroda et al., 2005). So, although FGFs are dominant in regulating the early responses to 
neural induction, they are not the only signals present and active within the first 5h. 
 
5.3.4 FGFs continue to be required for later responses to neural induction 
While FGFs make a significant early contribution to neural induction, our analysis also reveals 
that FGFs continue to regulate responses after 9h. They are still sufficient and required to 
induce expression of ETV4, SOX3 and MTA1 and inhibit GRHL2, GATA2, TFAP2A and VGLL1. 
However, they are sufficient but no longer required to regulate ERNI, MAFA and GRHL3, 
suggesting that other signals are now involved in maintaining these responses. FGFs are 
sufficient for ZNF423 expression but are only required for the expression of other later neural 
markers including GLI2, GLI3, ZEB2, LHX5 and LMO1. As shown previously (see Chapter 3.2.3), 
TRKC is relatively FGF independent but so is SOX2. This is unexpected as SOX2 expression has 
hitherto been shown to require FGFs (Linker and Stern, 2004, Delaune et al., 2005). It is 
possible that SU5402 treatment is no longer sufficient to reduce SOX2 and SPRY2 expression 
effectively after 9h, especially if these genes integrate signals from many other pathways. 
However, the continued inhibition of ETV4 and SOX3 expression would argue against this. To 
clarify whether SOX2 requires FGF signals it will be important to repeat this experiment using a 
higher concentration of SU5402 to inhibit FGFs effectively even after longer culture periods. To 
confirm these results, it will also be necessary to assess FGF inhibition using another inhibitor 
such as PD173074, as SU5402 is not specific for FGFR1 and can also inhibit signalling via 
VEGFR2, PDGFRβ and EGFR. Clearly though, FGF signals are required for the expression of later 
neural markers but are insufficient to induce new responses after 9h. So it seems that FGFs 
make a more minor contribution to neural induction after 9h. In the future, it will also be 
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important to use inhibitors which selectively target the MAPK, PI3K and PLCγ pathways 
downstream of FGFRs, to determine which intracellular cascades regulate specific markers.  
Although we suggest that FGF signalling is sufficient to regulate neural responses, the FGF 
gain-of function experiments must also be considered with some caution. Despite prior 
verification by in situ hybridisation that the concentration of FGF8b does not induce Brachyury 
expression (Appendix 9), NanoString is more sensitive in detecting an increase in Brachyury 
and TBX6 expression. If FGFs induce mesoderm, then the responses observed may not be 
direct. However, TBX6 is also normally expressed in the posterior epiblast of the pre-streak 
embryo at EGKXII-XIII (Fig. 4.17F); before mesoderm is induced. Therefore it is expressed 
transiently in epiblast cells fated to contribute to neural tissue, as well as cells that later form 
mesoderm (Hatada and Stern, 1994). Since TBX6 is at least transiently expressed during neural 
induction, it is possible that its upregulation after 5h actually reflects a normal ectodermal 
response to FGF signals and not necessarily the formation of mesoderm. In support of this, 
mesodermal cells which can be induced by high FGF concentrations (Streit and Stern, 1999, 
Linker and Stern, 2004) were never observed around the grafted beads. Even so, we cannot 
exclude the possibility that mesoderm is induced. To resolve this issue it is necessary to repeat 
FGF gain-of function experiments with lower FGF8b concentrations and also to assess 
expression of other definitive mesodermal markers such as MIXL1 (Peale et al., 1998, Stein et 
al., 1998) and Paraxis (Burgess et al., 1995). 
 
5.3.5 FGF signalling may cross-talk with other pathways 
Within 3h of signals from a node graft, dramatic changes are also observed in the expression of 
reporters of other signalling pathways. FGF signalling contributes to these as 5h of FGF activity 
is sufficient and necessary to upregulate PTCH2 but downregulate GATA2 and MSX1. In 
addition, it is sufficient but not required to downregulate RARB and AXIN2. After 9h it 
continues to be important for these responses, though it is now only sufficient for SPRY2 and 
PTCH2 expression and AXIN2 and RARB repression. Therefore at early and later stages of 
neural induction, FGFs significantly influences the expression of BMP, WNT, retinoic acid and 
hedgehog pathway targets. 
From these experiments, we cannot distinguish whether these effects are a result of FGF cross-
talk with other signalling pathways, or their direct regulation of these targets. However, the 
ability of FGFs to inhibit BMP signalling has previously been demonstrated and integrated into 
the default model (Pera et al., 2001, Pera et al., 2003) through the convergence of FGF 
signalling on SMAD1 (Kretzschmar et al., 1997, Kretzschmar et al., 1999). The proposed model 
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suggests that MAPK activation leads to phosphorylation of the SMAD1 linker region by ERK, 
thus preventing its translocation to the nucleus and therefore BMP signalling. Our 
observations that FGFs can effectively acts as BMP inhibitors do agree with these suggestions, 
but we cannot determine the mechanism of action. Given the rapid and robust contribution of 
FGF signals to BMP inhibition, it is difficult to argue for the proposed sufficiency of endogenous 
BMP antagonists during neural induction (Smith and Harland, 1992, Lamb et al., 1993, 
Hemmati-Brivanlou et al., 1994, Hemmati-Brivanlou and Melton, 1994, Sasai et al., 1994, Sasai 
et al., 1995, Piccolo et al., 1996), as originally suggested by the “default” model (Hemmati-
Brivanlou and Melton, 1997). Future experiments perturbing the BMP pathway using 
endogenous antagonists are necessary to determine their relative impact on the expression of 
these markers, and therefore the overall process. 
We also demonstrate that FGFs are sufficient, but not necessary to downregulate RARB over 5 
and 9h. FGFs are already known to downregulate RARB as one of the mechanisms by which 
they antagonise retinoid signalling (Mercader et al., 2000, Olivera-Martinez and Storey, 2007). 
However we cannot distinguish whether retinoid signalling is inhibited globally, just via RARB 
or whether there is a requirement for only low retinoid levels. The retinoic acid synthesising 
enzymes ALDH1A1 and ALDH1A2 (also known as RALDH1 and RALDH2 respectively) (Blentic et 
al., 2003, Cui et al., 2003, Reijntjes et al., 2005) are not expressed in the prospective neural 
plate, while ALDH1A1, ALDH1A3, ALDH3B1 and ALDH6 were generally downregulated in the 
RNA-Seq screen (Appendix 8). These findings perhaps point towards a general reduction in 
retinoid signalling over 5-12h. This seemingly contradicts suggestions that retinoic acid is 
required for neural development (Chen et al., 1992, Chen and Solursh, 1992, Albazerchi and 
Stern, 2007, Stavridis et al., 2010), though as its contribution has been predicted be very early, 
it may be necessary to assess the contribution of retinoic acid much earlier than 5h. FGFs are 
also sufficient but not required for AXIN2 downregulation, so other factors must normally 
inhibit the WNT pathway. Certainly the organizer is a potent source of WNT antagonists 
including DKK1 (Foley et al., 2000) and Cerberus (Zhu et al., 1999), which probably contribute 
to this. As with BMP antagonists, further experiments are required to evaluate the 
contributions of endogenous WNT antagonists and retinoid signalling and/or inhibition to 
neural induction. 
It is possible that later neural markers are simply induced as a result of accumulating step-wise 
responses to preceding signals. However, increasing evidence implicates the hedgehog 
pathway later during neural induction. FGFs are sufficient and necessary to upregulate the 
hedgehog pathway receptor PTCH2 (Pearse et al., 2001) after 5h and sufficient but no longer 
necessary for its maintenance after 9h. This suggests that FGFs initially facilitate hedgehog 
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signalling by inducing PTCH2, before its expression is later maintained by sonic hedgehog from 
Hensen’s node and notochord (Levin et al., 1995). This observation resembles recent findings 
that FGFs behave as competence factors for SHH-mediated induction of floor plate markers in 
the neural tube (Sasai et al., 2014). It also positions hedgehog signals as possible regulators of 
later markers and particularly the transition from pre-neural to neural specification, especially 
as FGFs are required, but insufficient for expression of hedgehog effectors and SOX2-like 
markers GLI2 and GLI3 after 9h. Therefore it will be particularly interesting to assess the 
specific contributions of hedgehog signalling to neural induction. 
Although these readouts illustrate only a handful of the signalling events that accompany 
neural induction, they provide evidence that FGF signals could be responsible for the inhibition 
of BMP, WNT and retinoid targets observed after a Hensen’s node graft. Many of the changes 
described occur quickly (within 1-3h of a grafted node) and persist until 12h. Therefore 
modulation of BMP, WNT and retinoid signalling by FGFs may have ongoing consequences for 
downstream events in the neural induction cascade. Given the possible contribution of FGF 
signals to these changes, a thorough analysis of the contributions of endogenous BMP (Smith 
and Harland, 1992, Lamb et al., 1993, Hemmati-Brivanlou et al., 1994, Sasai et al., 1994, Sasai 
et al., 1995, Piccolo et al., 1996, Fainsod et al., 1997) and WNT antagonists (Zhu et al., 1999, 
Foley et al., 2000, Wilson et al., 2001) is necessary as these have often been considered key 
regulators of neural induction. The possible contributions or effects on calcium (Leclerc et al., 
2011, Papanayotou et al., 2013) and Notch (Linker et al., 2009) signalling have also not been 
considered here. In the future it will also be necessary to test the effects of combinations of 
signals, but at the time of thesis submission, experiments have been conducted to test the 
contribution of BMP and WNT inhibition to neural induction and are waiting NanoString 
processing. 
 
5.3.6 Neural induction begins with a “pre-neural/pre-border” state 
To monitor the changes in specification that accompany the onset of neural induction, we 
decided to focus on the earliest responses to neuralising signals. In particular, evidence from 
the neural plate marker SOX3 and NPB/PPR marker ERNI (Streit et al., 2000), suggested that 
the neural plate and PPR might derive from a common “border-like” domain (Streit, 2008), 
which exists before gastrulation (Stern, 2004). To determine whether this is a more general 
characteristic of neural induction, we sought to identify other ERNI and SOX3-like markers 
within the RNA-Seq screen data. This was done by focusing specifically on early responses to a 
node graft that were common to a microarray screen of PPR tissue conducted by Andrea 
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Streit’s group at King’s College London. Analysis of their expression at EGKXII-XIII and HH3-4 
reveals that 80% of the markers selected (including ERNI and SOX3), are expressed strongly in 
the epiblast at EGKXII-XIII and later in the prospective neural plate at HH3-4. Therefore, all 
markers are expressed in a striking ERNI/SOX3-like pattern. As so many border markers define 
this pre-neural state, it suggests that it can be more generally characterised as “border-like”. 
The 14 new markers common to this pre-neural state include the transcription factors ETV5, 
SOX11, MYCN, OTX2, and ZIC3 and putative chromatin modifiers BMI1, DNMT3A, DNMT3B, 
NSD1, SETD2, TRIM24, YEATS4 and ZNF462. NanoString experiments further confirm that these 
are induced within 5h of signals from a node graft, but even within this brief window, 
responses can be separated across 1, 3 and 5h. Therefore, neural induction begins with the 
expression of pre-neural markers which contribute to a “border-like” specification state. This 
goes some way to explain observations that, like the neural plate border (Streit and Stern, 
1999, Bailey et al., 2006), the pre-streak epiblast can respond to BMP signalling (Wilson et al., 
2000, Wilson et al., 2001) and differentiates into a lens when placed in culture (Stower, 2012). 
Considering that the expression of many markers from the 5h time point of the RNA-Seq 
screen have not yet been confirmed, and the PPR microarray is limited by the probes present 
on the array chip, it is likely that more markers that define this state are yet to be described.  
However, we already know from Chapter 4 that there are many other markers with similar 
expression patterns. The ERNI-like markers CITED4 (Fig. 4.6U-Y), ETV4 (Fig. 4.8K-O) and MAFA 
(Fig. 4.12A-E) and PRDM1 (Fig. 4.14P-T) and SOX3-like markers MTA1 (Fig. 4.12U-Y), SOX13 
(Fig. 4.16U-Y), STOX2 (Fig. 4.17A-E) and TCF7L2 (Fig. 4.17Z-AD) were already selected to 
characterise the earliest responses to neural induction and are also regulated by FGFs. 
Additional markers include CRIP2 (Fig. 4.6Z-AD), DACH1 (Fig. 4.7A-E) and KDM4A (Fig. 4.11A-E), 
which are expressed in the NPB or PPR at later stages but were only identified in the RNA-Seq 
screen and not the PPR microarray perhaps because RNA-Seq is more sensitive. The PPR 
transcriptome is currently being reassessed using RNA-Seq, but a considerable body of 
evidence already exists from the expression patterns presented here to suggest that the pre-
streak epiblast transcriptionally resembles the neural plate border.  
However we also show that new border markers DMBX1 (Fig. 4.7F-J), LHX5 (Fig. 4.11F-J) and 
MEIS2 (Fig. 4.12P-T), and classical border/PPR markers such as SIX3 (Fig. 4.15P-T) or EYA2 (Fig. 
4.8U-Y) are not among the earliest responses to neural inducing signals and are not expressed 
in the pre-streak embryo. These are expressed after HH4 in the embryo or after 9h of signals 
from a grafted node. So, although the pre-streak epiblast may be “border-like”, it does not 
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express mature PPR or border markers, suggesting that it has a more primitive or “pre-border” 
specification. 
 
5.3.7 FGFs are sufficient and necessary to induce “pre-neural/pre-border” 
markers 
While we already demonstrate the importance of FGFs for the onset of neural induction (see 
Chapter 5.2.1.2), we also show that they are necessary and sufficient to induce ING5, YEATS4, 
ZIC3 and probably also BMI1, DNMT3B, ETV5, MYCN, SETD2 and ZNF462. ETV5 is a known 
target of FGF signalling (Lunn et al., 2007) and in agreement with previous work (Streit et al., 
1998, Streit et al., 2000) we confirm that FGFs are necessary and sufficient to induce SOX3. 
They are required, but not sufficient for the expression of OTX2, which can only be induced by 
a combination of FGFs together with BMP and WNT inhibition (Albazerchi and Stern, 2007). 
Despite this, FGFs seems to be the major signal regulating this early state, as they induce 
almost all pre-neural markers. However, as mentioned already, the FGF gain-of-function 
experiments described here should be considered with caution. 
Although this study describes neural induction as a set of responses induced by Hensen’s node, 
the hypoblast is the source of signals necessary to initiate neural induction before gastrulation. 
Hypoblast grafts can transiently induce early markers such as ERNI, SOX3 and OTX2 (Albazerchi 
and Stern, 2007), and it is a known source of FGF8, retinoic acid and the WNT antagonists 
Crescent, Cerberus and DKK1 (Foley et al., 2000). To verify whether early pre-neural responses 
to a Hensen’s node graft accurately reflect events during endogenous neural induction, it will 
be necessary to assess hypoblast function in the context of these new markers. A direct 
comparison of the responses induced by the hypoblast and by Hensen’s node will confirm the 
earliest responses and separate the contribution of particular signalling pathways to neural 
induction. It would also clarify a role for the hypoblast, which is able to induce a “pre-
neural/pre-forebrain” state (Foley et al., 2000, Albazerchi and Stern, 2007) and confirm 
whether some of the FGF-regulated responses we detect are a possible consequence of the 
caudalising effect of potent FGF signalling (Storey et al., 1998), as may be the case with DLX5 
(Litsiou et al., 2005) and MSX1 (Streit and Stern, 1999), which are expressed caudally (Fig. 
4.22F-J and 4.28F-J) and aberrantly upregulated by FGFs in our gain-of-function experiments. 
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5.3.8 FGFs may regulate gene expression and chromatin organisation via 
chromatin modifiers during neural induction 
Changes in chromatin structure are predicted to accompany transitions between specification 
states, so it is satisfying that chromatin modifiers are identified as early responses to 
neuralising signals. Furthermore, we demonstrate a specific link between cell signalling and 
chromatin structure and activity, via the induction of specific chromatin modifiers such as 
TRIM24, ING5, YEATS4, DNMT3B and SETD2. FGF signals are necessary, and probably also 
sufficient for their induction. This is especially critical in light of recent findings that FGF signals 
regulate chromatin organisation at neural differentiation loci such as PAX6 and IRX3 (Patel et 
al., 2013) and that FGFs are necessary and sufficient to induce HDAC1 expression in neural 
precursors of the spinal cord (Olivera-Martinez et al., 2014). Our findings that FGFs induce a 
broad range of chromatin modifiers suggest that this may be a general mechanism by which 
FGF signals indirectly regulate gene expression.  
Unfortunately, we were unable to quantify expression of DNMT3A, NSD1 and SOX11 
accurately during neural induction or in response to FGF gain- and loss-of-function 
experiments. These targets were barely detected in any assay. With the knowledge that they 
are expressed strongly in the pre-streak embryo and are predicted to be highly expressed by 
the RNA-Seq screen, we must assume that the NanoString probes designed to recognise them 
do not hybridise appropriately. However, their spatio-temporal expression patterns predict 
that they too are probably co-regulated by FGFs. The possibility that DNMT3A may also be a 
target of FGF signalling is of particular interest since it is known to interact at SOX3 and SOX2 
loci (Hu et al., 2012), which require FGF signals for their expression (Streit et al., 2000, Linker 
and Stern, 2004). 
 
5.3.9 “Pre-neural/pre-border” specification; implications for pluripotency 
This study ultimately takes advantage of Hensen’s node ability to transform ectodermal cells of 
the area opaca from an extra-embryonic fate towards a neural specification. The earliest steps 
in this process re-programme cells to adopt a pre-neural state which exists in the embryo at 
EGKXII-XIII, before gastrulation. The expression territory of pre-neural markers covers a broad 
domain of epiblast cells fated to form the future nervous system, but also many other cell 
types (Hatada and Stern, 1994). Therefore, pre-neural markers are common to the initial 
development of multiple cell lineages that arise later.  
This raises the possibility that the combination of pre-border transcription factors and 
chromatin modifiers described here might actually define a more general pluripotent state 
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that exists in the early ectoderm, directly implicating them in cellular and epigenetic 
reprogramming during pluripotency. Many of these factors have already been studied in this 
context, lending considerable support to this idea. For example PRDM1 and TFAP2C form part 
of a complex sufficient to reset the epigenome towards a basal state (Magnúsdóttir et al., 
2013), while ERNI has been associated with pluripotency (Papanayotou et al., 2008, Jean et al., 
2013) and is expressed in chick embryonic stem cells while they self-renew (Acloque et al., 
2001, Papanayotou et al., 2008, Intarapat and Stern, 2013). Furthermore, SOX3 expression in 
chick is more similar to SOX2 in the mouse, another transcription factor of the SOXB1 family 
(Kamachi et al., 2000), which has also been associated with pluripotency (Takahashi and 
Yamanaka, 2006) or multipotency (Avilion et al., 2003). Alternatively, some responses may 
reflect an early exit from a pluripotent state, as DNMT3A and DNMT3B regulate NANOG during 
the differentiation of pluripotent cells (Li et al., 2007) and OTX2 is critical for exit from ground 
state pluripotency (Yang et al., 2014). Therefore, future efforts to confirm additional markers 
and the specific signals from Hensen’s node that induce this state are of fundamental 
importance, not only to neural induction during embryonic development, but possibly for 
reprogramming and pluripotency. 
 
5.4 Conclusions 
Having assessed the precise timing and signals responsible for regulating key responses, we 
find that FGF signals make a significant contribution to neural induction. Within the first 5h, 
they induce most pre-neural markers, but are not sufficient or required for all early responses, 
suggesting that other signals are also important to initiate neural induction. Later, FGFs 
continue to be required but are insufficient to induce new responses. Therefore they make a 
major early contribution to the onset of neural induction, but their role becomes more minor 
as additional signals become involved.  
FGFs also have a major early and persisting influence on BMP, WNT and retinoid pathways and 
they may facilitate later hedgehog signalling by inducing PTCH2. Increasing evidence suggests 
hedgehog ligands, receptors and target genes are expressed at the appropriate time to 
influence the induction of later neural markers such as SOX2. Therefore hedgehog signalling 
might be a crucial missing piece to the neural induction puzzle. 
We also demonstrate that the induction of a “pre-neural/pre-border” state is among the 
earliest events during neural induction. This largely occurs in response to FGF signals which are 
necessary and sufficient to induce the transcription factors ETV5, ERNI, SOX3, MYCN, and ZIC3 
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and chromatin modifiers BMI1, DNMT3B, ING5, SETD2, TRIM24, YEATS4 and ZNF462, which 
define this state.  
Although such genes are induced as responses to neuralising signals from Hensen’s node, their 
expression in the early embryo marks cells fated to contribute to other lineages as well as the 
future nervous system. This raises the possibility that markers of this “pre-neural/pre-border” 
state actually define a more general pluripotent state that exists during early development. If 
so, then these early responses to signals from Hensen’s node have implications for 
reprogramming during pluripotency as well as the initiation of neural induction.  
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Chapter 6: General Discussion 
6.1  The timing of neural induction 
Until now, it has been difficult to determine precisely how and when neural induction occurs. 
Since induction of an ectopic nervous system by a graft of Hensen’s node appears to follow 
similar morphological and molecular events to the embryo’s own neural plate (Pinho et al., 
2011), the node graft assay has proved to be a useful tool to study the process. Our results 
confirm that the earliest responses to a grafted node occur within the first 1-3h (Pinho et al., 
2011), but that 9h of signals are required to induce the definitive neural marker SOX2 robustly 
and 12h to induce SOX1 and commit cells to a neural fate. This provided the first evidence that 
cells acquire a neural fate as a consequence of molecular steps that occur within 0-12h of a 
node graft. All transcriptional responses to neural induction that occur within this period were 
then identified using RNA-Seq. Thousands of differentially expressed transcriptional responses 
to neural induction were detected, including 482 transcriptional regulators. A proportion of 
these were verified by in situ hybridisation, revealing that they are expressed appropriately: 
upregulated genes are expressed in neural tissue at some stage, while downregulated markers 
are relatively absent. Furthermore, markers are detected at the appropriate time after a node 
graft, compared to their endogenous expression. This confirms that the genes identified 
represent accurate markers for the sequence of events that occur during neural induction in 
the normal embryo, revealing that neural induction is accompanied by complex transcriptional 
changes over time. 
By assessing a subset of key markers in greater detail, neural induction can now be described 
as follows. It begins with the induction of ERNI-like and SOX3-like markers within the first 3h of 
a node graft; markers which are already expressed the epiblast of normal EGKXII-XIII embryos. 
Their patterns of expression later in development suggest that this set of markers defines a 
pre-neural state prior to gastrulation that has “neural plate border-like” properties. FGFs, 
which are probably secreted from the hypoblast, are largely responsible for the induction of 
these pre-neural markers, but they also act to prevent expression of non-neural ectoderm 
markers. These early responses are reinforced and maintained between 3-5h of a node graft, 
as they are in the prospective neural plate of normal embryos at HH3-4. Later neural markers 
including SOX2 are first induced after 7h but only at very low levels, which correlates closely 
with the start of neural plate formation around Hensen’s node at HH4. Neural plate markers 
and markers of anterior-posterior patterning such as SIX3 are robustly expressed by HH5-6, or 
after 9h of a node graft. However cells specified as neural plate are not committed to this fate 
until they have received at least 12h of signals from a grafted node. This corresponds with the 
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onset of SOX1 expression, which first occurs in the neural tube at HH8-9. Therefore neural 
induction begins with the simultaneous induction of pre-neural markers and repression of non-
neural markers. These responses are maintained as additional markers are acquired which 
confer neural specification and patterning, before concluding with neural commitment. 
Furthermore, our analyses highlight the significant contribution of FGF signalling in launching 
this process. Although they are not the only early signal, FGFs induce some of the earliest 
responses but also contribute to the repression of non-neural markers, including typical BMP 
target genes. Therefore, consistent with previous observations (Wilson et al., 2000, Pera et al., 
2001), FGFs appear to act at least partially as BMP inhibitors, though our experiments do not 
distinguish the mechanism by which this occurs. Although we are yet to test the specific 
contribution of endogenous BMP antagonists to the expression of these markers, they are 
already known as insufficient to induce a number of the earliest responses (Streit et al., 2000, 
Sheng et al., 2003, Gibson et al., 2011, Pinho et al., 2011, Papanayotou et al., 2013). This 
confirms the importance of BMP/SMAD1-independent FGF signalling (Launay et al., 1996) 
(Sasai et al., 1996, Linker and Stern, 2004, Delaune et al., 2005, Stavridis et al., 2007) as an 
early step in neural induction. However BMP antagonists do seem to be required later (Linker 
and Stern, 2004), when they maintain SOX3 expression after 5h of a grafted node (Streit et al., 
1998). However additional signals must be required, since no combination of BMP antagonists 
and FGFs is sufficient to induce the neural plate marker SOX2 (Streit and Stern, 1999, Linker 
and Stern, 2004, Linker et al., 2009). 
Of the responses we describe, no individual event in isolation seems to be sufficient for cells to 
acquire a neural fate. It cannot be just an early but reversible bias towards a neural fate nor 
the onset of SOX2 expression in the neural plate, or the final commitment to neural 
specification. Furthermore, each of these developmental events is likely to comprise many 
layers of transcriptional change. As it is not possible to identify a single “inductive” event, we 
must consider neural induction to comprise the sum of all molecular steps which ultimately 
result in cellular commitment to a neural fate. Our findings indicate that neural induction 
occurs as a cascade of molecular events in response to multiple signals, which begins in the 
early embryonic ectoderm prior to gastrulation in response to FGF signals, and ends when cells 
acquire commitment to neural differentiation in the forming neural plate and tube. These 
changes occur in the embryo between EGKXII-XIII and HH8-9, within the first 30h of incubation 
after an egg is laid. This contrasts with the “default model” of neural induction (Hemmati-
Brivanlou and Melton, 1997) which implies that a single stimulus (BMP antagonism by Chordin, 
Noggin or Follistatin) is sufficient for neural induction and SOX2 expression.  
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6.2  Neural induction begins by inducing a “pre-neural/pre-border” 
state with a pluripotency-related gene signature 
The earliest responses to neural induction include neural plate border markers such as ERNI 
(Fig. 4.8A-E) (Streit et al., 2000), TFAP2C (Fig. 4.32F-J) (Qiao et al., 2012), PRDM1 (Fig. 4.14P-T) 
(Riddle et al., 1995) and ETV4 (Fig. 4.8K-O) (Lunn et al., 2007). These are upregulated within 
the first 1-3h of a node graft and their expression in the early embryonic ectoderm suggests 
that neural induction begins with the induction of a “pre-neural/pre-border”-like state. FGF 
signals are a major contributor to the induction of these early markers and probably impart 
“border-like” properties to the early epiblast (Streit et al., 2000, Wilson et al., 2000, Wilson et 
al., 2001, Bailey et al., 2006, Stower, 2012).  
Although pre-neural markers illustrate transcriptional changes during neural induction, a 
number are also associated with epigenetic reprogramming, stem cell self-renewal or 
pluripotency. The pluripotency factors NANOG (Fig. 4.28U-Y) and TFAP2C (Fig. 4.32F-J) are 
expressed in the early embryo and prospective neural plate, though they were actually 
identified in the RNA-Seq screen by virtue of their later downregulation. MTA1 (Fig. 4.12U-Y) 
forms a complex with NANOG and OCT4 to regulate repression in stem cells (Liang et al., 
2008), while MYCN (N-MYC) (Fig. 4.12Z-AD), a close relative of C-MYC (one of the original 
“Yamanaka factors” (Takahashi and Yamanaka, 2006)), induces the pluripotency factors KLF2, 
KLF4 and LIN28B (Cotterman and Knoepfler, 2009). Furthermore, TCF7L1 (Fig. 4.17Z-AD) co-
occupies promoter sites throughout the genome with OCT4 and NANOG (Cole et al., 2008), 
while DNMT3B (Fig. 4.7P-T) is expressed in primordial germ cells (Rengaraj et al., 2011). There 
is also evidence that BMI1 (Fig. 4.6A-E) (Moon et al., 2011), ERNI (Fig. 4.8A-E) (Acloque et al., 
2001, Papanayotou et al., 2008, Intarapat and Stern, 2013), ZNF462 (Fig. 4.19U-Y) (Masse et 
al., 2011) and ZIC3 (Fig. 4.19K-O) (Lim et al., 2007) also contribute to the regulation of 
pluripotency.  
Many other markers associated with reprogramming and pluripotency which were not studied 
in greater detail here, are also expressed in the epiblast at EGKXII-XIII. For example the 
transcriptional repressor SALL1 (Fig. 4.15F-J) which interacts with NANOG to regulate stem cell 
pluripotency (Karantzali et al., 2011), LIN28A (Fig. 4.11K-O) and LIN28B (Fig. 4.11P-T) (Yu et al., 
2007, Cotterman and Knoepfler, 2009, Jean et al., 2015) have also been implicated. 
Surprisingly though the pluripotency factor OCT3/4 (Takahashi and Yamanaka, 2006, Yu et al., 
2007) was not identified, although it is expressed in the area opaca at the time of grafting 
(Lavial et al., 2007) which might explain why it is not differentially expressed. Therefore the 
pre-streak epiblast is likely to have properties associated with pluripotency and epigenetic 
reprogramming.  
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As overall levels of transcription seem generally to be quite low at pre-streak stages, it is 
unusual for genes to be as strongly expressed at EGKXII-XIII, as at later stages (ERNI is an 
exception, as it is expressed extremely strongly before streak formation). Therefore, it is 
possible that some of these markers are already expressed even earlier, perhaps as early as 
the transcription factor CP2 in the EGKX blastoderm (Acloque et al., 2004), from which tissue 
pluripotent stem cells can be derived (Petitte et al., 1990, Pain et al., 1996). Since this pre-
neural state covers a broad domain of cells fated to multiple lineages in the early embryonic 
epiblast, we predict that neural induction begins with the acquisition of a “pre-neural/pre-
border state” with pluripotent properties, which is largely induced by FGFs. To confirm if such 
markers contribute to pluripotency, their expression should be confirmed and functional 
experiments (gain- and loss-of-function) performed in embryonic stem cells and the embryo at 
EGKX. Given that we have only verified a proportion of new responses to neural induction by in 
situ hybridisation, there are likely to be many other factors associated with this state. 
Alternatively, after 5h we may be detecting responses that, like OTX2 (Yang et al., 2014), 
represent an early exit from pluripotency. Indeed, FGF inhibition is considered to promote 
stem cell self-renewal (Burdon et al., 1999, Ying et al., 2008) and FGF signalling to be an initial 
step towards differentiation (Chen et al., 2006, Kunath et al., 2007, Stavridis et al., 2007, 
Stavridis et al., 2010). Even if this is the case, many of the pluripotency associated markers, 
seem to still be expressed at the early stages of such a shift. Future experiments are necessary 
to more accurately profile the transcriptome of cells exposed to 1 or 3h of signals from a 
grafted node, which may provide additional pluripotency markers, but also to consider the 
specification state of the uninduced area opaca.  
Intriguingly, some “pre-neural/pre-border” markers are also expressed later in the lens, 
including BMI1 (Fraser and Sauka-Spengler, 2004), ETV4 (McCabe et al., 2006) and SOX3 
(Matsumata et al., 2005). Furthermore, ASL1 and ASL2 (encoding δ1- and δ2-crystallin), were 
upregulated in the RNA-Seq screen after 5h, in addition to MAFA which regulates lens 
differentiation (Benkhelifa et al., 1998, Ogino and Yasuda, 1998, Ring et al., 2000) and δ-
crystallin expression (Kanai et al., 2010). In addition, CP2 which is required for αA-crystallin 
expression in the lens (Murata et al., 1998) is also associated with pluripotency in the 
embryonic epiblast (Acloque et al., 2004). These observations suggest a surprising level of 
transcriptional similarity between the pluripotency-associated state of the pre-streak epiblast 
and neural plate border, to the specification of lens fate. Such markers probably contribute to 
the ability of the pre-streak epiblast (Stower, 2012), HH6 neural plate border (Bailey et al., 
2006) and human embryonic stem cells (Yang et al., 2010) to form lentoid bodies. 
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6.3  Neural induction involves multiple cell fate decisions 
Although acquisition of the “pre-neural/pre-border” state is integral to neural development, 
these early events also occur in epiblast cells which later migrate through the primitive streak 
between HH3-4. Therefore this “border-like” state is probably also common to early 
mesoderm and endoderm development. This observation further reinforces the idea that 
neural development does not just depend on decisions between epidermal and neural cell 
fates (at the neural plate border (Linker et al., 2009)), but also on events that regulate the 
choice between neural and mesendodermal cell fates at the anterior primitive streak (Sheng et 
al., 2003). As many downregulated responses to neural induction are markers of alternative 
fates, e.g. HAND1 (Fig. 4.24Z-AD) (Srivastava et al., 1995) and APOA1 (Bertocchini and Stern, 
2008), these and other responses may provide clues to some of the key decisions that occur in 
the divergence of mesodermal and endodermal lineages. Therefore, the node graft assay could 
turn out to be a useful tool to study embryonic pluripotency, as well as the early divergence of 
alternative lineages during neural induction. 
Since FGFs induce a “border-like” state, a crucial function of additional signals will be to 
mediate its transformation to a neural plate fate. To date, LMO1 (Fig. 4.11U-Y) may be a key 
specifier of the neural plate as it is the only neural marker that is absent from the neural plate 
border. However, since many markers are common to the neural plate and its border, the 
downregulation of specific border markers in the neural plate could also be central to this 
process. Although FGFs appear to significantly inhibit BMP signalling, we confirm that they 
induce the border markers MSX1 (Streit and Stern, 1999) and DLX5 (Litsiou et al., 2005), which 
are also BMP targets. As MSX1 and DLX5 are normally downregulated by a node graft, it will be 
particularly interesting to determine whether BMP antagonists counteract FGFs to 
downregulate these border markers. BMPs are known to position the neural plate border so 
BMP inhibition is likely to be important to define the domain that gives rise to the neural plate, 
especially as DLX5 misexpression in the neural plate represses SOX3 and SOX2 (McLarren et al., 
2003). This would fit with a permissive, rather than instructive role for BMP antagonists during 
neural induction, which are able to maintain SOX3 expression (Streit et al., 1998), though not 
induce neural markers de novo (Streit and Stern, 1999, Linker and Stern, 2004). 
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6.4 Regulating the transition from pre-neural to neural specification  
A key step in the divergence of neural fates from this “border-like” state occurs at HH4 when 
the neural plate proper arises around Hensen’s node and expresses markers of neural 
specification such as SOX2. Indeed the onset of SOX2 expression has generally been 
considered the neural “inductive event” in Xenopus and although it is a key step in the 
transition to a neural fate, it alone cannot account for the entire process of neural induction. 
However it is currently unclear how this transition occurs.  
Evidence from Xenopus originally suggested that BMP antagonists secreted by the organizer 
are sufficient to neuralise ectoderm (Smith and Harland, 1992, Lamb et al., 1993, Hemmati-
Brivanlou et al., 1994, Sasai et al., 1995, Hemmati-Brivanlou and Melton, 1997). However we 
now know that many experiments in the whole embryo, actually target cells that contribute to 
the neural plate or neural plate border. Therefore they represent an expansion of the 
prospective neural plate territory, and that this is not exactly equivalent to de novo SOX2 
induction in ectodermal cells remote from the neural plate (Linker and Stern, 2004, Linker et 
al., 2009). Furthermore, BMP antagonism is insufficient to induce neural markers in animal 
caps when FGF signalling is inhibited, suggesting that FGF activity is required upstream of BMP 
inhibition to neuralise these explants (Launay et al., 1996, Sasai et al., 1996, Linker and Stern, 
2004, Delaune et al., 2005). Therefore, animal caps are not a naïve ectoderm. Our finding that 
FGFs are critical to induce the pre-neural state, is consistent with evidence from Xenopus that 
FGFs function upstream of BMP inhibition during neural induction, though they too are 
insufficient to induce definitive neural markers even in combination with BMP antagonists 
(Launay et al., 1996, Sasai et al., 1996, Linker and Stern, 2004, Delaune et al., 2005). This 
suggests that other signals are also necessary to mediate the transition from a “pre-
neural/pre-border” state with pluripotent properties to neural specification. 
To date our analyses have been unable to reveal precisely which factors might be responsible 
for this. No new transcriptional responses are detected between 3-5h of a node graft, just 
prior to the onset of SOX2 expression. Instead, pre-neural ERNI-like and SOX3-like markers are 
maintained. However, only a fraction of the responses to neural induction have so far been 
analysed in this refined time course and only after all 400 markers on the NanoString probe set 
have been assessed, will we be able to confirm if this is a general characteristic.  
One mechanism that could contribute to SOX2 expression and neural specification after 7-9h is 
the simultaneous downregulation of pre-neural markers which are later absent from the 
neural plate. Downregulation of ERNI has already been implicated in relieving transcriptional 
repression at the SOX2 locus to allow expression (Papanayotou et al., 2008). Particularly 
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interesting evidence also comes from a recent study of the transcriptional repressor PRDM1 
(BLIMP1), suggesting that it normally suppresses SOX2 expression to promote germ cell fate 
(Lin et al., 2014). We observe that PRDM1 is expressed in the EGKXII-XIII epiblast and HH3-4 
prospective neural plate (Fig. 4.14P-T) but appears to clear from around the node at HH4, at 
precisely the time when SOX2 is upregulated. Later, when SOX2 is strongly expressed at HH6, 
PRDM1 is completely absent from the neural plate. Therefore PRDM1 might also serve as a 
molecular switch regulating the onset of SOX2 expression and neural specification during 
embryonic development.  
Since other pre-neural genes including TFAP2C seem to be downregulated later, this may 
represent a general mechanism regulating the transition from a pluripotent neural precursor 
state to neural specification and differentiation. In fact, although FGFs seem to be required as 
an early neural signal in embryonic stem cells and in the embryo (Streit et al., 2000, Kunath et 
al., 2007, Stavridis et al., 2007), they actually function to repress neural differentiation later 
(Stavridis et al., 2010). Furthermore, FGF signalling can influence chromatin architecture and 
activity around neural differentiation loci such as PAX6 and IRX3, to repress their transcription 
(Patel et al., 2013). Therefore the induction of early chromatin modifiers and transcriptional 
regulators that we observe in response to FGFs, may have the dual role of contributing to a 
“pre-neural/pre-border” precursor state, while simultaneously repressing the transition to 
neural differentiation during neural induction. Multiple layers of repression by FGF-induced 
pre-neural markers could build a tightly regulated switch controlling the onset of neural 
specification, a key step in neural development.  
This raises further questions about how such FGF-mediated repression could be relieved to 
permit neural specification and differentiation. Retinoid signalling, which generally antagonises 
the FGF pathway could play a key role in this process. Retinoic acid is required to promote 
SOX1 expression and neural differentiation by limiting FGF signalling (Stavridis et al., 2010). It 
may achieve this by relieving FGF-mediated chromatin compaction and transcriptional 
repression at neural differentiation loci (Patel et al., 2013). If retinoids were required in our 
assays, it would reveal striking similarities between neural induction in the early embryo and 
neural differentiation during body axis extension. There, FGFs promote cells in the caudal stem 
zone to form neural precursors, but also function to prevent their differentiation (Diez del 
Corral et al., 2003, Olivera-Martinez and Storey, 2007). FGF signals eventually induce 
expression of WNT8C which promotes retinoic acid mediated neural differentiation via 
RALDH2 (Olivera-Martinez and Storey, 2007).  
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However our assays suggest that neural induction is accompanied by downregulation of RARB 
at all stages, but we cannot determine whether this represents a general inhibition of retinoid 
signalling, inhibition just via the receptor RARB, or perhaps even a requirement for only low 
levels of retinoid signalling. This contrasts with CYP26A1 which can be induced by retinoic acid 
(White et al., 1996, Loudig et al., 2000) and is upregulated only after the 9 and 12h time points 
of the screen. The later timing of its induction perhaps suggests that retinoic acid signalling is 
more likely to play an active role at later stages, when it might be important to promote neural 
specification and a move towards differentiation by limiting FGFs. 
Furthermore, although our assays suggest that FGFs generally induce early responses, they are 
also sufficient to induce ZNF423, one later neural marker. ZNF423 can integrate BMP-SMAD 
signalling (Hata et al., 2000) but has also been implicated in mediating retinoic acid induced 
neural differentiation by interacting with the RAR-RXR nuclear complex (Huang et al., 2009). 
Therefore ZNF423 could provide an important link between the FGF-mediated onset of neural 
induction, with the later integration of BMP and retinoic acid signals during neural 
specification. Like Churchill (Sheng et al., 2003), it may also contribute to the acquisition of 
BMP signalling sensitivity that occurs in the epiblast after 5h of signals from a grafted node or 
source of FGFs (Streit et al., 1998).  
We do observe that the hedgehog pathway targets GLI2 and GLI3 are induced concurrently 
with SOX2 after 7h. In fact the hedgehog pathway may have a previously unappreciated role in 
the transition to neural specification as many components of the hedgehog pathway are 
expressed in the appropriate spatio-temporal manner. Furthermore our assays suggest that 
SHH is expressed in Hensen’s node (Levin et al., 1995) after the hedgehog pathway receptor 
PTCH2 is mildly upregulated by FGFs. Therefore early FGF signals may also function to facilitate 
competence to later hedgehog signals, as has been observed in the floor plate (Sasai et al., 
2014). The relative contribution of hedgehog signalling remains to be tested but the presence 
of a GLI2 binding site in a SOX2 enhancer and the loss of SOX2 expression in GLI2 deficient 
mice (Takanaga et al., 2009) further implicates this pathway in neural induction. 
In light of these observations, it will be important to evaluate the contribution of retinoid and 
hedgehog signalling in addition to BMP and WNT antagonism during neural induction. These 
pathways could be critical determinants of neural specification and SOX2 induction by 
functioning in combination with FGFs to repress the early induction of pre-neural genes or to 
directly regulate SOX2 transcription. Other signals not yet considered, such as calcium and 
Notch may also make important contributions to this process. 
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6.5  Towards a gene regulatory network for neural induction 
Having defined a time-course of regulatory states through which neural induction proceeds, 
we are now performing gain- and loss-of function experiments to evaluate the relative 
contribution of key signalling pathways to this process. So far, perturbation of the FGF 
pathway provides significant evidence that FGFs contribute to the onset of neural induction by 
inducing expression of markers which confer a “pre-neural/pre-border” state to the early 
ectoderm. Perturbation of other pathways will provide important information about the 
precise timing and signals responsible for regulating individual markers. This will enable 
transcriptional responses to grouped based not only on the spatio-temporal similarity of their 
expression, but also by the signals that regulate them. In this way, a rudimentary network can 
be constructed, describing neural induction as groups of distinct responses.  
However, additional information is required before a more complete network can be 
constructed. Targeted overexpression or knockdown of genes by electroporation of expression 
constructs or morpholinos will start to reveal their specific contributions and epistatic 
relationships (Streit et al., 2013). However they are unable to establish whether putative 
network interactions occur directly or indirectly. This requires the identification of cis-
regulatory elements such as enhancers and promoters that integrate upstream inputs on their 
transcriptional targets (Streit et al., 2013). New molecular and computational tools now enable 
such analysis on a systems level. Active and inactive cis-regulatory elements can be identified 
for responses to neural induction, based on their epigenetic signatures using ChIP-Seq (Rada-
Iglesias et al., 2011). Bioinformatics tools such as DREiVe are then able to identify conserved 
the transcription factor binding sites that comprise putative enhancers (Khan et al., 2013). 
Finally, the activity of putative enhancers can be tested in vivo by electroporating them as 
reporter constructs into the embryo (Streit et al., 2013).  
In this way, a network describing neural induction can be constructed by linking transcriptional 
responses to neuralising signals by their upstream regulatory elements and downstream 
targets, as has been done elegantly in the sea urchin by Eric Davidson (Davidson, 2010). 
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6.6  The conservation of neural induction 
Despite the finding that inter-species organizer grafts can also induce secondary axes 
(Waddington, 1934, Oppenheimer, 1936, Kintner and Dodd, 1991, Blum et al., 1992, Hatta and 
Takahashi, 1996), there has been some debate about whether the molecular basis of neural 
induction differs between vertebrates. This was due to apparent differences in the 
requirement of BMP inhibition in chick and Xenopus. In chick, BMP inhibition alone cannot 
induce neural plate markers in ectoderm (Streit et al., 1998, Streit and Stern, 1999, Linker and 
Stern, 2004), compared to Xenopus animal caps which are readily neuralised (reviewed in 
(Harland, 2000, Munoz-Sanjuan and Brivanlou, 2002, De Robertis and Kuroda, 2004)). These 
differences were reconciled by the finding that Xenopus animal caps contribute cells to the 
neural plate and even the smallest animal caps contribute to the neural plate border (Linker et 
al., 2009). In chick, the neural plate border is the only region sensitive to BMP inhibition, which 
causes expansion of neural markers (Streit and Stern, 1999, Linker et al., 2009). Since animal 
caps contain cells normally fated to contribute to the neural plate border, this raises the 
possibility that the only cells which respond to BMP inhibition may be those that would have 
done so anyway in the intact embryo. In addition, results in whole embryos suggest that, as in 
the chick, BMP inhibition can only travel between adjacent “border-like” cells (Linker et al., 
2009), so it can only expand the neural plate, but never to induce it in a more distant region. 
Indeed, BMP inhibition is not sufficient to induce neural markers in cells normally fated to form 
ventral epidermis or extra-embryonic tissue respectively in Xenopus or chick (Linker and Stern, 
2004, Delaune et al., 2005, Linker et al., 2009). Subsequently it was determined that FGFs are 
required for neural induction before gastrulation in both organisms, but that they too are 
insufficient to induce definitive neural markers (Streit et al., 1998, Streit et al., 2000, Linker and 
Stern, 2004, Delaune et al., 2005, Linker et al., 2009).  
These similarities suggest that neural induction may rely on the same signals and responses in 
chick and Xenopus. Indeed, the entire process of neural induction can now be reassessed in 
Xenopus, in the context of these newly identified responses to neural induction. If homologues 
of the novel markers described here are expressed in similar spatio-temporal patterns in 
Xenopus as in chick, this would point towards conservation of neural induction as a cascade of 
signals and responses. The conserved requirement for FGFs (Launay et al., 1996, Sasai et al., 
1996, Linker and Stern, 2004, Delaune et al., 2005) raises the possibility that they contribute to 
a similar “pre-neural/pre-border” state in the early Xenopus embryo. However some 
divergence could arise from the inheritance of maternal transcripts which might influence the 
earliest stages of neural induction, and perhaps explain reports that weak FGF plus BMP 
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inhibition is sufficient to induce the neural marker SOX2 in Xenopus (Delaune et al., 2005), but 
not in chick (Linker and Stern, 2004, Linker et al., 2009).  
 
6.7  Conclusions 
Although we cannot yet provide a detailed explanation for how neural induction occurs, the 
identification of all transcriptional responses during this process now offers new opportunities 
to assess the contribution of individual signalling pathways and interrogate the key molecular 
events. However, we can conclude that neural induction is a highly dynamic and complex 
process. It is accompanied by thousands of transcriptional responses including the differential 
expression of over 400 transcriptional regulators. These contribute to the induction of key 
states and regulate the progression from a non-neural state to pre-neural and neural 
specification, and finally the acquisition of neural commitment. It seems likely that key steps 
are tightly regulated by multiple layers of transcriptional repression and activation. Therefore, 
neural induction is not a single step process. Instead, our evidence predicts that neural 
induction proceeds as a cascade of molecular events, including responses to multiple signals at 
different time points – in this last respect, our findings suggest a different view of the process 
to the “default model”, which postulates a single important signalling event: inhibition of BMP 
signalling. 
FGF signalling makes a major contribution to the onset of neural induction, by inducing pre-
neural markers and downregulating non-neural and neural plate border markers. In particular, 
FGFs probably induce expression of transcription factors and chromatin modifiers in the pre-
streak epiblast, providing further evidence that neural induction begins before gastrulation. As 
this pre-neural state is transcriptionally similar to the neural plate border, it goes some way to 
explain how these tissues share functional similarities. Furthermore, many of these 
transcription factors and chromatin modifiers are associated with epigenetic reprogramming 
and pluripotency suggesting that a major consequence of FGF signalling might be the induction 
of neural precursor state with multipotent properties. However, FGFs are not sufficient for all 
early responses, suggesting that other signals are required even for the acquisition of this pre-
neural state. Furthermore, FGFs are required but insufficient to induce later neural markers, 
highlighting the need to confirm which additional signals instruct or permit neural specification 
and commitment. 
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6.8  Future perspectives 
Although this body of work provides new perspectives on neural induction, it also raises many 
new possibilities. Further insight will be gained from our experiments conducted to date, once 
all 400 markers on the NanoString probe set have been analysed in detail. However before the 
complexity of the entire process can be fully appreciated, future work in vivo is necessary to 
address the following questions:  
1. What other signals contribute to the induction of pre-neural markers? 
2. Given that FGFs impose BMP and WNT inhibition, what are the relative contributions 
of endogenous BMP and WNT antagonists to neural induction? 
3. Which signals trigger the transition from pre-neural to neural specification? 
4. Is there a role for hedgehog signalling in neural induction? 
5. Do these signals induce definitive neural markers directly, or by relieving repression 
which might be imposed on neural differentiation by the pre-neural state? 
6. Does PRDM1 regulate SOX2 expression during neural induction? 
7. What mechanisms regulate the choice between neural plate and neural plate border 
from the common “pre-neural/pre-border” state? 
8. Do pre-neural markers generally confer pluripotency to the early embryonic ectoderm 
and neural precursors? 
9. Since the neural crest is often described as a multipotent cell population, could the 
same “pre-neural/pre-border” markers confer multipotency to the neural plate border 
at later stages? 
10. Does SOX1 expression confer commitment to a neural fate after 12h? 
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Chapter 7:  Supplementary Data 
 
Appendix 1: Hensen’s node graft removal proof-of-principle.  
To demonstrate that induced tissue could be dissected cleanly, grafts of Hensen’s node were 
cultured and later removed, to check that excess graft cells did not remain. Nodes from 
transgenic cytoplasmic GFP chickens were grafted into the left and right sides of normal chick 
hosts at HH3+/4- (A). Embryos were cultured for 5, 9 or 12h and one of the grafts removed. 
Embryos were fixed and processed for anti-GFP staining to reveal where grafted cells 
remained. Grafted tissue spreads out during culture but the majority can be removed at each 
time point; 5h (B) 9h (C) and 12h (D). High magnification images of remaining grafts (B’, C’, D’) 
and graft removals (B’’, C’’, D’’) reveals that very few graft cells remain after node graft 
removal, which will not significantly contaminate induced tissue samples. Circled areas 
indicate the region of induced tissue which would have been dissected from underneath the 
graft (B’’, C’’, D’’). 
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Appendix 2: RNA quality reports for RNA-Seq library preparation.  
The quality of extracted total RNA for each sample for RNA-Seq analysis was assessed using the 
Agilent Bioanalyzer 2100 (A-G). The concentration, rRNA ratio and RNA Integrity Number (RIN) 
were calculated. All samples achieved a RIN value between 9.0-10.0; greater than the 7.0 value 
necessary for library preparation. 
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Appendix 3: Quality control box plots for 5h induced and uninduced RNA-Seq libraries.  
Quality Control (QC) box plots for reads sequenced from the 5h uninduced (A, B) and 5h 
induced (C, D) samples. QC was performed for reads in forward (A, C) and reverse (B, D) 
orientations in paired-end samples. For each plot, the X axis represents the read base position 
(from 1 to 100) and the Y axis measures the phred read quality at each base position. The 
median phred score is displayed as a horizontal black bar, with the upper and lower quartiles 
shown in red. Outliers are shown in blue. These plots were used to only select reads with 
phred values above 20 and then trim the last 10 bases at the 3' end where quality scores drop. 
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Appendix 4: Quality control box plots for 9h induced and uninduced RNA-Seq libraries. 
Quality Control (QC) box plots for reads sequenced from the 9h uninduced (A, B) and 5h 
induced (C, D) samples. For details, see Appendix 3. 
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Appendix 5: Quality control box plots for 12h induced and uninduced RNA-Seq libraries. 
Quality Control (QC) box plots for reads sequenced from the 12h uninduced (A, B) and 5h 
induced (C, D) samples. For details, see Appendix 3. 
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Appendix 6: Differentially expressed transcripts from Galgal3 RNA-Seq analysis. 
Reads that passed QC analysis were aligned to the Galgal3 chicken genome using “Tophat”, 
and annotated using the Ensembl Galgal3 GTF. Differential expression analysis was used to 
compare counts for each transcript between uninduced and induced conditions at each time 
point (5, 9 and 12h) using two separate methods; “Cuffdiff” and DE-Seq. Transcripts that were 
differentially expressed with a log2 fold change of at least 1.2 were extracted from each 
analysis. Each data set was combined in one spreadsheet and transcripts categorised as 
follows; transcripts commonly identified as statistically significant (using a P-value threshold of 
0.05) by both methods were displayed as red, transcripts identified as statistically significant 
by either method were displayed as orange and those identified as statistically insignificant by 
both methods were displayed as yellow. These analyses identified 7745 differentially 
expressed transcripts across 3 time points. Gene annotations could be assigned to 4508 of 
these, corresponding to 2333 unique genes. Due to the incomplete nature of the Galgal3 
chicken genome, 3237 transcripts were left unannotated. See spreadsheet on accompanying 
CD. 
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Appendix 7: Differential analysis of RNA-Seq Galgal3 data across 5, 9 and 12h.  
DE-Seq analysis was used to compare transcripts from uninduced and induced conditions at 
each time point, using the Galgal3 version of the chicken genome and a log2 fold change 
threshold of 1.2. Heat map representing the hierarchical clustering of all 7745 upregulated 
(red) and downregulated (green) transcripts across the following comparisons: 5h induced vs. 
5h uninduced, 9h induced vs. 9h uninduced and 12h induced vs. 12h uninduced (A). These 
correspond to 2333 unique annotated genes. Of these, 540 transcripts were extracted, coding 
for 284 unique transcriptional regulators (B). 
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Appendix 8: Differentially expressed transcripts from Galgal4 RNA-Seq analysis. 
Reads that passed QC analysis were aligned to the Galgal4 chicken genome using “Tophat”, 
and differential expression analysis was used to compare counts for each transcript between 
uninduced and induced conditions at each time point (5, 9 and 12h) using DE-Seq. Transcripts 
that were differentially expressed with a log2 fold change of at least 1.2 were extracted and 
annotations were added using the Ensembl Galgal4 GTF, Ensembl Biomart data, UCSC Galgal4 
GTF and annotation data from the UCSC table browser. Statistically significant (using a P-value 
threshold of 0.05) transcripts were colour-coded blue, while statistically insignificant 
transcripts were displayed as white. This reanalysis identified 8673 differentially expressed 
transcripts across all 3 time points. Gene annotations could be assigned to 7184 of these, 
corresponding to 4145 unique genes. Due to the incomplete nature of the chicken genome 
only 989 transcripts remain unannotated. See spreadsheet on accompanying CD. 
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Appendix 9: FGF pathway perturbation experiment validation.  
Appropriate concentrations of FGF8 and SU5402 were used for FGF gain- and loss-of-function 
experiments. Heparin beads soaked in 25µg/ml FGF8 were able to induce SOX3 (A; 6/6), 
without inducing Brachyury (B; 0/6), when grafted into the area opaca at HH4 and incubated 
for 5h. AG1X2 beads soaked in 25µM SU5402, reduced induction of SOX3 by a node graft after 
5h (D; 4/4) compared to normal induction of SOX3 after 5h, which is much stronger (C; 6/6). 
For each comparison, embryos were processed simultaneously. 
 
Appendix 10: The induction of neural and non-neural markers in a refined time-course and 
after FGF perturbation. 
Graphs showing the expression of neural and non-neural markers after 1, 3, 5, 7, 9 and 12h of 
a grafted node (Fig 5.1-5.6), and the responses of these markers to FGF signalling and FGF 
inhibition after 5h (Fig. 5.7, 5.8) and 9h (Fig. 5.10, 5.11) are also provided a slideshow. This 
allows a more interactive view of the subtle changes in expression that occur across time 
points and between conditions. See Powerpoint document on accompanying CD. 
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Appendix 11: The early expression of BCL11A, HEY1, TBL1XR1 and ZHX2.  
The expression of 20 markers, common to a microarray screen of PPR tissue and an RNA-Seq 
screen for responses to 5h of neural inducing signals, was assessed. Expression patterns were 
confirmed at two stages; prior to gastrulation at EGKXII-XIII (A-D), and during gastrulation at 
HH3-4 (E-H). Of these, 16 are robustly expressed in the epiblast at EGKXII-XIII and in the 
prospective neural plate at HH3-4 as predicted. Specific expression of four markers was not 
observed at these stages, including BCL11A (A E), HEY1 (B, F), TBL1XR1 (C, G) and ZHX2 (D, H). 
 
Appendix 12: The induction of pre-neural markers in a refined time course and after FGF 
perturbation. 
Graphs showing the expression of pre-neural markers after 1, 3, 5, 7, 9 and 12h of a grafted 
node (Fig 5.14-5.16), and the responses of these markers after 5h of FGF signalling (Fig. 5.18) 
and FGF inhibition (Fig. 5.19) are also provided also a slideshow. This allows a more interactive 
view of the subtle changes in expression that occur across time points and between 
conditions. See Powerpoint document on accompanying CD. 
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